Document:

License Agreement

 EXHIBIT 10.39 

 

					
		 		 	 *  Confidential Treatment has been requested for the marked portions of this exhibit pursuant to Rule 24B-2 of the
Securities Exchange Act of 1934, as amended.

 EXECUTION COPY 

LICENSE AGREEMENT 
 by and between 
 THE SCRIPPS RESEARCH INSTITUTE, 

a California nonprofit 
 public benefit corporation 
 and 

ALLOZYNE, INC. 
 a Delaware corporation 

 EXECUTION COPY 

 

 LICENSE AGREEMENT 

This License Agreement is entered into and made effective as of this 25th day of June, 2010 (the “Effective Date”), by
and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation (“TSRI”), and ALLOZYNE, INC., a Delaware corporation (“Licensee”), each located at the respective address set forth in
Section 14.15 below, with respect to the facts set forth below. TSRI and Licensee may each be referred to in this Agreement individually as a “Party” and collectively as the “Parties.” 

RECITALS 
 A. TSRI is engaged in fundamental scientific biomedical and biochemical research including research relating to [*] ligation processes. 

B. Licensee is engaged in the discovery and development of pharmaceutical products. 

C. TSRI desires to grant to Licensee, and Licensee wishes to acquire from TSRI, an exclusive, worldwide right and license under certain
TSRI patent rights in the Therapeutic Field (as defined herein), and a non-exclusive, worldwide right and license under those TSRI patent rights in the Diagnostic Field (as defined herein), subject to certain rights of the U.S. Government resulting
from the receipt by TSRI of certain funding from the U.S. Government, and other reserved rights of TSRI, all subject to the terms and conditions set forth herein. 
 AGREEMENT 
 NOW, THEREFORE, in consideration of the mutual covenants
and conditions set forth herein, TSRI and Licensee hereby agree as follows: 
 1. Definitions. Capitalized terms shall have the
meaning set forth herein. 
 1.1 Affiliate. The term “Affiliate” shall mean any entity which directly or
indirectly controls, or is controlled by Licensee. The term “control” as used herein means (a) in the case of corporate entities, direct or indirect ownership of at least fifty percent (50%) of the stock or shares entitled to
vote for the election of directors; or (b) in the case of non-corporate entities, direct or indirect ownership of at least fifty percent (50%) of the equity interests with the power to direct the management and policies of such
non-corporate entities. 
 1.2 Amino Acid. The term “Amino Acid” shall mean any organic
compound containing an amino group (-NH2), a carboxylic acid
group (-COOH), and any of various side groups. 
 1.3 Challenge. Licensee or an Affiliate or a Sublicensee (as
applicable) will be deemed to have made a “Challenge” of the Licensed Patent Rights if Licensee or such Affiliate or Sublicensee: (a) institutes, or causes its counsel to institute on Licensee’s or such Affiliate’s or
Sublicensee’s behalf, any interference, opposition, re-examination or similar proceeding with respect to any Licensed Patent Right with the U.S. Patent and Trademark Office or any foreign patent office; or (b) makes any filing or
institutes any legal proceeding, or causes its counsel to 

  

*Confidential Treatment Requested. 
 1 

 EXECUTION COPY 

 

 
make any filing or institute any legal proceeding on Licensee’s or such Affiliate’s or Sublicensee’s behalf, with a court or other governmental body (including, without limitation,
the U.S. Patent and Trademark Office or any foreign patent office) in which one or more claims or allegations challenges the validity or enforceability of any Licensed Patent Right. 

1.4 Commercially Reasonable Efforts. The term “Commercially Reasonable Efforts” shall mean, with respect to
Licensee’s efforts to accomplish a particular objective with respect to development and commercialization of a Licensed Product under this Agreement, such reasonable and good faith efforts to accomplish a particular objective hereunder as are
consistent with the efforts biopharmaceutical companies (defined below) typically devote to compounds of similar market potential and at a similar stage of research or development as the Licensed Product, taking into account efficacy, safety,
approved labeling, competitive products in the marketplace, the patent and other proprietary position of the Licensed Product, and other industry standard relevant factors. For purposes of this definition, “biopharmaceutical companies”
means companies in the biopharmaceutical industry of a size and stage of development similar to that of Licensee. Commercially Reasonable Efforts shall be determined on a market-by-market basis for a Licensed Product, and it is anticipated that the
level of effort shall be different for different markets, and shall change over time, reflecting changes in the status of the Licensed Product and the market(s) involved. For purposes of clarity, Licensee’s obligations to use Commercially
Reasonable Efforts with respect to a Licensed Product under this Agreement shall allow for the delay, suspension or termination of efforts to develop or market the Licensed Product if, consistent with good medical or scientific judgment, Licensee
determines that such delay, suspension or termination is warranted based on any adverse condition or event relating to the safety or efficacy of the Licensed Product. 
 1.5 Confidential Information. The term “Confidential Information” shall mean any and all proprietary or confidential information of TSRI or Licensee (which shall include, for purposes of
this Section 1.4, proprietary or confidential information of its Affiliates and Sublicensees) that such Party (the “Disclosing Party”) discloses to the other Party (the “Receiving Party”) at any time and from
time to time during the term of this Agreement. In addition, Confidential Information of a Party shall include any and all proprietary or confidential information of such Party that it disclosed to the other Party prior to the Effective Date
pursuant to the Mutual Non-Disclosure Agreement between Licensee and TSRI, dated December 19, 2006, or the Mutual Non-Disclosure Agreement between Licensee and TSRI, dated August 7, 2008 (collectively, the “CDAs”). This
Agreement, including its terms and conditions, shall be considered Confidential Information of both Parties. Information shall not be considered confidential to the extent that the Receiving Party can establish by competent proof that it:

 (a) Is publicly disclosed through no fault of the Receiving Party, either before or after it becomes known to
the Receiving Party; or 
 (b) Was known to the Receiving Party prior to the date of this Agreement, which
knowledge was acquired independently and not from the Disclosing Party (or such Disclosing Party’s employees); or 

  
 2 

 EXECUTION COPY 

 

 (c) Is subsequently disclosed to the Receiving Party in good faith by a
third party who is not under any obligation to maintain the confidentiality of such information, and without breach of this Agreement by the Receiving Party; or 
 (d) Has been published by a third party as a matter of right. 
 1.6
Controlled. The term “Controlled” shall mean the possession by a Party of the legal authority or right, with respect to information, materials or intellectual property owned by such Party or licensed to such Party by a third party,
to grant licenses or sublicenses to another without violating the terms of any agreement or other arrangement between such Party and a third party. 
 1.7 Diagnostic Field. The term “Diagnostic Field” shall mean the use of a [*] and [*] to quantitate, qualitate, assess or measure one or more parameters in a human or animal, or in
samples obtained therefrom, to use a diagnostic product to monitor the effects of a drug, and/or to identify, diagnose, prognose, or monitor a disease, state of health, or medical- or health-related condition of a human and/or animal, including but
not limited to in vivo testing, assessment or measurement. The term “Diagnostic Field” shall expressly exclude [*] for diagnostic or imaging purposes. 
 1.8 Licensed Patent Rights. The term “Licensed Patent Rights” shall mean rights arising out of or resulting from: 

(a) United States Patent No. [*] and United States patent application Serial No. [*]; 

(b) the patents issued from the application referenced in sub-clause (a) above; 

(c) all foreign counterparts sharing the priority dates of the patent(s) and application(s) referenced in sub-clauses
(a) and (b) above; 
 (d) divisionals, continuations, reissues, reexaminations, renewals, and
extensions of any patent or application set forth in sub-clauses (a)-(c) above; and 
 (e) all claims of
continuations-in-part of any application set forth in sub-clauses (a)-(d) above that are (i) specifically directed to subject matter disclosed in the specification(s) of the patent(s) and application(s) referenced in sub-clauses (a) and
(b) above, and (ii) entitled to the benefit of the priority date of the patent(s) and application(s) referenced in sub-clauses (a) and (b) above. 
 Licensed Patent Rights are set forth in Exhibit A, as it may be updated from time to time. 
 1.9 Licensed Product. The term “Licensed Product” shall mean any product, the manufacture, use, importation, sale or offer for sale of which would, in the absence of the licenses granted
herein, infringe a Valid Claim. 

  

*Confidential Treatment Requested. 
 3 

 EXECUTION COPY 

 

 1.10 Major Market. The term “Major Market” shall mean any one of the
following: the United States of America, France, Italy, Spain, Germany, the United Kingdom, the European Union as a whole or Japan. 
 1.11 Net Sales. The term “Net Sales” shall mean the gross amounts invoiced by Licensee, its Affiliates, its Sublicensees, or any of them, on all sales of Licensed Products, less the
following items, as applicable to such Licensed Products: 
 (a) discounts, rebates and retroactive price
reductions actually allowed or granted; 
 (b) credits or allowances actually granted upon claims regarding
non-conforming product, rejections or returns of such sales of Licensed Products, including recalls; 
 (c)
transportation charges, including handling charges and insurance premium relating thereto; 
 (d)
government-mandated and other government sponsored or initiated rebates (such as those in respect of any state or federal Medicare, Medicaid or similar programs); 

(e) charge backs, including those granted to managed care entities; 

(f) sales, use, excise, value added or other direct taxes imposed on the sale of Licensed Products (but excluding what are
commonly known as income or gross receipt taxes), and customs duties, tariffs and other similar governmental charges imposed on the import or export of Licensed Products for sale; 

provided, however, in each of the cases identified in sub-clauses (a) - (f) above, that (1) such deducted amounts are either
(i) included as line items in the invoice, or (ii) otherwise documented as being specifically attributable to actual sales of Licensed Products in accordance with U.S. Generally Accepted Accounting Standards (“GAAP”) or
International Financing Reporting Standards (“IFRS”), as applicable, consistently applied throughout the organization of the selling party, and such amounts are included in the Royalty Reports (as defined in Section 6.3) that
Licensee sends to TSRI pursuant to Section 6.3; and (2) if Licensee or other selling party receives refunds or reimbursements of any amounts deducted as set forth herein, then such refunded or reimbursed amounts shall be considered Net
Sales in the applicable reporting period in which such refunded or reimbursed amounts are received; and 
 (g) a
reasonable allowance for bad debts directly relating to sales of Licensed Products and which have been written off as bad debts by Licensee or other selling party, taken in accordance with GAAP or IFRS, as applicable, consistently applied throughout
the organization of the selling party, provided that such allowance shall not exceed [*] of gross invoiced amounts for the applicable Royalty Report period. Licensee and its Affiliates agree to use Commercially Reasonable Efforts to collect
and enforce such bad debts from the debtors, and all Sublicensees shall agree to do the same. 

  

*Confidential Treatment Requested. 
 4 

 EXECUTION COPY 

 

 Net Sales shall include all consideration charged by Licensee, Affiliates or
Sublicensees in exchange for any Licensed Products, including without limitation any monetary payments or, with regard to any other property paid in exchange for any Licensed Products, an amount in cash equal to the fair market value of such
property. Sales of Licensed Products by Licensee to any Sublicensee or Affiliate for resale, by any Affiliate to Licensee or any Sublicensee for resale, or by any Sublicensee to Licensee or any Affiliate of Licensee or of Sublicensee for resale,
shall be excluded from Net Sales, and only the subsequent sale of such Licensed Products by Licensee or such Sublicensees or Affiliates to unrelated parties shall be deemed Net Sales hereunder. 

For purposes of clarity, neither the use of any Licensed Product in clinical trials, pre- clinical studies or other research or
development activities by or on behalf of Licensee or any Affiliate or Sublicensee, nor disposal or transfer of License Products in a sampling program or compassionate use program in which, in each case, no monetary or other consideration is paid to
or received by Licensee or any Affiliate or Sublicensee, shall give rise to any Net Sales. 
 1.12 NNAA Protein. The term
“NNAA Protein” shall mean a Protein having, containing or incorporating one or more Non-Natural Amino Acid(s), where such Non-Natural Amino Acid(s) is/are added or incorporated in the Protein in vivo. 

1.13 NNAA Protein Bioconjugate. The term “NNAA Protein Bioconjugate” shall mean an NNAA Protein conjugated to one or
more [*] molecular or chemical entities forming [*] between the NNAA Protein and such molecular or chemical entity or entities. The following are non-limiting examples of “molecular or chemical entities”: synthetic compounds (such as PEG
and other polymers, as well as other chemical entities) and biomaterials (such as Amino Acids, peptides, proteins, sugars, carbohydrate moieties and nucleic acids). For clarity, NNAA Protein Bioconjugate shall [*]. 

1.14 Non-Natural Amino Acid. The term “Non-Natural Amino Acid” shall mean any Amino Acid other than one of the following
naturally occuring Amino Acids (Glycine, Alanine, Valine, Leucine, Isoleucine, Proline, Cysteine, Methionine, Phenylalanine, Tryptophan, Serine, Threonine, Tyrosine, Asparagine, Glutamine, Lysine, Arginine, Histidine, Aspartic Acid, Glutamic Acid,
Pyrrolysine and Selenocysteine). 
 1.15 [*] Research Products Nonexclusive License. “[*] Research Products
Nonexclusive License” shall mean the non-exclusive, worldwide license rights (without the right to sublicense) granted by TSRI to [*] under the Licensed Patent Rights to make and use (but not sell) Research Products. “Research
Products” is defined to mean any product, process or device which is designed or utilized for discovering, improving or testing a Therapeutic Product, Preventative Medicine Product, or Diagnostic Product. “Diagnostic Product” means
any product, process or device that is designed or utilized for diagnosis of a disease or condition in humans or vertebrate animals. “Preventative Medicine Product” means any product, process or device that is designed or utilized to
prevent the occurrence of any disease state in humans or vertebrate animals. “Therapeutic Product” means any product, process or device which is designed or utilized for treatment or mitigation of an existing disease state in humans or
vertebrate animals. 

  

*Confidential Treatment Requested. 
 5 

 EXECUTION COPY 

 

 1.16 Polypeptide. The term “Polypeptide” shall mean a polymer
comprising Amino Acids joined by peptide bonds, and includes (without limitation) non-natural and low molecular weight polymers. Non-limiting examples of Proteins include an antibody, an antibody fragment and a peptide aptamer. 

1.17 Protein. The term “Protein” shall mean conjugated or unconjugated Amino Acids, peptides, peptidomimetics,
Polypeptides, proteins and protein mimetics. 
 1.18 Stapled Peptide. The term “Stapled Peptide” shall mean a
Protein that has at least one [*] within a single Polypeptide chain that is [*]. 
 1.19 Stapled Protein. The term
“Stapled Protein” shall mean an NNAA Protein that has at least one [*] within a single Polypeptide chain that is [*]. 

1.20 Sublicensee. The term “Sublicensee” shall mean any third party to whom Licensee or an Affiliate grants a sublicense
with respect to the rights conferred upon Licensee and Affiliates under this Agreement, as permitted by Section 2.4. In addition, “Sublicensee” shall include any and all permitted third party sublicensees under Section 2.4.

 1.21 Sublicense Revenues. The term “Sublicense Revenues” shall mean the consideration actually received by
Licensee or an Affiliate from a Sublicensee in consideration for the grant of rights which includes a sublicense of the Licensed Patent Rights. Sublicense Revenues shall include up-front or license fees, milestone payments, premiums above the fair
market value on sales of debt or equity securities of Licensee or such Affiliate, annual maintenance fees, and any other payments received by Licensee or such Affiliate in respect of such grant of rights which includes a sublicense of the Licensed
Patent Rights; provided, however, that Sublicense Revenues shall exclude: (a) running royalties on any Net Sales of Licensed Products due TSRI under Section 3.4 of this Agreement; (b) funding or reimbursement for costs of
specific research and development activities conducted subsequent to the execution of and pursuant to such sublicense (including manufacturing development and pre-commercial manufacturing or production costs, as well as reasonable overhead costs
that are directly attributable to Licensed Products); (c) payments for debt or equity securities of Licensee or such Affiliate (other than premiums above the fair market value of such securities as of the date of such payments); and
(d) payments and reimbursements by any Sublicensee of all or a portion of the patent costs relating to the prosecution, maintenance, or enforcement of the Licensed Patent Rights which are incurred by Licensee or such Affiliate, including but
not limited to costs incurred in connection with interferences, oppositions and litigation. 
 1.22 Therapeutic Field.
The term “Therapeutic Field” shall mean the treatment or amelioration of a specific disease, symptom, state of health, or medical- or health-related condition in humans and/or animals. 

1.23 Valid Claim. The term “Valid Claim” shall mean a claim of any issued and unexpired patent within the Licensed
Patent Rights which has not been held unenforceable, unpatentable or invalid by a decision of a court or governmental body of competent jurisdiction in a ruling that is unappealed or unappealable. 

  

*Confidential Treatment Requested. 
 6 

 EXECUTION COPY 

 

 2. Grant of License. 

2.1 Grant of Exclusive and Non-Exclusive License Under Licensed Patent Rights in the Therapeutic Field. TSRI hereby grants and
Licensee and its Affiliates accept, subject to the terms and conditions of this Agreement, (a) an exclusive worldwide license under the Licensed Patent Rights, with a right to sublicense in accordance with Section 2.4, to make and have
made, to use and have used, to sell and have sold, to offer to sell and to import Licensed Products that are or contain one or more NNAA Protein Bioconjugates in the Therapeutic Field and (b) a non-exclusive worldwide license under the Licensed
Patent Rights, with a right to sublicense in accordance with Section 2.4, to make and have made, to use and have used, to sell and have sold, to offer to sell and to import Licensed Products that are or contain one or more Stapled Proteins in
the Therapeutic Field. 
 2.2 Grant of Non-Exclusive License Under Licensed Patent Rights in the Diagnostic Field. TSRI
hereby grants and Licensee and its Affiliates accept, subject to the terms and conditions of this Agreement, a non-exclusive worldwide license under the Licensed Patent Rights, with a right to sublicense in accordance with Section 2.4, to make
and have made, to use and have used, to sell and have sold, to offer to sell and to import any Licensed Products that are or contain one or more NNAA Protein Bioconjugates or that are or contain one or more Stapled Proteins in the Diagnostic Field.

 2.3 Covenants. As of the Effective Date and until this Agreement is terminated, (a) TSRI covenants not to grant
to any third party any rights to Licensed Patent Rights for NNAA Protein Bioconjugates in the Therapeutic Field, except as permitted under Sections 2.6, 2.7 and 2.8 hereof, and (b) Licensee covenants not to practice or use the Licensed Patent
Rights outside of the scope of the rights granted in Sections 2.1 and 2.2 above. 
 2.4 Sublicensing. Licensee and its
Affiliates shall have the right to grant and authorize sublicenses to any third party (which may grant further sublicenses) with respect to the rights conferred upon Licensee and its Affiliates under Sections 2.1 and 2.2 of this Agreement;
provided, however, that any sublicense or further sublicense granted under this Section 2.4 shall be subject in all respects to the applicable provisions contained in this Agreement (including, without limitation, the provisions
regarding governmental interest, reservation of rights, reporting, audit rights, indemnity, limited warranty, disclaimer, limitation of liability, confidentiality, and rights upon expiration or termination). 

Licensee and its Affiliates (and Sublicensees, if applicable) shall include in any such sublicense agreement provisions regarding the
Sublicensee’s institution or making of any Challenge (including the consequences thereof) that are at least as protective of, and favorable to, Licensee and its Affiliates as the provisions of this Agreement are protective of, and favorable, to
TSRI. In the event of a conflict between this Agreement and the terms of any sublicense, the terms of this Agreement shall control. Licensee shall forward to TSRI a copy of any and all fully executed sublicense agreements within thirty
(30) days of execution, provided that Licensee may redact from such copies any proprietary scientific or business information that is not necessary for TSRI to ascertain Licensee’s, an Affiliate’s or a Sublicensee’s
compliance with any of its or their obligations under this Agreement. 

  
 7 

 EXECUTION COPY 

 

 2.5 No Other License. This Agreement confers no license or rights by implication,
estoppel, or otherwise under any patent applications or patents of TSRI other than Licensed Patent Rights regardless of whether such patents are dominant or subordinate to Licensed Patent Rights. 

2.6 Governmental Interest. Licensee and TSRI acknowledge that TSRI has received, and expects to continue to receive, funding from
the United States Government in support of TSRI’s research activities. Licensee and TSRI acknowledge and agree that their respective rights and obligations pursuant to this Agreement shall be subject to all applicable rights of the United
States Government, existing and as amended, including, but not limited to, 37 CFR 401. 
 2.7 Reservation of Rights. TSRI
reserves the right to use the invention(s) claimed by the Licensed Patent Rights solely for non commercial research and educational purposes, without TSRI being obligated to pay Licensee any royalties or other compensation or to account to Licensee
in any way. In addition, TSRI reserves the right to grant non-exclusive licenses to other nonprofit or academic institutions under the Licensed Patent Rights solely for non commercial research and educational purposes, without the other nonprofit or
academic institution being obligated to pay Licensee any royalties or other compensation or to account to Licensee in any way. TSRI shall have no obligation to notify or inform Licensee of such use or licenses. 

2.8 [*] Non-Exclusive License. The license granted under Section 2.1 (a) of this Agreement is subject to the
non-exclusive license rights granted to [*] pursuant to the [*] Research Products Nonexclusive License. 
 3. Royalties and Other
Payments. 
 3.1 Equity Issuance. On or within [*] business days after the Effective Date, Licensee will issue to
TSRI twenty-five thousand (25,000) shares of Licensee’s common stock pursuant to the terms of a common stock issuance agreement to be executed by the Parties concurrently herewith and to be attached to this Agreement as Exhibit B.

 3.2 Patent Reimbursement Fee. On or within [*] business days after the Effective Date, Licensee agrees to pay and
shall pay to TSRI a one-time only, nonrefundable patent reimbursement fee, in the amount of [*]. This patent reimbursement fee will help defray costs incurred by TSRI in connection with acquisition of the Licensed Patent Rights. 

3.3 Annual Maintenance Fee. Licensee agrees to pay and shall pay to TSRI a nonrefundable annual maintenance
fee in the amount of (a) Twenty Thousand U.S. Dollars (U.S.$20,000) within [*] days after each of the second
(2nd) and third (3rd) anniversaries of the Effective Date, and (b) Thirty
Thousand U.S. Dollars (U.S.$30,000) within thirty (30) days after each anniversary of the Effective Date thereafter (i.e., beginning with the fourth (4th) anniversary of the Effective Date), during the term of this Agreement. Such annual maintenance fees will further
help defray the costs TSRI has incurred and will continue to incur with respect to the prosecution and maintenance of the Licensed Patent Rights. Such payments shall be credited against all payments owed by Licensee under Section 3 and 4, other
than the patent reimbursement fee set forth in Section 3.2, (for example, running royalties, milestone payments and Sublicense Payments) due for that twelve-month period from Effective Date anniversary to Effective Date anniversary, and not for
any preceding or subsequent twelve-month period, and Licensee’s Royalty Reports shall reflect all such credit(s). 

  

*Confidential Treatment Requested. 
 8 

 EXECUTION COPY 

 

 3.4 Running Royalties for Licensed Products. Licensee agrees to pay and shall pay
to TSRI a running royalty on annual Net Sales by Licensee, Affiliates, or Sublicensees of Licensed Products, on a Licensed Product-by-Licensed Product and country-by-country basis, in each country in which (a) the manufacture, use, importation,
sale or offer for sale of such Licensed Product would, in the absence of the licenses granted pursuant to Sections 2.1 and 2.2, infringe at least one Valid Claim of the Licensed Patent Rights in such country (such Licensed Product shall be referred
to herein as “Covered” by the Licensed Patent Rights, and “Covers” is used herein in reference to such Valid Claim), at the applicable rates set forth below, and (b) the manufacture, use, importation, sale or
offer for sale of a product is not Covered by an Issued Valid Claim, but would infringe at least one claim of a pending patent application within the Licensed Patent Rights in such country if such pending claim was an issued claim, at the applicable
rate set forth below: 
  

					
	 	  	Licensed
Products in
Therapeutic
Field	 	Licensed Products in
Diagnostic Field
	 Covered by Issued Valid Claim
	  	[*]	 	[*]
	 Not Covered by Issued Valid Claim
	  	[*]	 	[*]

 3.5 More Favorable Royalty Rate Offered in the Diagnostic Field. If TSRI should offer to any of
TSRI’s other licensees of Licensed Patent Rights in the Diagnostic Field a more favorable royalty rate than the royalty rate in the Diagnostic Field set forth in Section 3.4 (as such unadjusted royalty rate may be modified from
time-to-time pursuant to this Section 3.5, or may be adjusted pursuant to one or more provisions set forth in this Section 3 (for example, through application of royalty stacking or combination product adjustments, or by modification of
the Royalty Floor)), TSRI will advise Licensee promptly of such more favorable royalty rate, at which point, at Licensee’s discretion and written notification to TSRI, the royalty rate payable in the Diagnostic Field (as recited in
Section 3.4) shall reset to such more favorable royalty rate. If Licensee reasonably believes that TSRI has offered a more favorable royalty rate in the Diagnostic Field to another licensee, then Licensee may inquire whether TSRI has made such
offer. Licensee shall receive credit for any overpayment of royalties that resulted from TSRI’s failure to promptly advise Licensee of such more favorable royalty rate. 

  

*Confidential Treatment Requested. 
 9 

 EXECUTION COPY 

 

 3.6 Royalty Credit. 

(a) If Licensee or any of its Affiliates or its Sublicensees determines, after consultation with patent counsel, that it
is necessary to obtain a license under patent rights of one or more third parties with respect to Licensee’s (or its Affiliate’s or Sublicensee’s) manufacture, use, sale, offer for sale or importation of a given Licensed Product, then
Licensee shall be entitled to deduct from the royalties due under Section 3.4 with respect to Net Sales of such Licensed Product in that particular country [*] of the royalties actually paid by Licensee and Affiliates and Sublicensees to any
and all such third parties. For example, Licensee may in-license from one or more third parties a compound, product and/or a method of therapeutic or diagnostic use with potential applicability to a Licensed Product in the Therapeutic Field or the
Diagnostic Field. Royalty credit(s) under this subsection (a) shall include royalties payable to a third party with respect to patent rights directed to (1) a compound that is incorporated in a Licensed Product for use in the Therapeutic
Field; (2) a compound, product and/or a method that is used with a Licensed Product in the Diagnostic Field, or (3) a method of using a compound incorporated in a Licensed Product in the Therapeutic Field. 

(b) The above right to deduct is subject to (i) the requirement that the royalties payable to TSRI under
Section 3.4 with respect to such Licensed Product shall not be reduced by more than [*] of the amounts due to TSRI in such particular country (the “Royalty Floor”) in any calendar quarter as a result of any and all such
deductions in the aggregate; and (ii) the exclusion of third-party royalty obligations owed by Licensee and Affiliates and Sublicensees as of the Effective Date. For clarity, only one of Licensee, Affiliate or Sublicensee may exercise such
right to deduct with respect to a given third-party royalty obligation. Notwithstanding the above, Licensee, its Affiliates or its Sublicensees shall have no right to deduct any royalties or other amounts with respect to any third party technology
that is the subject of any cross license or similar arrangements (whether in the same or related transactions) where Licensee, its Affiliates or its Sublicensees grant or provide to such third party licenses, options or other rights to existing or
future technology, intellectual property, or products of Licensee, of Affiliate(s) or of Sublicensee(s). 
 3.7 Combination
Products. If a Licensed Product is sold in any country in combination with one or more other active ingredients, which other active ingredient(s) if sold alone would not be subject to a royalty payment hereunder (such combination, a
“Combination Product”), then Net Sales of the Licensed Product portion of such Combination Product, for purposes of calculating the amounts due under Section 3.4, shall be calculated by multiplying the Net Sales of the
Combination Product (as determined in accordance with Section 1.10) in such country by the fraction A/(A+B), where “A” is the average gross invoiced price of the Licensed Product in such country during the royalty period in question,
when sold separately from such other active ingredient(s), and “B” is the average gross invoiced price of the other active ingredient(s) in that country during the royalty period in question, when sold separately from the Licensed Product.
If such average gross invoiced price cannot be determined for both the Licensed Product, when sold separately from the other active ingredient(s), and the other active ingredient(s), when sold separately from the Licensed Product, then the Net Sales
of such Licensed Product portion of such Combination Product for purposes of determining royalty payments shall be negotiated in good faith by the Parties, based on the relative value contributed by each component and mutually agreed in writing,
which agreement shall not be unreasonably withheld or delayed. 

  

*Confidential Treatment Requested. 
 10 

 EXECUTION COPY 

 

 3.8 No Multiple Royalties. No multiple royalties shall be due because any
Licensed Product is Covered by more than one Valid Claim of the Licensed Patent Rights. In such case, Licensee shall pay only one royalty at the applicable rate(s) pursuant to Section 3.4 above. 

3.9 Arms-Length Transactions. On sales of Licensed Products which are made in other than an arm’s-length transaction, the
value of the Net Sales attributed under this Section 3 to such a transaction shall be that which would have been received in an arm’s-length transaction, based on sales of like quality and quantity products on or about the time of such
transaction. 
 3.10 Duration of Royalty Obligations. The royalty payment obligations of Licensee, Affiliates and
Sublicensees as to each Licensed Product shall continue on a country by country basis until the expiration of the last to expire of a Valid Claim that Covers such Licensed Product in that country. 

3.11 Royalty Adjustment in the Event of Challenge. In the event Licensee or an Affiliate or a Sublicensee directly or indirectly
institutes or makes any Challenge, the payment obligations specified in Sections 3 and 4 of this Agreement shall be [*] during the pendency of such Challenge from the date such challenging party first institutes or makes such Challenge and during
the pendency of such Challenge, and shall continue to apply after the conclusion of such Challenge in the event that at least one (1) Valid Claim being challenged that Covers such Licensed Products is held to be valid and enforceable.

 3.12 Pre-Challenge Requirements. Licensee will provide prior written notice to TSRI of Licensee’s intention to
institute or make any Challenge and shall not institute or make such Challenge without complying with this Section 3.12. Within 30 days after the date of such notice, the Parties shall meet in person or by telephone or videoconference to
discuss Licensee’s basis for such Challenge and to attempt in good faith to reach mutual agreement regarding such matter, and Licensee agrees not to institute such Challenge for at least 90 days after the date of such notice. During such 90-day
period, the Parties will discuss relevant prior art and other facts supporting Licensee’s contention that the Licensed Patent Rights are invalid or unenforceable. After expiration of such 90-day period, Licensee may institute such Challenge.

 3.13 No Right to Recoup Royalties. In the event Licensee or an Affiliate or a Sublicensee institutes or makes any
Challenge, Licensee shall have no right to recoup, recover, set off or otherwise get reimbursement of any royalties, equity, Sublicense Payments, milestone payments, patent reimbursement fee or other monies paid hereunder to TSRI prior to or during
the period of such Challenge. Licensee hereby voluntarily and irrevocably waives any right to seek return of such royalties, equity, Sublicense Payments, milestone payments, patent reimbursement fee or other monies in the event Licensee or an
Affiliate or a Sublicensee institutes or makes any Challenge. 

  

*Confidential Treatment Requested. 
 11 

 EXECUTION COPY 

 

 4. Sublicense Payments; Milestone Payments. 

4.1 Sublicense Payments. All Sublicense Revenues shall be reported to TSRI by Licensee in accordance with Section 6.3. Any
non-cash item of Sublicense Revenues received by Licensee or an Affiliate from a Sublicensee shall be valued at its fair market value as of the date of receipt, as determined in good faith by Licensee. Sublicense Revenues derived in whole or in part
from a sublicense that includes intellectual property Controlled by Licensee (other than the Licensed Patent Rights) directed to a composition of matter, a formulation or a method of diagnostic or therapeutic use, wherein in vivo pre-clinical
data in the Therapeutic Field or Diagnostic Field have been generated by or on behalf of Licensee in connection with such compound, product and/or method of use as of the effective date of such sublicense, shall be referred to herein as Sublicense
Revenues from a “Product Sublicense.” Sublicense Revenues derived from any sublicense that does not constitute a Product Sublicense shall be referred to herein as Sublicense Revenues from a “Platform Sublicense.”
Licensee shall pay to TSRI a non-creditable, non-refundable percentage of these Sublicense Revenues according to the following schedule (“Sublicense Payments”): 

 

					
	 Source of Sublicense Revenue:
	  	 Product Sublicense
	  	 Platform Sublicense

	 Sharing Percentage and Caps
	  	[*] of aggregate Sublicense Revenues received for Product Sublicense; total Sublicense Payments to TSRI from Product Sublicenses are capped at [*] in aggregate.	  	[*] of aggregate Sublicense Revenues received for Platform Sublicense; total Sublicense Payments to TSRI from Platform Sublicenses are capped at [*] in
aggregate.

 Any milestone payment that Licensee makes to TSRI under Section 4.2 below upon achievement of a
given milestone event by a Sublicensee shall be credited against any payment due to TSRI under this Section 4.1, but only with respect to Sublicense Revenues received in connection with achievement of the same milestone event. 

4.2 Milestone Payments. For each Licensed Product Covered by a Valid Claim in the United States or in a Major Market in the
European Union (to the extent applicable), Licensee agrees to pay and shall pay to TSRI the following non-creditable, non-refundable milestone payments within [*] days of the occurrence of each milestone event set forth below, as follows:

  

*Confidential Treatment Requested. 
 12 

 EXECUTION COPY 

 

									
	 Milestone Event
	  	First (1) Licensed
Product to
Achieve Milestone
Event	 	  	Each of the
Subsequent Four
(4) Licensed
Products to
Achieve
Milestone
Event	 
	 [*]
	  	 	[*]	  	  	 	[*]	  
	 [*]
	  	 	[*]	  	  	 	[*]	  
	 [*]
	  	 	[*]	  	  	 	[*]	  
	 [*]
	  	 	[*]	  	  	 	[*]	  
	 [*]
	  	 	[*]	  	  	 	[*]	  
	 Maximum aggregate milestone payments
	  	$	1,925,000	  	  			

  

	*	The milestone payment for achievement of this milestone event by a particular Licensed Product shall be payable only if such milestone event is supporting [*] in which
the manufacture, use, importation, sale or offer for sale of such Licensed Product in such country would, in the absence of the licenses granted pursuant to Section 2.1 and 2.2, infringe at least one Valid Claim of the Licensed Patent Rights in
that country at the time of achievement of such milestone event. 

 For purposes of this Section 4.2: 

(a) the term “Subsequent Licensed Product” shall mean a Licensed Product differing in structure from
Licensed Product(s) that have achieved the stated milestone event previously. For example, a new formulation of a given Licensed Product, or an additional indication for a given Licensed Product, shall not constitute a Subsequent Licensed Product.

 (b) the term “[*]” shall mean [*]; and 

(c) the term “[*]” shall include [*] (the following website provides additional information:[*];

 (d) the phrase “[*]” shall mean [*]. 

(e) the term “[*]” shall mean [*]; and 

(f) the term “Launch” shall mean the first commercial sale of a Licensed Product in [*] or in a Major
Market in [*] (if applicable) after all regulatory approvals required for such first commercial sale have been obtained. 
 5. Royalty
Payments. Royalties on Net Sales pursuant to Section 3.4 and Sublicense Payments pursuant to Section 4.1 shall be payable by Licensee quarterly, within [*] days after the end of each calendar quarter, based upon Net Sales by
Licensee, Net Sales reported by Affiliates and Sublicensees and Sublicense Revenues received by Licensee or reported by Affiliates during such calendar quarter. 
 6. Development and Commercialization Activities. 
 6.1
Certification. Licensee has certified to TSRI that its first Licensed Product (AZ01) is in clinical development (Phase 1 clinical trial(s)) as of the Effective Date. 

  

*Confidential Treatment Requested. 
 13 

 EXECUTION COPY 

 

 6.2 Licensee’s Commercialization Activities. Licensee shall use Commercially
Reasonable Efforts to achieve first commercial sale of at least one Licensed Product as promptly as is reasonably and commercially feasible. Following Licensee’s receipt of necessary regulatory approvals for a Licensed Product, Licensee shall
use Commercially Reasonable Efforts to produce and sell reasonable quantities of such Licensed Product sufficient to meet market demands. Licensee shall keep TSRI generally informed as to Licensee’s progress in its research and development,
regulatory, marketing, production and sale of Licensed Products, including its efforts, if any, in promoting Product Sublicenses and Platform Sublicenses. Licensee shall also deliver to TSRI an annual written report of all such efforts by
June 30 of each calendar year during the term of this Agreement and such other reports of its efforts as TSRI may reasonably request from time to time. Licensee shall also notify TSRI in writing of the achievement of each milestone event set
forth in Section 4.2 within thirty (30) days of its occurrence. The contents of Licensee’s progress reports to TSRI and Licensee’s certification to TSRI pursuant to Sections 6.1 and 6.2 shall be deemed to be Licensee’s
Confidential Information. 
 TSRI acknowledges that pharmaceutical development and the regulatory approval process is inherently
uncertain and involves high risks of failure, and that many factors beyond the reasonable control of Licensee may delay or prevent Licensee and its Affiliates and/or Sublicensees from achieving the milestone events set forth in Section 4.2 or
from obtaining regulatory approval for any Licensed Product. 
 6.3 Reports on Revenues and Payments. Licensee shall
submit to TSRI, at the time that each royalty payment and Sublicense Payment pursuant to Section 5 is due, on a country-by-country and per Licensed Product basis, a royalty report (the “Royalty Report”) setting forth for such
quarter: 
 (a) the number of units of Licensed Products sold by Licensee and the number of units of Licensed
Products reported sold by each of its Affiliates and Sublicensees; 
 (b) the gross amount invoiced for such
Licensed Products by Licensee and the gross amount invoiced for such Licensed Products as reported by each of its Affiliates and Sublicensees; 
 (c) a reasonably detailed listing of any offsets under Section 3.6, and calculations on Combination Products under Section 3.7, and a summary of deductions, itemized by general category, used to
determine Net Sales included in each Royalty Report, and any refunds or reimbursed amounts previously deducted which are deemed Net Sales pursuant to Section 1.10; 

(d) the amount of royalty due under Section 3, or if no royalties are due to TSRI for any reporting period, the
statement that no royalties are due and an explanation why they are not due for that quarterly period; 
 (e) the
amount of Sublicense Revenues received by Licensee and/or reported as received by Affiliates; and 

  
 14 

 EXECUTION COPY 

 

 (f) the amount of Sublicense Payments due under Section 4.1, or if
no Sublicense Payments are due to TSRI for any reporting period, the statement that no Sublicense Payments are due. 
 Such
Royalty Report shall be certified as correct by an officer of Licensee. The contents of such Royalty Reports shall be deemed to be Licensee’s Confidential Information. 
 6.4 Royalty Payments. Licensee agrees to pay and shall pay to TSRI with each Royalty Report the amount of royalty and/or Sublicense Payments due with respect to such calendar quarter. All payments
due hereunder shall be deemed received when funds are credited to TSRI’s bank account and shall be payable by check or wire transfer in United States Dollars. 
 6.5 Foreign Sales. The remittance of royalties payable on sales outside the United States shall be payable to TSRI in United States Dollar equivalents at the official rate of exchange of the
currency of the country from which the royalties are payable, as quoted in The Wall Street Journal for the last business day of the calendar quarter in which the royalties are payable. If the transfer of or the conversion into the United
States Dollar equivalents of any such remittance in any such instance is not lawful or possible, the payment of such part of the royalties as is necessary shall be made by the deposit thereof, in the currency of the country where the sale was made
on which the royalty was based to the credit and account of TSRI or its nominee in any commercial bank or trust company of TSRI’s choice located in that country, prompt written notice of which shall be given by Licensee to TSRI. 

6.6 Foreign Taxes. Any tax required to be withheld by Licensee under the laws of any foreign country for any royalties or other
amounts due hereunder or for the accounts of TSRI shall be promptly paid by Licensee for and on behalf of TSRI to the appropriate governmental authority, and Licensee shall furnish TSRI with proof of payment of such tax together with official or
other appropriate evidence issued by the applicable government authority. Any such tax actually paid on TSRI’s behalf shall be deducted from payments due TSRI. 
 7. Record Keeping. Licensee shall keep, and shall require its Affiliates and Sublicensees to keep, accurate records (together with reasonable supporting documentation) of sales of Licensed
Products as appropriate to determine the amount of royalties, Sublicense Payments, milestone payments and other monies due to TSRI hereunder, as well as records regarding the calculations of royalty credits and Combination Products. Such records
shall be retained for at least four (4) years following the end of the reporting period to which such records relate. Such records shall be available during normal business hours, upon reasonable prior written notice to Licensee, for
examination and copying by an independent certified public accounting firm selected by TSRI and reasonably acceptable to Licensee for the sole purpose of verifying that Licensee’s reports and payments are accurate and that it is in compliance
with this Agreement. In conducting such examinations pursuant to this Section 7, TSRI’s accountant (employed by such independent certified public accounting firm) shall have access to all such records which such accountant reasonably
believes to be relevant to the calculation of royalties under Section 3, non-royalty payments under Section 4, and other financial obligations under this Agreement. Such accountant will execute a reasonable written confidentiality
agreement with Licensee. Such accountant may disclose to TSRI its audit report and any information, including without limitation work papers, notes, interim reports and other work product of the accountant (but

  
 15 

 EXECUTION COPY 

 

 
excluding any direct source documents of Licensee), that the accountant reasonably believes to be relevant to the calculation of royalties under Section 3, non-royalty payments under
Section 4, and other financial obligations under this Agreement, provided that all of such information that such accountant discloses to TSRI shall be concurrently disclosed to Licensee. The contents of the accountant’s audit report
(and any accompanying information permitted hereunder to be provided therewith) shall be deemed to be Licensee’s Confidential Information. Such accountant will send a copy of the audit report to Licensee at the same time it is sent to TSRI. The
audit report sent to both Parties will include the methodology and calculations used by the accountant to determine the reported results. Such examination shall be at TSRI’s expense, except that if such examination shows an underreporting or
underpayment for any calendar year of the greater of [*] or [*] (or more), then Licensee shall pay the cost of such examination (including without limitation TSRI’s attorneys’ fees, accountants’ fees and other out-of-pocket costs
incurred by TSRI in conducting the audit), as well as any additional payments that would have been payable to TSRI under this Agreement had Licensee reported correctly, plus interest on such additional payments calculated in accordance with
Section 14.2. If such examination shows an overreporting or overpayment by Licensee in any calendar quarter, such excess amount shall be applied as a credit against future Royalty Payments or Sublicense Payments by Licensee under this
Agreement, and such credit shall be properly noted on Licensee’s Royalty Reports. All payments due hereunder shall be made within thirty (30) days of Licensee’s receipt of a copy of the audit report. TSRI may exercise its audit rights
under this Section 7 no more frequently than once in any calendar year, and no calendar year shall be subject to audit under this Section 7 more than one time. 
 8. Patent Matters. 
 8.1 Patent Prosecution and
Maintenance. From and after the Effective Date, the provisions of this Section 8 shall control the preparation, filing and prosecution of any patent application and maintenance of any patent included within Licensed Patent Rights. TSRI
shall (a) direct and control the preparation, filing and prosecution of the United States and foreign patent applications within Licensed Patent Rights (including without limitation any reissues, reexaminations, appeals to appropriate patent
offices and/or courts, interferences and foreign oppositions and inter partes proceedings); and (b) maintain the patents issuing therefrom; in each case, using TSRI’s Office of Patent Counsel (“OPC”) or outside
patent counsel selected solely by TSRI. Licensee’s only obligation regarding patent costs incurred by TSRI in connection with the Licensed Patent Rights, whether such costs are incurred by TSRI prior to or on or after the Effective Date, are
the annual maintenance fees payable to TSRI under Section 3.3 and the one-time payment to TSRI of the patent reimbursement fee set forth in Section 3.2. Before submitting any material communication to the United States or any foreign
patent office regarding such Licensed Patent Rights, TSRI shall furnish to Licensee copies of all relevant documents reasonably in advance of such submission to enable Licensee to provide to TSRI meaningful comments about that portion of the
proposed submission, if any, that applies to the Licensed Patent Rights covering Licensed Products that are or contain one or more NNAA Protein Bioconjugates in the Therapeutic Field. However, TSRI has the right, in its sole discretion, to decide
what to incorporate into all such submissions. TSRI shall have the sole right and authority overall all matters regarding the preparation, filing, prosecution, and/or maintenance of all United States and foreign patent applications and patents
within the Licensed Patent Rights (including without limitation any reissues, reexaminations, appeals to appropriate patent offices and/or courts, interferences, and foreign oppositions and inter partes proceedings). 

  

*Confidential Treatment Requested. 
 16 

 EXECUTION COPY 

 

 8.2 Information to Licensee. TSRI shall keep, and shall instruct OPC and outside
patent counsel to keep, Licensee regularly informed with regard to the patent preparation, filing, prosecution and maintenance processes, involving the Licensed Patent Rights by promptly delivering, and instructing OPC and outside patent counsel
promptly to deliver, to Licensee copies of all official correspondence with the United States and foreign patent offices, including but not limited to patent applications, amendments, issued patents, related correspondence, and other related
documents. 
 8.3 Ownership. The patent applications filed and the patents obtained pursuant to Section 8.1 hereof
claiming inventions made solely by TSRI personnel shall be owned solely by TSRI and deemed a part of Licensed Patent Rights. 

8.4 Infringement Actions. 
 8.4.1 Prosecution of Infringements solely in the Exclusive Infringement Field. 
 The following provisions apply to any infringement of, or any challenge to the validity or enforceability of, the Licensed Patent Rights that occurs solely with respect to products that are or contain one
or more NNAA Protein Bioconjugates in the Therapeutic Field (“Exclusive Infringement Field”): 

(a) TSRI and Licensee shall promptly notify the other in writing of any alleged or threatened infringement of, or any
challenge to the validity or unenforceability of, Licensed Patent Rights in the Exclusive Infringement Field of which it becomes aware. After receiving notice from the other Party of a possible infringement of the Licensed Patent Rights in the
Exclusive Infringement Field by a third party, the Parties will consult with each other about whether and to what extent such third party’s products or activities are infringing upon the Licensed Patent Rights solely in the Exclusive
Infringement Field in that country, and the extent to which the infringing products or activities are damaging sales of Licensee’s Licensed Products in the Exclusive Infringement Field in such country; provided, however, that promptly
after delivery of such notice, and in any event prior to engaging in any such consultation or discussion, TSRI and Licensee shall enter into a mutually acceptable joint defense/common interest agreement for the purpose of preserving all applicable
privileges attaching to the Parties’ discussion and pursuit of their mutual interest in the enforcement and/or defense of the Licensed Patent Rights solely in the Exclusive Infringement Field. In this way, the Parties will attempt to reach a
mutual agreement regarding what, if any, action should be taken against the third party. 
 (b) If
(i) Licensee believes in good faith that such third party’s products or activities are literally infringing upon the Licensed Patent Rights solely in the Exclusive Infringement Field in a Major Market country, and (ii) lost sales of
Licensed Products as a result of such infringing activity exceed [*] in the Major Market countries, then, except as otherwise mutually agreed by the Parties pursuant to Section 8.4.1(a), Licensee shall have the obligation to prosecute such
infringement (including defense of actions for declaratory relief of non-infringement) by that third party. If the Parties cannot agree on a course of action to be taken 

  

*Confidential Treatment Requested. 
 17 

 EXECUTION COPY 

 

 
against such third party infringer, and such third party’s products or activities are occurring in a non-Major Market country, then Licensee shall have the first right, but not the
obligation, to prosecute such infringement. In addition, if the Parties cannot agree on a course of action to be taken with respect to a challenge by a third party to the validity or enforceability of the Licensed Patent Rights solely in the
Exclusive Infringement Field, where such challenge is the only claim by the third party with respect to the Licensed Patent Rights solely in the Exclusive Infringement Field and which occurs outside of the context of any infringement action or
non-infringement declaratory relief action with respect to the Licensed Patent Rights solely in the Exclusive Infringement Field, then Licensee shall have the first right, but not the obligation, to defend against such challenge. Licensee may enter
into settlements, stipulated judgments or other arrangements respecting such infringement or challenge, at its own expense, but only with TSRI’s prior written consent, which will not be unreasonably withheld or delayed. TSRI shall permit any
action to be brought in its name and/or join in such action if required by law, and Licensee shall hold TSRI harmless from any costs, expenses or liability respecting such action. TSRI shall cooperate in such action as reasonably requested by
Licensee, including any reasonable assistance of a technical nature which Licensee may request in any litigation arising in accordance with the provisions of this Section 8.4.1, for which Licensee shall pay to TSRI a reasonable hourly rate of
compensation. Notwithstanding the above, in the event Licensee prosecutes any such infringement actions or defends against any such challenges, TSRI, at its expense, shall have the right to retain separate independent counsel to assist Licensee in
prosecuting or defending such actions. 
 (c) In the event Licensee fails to bring an infringement action or
proceeding against the third party or to defend such third-party challenge solely in the Exclusive Infringement Field within ninety (90) days after the later of (i) mutual agreement by the Parties to bring such action or proceeding, and
(ii) initiation of consultation between the Parties pursuant to Section 8.4.1(a) (i.e., either in the circumstances where Licensee has the obligation to enforce or the first right to enforce under Section 8.4.1(b)), then TSRI
shall have the right, but not the obligation, to prosecute such infringement or to defend such challenge on its own behalf. If in exercising TSRI’s right to prosecute such infringement or defend such challenge of the Licensed Patent Rights
solely in the Exclusive Infringement Field, (A) TSRI sends a formal written communication to such third party specifically relating to the Licensed Patent Rights solely in the Exclusive Infringement Field and copies Licensee at the time of such
communication, and (B) TSRI subsequently notifies Licensee that TSRI and the third party have reached agreement in principle regarding the terms on which a non-exclusive sublicense under the relevant Licensed Patent Rights solely in the
Exclusive Infringement Field would be granted by Licensee to such third party (and TSRI shall use good faith efforts to negotiate a sublicense to such third party that has a scope which covers only the alleged infringing products and directly
related infringing activities), then Licensee shall grant to that third party a non-exclusive, non-sublicensable sublicense under the relevant Licensed Patent Rights solely in the Exclusive Infringement Field of the scope and specific terms
negotiated by TSRI, and delivered by TSRI to Licensee, and Licensee further shall execute such additional documents and perform such acts as are reasonably requested by TSRI in order to effect such sublicense grant to such third party; provided,
however, that TSRI and Licensee agree that all fees, royalties, payments and any other consideration to be paid by that third party under such non-exclusive sublicense shall be paid to TSRI; and provided, further, that if Licensee fails
to execute such above-mentioned documents that are provided to Licensee by TSRI regarding the non-exclusive, non-sublicensable sublicense 

  
 18 

 EXECUTION COPY 

 

 
of Licensed Patent Rights solely in the Exclusive Infringement Field within five (5) business days after TSRI’s written notice to Licensee regarding such negotiated sublicense, then
effective as of the end of such five (5)-business day period, Licensee shall be deemed to have granted, and hereby does grant, to TSRI the right to grant and enter into such sublicense, on Licensee’s behalf, under the relevant Licensed Patent
Rights solely in the Exclusive Infringement Field to such third party in accordance with the scope and terms negotiated by TSRI, and further appoints TSRI as Licensee’s attorney-in-fact, coupled with an interest for this limited purpose, to
execute such sublicense with the third party in Licensee’s name. TSRI shall not have any right to require Licensee to grant any such sublicense unless TSRI had sent a formal written communication to such third party specifically relating to the
Licensed Patent Rights solely in the Exclusive Infringement Field (as described in clause (A) above) - i.e., Licensee shall have no obligation to grant any such sublicense under the Licensed Patent Rights solely in the Exclusive
Infringement Field unless TSRI had first sent a formal written communication to such third party specifically relating to the Licensed Patent Rights solely in the Exclusive Infringement Field, copying Licensee at the time of such communication.

 (d) Except as otherwise agreed by the Parties in writing (for example, as part of an alternate cost-sharing
arrangement), any damages, settlements or other recoveries obtained as a result of any infringement or defense action pursuant to Section 8.4.1, shall first be used to reimburse the Party that brought such action for the fees and expenses
incurred by it in such action, and then to reimburse the fees and expenses incurred by the other Party in such action. If, after such reimbursement of both Parties’ fees and expenses, any funds remain from such damages, settlements or other
recoveries obtained as a result of such infringement or defense actions, such funds (the “Remainder”) shall belong to the Party that brought such action pursuant to Section 8.4.1; provided, however, that if Licensee was
the Party that brought such action: 
 (i) out of the portion of the Remainder that constitutes compensatory
damages attributable to lost sales, lost profits or a reasonable royalty with respect to Licensed Products, Licensee shall pay to TSRI an amount equivalent to the royalty payments that would have been due TSRI had the infringing sales that Licensee
lost to the infringer been made by Licensee under this Agreement (where such lost sales, lost profits or reasonable royalty will be used to calculate such lost infringing sales); 

(ii) any portion of the Remainder that constitutes punitive, special, exemplary or other non compensatory damages, shall
be treated as Sublicense Revenues, and such deemed Sublicense Revenues shall be subject to Licensee’s payment obligations specified in Section 4.1, with the applicable percentage to be determined as though Licensee had granted a Product
Sublicense or a Platform Sublicense (as applicable); 
 and provided, further, that in no event shall the portion of the Remainder to
which TSRI is entitled pursuant to the preceding subparagraphs (a) and (b) exceed [*] of the Remainder. 
 8.4.2 Prosecution of Infringements solely outside of the Exclusive Infringement Field. 

  

*Confidential Treatment Requested. 
 19 

 EXECUTION COPY 

 

 The following provisions apply to any infringement of, or any challenge to the validity
or enforceability of, the Licensed Patent Rights that occurs solely outside of the Exclusive Infringement Field (including without limitation any infringement or challenge relating to Licensed Products that are or contain one or more Stapled
Proteins in the Therapeutic Field, Licensed Products in the Diagnostic Field, or products in other fields) (collectively “Outside Infringement Field”): 
 (a) TSRI shall have the exclusive right, but not the obligation, to control any actions or proceedings with respect to any infringement of, or any challenge to the validity or enforceability of, the
Licensed Patent Rights that occurs solely in the Outside Infringement Field. Licensee shall have no right to enforce or prosecute any infringement of, or defend any challenge to the validity or enforceability of, the Licensed Patent Rights that
occurs solely in the Outside Infringement Field, whether or not TSRI exercises its above-referenced rights. 
 (b) In the event
TSRI brings an infringement action or proceeding against a third party infringer, defends against any challenge brought by such a third party, or negotiates a license or other settlement with such third party solely in the Outside Infringement
Field, TSRI shall have the right to retain [*] of all damages, settlements, fees, payments and other recoveries obtained or received from such third party. 
 8.4.3 Prosecution of Infringements in the Exclusive Infringement Field and the Outside Infringement Field. 
 The following provisions apply to any infringement of, or any challenge to the validity or enforceability of, the Licensed Patent Rights that occurs in both the Exclusive Infringement Field and the
Outside Infringement Field: 
 (a) TSRI and Licensee shall promptly notify the other in writing of any alleged or threatened
infringement of, or any challenge to the validity or enforceability of, the Licensed Patent Rights that occurs in both the Exclusive Infringement Field and the Outside Infringement Field of which it becomes aware. With respect to such infringement
or challenge of the Licensed Patent Rights in both the Exclusive Infringement Field and the Outside Infringement Field, TSRI shall have the first right, but not the obligation, to prosecute such infringement and/or to defend against such challenge.

 (b) If TSRI elects to pursue, prosecute or defend such actions, any damages, settlements or other recoveries received by TSRI
as a result of such activities described in Section 8.4.2(a) shall first be used to reimburse TSRI for all fees and expenses incurred by it with respect to such actions, and then to reimburse the fees and expenses incurred by Licensee in such
action. If, after such reimbursement, any funds remain from such damages, settlements or other recoveries obtained as a result of such infringement or defense actions, such funds (the “Remaining Funds”) shall be distributed as
follows: (i) with respect to that portion of the Remaining Funds that represents damages, settlements or other recoveries in the Exclusive Infringement Field, TSRI shall pay to Licensee [*] of such amount, and TSRI shall retain [*] of such
amount; and (ii) with respect to that portion of the Remaining Funds that represents damages, settlements or other recoveries in the Outside Infringement Field, TSRI shall retain [*] of such amount. 

  

*Confidential Treatment Requested. 
 20 

 EXECUTION COPY 

 

 (c) In the event TSRI elects not to prosecute such infringement or defend against such
challenge of Licensed Patent Rights in both the Exclusive Infringement Field and the Outside Infringement Field, Licensee shall thereafter have the exclusive right, but not the obligation, to prosecute such infringement or defend against such
challenge of the Licensed Patent Rights in the Exclusive Infringement Field, and a non-exclusive right, but not the obligation, to prosecute such infringement or defend against such challenge of Licensed Patent Rights in the Outside Infringement
Field. Licensee understands and agrees that its non-exclusive right to prosecute such infringement or defend against such challenge of Licensed Patent Rights in the Outside Infringement Field shall be shared with other licensees of TSRI who may have
a similar non-exclusive right to prosecute such infringement or defend against such challenge of Licensed Patent Rights in the Outside Infringement Field in the event TSRI does not pursue such actions that occur in both the Exclusive Infringement
Field and the Outside Infringement Field. If Licensee elects to prosecute such infringement or defend against such challenge of Licensed Patent Rights in both the Exclusive Infringement Field and the Outside Infringement Field, any damages,
settlements or other recoveries obtained as a result of such infringement or defense actions shall first be used to reimburse Licensee and any other licensees of TSRI that elected to pursue their non-exclusive rights to enforce or defend such
actions in the Outside Exclusive Field for the fees and expenses incurred by those parties in bringing or defending against such actions. If, after such reimbursement, any funds remain from such damages, settlements or other recoveries obtained as a
result of such infringement or defense actions, such funds (the “Remaining Monies”) shall be distributed as follows: 
 (i) with respect to that portion of the Remaining Monies that represents damages, settlements or other recoveries in the Exclusive Infringement Field, Licensee shall pay to TSRI the following:
(x) out of that portion that constitutes compensatory damages attributable to lost sales, lost profits or reasonable royalty with respect to Licensed Products, Licensee shall pay to TSRI an amount equivalent to the royalty payments that would
have been due TSRI had the infringing sales that Licensee lost to the infringer been made by Licensee under this Agreement (where such lost sales, lost profits or reasonable royalty will be used to calculate such lost infringing sales); and
(y) the portion that constitutes punitive, special, exemplary or other non-compensatory damages shall be treated as Sublicense Revenues, and such deemed Sublicense Revenues shall be subject to Licensee’s payment obligations specified in
Section 4.1, with the applicable percentage to be determined as though Licensee had granted a Product Sublicense or a Platform Sublicense (as applicable); and 
 (ii) with respect to that portion of the Remaining Monies that represents damages, settlements or other recoveries in the Outside Infringement Field, Licensee (together with other licensees of TSRI who
participate in such actions) shall pay to TSRI [*] of such amount, and Licensee shall have the right to retain [*] of such amount; provided, however, that Licensee shall share, on a pro-rata basis, such [*] amount with all other licensees of
TSRI who participate in such actions. 

  

*Confidential Treatment Requested. 
 21 

 EXECUTION COPY 

 

 8.4.4 Defense of Infringement Claims Alleged by a Third Party.
Each Party shall promptly notify the other in writing of any allegation by a third party that the practice of any invention claimed by the Licensed Patent Rights in connection with a Licensed Product in the Therapeutic Field or in the Diagnostic
Field infringes or may infringe the intellectual property rights of such third party, and TSRI and Licensee shall confer with each other and cooperate during the defense of any such infringement action brought by such third party
(“Third-Party Allegation of Infringement”). 
 (a) Licensee shall have the first right, but not the obligation,
to defend any Third-Party Allegation of Infringement action or suit against Licensee or its Affiliates or Sublicensees which is solely due to Licensee’s or any Affiliate’s or Sublicensee’s practice of any invention claimed by the
Licensed Patent Rights in connection with Licensed Products that are or contain one or more NNAA Protein Bioconjugates in the Therapeutic Field (“Exclusive Defense Field”). If Licensee finds it necessary or desirable for TSRI to
become a party to such Third-Party Allegation of Infringement action or suit solely in the Exclusive Defense Field, TSRI shall execute all papers as may be reasonably necessary to add TSRI as a party to such action or suit only if TSRI approves the
independent outside counsel selected by Licensee to defend such action or suit (which approval will not be unreasonably withheld or delayed). If Licensee defends any such action or suit solely in the Exclusive Defense Field, Licensee shall bear all
fees and expenses incurred by Licensee and incurred by TSRI at the request of Licensee in connection with such suit or action or as the result of TSRI being named as a party to such suit or action. TSRI shall be entitled to, at its expense,
participate and have counsel selected by it participate in any such suit or action; provided that Licensee shall control and be responsible for such suit or action that involves solely the Exclusive Defense Field. TSRI shall not have any
out-of-pocket liability for costs of litigation or royalties, damages and/or settlement amounts resulting from any such action or suit defended by Licensee (except for fees and expenses of TSRI’s selected counsel as provided above). If the
third party’s intellectual property right asserted in such Third-Party Allegation of Infringement is held not to be infringed, or is held to be unenforceable or invalid, and Licensee receives any damages, settlements or other recoveries from
such third party in an action or suit that involves solely the Exclusive Defense Field, such amounts shall be applied first to reimburse all fees and expenses of Licensee, next to reimburse any fees and expenses of TSRI in accordance with this
Section 8.4.4(a), and thereafter Licensee shall be entitled to keep the balance remaining. For the purpose of clarity, the Parties acknowledge and agree that this Section 8.4.4 shall in no way limit Licensee’s indemnification
obligations under Section 9.1. 
 (b) With respect to any Third-Party Allegation of Infringement action or suit against
Licensee or its Affiliates or Sublicensees which is solely due to Licensee’s or any Affiliate’s or Sublicensee’s practice of any invention claimed by the Licensed Patent Rights in connection with Licensed Products that are or contain
one or more Stapled Proteins in the Therapeutic Field, or NNAA Protein Bioconjugates or Stapled Proteins in the Diagnostic Field (“Outside Defense Field”), or alleging infringement of such third party’s intellectual property
rights due to Licensee’s or any Affiliate’s or Sublicensee’s practice of any invention claimed by the Licensed Patent Rights in connection with Licensed Products both in the Exclusive Defense Field and the Outside Defense Field, TSRI
shall have the first right, but not the obligation, to defend any such actions or suits. In any of the circumstances referenced in the preceding sentence, Licensee shall be entitled to, at its expense, participate and have counsel selected by it
participate in any such 

  
 22 

 EXECUTION COPY 

 

 
suit or action; provided that, if TSRI elects to defend such action or suit, TSRI shall control and be responsible for such action or suit that involves solely the Outside Defense Field or
that involves both the Exclusive Defense Field and the Outside Defense Field. If TSRI elects not to defend such action or suit that involves solely the Outside Defense Field or that involves both the Exclusive Defense Field and the Outside Defense
Field, Licensee thereafter shall have the right, but not the obligation, to defend such action or suit. In either of the above cases (i.e., TSRI elects to defend and control, or if TSRI does not so elect and Licensee subsequently elects to
defend and control, any such action or suit that involves solely the Outside Defense Field or that involves both the Exclusive Defense Field and the Outside Defense Field), if the third party’s intellectual property right is held not to be
infringed, or is held to be unenforceable or invalid, and the Party who defended and controlled such action receives any damages, settlements or other recoveries from such third party, such amount shall be applied first to reimburse all fees and
expenses of the Party who defended and controlled such action or suit, next to reimburse any fees and expenses of the other Party in accordance with this Section 8.4.4(b), and thereafter the Party who defended and controlled such action or suit
shall be entitled to keep the balance remaining. 
 9. Indemnity and Insurance. 

9.1 Indemnity. Licensee hereby agrees to indemnify, defend (using counsel reasonably acceptable to TSRI) and hold harmless TSRI
and any parent, subsidiary or other affiliated entity of TSRI and their trustees, directors, officers, employees, scientist, students, agents, successors, and assigns (collectively, the “Indemnitees”) from and against all claims,
suits, actions, damages, liabilities, losses and other expenses, including without limitation reasonable attorneys’ fees, expert witness fees and costs incurred by the Indemnitees (collectively, “Losses”), with respect to any
third party claim, whether or not a lawsuit or other proceeding is filed (collectively “Claim”), that arise out of or relate to: (a) Licensee’s or any of its Affiliates’ or Sublicensees’ practice of any invention
claimed by the Licensed Patent Rights; (b) alleged defects or other problems with any of the Licensed Products manufactured, sold or distributed by Licensee or any Affiliate or Sublicensee, including without limitation any Claims for personal
injuries, death or property damages; (c) the research, development, manufacture, use, marketing, advertising, distribution, sale or importation of any Licensed Product by or on behalf of Licensee or any of its Affiliates or Sublicensees;
(d) the negligent or willful misconduct of Licensee or any of its Affiliates or Sublicensees; (e) any allegations that the Licensed Products developed, manufactured, sold or distributed by Licensee or any Affiliate or Sublicensee and/or
any trademarks, service marks, logos, symbols, slogans, or other materials used in connection with or to market Licensed Products violate or infringe upon the trademarks, service marks, trade dress, trade names, copyrights, patents, works of
authorship, inventorship rights, trade secrets, database rights, rights under unfair competition laws, rights of publicity, privacy or defamation, or any other intellectual or industrial property right of any third party; and/or
(f) Licensee’s or any Affiliate’s or Sublicensee’s failure to comply with any applicable laws, rules or regulations in connection with the exercise of its rights or the performance of its obligations under this Agreement; and/or
(g) Licensees’s or any Affiliate’s or Sublicensee’s labeling, packaging or patent marking of any Licensed Product. Licensee’s liability for Losses under this indemnity shall be reduced or apportioned to the extent the
applicable third party’s Claims arising out of or relating to the actions referenced above in sub-clauses (a) - (f) are proximately caused by the breach by TSRI of any warranty, representation, covenant, or agreement made by TSRI in this

  
 23 

 EXECUTION COPY 

 

 
Agreement. Licensee shall not enter into any settlement, stipulated judgment or similar arrangement with respect to such Claims that (i) imposes any obligation on TSRI, (ii) does not
unconditionally release TSRI from all liability, or (iii) acknowledges fault by an Indemnitee, without TSRI’s prior written consent. In the event an Indemnitee seeks indemnification with respect to a Claim under this Section 9.1, it
shall inform Licensee in writing of such Claim as soon as reasonably practicable after it receives notice of such Claim, shall permit Licensee to assume direction and control of the defense of the Claim (including the right to settle the Claim
solely for monetary consideration, subject to the limitations of the preceding sentence) using counsel selected by Licensee and reasonably acceptable to TSRI, and shall cooperate as reasonably requested (at the expense of Licensee) in the defense of
the Claim. Notwithstanding the above, Indemnitees, at their expense, shall have the right to retain separate independent counsel to assist the indemnifying Party in defending any such Claims. If Licensee assumes direction and control of defense of
the Claim, no Indemnitee shall agree to any settlement of such Claim without the prior written consent of Licensee. In the event Licensee fails to assume direction and control of such defense within fifteen (15) days after receiving written
notice of the Claim from an Indemnitee, such Indemnitee shall have the right, but not the obligation, to defend itself, and in that case, Licensee shall reimburse Indemnitees for all of their reasonable and documented attorneys’ fees,
out-of-pocket costs and damages incurred in settling or defending such Claim within thirty (30) days after receipt of any invoice therefor from such Indemnitee. This indemnity shall be a direct payment obligation and not merely a reimbursement
obligation of Licensee to Indemnitees. 
 9.2 Insurance. Licensee shall name TSRI and Indemnitees as additional insured
parties on any commercial general liability and product liability insurance policies maintained by Licensee applicable to the Licensed Products, and such policies shall cover claims resulting from not only Licensee’s actions or omissions but
also from all Affiliates’ and Sublicensees’ actions or omissions. 
 9.2.1 Beginning at the time any
such Licensed Product is being commercially distributed or sold (other than for the purpose of obtaining regulatory approvals) by Licensee or by an Affiliate or a Sublicensee, Licensee shall, at its sole cost and expense, procure and maintain
commercial general liability insurance in amounts and on terms consistent with industry standards for similarly situated pharmaceutical companies commercializing products, but in no case will such insurance be less than [*] per occurrence and [*]
annual aggregate. During clinical trials involving any Licensed Product, Licensee shall, at its sole cost and expense, procure and maintain clinical trial liability insurance with coverage of no less than [*] per occurrence and [*] annual aggregate.
Licensee’s commercial general liability insurance shall provide coverage for product liability, personal injury, broad form property damage, advertising injury, premises-operations, products and completed operations, and contractual liability,
including Licensee’s indemnity and other obligations under this Agreement. Licensee may elect to self insure all or part of the foregoing on commercially reasonable terms, which must be pre-approved by TSRI in writing; however, TSRI shall be
obligated to approve such self-insurance if Licensee has and continues to maintain minimum cash reserves covering such self-insurance or minimum book equity, in either case in the amount of [*], which Licensee sufficiently demonstrates to TSRI in
writing. The insurance coverage amounts specified herein or the maintenance of such insurance policies shall not in any way limit Licensee’s indemnity or other liability under this Agreement. 

  

*Confidential Treatment Requested. 
 24 

 EXECUTION COPY 

 

 9.2.2 In addition, Licensee waives (and shall ensure that
Licensee’s insurance policy(ies) provide for the insurance carrier’s waiver of) any and all claims and rights of recovery against TSRI and the Indemnitees, including without limitation all rights of subrogation, with respect to either
Party’s performance under this Agreement or for any loss or damage to Licensee or its property or the property of others under its control. Licensee’s commercial general liability insurance policy shall also include a waiver of subrogation
consistent with this Section 9.2.2 in favor of TSRI and Indemnitees. Licensee shall be responsible for obtaining such waiver of subrogation from its insurance carriers. Licensee’s insurance policies shall be primary and not contributory to
any insurance carried by its Affiliates or Sublicensees or TSRI. Upon TSRI’s request, Licensee shall deliver to TSRI copies of insurance certificates or binders and such waiver of subrogation evidencing Licensee’s compliance with this
Section 9.2. Licensee shall provide TSRI with written notice at least fifteen (15) days prior to the cancellation, non renewal or material adverse change in such insurance described in Section 9.2.1, provided that if Licensee
itself becomes aware of any such cancellation, non renewal or material adverse change less than fifteen (15) days before such cancellation, non renewal or material adverse change becomes effective, then Licensee shall provide TSRI with written
notice as promptly as practicable after Licensee becomes aware of same. If Licensee does not obtain replacement insurance providing comparable coverage within such fifteen (15) day period (or within fifteen (15) days after becoming aware
of such cancellation, non renewal or material adverse change, as applicable), TSRI shall have the right to terminate this Agreement pursuant to Section 12.3(e). 

9.2.3 Licensee shall maintain such commercial general liability insurance beyond the expiration or termination of this
Agreement during (a) the period that any Licensed Product is being commercially distributed or sold by Licensee or by a Sublicensee, Affiliate or agent of Licensee; and (b) a period that is five (5) years after the end of the period
described in Section 9.2.3(a). For the avoidance of doubt, Licensee shall not be obligated to maintain its clinical trial insurance policy after such time as no clinical trial of any Licensed Product is being conducted. 

10. Limited Warranty. 
 10.1 Limited Warranty. TSRI hereby represents and warrants that, as of the Effective Date: 
 (a) it has full right and power to enter into this Agreement; 
 (b)
this Agreement does not conflict with any other agreement to which TSRI is a party (other than any such license, option or other right that has expired unexercised, or has been waived in writing, such that TSRI is free to grant Licensee the license
and rights it purports to grant under this Agreement); 
 (c) subject to the rights of [*] and the U.S.
Government as described in this Agreement, to its actual knowledge, TSRI is the sole owner of all right, title and interest in and to the Licensed Patent Rights, and TSRI has not granted to any third party any license, option or other rights with
respect to the Licensed Patent Rights to produce Licensed Products that are or contain one or more NNAA Protein Bioconjugates in the Therapeutic Field (other than any such license, option or other right that has expired unexercised, or has been
waived in writing, such that TSRI is free to grant Licensee the license and rights it purports to grant under this Agreement); 

  

*Confidential Treatment Requested. 
 25 

 EXECUTION COPY 

 

 (d) TSRI is not a party to any legal action, suit or proceeding relating
to the Licensed Patent Rights (other than the prosecution of the Licensed Patent Rights before the U.S. Patent and Trademark Office or a foreign patent office), nor has TSRI’s internal Business Counsel received any written communication from
any third party threatening such action, suit or proceeding; and 
 (e) Section 1.14 is a true and accurate
statement of the scope of license rights granted by TSRI to [*] under the Licensed Patent Rights. 
 Licensee hereby represents
and warrants that, as of the Effective Date, it has full right and power to enter into this Agreement. 
 10.2
Disclaimer. EXCEPT AS PROVIDED IN SECTION 10.1, TSRI MAKES NO OTHER WARRANTIES CONCERNING LICENSED PATENT RIGHTS OR ANY OTHER MATTER WHATSOEVER, INCLUDING WITHOUT LIMITATION ANY EXPRESS OR IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A
PARTICULAR PURPOSE, NON-INFRINGEMENT OF THIRD PARTY RIGHTS OR ARISING OUT OF COURSE OF CONDUCT OR TRADE CUSTOM OR USAGE, AND DISCLAIMS ALL SUCH EXPRESS OR IMPLIED WARRANTIES. TSRI MAKES NO WARRANTY OR REPRESENTATION AS TO THE VALIDITY OR SCOPE OF
LICENSED PATENT RIGHTS, OR THAT ANY LICENSED PRODUCT WILL BE FREE FROM AN INFRINGEMENT ON PATENTS OR OTHER INTELLECTUAL PROPERTY RIGHTS OF THIRD PARTIES, OR THAT NO THIRD PARTIES ARE IN ANY WAY INFRINGING UPON ANY LICENSED PATENT RIGHTS COVERED BY
THIS AGREEMENT. FURTHER, TSRI HAS MADE NO INVESTIGATION AND MAKES NO REPRESENTATION THAT THE LICENSED PATENT RIGHTS ARE SUITABLE FOR LICENSEE’S PURPOSES. 
 10.3 Limitation of Liability. IN NO EVENT SHALL EITHER PARTY BE LIABLE FOR ANY INDIRECT, SPECIAL, INCIDENTAL, EXEMPLARY OR CONSEQUENTIAL DAMAGES (INCLUDING WITHOUT LIMITATION DAMAGES FOR LOSS OF
PROFITS OR EXPECTED SAVINGS) ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT OR ITS SUBJECT MATTER, EXCEPT FOR LIABILITY FOR BREACH BY SUCH PARTY OF ANY OF THE CONFIDENTIALITY PROVISIONS IN SECTION 11 AND EXCEPT FOR LICENSEE’S INDEMNITY
UNDER SECTION 9.1. TSRI’S AGGREGATE LIABILITY, IF ANY, FOR ALL DAMAGES OF ANY KIND RELATING TO THIS AGREEMENT OR ITS SUBJECT MATTER SHALL NOT EXCEED THE AMOUNT PAID BY LICENSEE TO TSRI UNDER THIS AGREEMENT. THE FOREGOING EXCLUSIONS AND
LIMITATIONS SHALL APPLY TO ALL CLAIMS AND ACTIONS OF ANY KIND AND ON ANY THEORY OF LIABILITY, WHETHER BASED ON CONTRACT, TORT (INCLUDING, BUT NOT LIMITED TO NEGLIGENCE OR STRICT LIABILITY), OR ANY OTHER GROUNDS, AND REGARDLESS OF WHETHER A PARTY HAS
BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, AND NOTWITHSTANDING ANY FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY. THE PARTIES FURTHER 

  

*Confidential Treatment Requested. 
 26 

 EXECUTION COPY 

 

 
AGREE THAT EACH WARRANTY DISCLAIMER, EXCLUSION OF DAMAGES OR OTHER LIMITATION OF LIABILITY HEREIN IS INTENDED TO BE SEVERABLE AND INDEPENDENT OF THE OTHER PROVISIONS BECAUSE THEY EACH REPRESENT
SEPARATE ELEMENTS OF RISK ALLOCATION BETWEEN THE PARTIES. 
 11. Confidentiality and Publication. 

11.1 Treatment of Confidential Information. The Parties agree that during the term of this Agreement, and for a period of five
(5) years after expiration or termination of this Agreement, a Party receiving Confidential Information of the other Party will (a) maintain in confidence such Confidential Information to the same extent such Party maintains its own
proprietary information; (b) not disclose such Confidential Information to any third party without prior written consent of the other Party; and (c) not use such Confidential Information for any purposes except those permitted by this
Agreement; provided further, that TSRI shall only disclose Confidential Information of Licensee to a TSRI trustee, director, officer, faculty member, or other employee on a need to know basis, and shall make such disclosure of such
Confidential Information only to the extent necessary to satisfy such need to know. Notwithstanding the foregoing, if a Party is required by law, regulation or court order to disclose Confidential Information of the other Party, the Party required
to make such disclosure shall (i) promptly send a copy of the order or notice to the other Party not later than ten (10) days before the proposed disclosure or such shorter period of time as may be reasonably practical under the
circumstances; (ii) cooperate with the other Party if the other Party wishes to object or condition such disclosure through a protective order or otherwise; (iii) limit the extent of such disclosure to the minimum required to comply with
the order or notice; and (iv) use reasonable efforts to seek confidential treatment (i.e., filing “under seal”) for that disclosure. In addition, Licensee may disclose Confidential Information of TSRI: (A) to its
Affiliates and employees, to Sublicensees and potential Sublicensees (in the case of Licensee), provided, in each case, that any such Affiliate, employee, Sublicensee, or potential Sublicensee agrees in writing to be bound by terms of
confidentiality and non-use at least as stringent as those set forth in this Section 11; and (B) on a confidential basis to other third parties who are investors or potential investors in connection with due diligence or similar
investigations or in confidential financing documents. In each of the cases described in clauses (A) and (B) above, the recipient of TSRI’s Confidential Information shall have no further right to disclose or distribute such
Confidential Information to any person outside of recipient’s organization. 
 11.2 Publications. Licensee agrees
that TSRI shall have the right to publish in accordance with its general policies, and that this Agreement shall not restrict, in any fashion, TSRI’s right to publish; provided, however, that TSRI shall, consistent with such policies,
use reasonable efforts to identify and protect patentable subject matter disclosed in such publications prior to publication; and provided further, that the foregoing shall not be construed to grant TSRI the right to publish or otherwise
disclose any Confidential Information of Licensee, its Affiliates or Sublicensees. 
 11.3 Publicity. Except as otherwise
required by any applicable law, rule or regulation (including, without limitation, rules of the U.S. Securities and Exchange Commission and rules of any stock exchange upon which Licensee’s securities may be listed), no Party shall originate
any publication, news release or other public announcement, written or oral, whether in the 

  
 27 

 EXECUTION COPY 

 

 
public press, stockholders’ reports, or otherwise, relating to this Agreement or to any sublicense hereunder, or to the performance hereunder or under any such sublicense agreements, without
the prior written approval of the other Party, which approval shall not be unreasonably withheld. Scientific publications published in accordance with Section 11.2 of this Agreement shall not be construed as publicity governed by this
Section 11.3. 
 12. Term and Termination. 
 12.1 Term. Unless terminated sooner in accordance with the terms set forth herein, this Agreement, and the licenses granted hereunder, shall terminate at such time as no further royalties are due
to TSRI hereunder as provided in Section 3.10 hereof. 
 12.2 Termination Upon Mutual Agreement. This Agreement may
be terminated by mutual written consent of both Parties. 
 12.3 Termination by TSRI. TSRI may terminate this Agreement
as follows: 
 (a) If Licensee does not make a payment due hereunder and fails to cure such non-payment
(including the payment of interest pursuant to Section 14.2) within [*] days after the date of Licensee’s receipt of a notice in writing of such non-payment by TSRI; 

(b) Upon written notice to Licensee in the event of the filing of bankruptcy by Licensee, or the appointment of a receiver
of any of Licensee’s assets, or the making by Licensee of any assignment for the benefit of creditors, or the filing by any third party of any involuntary bankruptcy proceedings against Licensee that is not dismissed within [*] days;

 (c) If Licensee is convicted of a felony relating to the development, manufacture, use, marketing,
distribution or sale of Licensed Products; 
 (d) If an examination by TSRI’s accounting firm pursuant to
Section 7 shows, for any calendar year, an underreporting or underpayment by Licensee of the greater of [*] and [*] (the “Threshold Amount”) or more, and a subsequent audit shows a second underreporting or underpayment by
Licensee of the Threshold Amount or more; or 
 (e) Except as provided in subparagraphs (a) —
(d) above, if Licensee materially breaches any provision of this Agreement and such breach has not been remedied within [*] days after the date of Licensee’s receipt of a notice in writing of such breach delivered by TSRI. 

12.4 Termination by Licensee. Licensee may terminate this Agreement (a) without cause by giving at least ninety
(90) days’ advance written notice of termination to TSRI, or (b) if TSRI materially breaches any provision of this Agreement and such breach has not been remedied within forty-five (45) days after the date of TSRI’s receipt
of a notice in writing of such breach delivered by Licensee. 
 12.5 Rights Upon Expiration. Notwithstanding anything to
the contrary in Section 12.1, upon expiration (but not earlier termination) of this Agreement, the licenses granted to Licensee hereunder shall survive on a fully paid, royalty free, irrevocable, perpetual basis.

  

*Confidential Treatment Requested. 
 28 

 EXECUTION COPY 

 

 
Except as provided in the preceding sentence, neither Party shall have any further rights or obligations upon the expiration of this Agreement in its entirety upon its regularly scheduled
expiration date, other than the obligation of Licensee to make any and all reports and payments due under Section(s) 3 and/or 4 with respect to events that occurred prior to such expiration in accordance with Sections 6.3, 6.4, 6.5 and 6.6.
Notwithstanding the above, Sections 2.5, 2.6, 2.7, 2.8, 7, 9, 10.2, 10.3, 11, 12, 13 and 14 shall also survive the expiration of this Agreement. 
 12.6 Rights Upon Termination. Notwithstanding any other provision of this Agreement, upon any termination of this Agreement prior to the regularly scheduled expiration date of this Agreement, all
licenses granted hereunder shall terminate and revert to TSRI, except as expressly provided in Section 12.7 of this Agreement with respect to work in progress. Each sublicense granted hereunder that was in effect immediately prior to such
termination will survive such termination, with TSRI as the Sublicensee’s direct licensor, provided that: 
 (a) such Sublicensee is not the cause of a breach that resulted in termination of this Agreement, and such Sublicensee is not itself in default of its sublicense or this Agreement; 

(b) such Sublicensee pays to TSRI any and all unpaid amounts (including but not limited to royalties, milestones,
Sublicensee Payments) owed by Licensee under this Agreement that were past-due at the time of termination within 30 days after receipt of an itemized (by type of payment) written invoice from TSRI. However, TSRI agrees that, if more than one
sublicense survives termination as described herein, then TSRI shall not have the right to recover more than 100% of any particular past-due amount from all such Sublicensees in the aggregate — e.g., if TSRI invoices one Sublicensee for,
and such Sublicensee pays, all past-due royalties, no other Sublicensee will be liable to TSRI for any such past-due royalties; and 
 (c) such Sublicensee’s payment obligations with respect to its surviving license to the Licensed Patent Rights shall be those set forth in this Agreement (and not those set forth in the sublicense
agreement between such Sublicensee and Licensee or its Affiliate); and 
 (d) such Sublicensee delivers to TSRI
within 60 days after termination of this Agreement an executed license agreement with TSRI in the form of, and on the terms and conditions set forth in, this Agreement (“New License Agreement”), which shall also contain provisions
that: (i) such Sublicensee shall not have any obligations to TSRI other than Sublicensee’s obligations to TSRI as set forth in the New License Agreement (ii) TSRI shall have no liability to such Sublicensee for any actual or alleged
breach of the sublicense agreement by the entity that granted such Sublicensee its sublicense (i.e., Licensee, an Affiliate or another Sublicensee, as applicable); and (iii) TSRI shall not have any obligations to such Sublicensee other
than TSRI’s obligations to such Sublicensee as set forth in the New License Agreement; and 
 (e) in no
event shall TSRI or such Sublicensees be obliged to accept provisions in the New License Agreement (i) unless such provisions correspond to rights granted by Licensee or the applicable sublicensor in conformance with this Agreement, and such
provisions are not in conflict with the rights, duties and obligations accruing to Licensee under this Agreement; or (ii) where such provisions are inconsistent with the legal obligations under any other sublicense agreement granted by Licensee
or the applicable sublicensor, or by applicable federal, state or local statute or regulation. 

  
 29 

 EXECUTION COPY 

 

 This Section 12.6 must be included or specifically referenced in a sublicense
agreement in order for the applicable Sublicensee’s sublicense to survive termination of this Agreement. 
 Any such
termination shall not relieve either Party from any obligations accrued to the date of such termination, including without limitation the obligation of Licensee to make any and all reports and payments due under Section(s) 3 and/or 4 with respect to
events that occurred prior to such termination or as provided in Section 12.7, in each case in accordance with Sections 6.3, 6.4, 6.5 and 6.6. Notwithstanding the above, Sections 2.5, 2.6, 2.7, 2.8, 7, 9, 10.2, 10.3, 11, 12, 13 and 14 shall
also survive the termination of this Agreement. 
 12.7 Work in Progress. Upon any early termination of the license
granted hereunder in accordance with this Agreement, Licensee shall be entitled to finish any work in progress and to sell any completed inventory of Licensed Products covered by such license which remain on hand as of the date of the termination,
so long as Licensee sells such inventory in the normal course of business and at regular selling prices and pays to TSRI the royalties applicable to such subsequent sales in accordance with the terms and conditions as set forth in this Agreement,
provided that no such sales shall be permitted after the expiration of six (6) months after the date of termination. 
 12.8 Final Royalty Report. Within 60 days after termination or expiration of this Agreement, Licensee shall submit a final Royalty Report to TSRI, and any payments due TSRI and invoiced by TSRI
shall become immediately payable with submission of the final Royalty Report. 
 13. Assignment; Successors. 

13.1 Assignment. Any and all assignments of this Agreement, or any rights granted hereunder, by Licensee without TSRI’s prior
written consent are void, except that: (a) Licensee may assign this Agreement or rights granted hereunder without TSRI’s prior written consent to an Affiliate; and (b) Licensee may assign this Agreement and its rights and obligations
hereunder without TSRI’s consent in connection with a merger or the transfer or sale of all or substantially all of Licensee’s assets or stock, provided that in either of the above cases the Affiliate or successor or assignee of
Licensee’s interest shall expressly assume in writing the performance of all the terms and conditions of this Agreement to be performed by Licensee and such written assumption shall be delivered to TSRI concurrently with the consummation of
such transfer or assignment. 
 13.2 Binding Upon Successors and Assigns. Subject to the limitations on assignment set
forth in Section 13.1, this Agreement shall be binding upon and inure to the benefit of any successors in interest and assigns of TSRI and Licensee. 

  
 30 

 EXECUTION COPY 

 

 14. General Provisions. 

14.1 Independent Contractors. The relationship between TSRI and Licensee is that of independent contractors. TSRI and Licensee are
not joint venturers, partners, principal and agent, master and servant, employer or employee, and have no other relationship other than independent contracting parties. TSRI and Licensee shall have no power to bind or obligate each other in any
manner, other than as is expressly set forth in this Agreement. 
 14.2 Late Payments. Late payments of any and all
payments due hereunder shall be subject to a charge of [*] per month, or, if lower, the maximum legally permissible interest rate. 
 14.3 Governmental Approvals and Marketing of Licensed Products. Licensee shall be responsible for obtaining all necessary governmental approvals for the development, production, distribution,
performance, sale and use of any Licensed Product, at Licensee’s expense, including, without limitation, any safety studies. Licensee shall have sole responsibility for any warning labels, packaging and instructions as to the use of Licensed
Products and for the quality control for any Licensed Products. 
 14.4 Patent Marking. To the extent required by
applicable law, Licensee shall mark all Licensed Products or their containers in accordance with the applicable patent marking laws. 
 14.5 No Use of Name. The use of the name “The Scripps Research Institute”, “Scripps”, “TSRI” or any variation thereof in connection with the marketing, advertising,
promotion, or, subject to Section 14.4, the distribution or sale, of Licensed Products is expressly prohibited. The use of the names of Licensee, its Affiliates and Sublicensees in connection with the marketing, advertising, and promotion
activities of TSRI without the prior written consent of Licensee is prohibited. 
 14.6 U.S. Manufacture. To the extent
required, Licensee agrees to abide by the Preference for United States Industry as set forth in 37 CFR 401.14 (I). 
 14.7
Foreign Registration. Licensee agrees to register this Agreement with any foreign governmental agency which requires such registration, and Licensee shall pay all costs and legal fees in connection therewith. In addition, Licensee shall
ensure that all foreign laws affecting this Agreement or the sale of Licensed Products are fully satisfied. 
 14.8
Arbitration. Any controversy or claim arising out of or relating to this Agreement, or the breach thereof, shall be referred to the Chief Executive Officer of Licensee and a designated official of TSRI with authority to resolve such dispute,
for resolution. Such individuals shall meet to discuss such controversy or claim within twenty (20) days after the request of either Party and shall work in good faith to resolve such controversy or claim within thirty (30) days
thereafter. In the event the two individuals referred to in the preceding sentence are unable to resolve such dispute prior to the end of such 30 day period, then, upon the written request of either Party to the other Party, the dispute shall be
settled by binding confidential arbitration in accordance with the Commercial Arbitration Rules (“Rules”) of the American Arbitration Association (“AAA”), and the procedures set forth below; provided,
however, that any Challenge and any controversy or claim relating solely to the construction of the claims of the Licensed Patent Rights or the infringement of the Licensed Patent Rights shall be determined solely by a court or other government
body of competent jurisdiction. In the event of any inconsistency between the Rules of AAA and the procedures set forth below, the procedures set forth below shall control. Judgment upon the award rendered by the arbitrators may be enforced in any
court having jurisdiction thereof. 

  

*Confidential Treatment Requested. 
 31 

 EXECUTION COPY 

 

 14.8.1 Location. The location of the arbitration shall be in the
County of San Diego. TSRI and Licensee hereby irrevocably submit to the exclusive jurisdiction and venue of the American Arbitration Association arbitration panel selected by the Parties and located in San Diego County, California for any claim or
controversy arising under this Agreement (excluding any Challenges), and waive any right to contest or otherwise object to such jurisdiction or venue. TSRI and Licensee further irrevocably submit to the exclusive jurisdiction and venue of the
federal courts located in San Diego County for any Challenges (other than Challenges which are subject to the exclusive jurisdiction of the U.S. Patent and Trademark Office and/or Board of Patent Appeals and Interferences) with respect to any U.S.
Licensed Patent Rights and any controversy or claim relating solely to the construction of the claims of any U.S. Licensed Patent Rights or the infringement of any U.S. Licensed Patent Rights, and waive any right to contest or otherwise object to
such jurisdiction or venue. 
 14.8.2 Selection of Arbitrators. The arbitration shall be conducted by a
panel of three neutral arbitrators who are independent and disinterested with respect to the Parties, this Agreement, and the outcome of the arbitration. Each Party shall appoint one neutral arbitrator, and these two arbitrators so selected by the
Parties shall then select the third arbitrator, and all arbitrators must have at least ten (10) years experience in mediating or arbitrating cases regarding the same or substantially similar subject matter as the dispute between Licensee and
TSRI. If one Party has given written notice to the other Party as to the identity of the arbitrator appointed by the Party, and the Party thereafter makes a written demand on the other Party to appoint its designated arbitrator within the next ten
days, and the other Party fails to appoint its designated arbitrator within ten days after receiving said written demand, then the arbitrator who has already been designated shall appoint the other two arbitrators. 

14.8.3 Discovery. The arbitrators shall decide all disputes referred to arbitration and shall control the process
concerning pre-hearing discovery matters. Pursuant to the Rules of AAA, the Parties may subpoena witnesses and documents for presentation at the hearing. 
 14.8.4 Case Management. Prompt resolution of any dispute is important to both Parties; and the Parties agree that the arbitration of any dispute shall be conducted expeditiously. The arbitrators
are instructed and directed to assume case management initiative and control over the arbitration process (including scheduling of events, pre-hearing discovery and activities, and the conduct of the hearing), in order to complete the arbitration as
expeditiously as is reasonably practical for obtaining a just resolution of the dispute. 
 14.8.5
Remedies. The arbitrators may grant any legal or equitable remedy or relief that the arbitrators deem just and equitable, to the same extent that remedies or relief could be granted by a state or federal court, subject to the limitations of
liability set forth in Section 10.3. The decision of any two of the three arbitrators appointed shall be binding upon the Parties. Notwithstanding anything to the contrary in this Agreement, prior to or while an arbitration proceeding is
pending, either Party has the right to seek and obtain injunctive and other equitable relief from a court of competent jurisdiction in the context of a bona fide emergency or prospective irreparable harm. 

  
 32 

 EXECUTION COPY 

 

 14.8.6 Expenses. The expenses of the arbitration, including the
arbitrators’ fees, expert witness fees, and attorneys’ fees, may be awarded to the prevailing Party, in the discretion of the arbitrators, or may be apportioned between the Parties in any manner deemed appropriate by the arbitrators.
Unless and until the arbitrators decide that one Party is to pay for all (or a share) of such expenses, both Parties shall share equally in the payment of the arbitrators’ fees as and when billed by the arbitrators. 

14.8.7 Confidentiality. Except as set forth below, and as necessary to obtain or enforce a judgment upon any
arbitration award, the Parties shall keep confidential the fact of the arbitration, the dispute being arbitrated, and the decision of the arbitrators. Notwithstanding the foregoing, the Parties may disclose information about the arbitration to
persons who have a need to know, such as directors, trustees, management employees, witnesses, experts, investors, attorneys, lenders, insurers, and others who may be directly affected. Additionally, a Party may make such disclosures as are required
by applicable securities laws or rules or, if such Party is publicly traded, regulations of any stock exchange upon which securities are traded or listed, but will use commercially reasonable efforts to seek confidential treatment for such
disclosure. 
 14.9 Entire Agreement; Modification. This Agreement and all of the attached Exhibits set forth the entire
agreement and understanding between the Parties as to the subject matter hereof, and supersede all prior or contemporaneous agreements or understandings, whether oral or written, between the Parties; provided that the terms of the CDAs shall
continue to apply to disclosures between the Parties before the Effective Date. There shall be no amendments or modifications to this Agreement, except by a written document which is signed by both Parties. 

14.10 California Law. This Agreement shall be construed and enforced in accordance with the laws of the State of California
without regard to its conflicts or choice of laws principles thereof. 
 14.11 Headings. The headings for each article
and section in this Agreement have been inserted for convenience of reference only and are not intended to limit or expand on the meaning of the language contained in the particular article or section. 

14.12 Severability. Should any one or more of the provisions of this Agreement be held invalid or unenforceable by a court of
competent jurisdiction, it shall be considered severed from this Agreement and shall not serve to invalidate the remaining provisions thereof. The Parties shall make a good faith effort to replace any invalid or unenforceable provision with a valid
and enforceable one such that the objectives contemplated by them when entering this Agreement may be realized. 
 14.13 No
Waiver. Any delay in enforcing a Party’s rights under this Agreement or any waiver as to a particular default or other matter shall not constitute a waiver of such Party’s rights to the future enforcement of its rights under this
Agreement, excepting only as to an express written and signed waiver as to a particular matter for a particular period of time. 

14.14 Name. Whenever there has been an assignment or a sublicense by Licensee as permitted by this Agreement, the term
“Licensee” as used in this Agreement shall also include and refer to, if appropriate, such assignee or Sublicensee (to the extent of such assignment or sublicense). 

  
 33 

 EXECUTION COPY 

 

 14.15 Notices. Any notices required by this Agreement shall be in writing, shall
specifically refer to this Agreement and shall be sent by registered or certified first class mail, postage prepaid, or by facsimile machine, charges prepaid, or by reputable overnight courier, postage prepaid and shall be forwarded to the
respective addresses set forth below unless subsequently changed by written notice to the other Party: 
  

			
	 For TSRI:
	  	 The Scripps Research Institute
 10550 North Torrey Pines Road, TPC-9
 La Jolla, California 92037

[*]
 [*]

		
	 with a copy to:
	  	 The Scripps Research Institute
 10550 North Torrey Pines Road, TPC-8
 La Jolla, California 92037

[*]
 [*]

		
	 For Licensee:
	  	 Allozyne, Inc.
 1600
Fairview Avenue East
 Suite 300

Seattle, Washington 98102
 Attention: Chief
Executive Officer
 Fax No.: (206) 518 5799

		
	 with a copy to:
	  	 (which shall not constitute notice)
 Cooley LLP
 719 Second Avenue
 Suite 900
 Seattle, WA 98104
 Attention: Gordon Empey
 Fax No.: 206-452-8800

 Notices shall be deemed delivered upon the earlier of (a) when received; (b) three (3) days after
deposit into the U.S. mail; (c) the date notice is sent via facsimile machine; or (d) the day immediately following delivery to an overnight courier guaranteeing next-day delivery (except Sunday and holidays). 

14.16 Compliance with U.S. Laws. Nothing contained in this Agreement shall require or permit TSRI or Licensee to do any act
inconsistent with the requirements of any United States law, regulation or executive order as the same may be in effect from time to time. 
 14.17 Counterparts. This Agreement may be executed by original or facsimile signature in two or more counterparts, all of which taken together shall constitute a single instrument. 

  

*Confidential Treatment Requested. 
 34 

 EXECUTION COPY 

 

 IN WITNESS WHEREOF, the Parties have executed this Agreement by their duly authorized
representatives as of the Effective Date. 
  

									
	TSRI:	 		 	LICENSEE:
			
	THE SCRIPPS RESEARCH INSTITUTE	 		 	ALLOZYNE, INC.
					
	By:	 	/s/	 		 	By:	 	/s/ MEENU CHHABRA
					
	Name:	 	 	 		 	Name:	 	MEENU CHHABRA
					
	Title:	 	 	 		 	Title:	 	PRESIDENT & CEO
					
	Date:	 	6 July 2010	 		 	Date:	 	July 7 2010

  
 35 

 EXECUTION COPY 

 

 EXHIBIT A 

LICENSED PATENT RIGHTS 
  

																					
	 Serial
Number
	  	Patent
Number	 	  	Inventors	 	  	Title	 	  	Filing Date	 	  	Issue Date	 
	 [*]
	  	 	[*]	  	  	 	[*]	  	  	 	[*]	  	  	 	[*]	  	  	 	[*]	  

  

*Confidential Treatment Requested. 
 36 

 EXECUTION COPY 

 

 EXHIBIT B 

ALLOZYNE, INC. 
 COMMON STOCK PURCHASE AGREEMENT 
 This Common Stock Purchase
Agreement (the “Agreement”) is made as of June 25, 2010 by and between Allozyne, Inc., a Delaware corporation (the “Company”), and The Scripps Research Institute, a California nonprofit public benefit
corporation (“Purchaser”). 
 1. Sale of Stock. Subject to the terms and conditions of this
Agreement, on the Purchase Date (as defined below) the Company will issue and sell to Purchaser, and Purchaser agrees to purchase from the Company, Twenty-Five Thousand (25,000) shares at $0.23 per share of the Company’s Common Stock (the
“Shares”) as partial consideration for the license to certain intellectual property granted by Purchaser to the Company pursuant to that certain License Agreement between the parties dated on or about the date hereof (the
“License Agreement”). The term “Shares” refers to the purchased Shares and all securities received in replacement of or in connection with the Shares pursuant to stock dividends or splits, all securities received in
replacement of the Shares in a recapitalization, merger, reorganization, exchange or the like, and all new, substituted or additional securities or other properties to which Purchaser is entitled by reason of Purchaser’s ownership of the
Shares. 
 2. Purchase. The purchase and sale of the Shares under this Agreement shall occur at the principal
office of the Company simultaneously with the execution of this Agreement by the parties or on such other date as the Company and Purchaser shall agree (the “Purchase Date”). On the Purchase Date, the Company will deliver to
Purchaser a certificate representing the Shares to be purchased by Purchaser (which shall be issued in Purchaser’s name) against payment of the purchase price therefor by Purchaser’s execution and delivery of the License Agreement.

 3. Limitations on Transfer. In addition to any other limitation on transfer created by applicable securities
laws, Purchaser shall not assign, encumber or dispose of any interest in such Shares except in compliance with the provisions below and applicable securities laws. 
 (a) Right of First Refusal. Before any Shares held by Purchaser or any transferee of Purchaser (either being sometimes referred to herein as the “Holder”) may be sold or
otherwise transferred (including transfer by gift or operation of law), the Company or its assignee(s) shall have a right of first refusal to purchase the Shares on the terms and conditions set forth in this Section 3(a) (the “Right of
First Refusal”). 
 (i) Notice of Proposed Transfer. The Holder of the Shares shall deliver to the
Company a written notice (the “Notice”) stating: (A) the Holder’s bona fide intention to sell or otherwise transfer such Shares; (B) the name of each proposed purchaser or other transferee (“Proposed
Transferee”); (C) the number of Shares to be transferred to each Proposed Transferee; and (D) the terms and conditions of each proposed sale or transfer. The Holder shall offer the Shares at the same price (the “Offered
Price”) and upon the same terms (or terms as similar as reasonably possible) to the Company or its assignee(s). 

  
 37 

 (ii) Exercise of Right of First Refusal. At any time within 30 days after
receipt of the Notice, the Company and/or its assignee(s) may, by giving written notice to the Holder, elect to purchase all, but not less than all, of the Shares proposed to be transferred to any one or more of the Proposed Transferees, at the
purchase price determined in accordance with subsection (iii) below. 
 (iii) Purchase Price. The purchase
price (“Purchase Price”) for the Shares purchased by the Company or its assignee(s) under this Section 3(a) shall be the Offered Price. If the Offered Price includes consideration other than cash, the cash equivalent value of
the non-cash consideration shall be determined by the Board of Directors of the Company in good faith. 
 (iv)
Payment. Payment of the Purchase Price shall be made, at the option of the Company or its assignee(s), in cash (by check), by cancellation of all or a portion of any outstanding indebtedness, or by any combination thereof within 30
days after receipt of the Notice or in the manner and at the times set forth in the Notice. 
 (v) Holder’s Right to
Transfer. If all of the Shares proposed in the Notice to be transferred to a given Proposed Transferee are not purchased by the Company and/or its assignee(s) as provided in this Section 3(a), then the Holder may sell or otherwise
transfer such Shares to that Proposed Transferee at the Offered Price or at a higher price, provided that such sale or other transfer is consummated within 60 days after the date of the Notice and provided further that any such sale or other
transfer is effected in accordance with any applicable securities laws and the Proposed Transferee agrees in writing that the provisions of this Section 3 shall continue to apply to the Shares in the hands of such Proposed Transferee. If the
Shares described in the Notice are not transferred to the Proposed Transferee within such period, or if the Holder proposes to change the price or other terms to make them more favorable to the Proposed Transferee, a new Notice shall be given to the
Company, and the Company and/or its assignees shall again be offered the Right of First Refusal before any Shares held by the Holder may be sold or otherwise transferred. 
 (vi) Right to Transfer to Inventors. Notwithstanding anything contrary in this Section 3(a), Purchaser has the right to transfer a portion of Shares to the inventors of the Licensed
Patent Rights (as defined in the License Agreement) which are the subject of the License Agreement (each such inventor, a “TSRI Transferee”). TSRI will notify the Company in writing of the name, address and number of Shares to be
transferred to each proposed TSRI Transferee. Furthermore, as a condition to permitting each TSRI Transferee to receive his/her Shares as set forth above, each TSRI Transferee shall execute and deliver to the Company a Common Stock Purchase
Agreement, in substantially the same form as this Agreement, pursuant to which each such TSRI Transferee shall agree to be bound by the terms and conditions hereof. The company may prohibit the transfer to any TSRI Transferee who refuses to execute
and deliver such Common Stock Purchase Agreement. 
 (b) Involuntary Transfer. 

(i) Company’s Right to Purchase upon Involuntary Transfer. In the event, at any time after the date of this Agreement,
of any transfer by operation of law or 

  
 38 

 
other involuntary transfer of all or a portion of the Shares by the record holder thereof, the Company shall have the right to purchase all of the Shares transferred at the greater of the
purchase price paid by Purchaser pursuant to this Agreement or the fair market value of the Shares on the date of transfer. Upon such a transfer, the person acquiring the Shares shall promptly notify the Secretary of the Company of such transfer.
The right to purchase such Shares shall be provided to the Company for a period of 30 days following receipt by the Company of written notice by the person acquiring the Shares. 

(ii) Price for Involuntary Transfer. With respect to any stock to be transferred pursuant to Section 3(b)(i), the
price per Share shall be a price set by the Board of Directors of the Company that will reflect the current value of the stock in terms of present earnings and future prospects of the Company. The Company shall notify Purchaser or his or her
executor of the price so determined within 30 days after receipt by it of written notice of the transfer or proposed transfer of Shares. However, if Purchaser does not agree with the valuation as determined by the Board of Directors of the Company,
Purchaser shall be entitled to have the valuation determined by an independent appraiser to be mutually agreed upon by the Company and Purchaser and whose fees shall be borne equally by the Company and Purchaser. 

(c) Assignment. The right of the Company to purchase any part of the Shares may be assigned in whole or in part to any
shareholder or shareholders of the Company or other persons or organizations. 
 (d) Restrictions Binding on
Transferees. All transferees of Shares or any interest therein will receive and hold such Shares or interest subject to the provisions of this Agreement. In the event of any purchase by the Company hereunder where the Shares or interest are
held by a transferee, the transferee shall be obligated, if requested by the Company, to transfer the Shares or interest to the Purchaser for consideration equal to the amount to be paid by the Company hereunder. Any sale or transfer of the Shares
shall be void unless the provisions of this Agreement are satisfied. 
 (e) Termination of Rights. The Right of
First Refusal and the Company’s right to repurchase the Shares in the event of an involuntary transfer pursuant to Section 3(b) above shall terminate upon the first sale of Common Stock of the Company to the general public pursuant to a
registration statement filed with and declared effective by the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”). 

(f) Lock-up Agreement. In connection with any public offering of the Company’s securities and upon request of the
Company or the underwriters managing such offering of the Company’s securities, Purchaser agrees not to sell, make any short sale of, loan, grant any option for the purchase of, or otherwise dispose of any securities of the Company (other than
those included in the registration) without the prior written consent of the Company or such underwriters, as the case may be, for such period of time (not to exceed 180 days in the Company’s initial public offering, but subject to such
extensions as may be required by the underwriters in order to publish research reports while complying with Rule 2711 of the Financial Industry Regulatory Authority, Inc.) from the effective date of such registration as may be requested by the
Company or such managing underwriters and to execute an agreement reflecting the foregoing as may be requested by the underwriters at the time of any such 

  
 39 

 
Company public offering. The Company may impose stop-transfer instructions with respect to the Common Stock owned by the Purchaser to enforce the provisions of this Section 3(f). 

4. Investment and Taxation Representations. In connection with the purchase of the Shares, Purchaser represents to the
Company the following: 
 (a) Purchaser is aware of the Company’s business affairs and financial condition and has acquired
sufficient information about the Company to reach an informed and knowledgeable decision to acquire the Shares. Purchaser is purchasing the Shares for investment for his or her own account only and not with a view to, or for resale in connection
with, any “distribution” thereof within the meaning of the Securities Act. 
 (b) Purchaser understands that the
Shares have not been registered under the Securities Act by reason of a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of Purchaser’s investment intent as expressed herein. 

(c) Purchaser understands that the Shares are “restricted securities” under applicable U.S. federal and state securities laws
and that, pursuant to these laws, Purchaser must hold the Shares indefinitely unless they are registered with the Securities and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification
requirements is available. Purchaser acknowledges that the Company has no obligation to register or qualify the Shares for resale. Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be
conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for the Shares, and requirements relating to the Company which are outside of the Purchaser’s control, and which the Company is
under no obligation and may not be able to satisfy. 
 (d) Purchaser understands that Purchaser may suffer adverse tax
consequences as a result of Purchaser’s purchase or disposition of the Shares. Purchaser represents that Purchaser has consulted any tax consultants Purchaser deems advisable in connection with the purchase or disposition of the Shares and that
Purchaser is not relying on the Company for any tax advice. 
 5. Restrictive Legends and Stop-Transfer Orders.

 (a) Legends. The certificate or certificates representing the Shares shall bear the following legends (as well
as any legends required by applicable state and federal corporate and securities laws): 
  

	 	(i)	 THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT
WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH SALE OR DISTRIBUTION MAY BE EFFECTED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY

  
 40 

	 	
THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OF 1933. 

  

	 	(ii)	THE SHARES REPRESENTED BY THIS CERTIFICATE MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND THE SHAREHOLDER, A COPY OF WHICH
IS ON FILE WITH THE SECRETARY OF THE COMPANY. 

  

	 	(iii)	Any legend required to be placed thereon by the California Commissioner of Corporations. 

(b) Stop-Transfer Notices. Purchaser agrees that, in order to ensure compliance with the restrictions referred to herein,
the Company may issue appropriate “stop transfer” instructions to its transfer agent, if any, and that, if the Company transfers its own securities, it may make appropriate notations to the same effect in its own records. 

(c) Refusal to Transfer. The Company shall not be required (i) to transfer on its books any Shares that have been sold
or otherwise transferred in violation of any of the provisions of this Agreement or (ii) to treat as owner of such Shares or to accord the right to vote or pay dividends to any purchaser or other transferee to whom such Shares shall have been
so transferred. 
 (d) Removal of Legend. When all of the following events have occurred, the Shares then held by
Purchaser will no longer be subject to the legend referred to in Section 5(a)(ii): (i) the termination of the Right of First Refusal; and (ii) the expiration or termination of the market standoff provisions of Section 3(f) (and
of any agreement entered pursuant to Section 3(f)). After such time, and upon Purchaser’s request, a new certificate or certificates representing the Shares not repurchased shall be issued without the legend referred to in
Section 5(a)(ii), and delivered to Purchaser. 
 6. Miscellaneous. 

(a) Governing Law. This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the
parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of Delaware, without giving effect to principles of conflicts of law. 
 (b) Entire Agreement; Enforcement of Rights. This Agreement sets forth the entire agreement and understanding of the parties relating to the subject matter herein and merges all prior
discussions between them. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing signed by the parties to this Agreement. The failure by either party to enforce any
rights under this Agreement shall not be construed as a waiver of any rights of such party. 
 (c) Severability.
If one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable
replacement for 

  
 41 

 
such provision, then (i) such provision shall be excluded from this Agreement, (ii) the balance of the Agreement shall be interpreted as if such provision were so excluded and
(iii) the balance of the Agreement shall be enforceable in accordance with its terms. 
 (d) Construction.
This Agreement is the result of negotiations between and has been reviewed by each of the parties hereto and their respective counsel, if any; accordingly, this Agreement shall be deemed to be the product of all of the parties hereto, and no
ambiguity shall be construed in favor of or against any one of the parties hereto. 
 (e) Notices. Any notice
required or permitted by this Agreement shall be in writing and shall be deemed sufficient when delivered personally or sent by fax or 48 hours after being deposited in the U.S. mail, as certified or registered mail, with postage prepaid, and
addressed to the party to be notified at such party’s address or fax number as set forth below or as subsequently modified by written notice. 
 (f) Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original and all of which together shall constitute one instrument. 

(g) Successors and Assigns. The rights and benefits of this Agreement shall inure to the benefit of, and be enforceable by
the Company’s successors and assigns. The rights and obligations of Purchaser under this Agreement may only be assigned with the prior written consent of the Company. 
 (h) California Corporate Securities Law. THE SALE OF THE SECURITIES WHICH ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE OF
CALIFORNIA AND THE ISSUANCE OF THE SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO THE QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS EXEMPT FROM QUALIFICATION BY SECTION 25100, 25102 OR 25105 OF
THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY CONDITIONED UPON THE QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT. 
 [Signature Page Follows] 

  
 42 

 The parties have executed this Agreement as of the date first set forth above. 

 

	
	COMPANY:
	
	ALLOZYNE, INC.

  

			
	By:	 	/S/ MEENU CHHABRA
		
	Name:	 	MEENU CHHABRA
		
	Title:	 	PRESIDENT & CEO
		
	Address:	 	
	
	1600 Fairview Avenue East
	Suite 300
	Seattle, Washington 98102
	Fax No.: (206)-518-5799

  

			
	PURCHASER:
	
	THE SCRIPPS RESEARCH INSTITUTE
		
	By:	 	 
		
	Name:	 	 
		
	Title:	 	 
		
	Address:	 	
	
	10550 North Torrey Pines Road, TPC-8
	La Jolla, California 92037

  
 43EX-10.1

 Exhibit 10.1 

Execution Version 
  

 
  

 
 AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT 

dated as of October 1, 2011 
 by and among 
 MPC TRADE RECEIVABLES COMPANY LLC, 

as Seller 

MARATHON PETROLEUM COMPANY LP, 
 as Servicer 
 THE PURCHASERS FROM TIME TO TIME PARTY HERETO 

THE MANAGING AGENTS FROM TIME TO TIME PARTY HERETO 
 THE L/C ISSUERS FROM TIME TO TIME PARTY HERETO 
 and 

JPMORGAN CHASE BANK, N.A., 
 as Administrative Agent 
  

 
 J.P. MORGAN
SECURITIES LLC, 
 as Sole Lead Arranger 
  

 
  

 TABLE OF CONTENTS 

 

							
	 	 	 	  	Page	 
	
	 ARTICLE I
 PURCHASE ARRANGEMENTS
	   

  

			
	 Section 1.1
	 	 Purchase Facility
	  	 	1	  
	 Section 1.2
	 	 Increases
	  	 	2	  
	 Section 1.3
	 	 Decreases
	  	 	3	  
	 Section 1.4
	 	 Payment Requirements
	  	 	3	  
	 Section 1.5
	 	 Letter of Credit Subfacility
	  	 	4	  
	
	 ARTICLE II
 PAYMENTS AND COLLECTIONS
	   

  

			
	 Section 2.1
	 	 Payments
	  	 	13	  
	 Section 2.2
	 	 Collections Prior to Amortization
	  	 	13	  
	 Section 2.3
	 	 Collections Following Amortization
	  	 	14	  
	 Section 2.4
	 	 Application of Collections
	  	 	14	  
	 Section 2.5
	 	 Payment Rescission
	  	 	15	  
	 Section 2.6
	 	 Maximum Purchaser Interests
	  	 	15	  
	 Section 2.7
	 	 Clean Up Call
	  	 	16	  
	
	 ARTICLE III
 CONDUIT PURCHASER FUNDING
	   

  

			
	 Section 3.1
	 	 CP Costs and Yield
	  	 	16	  
	 Section 3.2
	 	 CP Costs Payments
	  	 	16	  
	 Section 3.3
	 	 Calculation of CP Costs
	  	 	16	  
	 Section 3.4
	 	 Selection and Continuation of Tranche Periods
	  	 	17	  
	
	 ARTICLE IV
 COMMITTED PURCHASER FUNDING; CONDUIT PURCHASER FUNDING THROUGH SOURCE OTHER THAN COMMERCIAL PAPER
	   

   

			
	 Section 4.1
	 	Committed Purchaser Funding; Conduit Purchaser Funding Through Source Other Than Commercial Paper	  	 	17	  
	 Section 4.2
	 	 Yield Payments
	  	 	17	  
	 Section 4.3
	 	 Selection and Continuation of Tranche Periods
	  	 	18	  
	 Section 4.4
	 	 Committed Purchaser Interest Rates
	  	 	18	  
	 Section 4.5
	 	 Suspension of the Adjusted LIBO Rate
	  	 	18	  
	
	ARTICLE V	  
	REPRESENTATIONS AND WARRANTIES	  
			
	 Section 5.1
	 	 Representations and Warranties of the Seller Parties
	  	 	18	  

  
 Page ii

							
	
	 ARTICLE VI
 CONDITIONS OF CREDIT EVENTS
	   

  

			
	 Section 6.1
	 	 Conditions Precedent to Effectiveness of the Original RPA
	  	 	23	  
	 Section 6.2
	 	 Conditions Precedent to All Credit Events
	  	 	23	  
	 Section 6.3
	 	 Conditions Precedent to Amendment and Restatement of Original RPA and Initial Credit Event
	  	 	24	  
	
	 ARTICLE VII
 COVENANTS
	   

  

			
	 Section 7.1
	 	 Affirmative Covenants of the Seller Parties
	  	 	25	  
	 Section 7.2
	 	 Negative Covenants of the Seller Parties
	  	 	32	  
	
	 ARTICLE VIII
 ADMINISTRATION AND COLLECTION
	   

  

			
	 Section 8.1
	 	 Designation of Servicer
	  	 	34	  
	 Section 8.2
	 	 Duties of Servicer
	  	 	35	  
	 Section 8.3
	 	 Collection Notices
	  	 	36	  
	 Section 8.4
	 	 Responsibilities of Seller
	  	 	36	  
	 Section 8.5
	 	 Reports
	  	 	36	  
	 Section 8.6
	 	 Servicing Fees
	  	 	37	  
	
	 ARTICLE IX
 AMORTIZATION EVENTS
	   

  

			
	 Section 9.1
	 	 Amortization Events
	  	 	37	  
	 Section 9.2
	 	 Remedies
	  	 	40	  
	
	 ARTICLE X
 INDEMNIFICATION
	   

  

			
	 Section 10.1
	 	 Indemnities by the Seller Parties
	  	 	40	  
	 Section 10.2
	 	 Increased Cost and Reduced Return
	  	 	43	  
	 Section 10.3
	 	 Other Costs and Expenses
	  	 	44	  
	
	 ARTICLE XI
 THE ADMINISTRATIVE AGENT & THE MANAGING AGENTS
	   

  

			
	 Section 11.1
	 	 Authorization and Action
	  	 	45	  
	 Section 11.2
	 	 Delegation of Duties
	  	 	45	  
	 Section 11.3
	 	 Exculpatory Provisions
	  	 	46	  
	 Section 11.4
	 	 Reliance by Administrative Agent
	  	 	46	  
	 Section 11.5
	 	 Non-Reliance on Administrative Agent, Managing Agents, L/C Issuers and Other Purchasers
	  	 	47	  
	 Section 11.6
	 	 Reimbursement and Indemnification
	  	 	47	  
	 Section 11.7
	 	 Administrative Agent in its Individual Capacity
	  	 	47	  
	 Section 11.8
	 	 Successor Administrative Agent
	  	 	47	  

  
 Page iii

							
	
	 ARTICLE XII
 ASSIGNMENTS; PARTICIPATIONS
	   

  

			
	 Section 12.1
	 	 Assignments
	  	 	48	  
	 Section 12.2
	 	 Participations
	  	 	49	  
	 Section 12.3
	 	 Federal Reserve
	  	 	49	  
	 Section 12.4
	 	 Replacement of Purchase Groups
	  	 	49	  
	
	 ARTICLE XIII
 EXTENSION OF TERM; TERMINATING PURCHASE GROUPS
	   

  

			
	 Section 13.1
	 	 Extension of Term; Terminating Purchase Groups
	  	 	50	  
	
	 ARTICLE XIV
 MISCELLANEOUS
	   

  

			
	 Section 14.1
	 	 Waivers and Amendments
	  	 	51	  
	 Section 14.2
	 	 Notices
	  	 	52	  
	 Section 14.3
	 	 Setoff; Ratable Payments
	  	 	52	  
	 Section 14.4
	 	 Protection of Ownership Interests of the Purchasers
	  	 	53	  
	 Section 14.5
	 	 Confidentiality
	  	 	53	  
	 Section 14.6
	 	 Bankruptcy Petition
	  	 	54	  
	 Section 14.7
	 	 Limited Recourse
	  	 	55	  
	 Section 14.8
	 	 Limitation of Liability
	  	 	55	  
	 Section 14.9
	 	 CHOICE OF LAW
	  	 	55	  
	 Section 14.10
	 	 CONSENT TO JURISDICTION
	  	 	55	  
	 Section 14.11
	 	 WAIVER OF JURY TRIAL
	  	 	56	  
	 Section 14.12
	 	 Integration; Binding Effect; Survival of Terms
	  	 	56	  
	 Section 14.13
	 	 Counterparts; Severability; Section References
	  	 	57	  
	 Section 14.14
	 	 Agent Roles
	  	 	57	  
	 Section 14.15
	 	 Characterization
	  	 	57	  
	 Section 14.16
	 	 USA PATRIOT Act
	  	 	58	  
	 Section 14.17
	 	Amendment and Restatement; Consent to Amendment of Receivables Sale Agreement and Performance Undertaking and Receivables Transfer Agreement	  	 	58	  

  
 Page iv

 Exhibits and Schedules 
  

					
	 EXHIBIT I
	  	-	    	 Definitions

	 EXHIBIT II-A
	  	-	    	 Form of Purchase Notice

	 EXHIBIT II-B
	  	-	    	 Form of Letter of Credit Request

	 EXHIBIT III
	  	-	    	Places of Business of the Seller Parties; Locations of Records; Federal Employer Identification Number of Seller
	 EXHIBIT IV
	  	-	    	 Names of Collection Banks; Collection Accounts; Lock-Boxes

	 EXHIBIT V
	  	-	    	 Form of Compliance Certificate

	 EXHIBIT VI
	  	-	    	 Form of Monthly Report

	 EXHIBIT VII
	  	-	    	 Form of Assignment Agreement

			
	 SCHEDULE A
	  	-	    	 Purchase Groups; Commitments; Group L/C Sublimits; Group Purchase Limits

	 SCHEDULE B-I
	  	-	    	 Documents to Be Delivered Prior to Effectiveness of Original RPA

	 SCHEDULE B-II
	  	-	    	Documents to Be Delivered Prior to Effectiveness of Amendment and Restatement of Original RPA and the Initial Credit Event
	 SCHEDULE C
	  	-	    	 Credit and Collection Policy

	 SCHEDULE D
	  	-	    	 Notice Addresses

	 SCHEDULE E
	  	-	    	 Special Concentration Limits

  
 Page v

 MPC TRADE RECEIVABLES COMPANY LLC 

AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT 
 This Amended and Restated Receivables Purchase Agreement dated as of October 1, 2011, is made by and among MPC Trade Receivables Company LLC, a Delaware limited liability company
(“Seller”), Marathon Petroleum Company LP, a Delaware limited partnership (“MPC LP”), as initial Servicer (together with Seller, the “Seller Parties” and each a “Seller Party”), the
entities from time to time party hereto as Conduit Purchasers (together with their respective successors and permitted assigns hereunder, the “Conduit Purchasers”), the entities from time to time party hereto as Committed Purchasers
(together with their respective successors and permitted assigns hereunder, the “Committed Purchasers”), the entities from time to time party hereto as L/C Issuers, the entities from time to time party hereto as Managing Agents
(together with their respective successors and permitted assigns hereunder, the “Managing Agents”), and JPMorgan Chase Bank, N.A., as administrative agent for the Purchasers hereunder or any successor agent hereunder (together with
its successors and permitted assigns hereunder, the “Administrative Agent”). Unless defined elsewhere herein, capitalized terms used in this Agreement shall have the meanings assigned to such terms in Exhibit I. 

PRELIMINARY STATEMENTS 
 Seller, MPC LP, the Conduit Purchasers, the Committed Purchasers, the Managing Agents, the LC Issuers and the Administrative Agent are parties to that certain Receivables Purchase Agreement dated as of
July 1, 2011 (as heretofore amended, restated, supplemented or otherwise modified from time to time, the “Original RPA”). 
 Subject to the terms and conditions set forth herein, the parties hereto have agreed to amend and restate the Original RPA in its entirety. 

Seller desires to transfer and assign undivided percentage ownership interests in the Receivables, the Related Security and Collections
with respect thereto and the proceeds thereof from time to time. 
 Each Conduit Purchaser may, in its absolute and sole
discretion, purchase such undivided percentage ownership interests in the Receivables, the Related Security and Collections with respect thereto and the proceeds thereof, and, in the event that a Conduit Purchaser declines to make such purchase, the
Committed Purchasers in its related Purchase Group shall, at the request of Seller, purchase such undivided percentage ownership interests from time to time. 
 JPMorgan Chase Bank, N.A. has been requested and is willing to act as Administrative Agent on behalf of the Purchasers in accordance with the terms hereof. 

ARTICLE I 

PURCHASE ARRANGEMENTS 
 Section 1.1 Purchase Facility. 
 (a) From time to time prior to the
Amortization Date, upon the terms and subject to the conditions hereof, Seller may request that the Purchasers, acting through the Administrative Agent, purchase undivided percentage ownership interests in the Receivables, the Related Security and
Collections with respect thereto and all proceeds of the foregoing, by delivering immediately available funds to the Seller (an “Incremental Purchase”) or by issuing of one or more Letters of Credit for the benefit of the Seller or
its designee (an “L/C Purchase”), in each case, as provided herein. Subject to the terms and conditions set forth herein, each Conduit Purchaser may, at its option, or if any Conduit

  
 1 

 
Purchaser shall decline, the related Committed Purchasers in its related Purchase Group shall, make such Purchase Group’s Purchase Group Share of each Purchase from the Seller hereunder;
provided, that notwithstanding anything set forth herein to the contrary, under no circumstances shall any Purchaser make any Incremental Purchase or L/C Purchase hereunder to the extent that, after giving effect thereto: 

(i) the Aggregate Capital plus the L/C Undrawn Amount would exceed the Purchase Limit; 

(ii) the aggregate Capital of the Purchasers in any Purchase Group would exceed such Purchase Group’s Group Purchase Limit less its
Purchase Group Share of the L/C Undrawn Amount; or 
 (iii) the Capital of any Committed Purchaser would exceed its Commitment
less its Pro Rata Share of the L/C Undrawn Amount. 
 Effective as of the date of each Purchase, Seller hereby sells and assigns to the
Administrative Agent, for the benefit of the Purchasers, undivided percentage ownership interests in the Receivables, the Related Security and Collections with respect thereto and all proceeds of the foregoing, subject only to the payment by such
Purchasers of the applicable Purchase Price therefor or the issuance of Letters of Credit, in each case, in accordance with the terms of this Agreement. 
 (b) Seller may, upon at least five (5) days’ (or such shorter period as the Administrative Agent and the Managing Agents may agree) prior written notice to the Administrative Agent (and the
Administrative Agent shall promptly forward such written notice to each Managing Agent), terminate in whole or reduce in part the unused portion of the Purchase Limit; provided, that Seller may not reduce the Purchase Limit to an amount less
than the aggregate Stated Amounts of all Letters of Credit then outstanding unless Seller shall have Cash-Collateralized all such Letters of Credit. Upon any such reduction in the Purchase Limit, the Group Purchase Limits shall be permanently
reduced by a corresponding amount (ratably among the Purchase Groups in accordance with the Purchase Group Shares) and the Commitment of each Committed Purchaser in each Purchase Group shall be ratably reduced in accordance with such Committed
Purchaser’s Pro Rata Share. Each partial reduction of the Purchase Limit shall be in an amount equal to $5,000,000 or an integral multiple thereof. 
 (c) The Purchaser Interest shall be initially computed on the date hereof. Thereafter, until the Facility Termination Date, the Purchaser Interest shall be automatically recomputed (or deemed to be
recomputed) on each Business Day (after giving effect to any Purchase, if any, on such Business Day); it being understood that, for purposes of such calculation, the Net Receivables Balance (and all components thereof) shall be
determined on each Business Day based on the information set forth in the Monthly Report, Weekly Report or Daily Report most recently delivered (other than after an Amortization Event has occurred and is continuing and a notice thereof has been
delivered by the Administrative Agent to the Seller and the Servicer to compute such Net Receivables Balance (and all components thereof) on each such Business Day) pursuant to this Agreement and Net Receivables Balance (and the components thereof)
shall not be required to be recalculated as of each Business Day. Subject to the following sentence, from and after the Amortization Date, the Purchaser Interest shall be deemed to be 100%. The Purchaser Interest shall become zero on the Final
Payout Date. 
 Section 1.2 Increases. Seller shall provide the Administrative Agent (and the Administrative Agent
shall promptly forward such written notice to each Managing Agent and notify each Managing Agent of its Purchase Group’s Purchase Group Share of such Incremental Purchase) with at least one (1) Business Day’s (or, in the case of a
request for an Incremental Purchase to be funded with Tranche Funded Commercial Paper which is to replace Pooled Commercial Paper, seven (7) days’) prior 

  
 2 

 
written notice in a form set forth as Exhibit II-A hereto of each Incremental Purchase (a “Purchase Notice”); provided, that, with respect to any Incremental
Purchase to satisfy any outstanding Reimbursement Obligations (other than an Incremental Purchase funded with Tranche Funded Commercial Paper), Seller may provide notice of such Incremental Purchase on the day of such Incremental Purchase if such
notice is provided before 12:00 noon (Chicago time). Each Purchase Notice shall be subject to Section 6.2 hereof and, except as set forth below, shall be irrevocable and shall specify (a) the aggregate requested Purchase Price
(which shall not be less than $5,000,000) and date of purchase, (b) in the case of an Incremental Purchase to be funded by the Committed Purchasers, the requested Interest Rate and (c) in the case of an Incremental Purchase to be funded by
Tranche Funded Commercial Paper or by the Committed Purchasers, the Tranche Period. Following receipt of a Purchase Notice, each Managing Agent will determine whether the Conduit Purchasers in its Purchase Group agree to participate in the requested
Incremental Purchase. In the event that a Purchase Group has more than one Conduit Purchaser, the related Managing Agent may allocate the related Purchase Group Share of the Purchase Price for Incremental Purchases among such Conduit Purchasers in
its sole discretion. If the Conduit Purchasers in any Purchase Group decline to participate in an Incremental Purchase, the Managing Agent for such Purchase Group shall notify Seller and Seller may cancel the Purchase Notice in its entirety or, in
the absence of such a cancellation, the applicable Purchase Group Share of the requested Incremental Purchase shall be made by the Committed Purchasers in such Purchase Group ratably in accordance with their Pro Rata Shares. On the date of each
Incremental Purchase (other than to the extent that the proceeds of such Incremental Purchase are being used to satisfy outstanding Reimbursement Obligations which shall be funded in accordance with Section 1.5(f)), upon satisfaction of
the applicable conditions precedent set forth in Article VI, the applicable Purchasers in each Purchase Group shall initiate a wire transfer of immediately available funds to the account specified by Seller, no later than 12:00 noon (Chicago
time), in an aggregate amount equal to such Purchase Group’s Purchase Group Share of the Purchase Price for such Incremental Purchase. In no event shall the Purchasers be obligated to make more than fifteen (15) Incremental Purchases
requested by Seller during any calendar month. 
 Section 1.3 Decreases. Seller shall provide the Administrative
Agent (and the Administrative Agent shall promptly forward such written notice to each Managing Agent and notify each Managing Agent of its Purchase Group’s Purchase Group Share of such reduction) with prior written notice in conformity with
the Required Notice Period (a “Reduction Notice”) of any proposed reduction of Aggregate Capital from Collections. Such Reduction Notice shall designate (i) the proposed date upon which any such reduction of Aggregate Capital
shall occur (which date shall give effect to the applicable Required Notice Period), and (ii) the amount of Aggregate Capital to be reduced (the “Aggregate Reduction”) which shall be distributed ratably by the Administrative
Agent to each Purchase Group based upon the Capital held by each Purchase Group and which shall be applied by each Managing Agent to the Capital of the Purchasers in such Managing Agent’s Purchase Group as directed by Seller (x) to the
Capital of the Committed Purchasers in such Purchase Group ratably in accordance with the amount of Capital of such Committed Purchasers and/or (y) to the Capital of the Conduit Purchasers in such Purchase Group ratably in accordance with the
Capital of such Conduit Purchasers. Only one (1) Reduction Notice shall be outstanding at any time. No Aggregate Reduction will be made following the occurrence of the Amortization Date without the consent of the Administrative Agent.

 Section 1.4 Payment Requirements. All amounts to be paid or deposited by any Seller Party pursuant to any
provision of this Agreement shall be paid or deposited in accordance with the terms hereof no later than 11:00 a.m. (Chicago time) on the day when due in immediately available funds, and if not received by 11:00 a.m. (Chicago time) shall be deemed
to be received on the next succeeding Business Day. Amounts payable to the Administrative Agent for its own account shall be paid to the Administrative Agent at the account specified by the Administrative Agent to Seller from time to time. Amounts
payable to any Purchaser or L/C Issuer shall be paid to the Administrative Agent at the account 

  
 3 

 
specified by the Administrative Agent to Seller from time to time, and the Administrative Agent shall promptly forward such amounts to the Managing Agent for such Purchaser’s or L/C
Issuer’s Purchase Group, for the account of such Purchaser or L/C Issuer, as applicable, at the account specified by such Managing Agent from time to time. All computations of Yield, per annum fees calculated as part of any CP Costs, per annum
fees hereunder and per annum fees under the Fee Letter shall be made on the basis of a year of 360 days for the actual number of days elapsed; provided, that computations of Yield which accrues by reference to the Prime Rate shall be made on
the basis of a year of 365 days (or 366 days in the case of a leap year) for the actual number of days elapsed. If any amount hereunder shall be payable on a day which is not a Business Day, such amount shall be payable on the next succeeding
Business Day. 
 Section 1.5 Letter of Credit Subfacility. 

(a) Generally. Subject to the terms and conditions set forth herein, the L/C Issuers shall issue Letters of Credit requested by
Seller from time to time; provided, that no Letter of Credit shall be issued, amended, renewed or extended if, after giving effect to such issuance, amendment, renewal or extension (i) the L/C Undrawn Amount would exceed an amount equal
to the Purchase Limit minus the Aggregate Capital, (ii) the L/C Obligations would exceed the L/C Sublimit, (iii) the sum of the Aggregate Capital and the L/C Undrawn Amount would exceed the aggregate Commitments or (iv) the portion of
the L/C Obligations attributable to Letters of Credit of any L/C Issuer would exceed its related Group L/C Sublimit. 
 (b)
Letter of Credit Requests. To request an issuance of a Letter of Credit (or the amendment, renewal or extension of an outstanding Letter of Credit issued by any L/C Issuer) from an L/C Issuer, Seller shall deliver a written request therefor,
substantially in the form of Exhibit II-B hereto (each such request, a “Letter of Credit Request”) to Administrative Agent and the related Managing Agent of the applicable L/C Issuer not later than 10:00 a.m. (Chicago time)
on the date that is at least four (4) Business Days prior to the requested issuance date (or the requested date of such amendment, renewal or extension of such outstanding Letter of Credit ) of such Letter of Credit. Such Letter of Credit
Request shall, unless otherwise agreed by the applicable L/C Issuer, be irrevocable and shall specify the face amount of the requested Letter of Credit, the account party (which shall be an Originator or an Affiliate thereof) and beneficiary for the
requested Letter of Credit, the requested expiration date of such Letter of Credit and the requested date of the issuance (or amendment, renewal or extension, as applicable) thereof; provided, that each Letter of Credit issued hereunder shall
have a face amount of not less than $5,000,000; provided, further, that no L/C Issuer shall have any obligation to issue a Letter of Credit if any Committed Purchaser is at that time a Defaulting Committed Purchaser, unless such L/C
Issuer is satisfied that the actual fronting exposure with respect to the Defaulting Committed Purchaser’s related Purchase Group Share of any L/C Obligations in respect of issued Letters of Credit or any potential fronting exposure arising
from the Letter of Credit then proposed to be issued will be entirely covered by Cash-Collateral (or other satisfactory arrangements with respect thereto in the sole discretion of such L/C Issuer shall have been made) provided to such L/C Issuer in
accordance with this Agreement. The issuance, amendment, modification, renewal or extension by an L/C Issuer of any Letter of Credit shall be, in addition to the conditions precedent set forth in Article VI, subject to the conditions
precedent that Seller (and, to the extent required by the applicable L/C Issuer, MPC LP or the Affiliate thereof which is to be the “Account Party” with respect thereto) shall have executed and delivered such application agreement and/or
such other instruments and agreements relating to such Letter of Credit as the applicable L/C Issuer shall have reasonably requested (collectively, “Letter of Credit Application”) and Seller shall have paid, prior to the issuance,
amendment, modification, renewal or extension thereof, to the applicable L/C Issuer, any Fronting Fees and Other L/C Fees due and owing with respect to such Letter of Credit. Each Letter of Credit issued in connection with an L/C Purchase or
otherwise shall comply with the provisions of Section 1.5 and the related Letter of Credit Application. Seller shall have 

  
 4 

 
the right to give instructions and make agreements with respect to any Letter of Credit Application and the disposition of documents, and to agree with Administrative Agent, the applicable
Managing Agent and the applicable L/C Issuer upon any amendment, extension or renewal of any Letter of Credit. In no event shall an L/C Issuer be obligated to issue a modification in respect of a Letter of Credit if, on the proposed date of such
modification, the applicable L/C Issuer would not be obligated to issue new Letters of Credit under the terms hereof if requested or if the beneficiary does not consent to the proposed terms of the modification. 

(c) L/C Purchases. The related Managing Agent for an L/C Issuer shall promptly notify such L/C Issuer and Committed Purchasers in
its Purchase Group of the request by Seller for the issuance of a Letter of Credit hereunder, and shall provide the related L/C Issuer with the applicable Letter of Credit Application delivered to Administrative Agent and the applicable Managing
Agent by Seller pursuant to clause (b) above, by the close of business on the day received or if received on a day that is not a Business Day or on any Business Day after 11:00 a.m. (Chicago time) on such day, on the next Business Day.

 (d) Participation Commitment. Immediately upon the issuance of each Letter of Credit by an L/C Issuer (or an amendment
to a Letter of Credit increasing the Stated Amount thereof), each Committed Purchaser shall be deemed to, and hereby irrevocably and unconditionally agrees to, purchase from such L/C Issuer, a participation in such Letter of Credit (as it may be so
amended) and each drawing thereunder in an amount equal to such Committed Purchaser’s Pro Rata Share of the Stated Amount of such Letter of Credit and the amount of such drawing, respectively. Such participations in such L/C Purchases by each
Committed Purchaser shall constitute an agreement by such Committed Purchaser to make an Incremental Purchase under Section 1.2 in the event that the related Letter of Credit is subsequently drawn upon and Seller otherwise fails to
fulfill its Reimbursement Obligations in respect of such draw at such time in accordance herewith. In the event any Letter of Credit expires or is surrendered to the applicable L/C Issuer in accordance with its terms without being drawn (in whole or
in part) then, in such event, the foregoing obligation of the Committed Purchasers to make such Incremental Purchase in respect of such Letter of Credit shall expire to the extent of the face amount thereof which has expired or been so surrendered.

 (e) Issuance of Letters of Credit. (i) Each Letter of Credit shall, among other things, (A) provide for the
payment of sight drafts or other written demands for payment when presented for honor thereunder in accordance with the terms thereof and when accompanied by the documents described therein, (B) expire at or prior to the close of business on
the earlier of (x) unless a later date is otherwise agreed to in writing by the applicable L/C Issuer and the Administrative Agent, the date that is one year after the date of the issuance of such Letter of Credit (or, in the case of any
renewal or extension thereof, one year after such renewal or extension) and (y) the Liquidity Termination Date; provided, that in accordance with clause (ii) of this subsection (e), a Letter of Credit may provide for the automatic
renewal thereof for additional periods which shall not extend beyond the Liquidity Termination Date; provided, further, that a Letter of Credit may be issued or extended such that it expires after the Liquidity Termination Date so long
as upon the issuance or extension thereof, Seller shall have provided cash-collateral or other arrangements in respect of such Letter of Credit, in an amount and otherwise on terms acceptable to the applicable L/C Issuer in its sole discretion, and
(C) be in form and substance reasonably acceptable to the applicable L/C Issuer in its sole discretion. 
 (ii) If Seller
so requests in any applicable Letter of Credit Request or Letter of Credit Application, each L/C Issuer may, in its sole discretion, issue a Letter of Credit that has automatic extension provisions (each, an “Auto-Extension Letter of
Credit”); provided that any such Auto-Extension Letter of Credit must permit the L/C Issuer which issued such Letter of Credit to prevent any such extension at least once in each twelve-month period (commencing with the date of
issuance of such Letter of Credit) by giving prior notice to the beneficiary thereof and Seller not later than a day (the 

  
 5 

 
“Non-Extension Notice Date”) in each such twelve-month period to be agreed upon at the time such Letter of Credit is issued. Unless otherwise directed by an L/C Issuer, Seller
shall not be required to make a specific request to the applicable L/C Issuer for any such extension. Once an Auto-Extension Letter of Credit has been issued, the Purchasers shall be deemed to have authorized (but may not require) the L/C Issuer to
permit the extension of such Letter of Credit at any time to an expiry date not later than the Liquidity Termination Date; provided, however, that no L/C Issuer shall permit any such extension if (A) such L/C Issuer has determined
that it would not be permitted, or would have no obligation, at such time to issue such Letter of Credit in its revised form (as extended) under the terms hereof, or (B) it has received notice (which may be by telephone or in writing) on or
before the day that is seven (7) Business Days before the Non-Extension Notice Date from the Administrative Agent, any Purchaser or any Seller Party that one or more of the applicable conditions specified in Section 6.2 is not then
satisfied and directing such L/C Issuer not to permit such extension; provided, further, that an Auto-Extension Letter of Credit may be issued or extended such that it expires after the Liquidity Termination Date so long as upon the
issuance or extension thereof, Seller shall have provided cash-collateral or other arrangements in respect of such Letter of Credit, in an amount and otherwise on terms acceptable to the applicable L/C Issuer in its sole discretion. 

(iii) Each L/C Issuer may, at its election (or as required by the Administrative Agent at the direction of the Required Managing Agents),
deliver any notices of termination or other communications to any Letter of Credit beneficiary, and take any other action as necessary or appropriate, at any time and from time to time, in order to cause the expiry date of any Auto-Extension Letter
of Credit issued by such L/C Issuer to be a date not later than the Liquidity Termination Date. 
 (iv) Seller hereby authorizes
and directs each L/C Issuer to name MPC LP (or any Affiliate of MPC LP designated by MPC LP pursuant to the Receivables Sale Agreement or the Receivables Transfer Agreement, as applicable, and specified to the applicable L/C Issuer in the Letter of
Credit Request) as the “Account Party” of each Letter of Credit. 
 (f) Letter of Credit Participations;
Disbursements, Reimbursement. 
 (i) In the event of any request for a drawing under a Letter of Credit issued by a L/C
Issuer by the beneficiary thereof, the applicable L/C Issuer will promptly notify Administrative Agent, each Managing Agent and Seller of such request. Seller shall reimburse the applicable L/C Issuer, by paying to the Administrative Agent (and the
Administrative Agent shall promptly forward such amounts to such L/C Issuer) in an amount equal to the amount paid by such L/C Issuer thereunder in respect of such drawing not later than (a) 2:00 p.m. (Chicago time) on the date on which such
drawing is paid by such L/C Issuer (the “Drawing Date”), if Seller shall have received notice of such drawing prior to 11:00 a.m. (Chicago time) on such Drawing Date or (b) 11:00 a.m. (Chicago time) on the Business Day
immediately following the Drawing Date (or the date on which Seller shall have received such notice), if Seller shall have received notice of such drawing after 11:00 a.m. (Chicago time) on the Drawing Date (or such other date). In the event Seller
fails to reimburse the applicable L/C Issuer for the full amount of any drawing under any Letter of Credit by payment to the Administrative Agent as and when required in accordance with the immediately preceding sentence, then the Administrative
Agent shall promptly notify each Managing Agent thereof, and Seller shall be deemed to have requested that an Incremental Purchase be made ratably by the Purchase Groups to be disbursed on the date of delivery of such notice with respect to such
Letter of Credit in accordance with Section 1.2. Any notice given by an L/C Issuer pursuant to this Section may be oral if immediately confirmed in writing by the Administrative Agent; provided that the lack of such an immediate
confirmation shall not affect the conclusiveness or binding effect of such notice. 

  
 6 

 (ii) Upon any notice of the failure by Seller to reimburse an L/C Issuer given to the
Managing Agents pursuant to clause (i) above, the Conduit Purchasers may, each at its option, and the related Committed Purchasers shall if such Conduit Purchasers decline to, make available to the applicable L/C Issuer an amount in immediately
available funds equal to the related Purchase Group Share of the amount of such unreimbursed drawing, whereupon each Committed Purchaser or Conduit Purchaser, as applicable, shall each be deemed to have made an Incremental Purchase in such amount.
If any Committed Purchaser so notified fails to (and its related Conduit Purchaser has elected not to) make available to such L/C Issuer the amount of such Committed Purchaser’s Pro Rata Share of such amount by no later than 2:00 p.m.
(Chicago time) on the date of delivery of such notice, then interest shall accrue on the amount of such payment owing by such Committed Purchaser, from such date to the date on which such Committed Purchaser makes such payment (x) at a rate per
annum equal to the Federal Funds Effective Rate during the first three (3) days following such date and (y) at a rate per annum equal to the Alternate Base Rate on and after the fourth day following such date. Each L/C Issuer will promptly
give notice of the occurrence of the Drawing Date affecting it, but failure of an L/C Issuer to give any such notice on a Drawing Date or in sufficient time to enable any related Committed Purchaser to effect such payment on such date shall not
relieve any Committed Purchaser from its obligation under this subclause (iii), provided that such Committed Purchaser shall not be obligated to pay interest as provided in the foregoing clauses (x) and (y) until and
commencing from the date of receipt of notice from an L/C Issuer, the Administrative Agent or such Committed Purchaser’s related Managing Agent of a drawing. Each Committed Purchaser’s obligation under this Section 1.5 shall
continue until the occurrence of each of the following: (A) the related L/C Issuer ceases to be obligated to issue or cause to be issued Letters of Credit hereunder; (B) no Letter of Credit issued hereunder by such L/C Issuer remains
outstanding and uncancelled; (C) all Persons (other than Seller) have been fully reimbursed for all payments made under or relating to all of the Letters of Credit issued hereunder; and (D) the Facility Termination Date shall have
occurred. 
 (g) Repayment of Letter of Credit Participation Advances. 

(i) Upon (and only upon) receipt by an L/C Issuer for its account of immediately available funds from Seller (A) in reimbursement of
any payment made by such L/C Issuer under a Letter of Credit with respect to which any Purchaser has made a payment pursuant to clause (f) of this Section 1.5, or (B) in payment of CP Costs or Yield on the Incremental Purchases
made or deemed to have been made in connection with any such draw, the applicable L/C Issuer will pay to the applicable Purchasers, ratably (based on the outstanding drawn amounts funded by each such Purchaser in respect of such Letter of Credit),
in the same funds as those received by such L/C Issuer; it being understood that such L/C Issuer shall retain the ratable amount of such funds that were not the subject of any payment in respect of such Letter of Credit by any
Purchaser. 
 (ii) If an L/C Issuer is required at any time to return to Seller, or to a trustee, receiver, liquidator,
custodian, or any official in any insolvency proceeding, any portion of the payments made by Seller to such L/C Issuer pursuant to this Agreement or any Letter of Credit issued by it in reimbursement of a payment made under any such Letter of Credit
or interest or fee thereon or with respect thereto, each Committed Purchaser shall, on demand of such L/C Issuer, forthwith return to such L/C Issuer the amount of its Pro Rata Share of any amounts so returned by such L/C Issuer plus interest at the
Federal Funds Effective Rate. 
 (h) Documentation. Seller agrees to be bound by the terms of the applicable Letter of
Credit Application and by the applicable L/C Issuer’s interpretations of any Letter of Credit it issues and by such L/C Issuer’s written regulations and customary practices relating to Letters of Credit, though the terms of each Letter of
Credit Application, each applicable L/C Issuer’s interpretation of its Letters of Credit and each L/C Issuer’s regulations and practices may be different from Seller’s own and from that of another

  
 7 

 
L/C Issuer. In the event of a conflict or inconsistency between a Letter of Credit Application and this Agreement, this Agreement shall control. It is understood and agreed that, except in the
case of gross negligence or willful misconduct by an L/C Issuer, as determined by a final non-applicable judgment of a Court of competent jurisdiction, such L/C Issuer shall not be liable for any error, breach, negligence and/or mistakes, whether of
omission or commission, in following Seller’s instructions or those contained in the Letters of Credit issued by it or any modifications, amendments or supplements thereto. 

(i) Determination to Honor Drawing Request. In determining whether to honor any request for drawing under any Letter of Credit by
the beneficiary thereof, each L/C Issuer shall be responsible only to determine that the documents and certificates required to be delivered under such Letter of Credit have been delivered and that they comply on their face with the requirements of
such Letter of Credit and that any other drawing condition appearing on the face of such Letter of Credit has been satisfied in the manner so set forth. 
 (j) Nature of Participation and Reimbursement Obligations. Each Committed Purchaser’s obligation in accordance with this Agreement to make participation advances as a result of a drawing under
a Letter of Credit issued by the L/C Issuer under this Section 1.5, and the obligations of Seller to reimburse each L/C Issuer upon a draw under a Letter of Credit, shall be absolute, unconditional and irrevocable, shall not be subject
to any defenses whatsoever (other than the occurrence of the Liquidity Termination Date), and shall be performed strictly in accordance with the terms of this Section 1.5 under all circumstances, including each of the following
circumstances: 
 (1) any set-off, counterclaim, recoupment, defense or other right which such Committed
Purchaser may have against an L/C Issuer, any Conduit Purchaser, another Committed Purchaser, any Managing Agent, the Administrative Agent, Seller, Servicer, any Originator, Marathon or any other Person for any reason whatsoever; 

(2) the failure of Seller or any other Person to comply with the conditions set forth in this Agreement for the making of
a purchase, reinvestments, requests for Letters of Credit or otherwise, it being acknowledged that such conditions are not required for the making of participation advances hereunder; 

(3) any lack of validity or enforceability of any Letter of Credit; 

(4) any claim of breach of warranty that might be made by Seller, Servicer, any Originator, Marathon, the Administrative
Agent, any L/C Issuer, any Managing Agent, any Purchaser or any other Person against the beneficiary of a Letter of Credit, or the existence of any claim, set-off, defense or other right which Seller, Servicer, any Originator, Marathon, the
Administrative Agent, any L/C Issuer, any Managing Agent, any Purchaser or any other Person may have at any time against a beneficiary, any successor beneficiary or any transferee of any Letter of Credit or the proceeds thereof (or any Persons for
whom any such transferee may be acting), any L/C Issuer, any Conduit Purchaser, any Committed Purchaser, any Managing Agent, the Administrative Agent or any other Person, whether in connection with this Agreement, the transactions contemplated
herein or any unrelated transaction (including any underlying transaction between Servicer, any Originator, Marathon, Seller or any of their respective Subsidiaries or Affiliates and the beneficiary for which any Letter of Credit was procured);

 (5) the lack of power or authority of any signer of, or lack of validity, sufficiency, accuracy,
enforceability or genuineness of, any draft, demand, instrument, certificate or other document presented under any Letter of Credit, or any such draft, demand, instrument, certificate or other document proving to be forged, fraudulent, invalid,
defective or insufficient in any 

  
 8 

 
respect or any statement therein being untrue or inaccurate in any respect, even if another L/C Issuer, the Administrative Agent, a Managing Agent or a Purchaser has been notified thereof;
provided, that the foregoing shall not be construed to excuse any L/C Issuer from liability to Seller to the extent of any direct damages (as opposed to consequential damages, claims in respect of which are hereby waived by Seller to the
extent permitted by applicable law) suffered by Seller that are caused by such L/C Issuer’s failure to exercise care when determining whether drafts and other documents presented under a Letter of Credit comply with the terms thereof;
provided, further, that, in the absence of gross negligence or willful misconduct on the part of the applicable L/C Issuer (as finally determined by a court of competent jurisdiction), such L/C Issuer shall be deemed to have exercised
care in each such determination; 
 (6) payment by an L/C Issuer under a Letter of Credit issued by it against
presentation of a demand, draft or certificate or other document which does not comply with the terms of such Letter of Credit other than as a result of the gross negligence or willful misconduct of such L/C Issuer; 

(7) the solvency of, or any acts or omissions by, any beneficiary of any Letter of Credit, or any other Person having a
role in any transaction or obligation relating to a Letter of Credit, or the existence, nature, quality, quantity, condition, value or other characteristic of any property or services relating to a Letter of Credit; 

(8) any failure by an L/C Issuer or any of an L/C Issuer’s Affiliates to issue any Letter of Credit in the form
requested by Seller; 
 (9) any Material Adverse Effect with respect to any Seller Party, any Originator,
Marathon or any their respective Affiliates; 
 (10) any breach of this Agreement or any other Transaction
Document by any party thereto; 
 (11) the occurrence and/or continuance of an Amortization Event or a Potential
Amortization Event; 
 (12) the fact that this Agreement or the obligations of Seller or Servicer hereunder shall
have been terminated; and 
 (13) any other circumstance or happening whatsoever, whether or not similar to any
of the foregoing. 
 (k) Fronting Fees; Other L/C Fees. With respect to each Letter of Credit, Seller shall pay to the
applicable L/C Issuer all fronting fees or similar fees with respect to such Letter of Credit in the amount and otherwise in accordance with the terms agreed in writing between Seller and such L/C Issuer (the “Fronting Fees”).
Seller shall pay all Fronting Fees accrued through and including the last day of each calendar month, as reflected in an invoice delivered to Seller by such L/C Issuer not later than five (5) Business Days prior to the applicable Monthly
Settlement Date, in arrears, on the Monthly Settlement Date immediately succeeding the end of such calendar month. Seller shall pay to each L/C Issuer, in addition to all other amounts due hereunder, all customary expenses incurred by each L/C
Issuer in connection with each Letter of Credit issued by it or the maintenance thereof and its customary drawing, amendment, renewal, extension, processing, transfer and other applicable customary fees (collectively, “Other L/C
Fees”). Seller shall pay all Other L/C Fees on demand or as otherwise agreed between Seller and such L/C Issuer. 

  
 9 

 (l) Liability for Acts and Omissions. (i) As between Seller, on the one hand,
and each L/C Issuer and each other Indemnified Party, on the other, Seller assumes all risks of the acts and omissions of, or misuse of the Letters of Credit by, the respective beneficiaries of such Letters of Credit. In furtherance and not in
limitation of the respective foregoing, no Indemnified Party shall be responsible for: (i) the form, validity, sufficiency, accuracy, genuineness or legal effect of any document submitted by any party in connection with the application for an
issuance of any such Letter of Credit, even if it should in fact prove to be in any or all respects invalid, insufficient, inaccurate, fraudulent or forged (even if such L/C Issuer or such other Indemnified Party shall have been notified thereof);
provided, that the foregoing shall not be construed to excuse any L/C Issuer from liability to Seller to the extent of any direct damages (as opposed to consequential damages, claims in respect of which are hereby waived by Seller to the
extent permitted by applicable law) suffered by Seller that are caused by such L/C Issuer’s failure to exercise care when determining whether drafts and other documents presented under a Letter of Credit comply with the terms thereof;
provided, further, that, in the absence of gross negligence or willful misconduct on the part of the applicable L/C Issuer (as finally determined by a court of competent jurisdiction), such L/C Issuer shall be deemed to have exercised
care in each such determination; (ii) the validity or sufficiency of any instrument transferring or assigning or purporting to transfer or assign any such Letter of Credit or the rights or benefits thereunder or proceeds thereof, in whole or in
part, which may prove to be invalid or ineffective for any reason; (iii) the failure of the beneficiary of any such Letter of Credit, or any other party to which such Letter of Credit may be transferred, to comply fully with any conditions
required in order to draw upon such Letter of Credit or any other claim of Seller against any beneficiary of such Letter of Credit, or any such transferee, or any dispute between or among Seller and any beneficiary of any Letter of Credit or any
such transferee; (iv) errors, omissions, interruptions or delays in transmission or delivery of any messages, by mail, cable, telegraph, telex or otherwise, whether or not they be in cipher; (v) errors in interpretation of technical terms;
(vi) any loss or delay in the transmission or otherwise of any document required in order to make a drawing under any such Letter of Credit or of the proceeds thereof; (vii) the misapplication by the beneficiary of any such Letter of
Credit of the proceeds of any drawing under such Letter of Credit; or (viii) any consequences arising from causes beyond the control of such Indemnified Party, and none of the above shall affect or impair, or prevent the vesting of, any of any
L/C Issuer’s or any other Indemnified Party’s rights or powers hereunder. In no event shall any of such L/C Issuer or other Indemnified Party be liable to Seller or any other Person for any indirect, consequential, incidental, punitive,
exemplary or special damages or expenses (including attorneys’ fees), or for any damages resulting from any change in the value of any property relating to a Letter of Credit. 

(ii) Without limiting the generality of the foregoing, each L/C Issuer (i) may rely on any written communication believed in good
faith by such Person to have been authorized or given by or on behalf of the applicant for a Letter of Credit; (ii) may honor any presentation if the documents presented appear on their face to comply with the terms and conditions of the
relevant Letter of Credit; (iii) may honor a previously dishonored presentation under a Letter of Credit, whether such dishonor was pursuant to a court order, to settle or compromise any claim of wrongful dishonor, or otherwise, and shall be
entitled to reimbursement to the same extent as if such presentation had initially been honored, together with any interest paid by an L/C Issuer or its Affiliates; (iv) may honor any drawing that is payable upon presentation of a statement
advising negotiation or payment, upon receipt of such statement (even if such statement indicates that a draft or other document is being delivered separately), and shall not be liable for any failure of any such draft or other document to arrive,
or to conform in any way with the relevant Letter of Credit; and (v) may pay any paying or negotiating bank claiming that it rightfully honored under the laws or practices of the place where such bank is located. 

(iii) In furtherance and extension and not in limitation of the specific provisions set forth above, any action taken or omitted by an
L/C Issuer under or in connection with the Letters of Credit issued by it or any documents and certificates delivered thereunder, if taken or omitted in good faith and 

  
 10 

 
without gross negligence or willful misconduct, as determined by a final non-appealable judgment of a court of competent jurisdiction, shall not put such L/C Issuer under any resulting liability
to any Seller Party, any Originator, any Purchaser, any Managing Agent, the Administrative Agent or any other Person. 
 (m)
Termination of Letters of Credit. An L/C Issuer shall only terminate a given Letter of Credit (in whole or in part) upon receipt of appropriate documentation from the beneficiary thereof or, upon the expiration thereof in accordance with its
terms and, promptly thereafter, the Administrative Agent shall return to Seller any Cash-Collateral or other collateral provided in respect of such Letter of Credit in excess of the Required Cash-Collateral Amount for such Letter of Credit.

 (n) Defaulting Committed Purchasers. Notwithstanding any provision of this Agreement to the contrary, if at any time a
Committed Purchaser shall become a Defaulting Committed Purchaser, and until such time as the Administrative Agent, the Managing Agents and the L/C Issuers shall have determined that such Defaulting Committed Purchaser has adequately remedied all
matters that caused such Committed Purchaser to be a Defaulting Committed Purchaser: 
 (i) so long as no Amortization Event
shall then exist, all or any part of such Defaulting Committed Purchaser’s Pro Rata Share of the L/C Undrawn Amount shall be reallocated (effective as of the date such Committed Purchaser becomes a Defaulting Committed Purchaser) among the
other Committed Purchasers in accordance with their respective Pro Rata Shares (for the purposes of such reallocation, such Defaulting Committed Purchaser’s Commitment shall be disregarded in determining the other Committed Purchasers’
respective Pro Rata Shares), but only to the extent that (x) the sum of the Aggregate Capital of all non-Defaulting Committed Purchasers plus the L/C Undrawn Amount shall not exceed the Purchase Limit and (y) the sum of each non-Defaulting
Committed Purchaser’s Pro Rata Share of the L/C Undrawn Amount plus such non-Defaulting Committed Purchaser’s Capital shall not exceed such non-Defaulting Committed Purchaser’s Commitment; 

(ii) if the reallocation described in clause (i) above cannot, or can only partially, be effected, Seller shall, within three
(3) Business Days following Seller’s receipt of written notice from the Administrative Agent, Cash-Collateralize the portion of such Defaulting Committed Purchaser’s Pro Rata Share of the L/C Undrawn Amount which has not been
reallocated to the other Committed Purchasers under clause (i) above; 
 (iii) if Seller Cash-Collateralizes any portion of
such Defaulting Committed Purchaser’s Pro Rata Share of the Letters of Credit pursuant to clause (ii) above, Seller shall not be required to pay the Undrawn L/C Fee to such Defaulting Committed Purchaser pursuant to this Agreement or the
Fee Letter with respect to such Defaulting Committed Purchaser’s participation in the L/C Undrawn Amount during the period from the date of Seller’s deposit of such Cash-Collateral with the Administrative Agent and ending upon the return
of such Cash-Collateral to Seller; and 
 (iv) any payment of principal, interest, fees or other amounts received by the
Administrative Agent or the applicable Managing Agent from Seller or Servicer for the account of such Defaulting Committed Purchaser, shall be applied at such time or times as may be determined by the Administrative Agent and such Managing Agent as
follows: first, to the payment on a pro rata basis of any amounts owing by that Defaulting Committed Purchaser to the L/C Issuers hereunder; second, if so determined by the Administrative Agent and such Managing Agent or requested
by any L/C Issuer, to Cash-Collateralize the obligations of such Defaulting Committed Purchaser in respect of any Letter of Credit (and, if Seller has provided Cash-Collateral in respect of such Defaulting Committed Purchaser pursuant to clause
(ii) above, the amount, if any, of such Cash-Collateral which, after giving effect to amounts retained pursuant to this clause second, is not necessary in order for the Cash-Collateral in respect of such Defaulting Committed Purchaser to
equal such Defaulting Committed Purchaser’s Pro 

  
 11 

 
Rata Share of the L/C Issuer Undrawn Amount shall be returned to Seller); and third, to such Defaulting Committed Purchaser or as otherwise directed by a court of competent jurisdiction.
Any payments, prepayments or other amounts paid or payable to a Defaulting Committed Purchaser that are applied (or held) to pay amounts owed by a Defaulting Committed Purchaser or to Cash-Collateralize Letters of Credit pursuant to this
Section 1.5(n) shall be deemed paid to and redirected by that Defaulting Committed Purchaser, and each Purchaser irrevocably consents hereto. The rights and remedies against, and with respect to, a Defaulting Committed Purchaser under
this Section 1.5(n) are in addition to, and cumulative and not in limitation of, all other rights and remedies that the Administrative Agent, any Purchaser, any L/C Issuer, any Managing Agent or Seller or any other Person may at any time
have against, or with respect to, such Defaulting Committed Purchaser. 
 In the event that the Administrative Agent, each L/C Issuer and each
Managing Agent shall have determined that such Defaulting Committed Purchaser has adequately remedied all matters that caused such Committed Purchaser to be a Defaulting Committed Purchaser, then the Pro Rata Share of the L/C Undrawn Amount of the
other Committed Purchasers shall be readjusted to reflect the inclusion of the Commitment of such Committed Purchaser, and on such date such Committed Purchaser shall purchase at par such of the Capital of the other Committed Purchasers as the
Administrative Agent shall determine may be necessary in order for such Committed Purchaser to hold Capital in accordance with its Pro Rata Share. 
 (o) L/C Collateral Account. (i) The Administrative Agent shall maintain a segregated cash collateral account (such account the “L/C Collateral Account”) at the
Administrative Agent into which Cash-Collateral shall be deposited as and when required under the terms of this Agreement. Such deposits shall be held by the Administrative Agent as collateral for the payment and performance of the obligations of
Seller (or, with respect to Cash-Collateral deposited in respect of a Defaulting Committed Purchaser, such Defaulting Committed Purchaser) under this Agreement and the other Transaction Documents. The Administrative Agent (for the benefit of the L/C
Issuers and the Purchasers) shall have exclusive dominion and control, including the exclusive right of withdrawal, over the L/C Collateral Account. Other than any interest earned on the investment of such deposits (in the event any such investment
is made pursuant to the following sentence), funds on deposit in the L/C Collateral Account shall not bear interest. The Administrative Agent shall not be required to invest any funds on deposit in the L/C Collateral Account; provided that if
the Administrative Agent elects to invest any such funds, the Administrative Agent shall invest such funds in one or more types of Eligible Investments, and such investments shall be at Seller’s risk and expense. Interest or profits, if any, on
such investments shall accumulate in the L/C Collateral Account.  
 (ii) Amounts on deposit in the L/C Collateral
Account shall be applied by the Administrative Agent to reimburse the applicable L/C Issuer for Reimbursement Obligations for which it has not been reimbursed or, if the Amortization Date has occurred, shall be applied to satisfy other Aggregate
Unpaids. If on any Settlement Date, the balance in the L/C Collateral Account in respect of any Letter of Credit exceeds the Required Cash-Collateral Amount for such Letter of Credit as of such Settlement Date, then, unless an Amortization Event or
Potential Amortization Event shall exist and be continuing, the Administrative Agent shall release the excess Cash-Collateral to Seller. 
 (iii) Upon the declaration or automatic occurrence of the Amortization Date or, upon the request of the Required Managing Agents, after the occurrence of an Amortization Event, Seller shall
Cash-Collateralize all outstanding Letters of Credit. 

  
 12 

 ARTICLE II 
 PAYMENTS AND COLLECTIONS 
 Section 2.1 Payments. Notwithstanding any
limitation on recourse contained in this Agreement, Seller shall immediately pay when due to the Administrative Agent or the related Managing Agent, as applicable, for the account of the relevant Purchasers and L/C Issuers, the Administrative Agent,
Funding Sources or Indemnified Parties on a full recourse basis, as applicable, (i) such fees as set forth in the Fee Letter (which fees shall be sufficient to pay all fees owing to the Committed Purchasers), (ii) all CP Costs,
(iii) all amounts payable as Yield, (iv) all amounts payable as Deemed Collections (which shall be immediately due and payable by Seller on the Settlement Date following deemed receipt by Seller and applied to reduce outstanding Aggregate
Capital hereunder in accordance with Sections 2.2 and 2.3 hereof), (v) all amounts required pursuant to Section 2.6, (vi) all amounts payable pursuant to Article X, if any, (vii) all unreimbursed
Reimbursement Obligations, (viii) all Servicer costs and expenses, including the Servicing Fee, in connection with servicing, administering and collecting the Receivables, (ix) all Broken Funding Costs and (x) all Default Fees
(collectively, the “Obligations”). Upon the occurrence and during the continuation of an Amortization Event, the Default Fee shall accrue and be payable on each Settlement Date, or, if earlier, on demand by the Administrative Agent.
Notwithstanding the foregoing, no provision of this Agreement or the Fee Letter shall require the payment or permit the collection of any amounts hereunder in excess of the maximum permitted by applicable law. If at any time Seller receives any
Collections or is deemed to receive any Deemed Collections, Seller shall immediately remit such Collections or Deemed Collections to Servicer for application in accordance with the terms and conditions hereof and, at all times prior to such payment,
such Collections or Deemed Collections shall be held in trust by Seller for the exclusive benefit of the Purchasers and the Administrative Agent. 
 Section 2.2 Collections Prior to Amortization. 
 (a) Prior to the
Amortization Date, any Collections and/or Deemed Collections received by Servicer shall be set aside and held in trust by Servicer for the payment of any accrued and unpaid Aggregate Unpaids or for a Reinvestment as provided in this
Section 2.2. If at any time any Collections and/or Deemed Collections are received by Servicer prior to the Amortization Date, (i) Servicer shall set aside the Termination Percentage (hereinafter defined) of Collections allocable to
each Terminating Purchase Group (which amount shall be payable on the next Settlement Date to reduce the Capital then held by the Terminating Purchasers in such Terminating Purchase Group) and (ii) Seller hereby requests and the Purchasers
(other than the Terminating Purchasers) (except to the extent contemplated in any Reduction Notice) hereby agree to make, simultaneously with such receipt, but subject to the conditions precedent set forth herein, including the conditions set forth
in Section 6.2, a reinvestment (each a “Reinvestment”) with that portion of the balance of each and every Collection received by Servicer (other than the Termination Percentage of any Collections allocable to each
Terminating Purchase Group and Collections set aside to reduce the Aggregate Capital outstanding in accordance with Section 1.3), such that after giving effect to such Reinvestment, the Aggregate Capital immediately after such receipt
and corresponding Reinvestment shall be equal to the amount of Capital immediately prior to such receipt (net of any reduction contemplated in a Reduction Notice). 
 (b) On each Settlement Date prior to the occurrence of the Amortization Date, Servicer shall remit to each Managing Agent’s account its Purchase Group Share (or Termination Percentage) of the amounts
set aside during the preceding Accrual Period that have not been subject to a Reinvestment or used for an Aggregate Reduction pursuant to Section 1.3 and apply such amounts (if not previously paid in accordance with
Section 2.1) to reduce unpaid CP Costs, Yield and other Obligations, if any, that are then due and owing to the members of such Group (or Terminating Purchase Group). If such Capital, CP Costs, Yield and other Obligations shall be
reduced to zero, (i) each Managing Agent’s Purchase Group 

  
 13 

 
Share of any additional Collections received by Servicer, if applicable, shall be remitted to such Managing Agent’s account no later than 11:00 a.m. (Chicago time) to the extent required to
fund any Aggregate Reduction on such Settlement Date and (ii) any balance remaining thereafter shall be remitted from Servicer to Seller on such Settlement Date. Each Terminating Purchase Group shall be allocated a ratable portion of
Collections from the Scheduled Liquidity Termination Date of such Terminating Purchase Group until the Capital of all Purchasers in such Terminating Purchase Group shall be paid in full. This ratable portion shall be calculated on the
Scheduled Liquidity Termination Date of each Terminating Purchase Group as a percentage equal to (i) Capital of all Purchasers in such Terminating Purchase Group outstanding on its Scheduled Liquidity Termination Date, divided by
(ii) the Aggregate Capital outstanding on such Scheduled Liquidity Termination Date (the “Termination Percentage”). Each Terminating Purchase Group’s Termination Percentage shall remain constant prior to the Amortization
Date. On and after the Amortization Date, each Termination Percentage shall be disregarded, and each Purchaser’s Capital thereafter shall be reduced ratably with all Purchasers in accordance with Section 2.3. 

Section 2.3 Collections Following Amortization. On the Amortization Date and on each day thereafter, Servicer shall set aside
and hold in trust, for the Purchasers and L/C Issuers, all Collections and/or Deemed Collections received on such day and an additional amount for the payment of any accrued and unpaid Obligations owed by Seller and not previously paid by Seller in
accordance with Section 2.1. On and after the Amortization Date, Servicer shall, at any time upon the request from time to time by (or pursuant to standing instructions from) the Administrative Agent (i) remit to the Administrative
Agent’s or each Managing Agent’s account the amounts set aside pursuant to the preceding sentence, and (ii) apply such amounts to (A) reduce the Aggregate Capital, (B) reduce any outstanding Reimbursement Obligations,
(C) Cash-Collateralize all outstanding Letters of Credit and (D) reduce any other Aggregate Unpaids. 

Section 2.4 Application of Collections. If there shall be insufficient funds on deposit for Servicer to distribute funds in
payment in full of the aforementioned amounts pursuant to Section 2.2 or 2.3 (as applicable), Servicer shall distribute funds: 
 first, if MPC LP or one of its Affiliates is not then acting as Servicer, to the payment of Servicer’s reasonable out-of-pocket costs and expenses in connection with servicing, administering
and collecting the Receivables, including the Servicing Fee; 
 second, to the reimbursement of the
Administrative Agent’s and the Managing Agents’ costs of collection and enforcement of this Agreement; 

third, to the Administrative Agent, to be distributed to each Managing Agent for the benefit of the L/C Issuer in
its Purchase Group, if any, in payment of all amounts due and owing to such L/C Issuer from a Defaulting Committed Purchaser as required under Section 1.5(n); 

fourth, to the Administrative Agent, to be distributed to each Managing Agent, for the benefit of the Purchasers in
its Purchase Group, in payment of all accrued and unpaid fees under the Fee Letter (including, the Commitment Fees and Undrawn L/C Fees), CP Costs, Fronting Fees, Other L/C Fees, Broken Funding Costs and Yield then due and payable, ratably in
accordance with such amounts owed to such parties; 
 fifth, to the Administrative Agent, to be
distributed to each Managing Agent, for the benefit of the Purchasers and L/C Issuer in its Purchase Group, in reduction of the Aggregate Capital and Reimbursement Obligations then due and payable, ratably in accordance with each Purchase Group
Share; 

  
 14 

 sixth, ratably, (a) at any time there is a Defaulting Committed
Purchaser, to the Administrative Agent, to be held in the L/C Collateral Account for the benefit of the applicable L/C Issuers and the Purchasers, in an amount sufficient to Cash-Collateralize such Defaulting Committed Purchaser’s Pro Rata
Share of the L/C Undrawn Amount and (b) to the extent required pursuant to Section 1.5(o)(iii), to the Administrative Agent, to be held in the L/C Collateral Account for the benefit of the applicable L/C Issuers and the Purchasers,
in an amount sufficient to Cash-Collateralize all outstanding Letters of Credit; 
 seventh, for the
ratable payment of all other unpaid Obligations; provided that to the extent such Obligations relate to the payment of Servicer costs and expenses, including the Servicing Fee, when MPC LP or one of its Affiliates is acting as Servicer, such
costs and expenses shall not be paid until after the payment in full of all other Obligations; and 

eighth, after the Aggregate Unpaids have been indefeasibly reduced to zero, to Seller. 

Collections applied to the payment of Aggregate Unpaids shall be distributed in accordance with the aforementioned provisions, and, giving effect to each
of the priorities set forth above in this Section 2.4, shall be shared ratably (within each priority) among the Administrative Agent, the L/C Issuers and the Purchasers in accordance with the amount of such Aggregate Unpaids owing to
each of them in respect of each such priority. Each Managing Agent shall distribute the amounts received pursuant to clauses fourth and fifth above to the Purchasers, L/C Issuer, if any, and Terminating Purchasers, if any, in its
Purchase Group ratably according to the applicable amounts owed to such Purchasers and L/C Issuer. On and after the Amortization Date, in the event that applications of Collections are made on a date other than a Settlement Date, if any Managing
Agent so directs the Administrative Agent, the Administrative Agent shall set aside from Collections for distribution to such Managing Agent on the next Settlement Date, the accrued and unpaid fees under the Fee Letter and accrued and unpaid Yield
which are (or will be) due and payable to the Managing Agents, the L/C Issuer and the Purchasers in the related Purchase Group on the next Settlement Date. 
 Section 2.5 Payment Rescission. No payment of any of the Aggregate Unpaids shall be considered paid or applied hereunder to the extent that, at any time, all or any portion of such payment or
application is rescinded by application of law or judicial authority, or must otherwise be returned or refunded for any reason. Seller shall remain obligated for the amount of any payment or application so rescinded, returned or refunded, and shall
promptly pay to the Administrative Agent (for application to the Person or Persons who suffered such rescission, return or refund) the full amount thereof, plus the Default Fee from the date of any such rescission, return or refunding. 

Section 2.6 Maximum Purchaser Interests. Seller shall ensure that the Purchaser Interest of the Purchasers and L/C Issuers
shall at no time exceed in the aggregate 100%. If the aggregate of the Purchaser Interest of the Purchasers and L/C Issuers exceeds 100%, Seller shall pay within one (1) Business Day an amount to the Administrative Agent (and the Administrative
Agent shall promptly forward the same to each Managing Agent, ratably based upon each such Purchase Group’s Capital which amounts shall be applied by each Managing Agent to the Capital of the Purchasers in such Managing Agent’s Purchase
Group as directed by Seller (x) to the Capital of the Committed Purchasers in such Purchase Group ratably in accordance with the amount of Capital of such Committed Purchasers and/or (y) to the Capital of the Conduit Purchasers in such
Purchase Group ratably in accordance with the Capital of such Conduit Purchasers) to be applied to reduce the Aggregate Capital such that after giving effect to such payment (and the application thereof to reduce the Aggregate Capital) the aggregate
of the Purchaser Interest equals or is less than 100%. 

  
 15 

 Section 2.7 Clean Up Call. In addition to Seller’s rights pursuant to
Section 1.3, Seller shall have the right (after providing written notice to the Managing Agents in accordance with the Required Notice Period), at any time following the reduction of the Aggregate Capital to a level that is less than
10.0% of the original Purchase Limit, to repurchase from the Administrative Agent all, but not less than all, of the Aggregate Capital. The price to be paid in respect of such repurchase shall be an amount equal to (i) the Aggregate Unpaids
minus (ii) the L/C Obligations, in each case, through the date of such repurchase, payable in immediately available funds. Upon the exercise of such repurchase, Seller shall Cash-Collateralize all of the outstanding L/C Obligations. Such
repurchase shall be without representation, warranty or recourse of any kind by, on the part of, or against any Purchaser, any L/C Issuer or the Administrative Agent. 
 ARTICLE III 
 CONDUIT PURCHASER FUNDING 

Section 3.1 CP Costs and Yield. (a) Seller shall pay CP Costs with respect to the Capital of a Conduit Purchaser funded with
Commercial Paper for each day that any such Capital is outstanding. The Capital of a Conduit Purchaser funded substantially with Pooled Commercial Paper shall accrue CP Costs each day on a pro rata basis, based upon the percentage share such
Capital represents in relation to all assets held by the applicable Conduit Purchaser and funded substantially with Pooled Commercial Paper. 
 (b) The portion of the Capital of a Conduit Purchaser funded by a source other than Pooled Commercial Paper or Tranche Funded Commercial Paper (including, without limitation, each Tranche funded or
maintained by a Conduit Purchaser under a Funding Agreement) shall accrue Yield as described in Article IV hereof. 

Section 3.2 CP Costs Payments. On each Settlement Date, Seller shall pay to each Managing Agent (for the benefit of each
Conduit Purchaser in its Purchase Group) an aggregate amount equal to all accrued and unpaid CP Costs in respect of the Capital of each such Conduit Purchaser funded with Pooled Commercial Paper or Tranche Funded Commercial Paper for the
immediately preceding Accrual Period in accordance with Article II. 
 Section 3.3
Calculation of CP Costs. On or before the fifth
(5th) Business Day immediately preceding each
Settlement Date, each Managing Agent shall calculate the aggregate amount of CP Costs and Yield, if any, due and payable to each Conduit Purchaser in its Purchase Group for the immediately preceding Accrual Period and shall notify Seller of such
aggregate amount. Such aggregate amount shall be calculated in respect of each Conduit Purchaser using an estimate of the CP Costs, if necessary, for the remaining days in such Accrual Period, provided, that such aggregate amount shall be
adjusted as follows: if the Managing Agent of such Conduit Purchaser shall have used an estimate of CP Costs with respect to the preceding Accrual Period, such Managing Agent shall compute the actual aggregate CP Costs of such Conduit Purchaser for
such preceding Accrual Period and (i) if the actual aggregate CP Costs of such Conduit Purchaser so computed are greater than the estimated aggregate CP Costs calculated for such preceding Accrual Period, the aggregate CP Costs for such Conduit
Purchaser calculated pursuant to the preceding sentence for the current Accrual Period shall be increased by the amount of such difference, and (ii) if the actual aggregate CP Costs of such Conduit Purchaser so computed are less than the
estimated aggregate CP Costs for such preceding Accrual Period, the aggregate CP Costs for such Conduit Purchaser calculated pursuant to the preceding sentence for the current Accrual Period shall be decreased by the amount of such difference.

  
 16 

 Section 3.4 Selection and Continuation of Tranche Periods. 

(a) With consultation from (and approval by) the related Managing Agent with respect to a Purchase Group having one or more
Tranche Funding Conduit Purchasers, Seller may from time to time request Tranche Periods and allocate Tranches to each selected Tranche Period; provided, that (i) no more than five (5) Tranche Periods for such Purchase Group
shall be outstanding at any time and (ii) such Managing Agent shall have the ultimate authority to make all selections of Tranche Periods and the allocation of Tranches to its related Conduit Purchaser’s Tranche Funded Commercial
Paper in its sole and absolute discretion. 
 (b) At least two (2) Business Days prior to the end of a Tranche Period
applicable to any Tranche funded with Tranche Funded Commercial Paper (a “Terminating CP Tranche”), the related Managing Agent or, upon notice to and consent by such Managing Agent received at least three (3) Business Days
prior to the last day of such Terminating CP Tranche, Seller, may, effective on the last day of such Terminating CP Tranche: (i) divide such Terminating CP Tranche into multiple Tranches, (ii) combine any such Tranche with one or more
other Tranches funded by such Tranche Funding Conduit Purchasers that have a Terminating CP Tranche ending on the same day as such Terminating CP Tranche or (iii) combine any such Tranche with a new Tranche to be purchased by such
Tranche Funding Conduit Purchasers on the day such Terminating CP Tranche ends; provided, that in no event may a Tranche of any Tranche Funded Conduit Purchaser be combined with a Tranche of a Committed Purchaser or with a Tranche
funded with Pooled Commercial Paper. If none of the above actions is taken with respect to such Terminating CP Tranche, such Tranche shall, as of the end of the applicable Tranche Period, be funded by Pooled Commercial Paper. 

ARTICLE IV 

COMMITTED PURCHASER FUNDING; CONDUIT PURCHASER FUNDING THROUGH SOURCE 

OTHER THAN COMMERCIAL PAPER 
 Section 4.1 Committed Purchaser Funding; Conduit Purchaser Funding Through Source Other Than Commercial Paper. (x) Each Tranche of a Committed Purchaser in a Commercial Paper Purchase
Group, and each Tranche of a Conduit Purchaser funded through a source other than Commercial Paper, shall accrue Yield at either the Adjusted LIBO Rate or the Alternate Base Rate and (y) each Tranche of a Committed Purchaser in a Balance Sheet
Purchase Group shall accrue Yield at the Adjusted LIBO Rate, for each day during each Accrual Period in accordance with the terms and conditions hereof. Until Seller gives timely notice to the Administrative Agent of another Interest Rate in
accordance with Section 4.4, the initial Interest Rate for any Tranche transferred to a Committed Purchaser in a Commercial Paper Purchase Group pursuant to the terms and conditions hereof, or funded by a Funding Source pursuant to the
terms and conditions of any Funding Agreement, shall be the Alternate Base Rate. The initial Interest Rate for any Tranche funded by the Committed Purchasers and/or Conduit Purchasers to refinance any outstanding Obligations upon same-day notice
shall be the Prime Rate for the date of such funding and thereafter, Yield and/or CP Costs, as applicable, shall accrue in respect thereof in accordance with the terms of Article III and this Article IV. 

Section 4.2 Yield Payments. On each Settlement Date, Seller shall pay to each Managing Agent (for the benefit of the
Committed Purchasers, Conduit Purchasers and Terminating Purchasers, if any, in its Purchase Group, as applicable) an aggregate amount equal to the accrued and unpaid Yield for each Tranche Period in accordance with Article II. 

  
 17 

 Section 4.3 Selection and Continuation of Tranche Periods. 

(a) At any time that a Tranche which accrues Yield at the Adjusted LIBO Rate is funded or maintained by a Committed Purchaser in a
Commercial Paper Purchase Group or by a Conduit Purchaser through a source other than Commercial Paper, Seller shall from time to time request, in consultation with (and approval by) the related Managing Agent, Tranche Periods for such Tranches,
provided, that each Tranche Period shall end on a Settlement Date. 
 (b) Seller, upon notice to and consent by the
applicable Managing Agent received at least three (3) Business Days prior to the end of a Tranche Period (the “Terminating Tranche”) for any Tranche may, effective on the last day of the Terminating Tranche: (i) divide any
such Tranche funded by the Committed Purchasers and Terminating Committed Purchasers in the same Purchase Group into multiple Tranches, (ii) combine any such Tranche with one or more other Tranches of a Committed Purchaser or Terminating
Committed Purchaser in the same Purchase Group that have a Terminating Tranche ending on the same day as such Terminating Tranche or (iii) combine any such Tranche with one or more other Tranches which either end on such day or are newly
created on such day; provided, that in no event may a Tranche of any Conduit Purchaser be combined with a Tranche of a Committed Purchaser. 
 Section 4.4 Committed Purchaser Interest Rates. Seller may select the Adjusted LIBO Rate or the Alternate Base Rate for each Tranche of the Committed Purchasers in a Commercial Paper Purchase
Group and each Tranche of Conduit Purchaser funded through a source other than Commercial Paper. Seller shall by 11:00 a.m. (Chicago time): (i) at least three (3) Business Days prior to the expiration of any Terminating Tranche with
respect to which the Adjusted LIBO Rate is being requested as a new Interest Rate and (ii) at least one (1) Business Day prior to the expiration of any Terminating Tranche with respect to which the Alternate Base Rate is being requested as
a new Interest Rate, give each Managing Agent irrevocable notice of the new Interest Rate for such Terminating Tranche. Until Seller gives timely notice to the Administrative Agent of another Interest Rate, the initial Interest Rate for any Tranche
transferred to the Committed Purchasers or funded by Conduit Purchaser through a source other than Commercial Paper shall be the Alternate Base Rate. 
 Section 4.5 Suspension of the Adjusted LIBO Rate. If any Committed Purchaser or Funding Source notifies the Administrative Agent that it has determined that funding its interest in the
Aggregate Capital at the Adjusted LIBO Rate would violate any applicable law, rule, regulation, or directive of any governmental or regulatory authority, whether or not having the force of law, or that (i) deposits of a type and maturity
appropriate to match fund such interest at such Adjusted LIBO Rate are not available or (ii) such Adjusted LIBO Rate does not accurately reflect the cost of acquiring, funding or maintaining such interest in the Aggregate Capital at such
Adjusted LIBO Rate, then the Administrative Agent shall suspend the availability of such Adjusted LIBO Rate and require Seller to select the Alternate Base Rate for any such interest accruing Yield at such Adjusted LIBO Rate. 

ARTICLE V 

REPRESENTATIONS AND WARRANTIES 
 Section 5.1 Representations and Warranties of the Seller Parties. Each Seller Party hereby represents and warrants to the Administrative Agent, each Managing Agent and each Purchaser, as to
itself, as of the date hereof and as of the date of each Credit Event that: 
 (a) Corporate Existence and Power. Such
Seller Party is a limited liability company, in the case of Seller, or limited partnership, in the case of MPC LP, duly organized, validly existing, organized solely and in good standing under the laws of its state of organization. Such Seller Party
is duly qualified to do business and is in good standing as a foreign limited liability company or limited partnership, as 

  
 18 

 
applicable, and has and holds all limited liability company or limited partnership power, as applicable, and all governmental licenses, authorizations, consents and approvals required to carry on
its business in each jurisdiction in which its business is conducted, except in the case of Servicer only, where the failure to so qualify or be in good standing or the failure to so have or hold would not reasonably be expected to have a Material
Adverse Effect. Such Seller Party constitutes a “registered organization” (within the meaning of Section 9-102(a) of the UCC) of its state of organization. 
 (b) Power and Authority; Due Authorization, Execution and Delivery. The execution and delivery by such Seller Party of this Agreement and each other Transaction Document to which it is a party, and
the performance of its obligations hereunder and thereunder and, in the case of Seller, Seller’s use of the proceeds of purchases made hereunder, are within its limited liability company or limited partnership powers and authority, as
applicable, and have been duly authorized by all necessary limited liability company or limited partnership action, as applicable, on its part. This Agreement and each other Transaction Document to which such Seller Party is a party has been duly
executed and delivered by such Seller Party. 
 (c) No Conflict. The execution and delivery by such Seller Party of this
Agreement and each other Transaction Document to which it is a party, and the performance of its obligations hereunder and thereunder (i) do not contravene or violate (A) its certificate of formation or certificate of limited partnership,
as applicable, or its partnership or operating agreement, as applicable, or other organizational documents, (B) any law, rule or regulation applicable to it, (C) any restrictions under any agreement, contract or instrument to which it is a
party or by which it or any of its property is bound, or (D) any order, writ, judgment, award, injunction or decree binding on or affecting it or its property, except, in the case of clauses (B), (C) and (D) with respect to Servicer,
where such contravention or violation would not reasonably be expected to have a Material Adverse Effect and (ii) do not result in the creation or imposition of any Adverse Claim on assets of such Seller Party or its Subsidiaries (except as
created hereunder, under the Receivables Sale Agreement or the Receivables Transfer Agreement); and no transaction contemplated hereby requires compliance with any bulk sales act or similar law. 

(d) Governmental Authorization. Other than (i) the filing of the financing statements required hereunder, under the
Receivables Sale Agreement or under the Receivables Transfer Agreement, and (ii) such authorizations, approvals, notices, filings or other actions as have been obtained, made or taken prior to the date hereof, no authorization or approval or
other action by, and no notice to or filing with, any Governmental Authority is required for the due execution and delivery by such Seller Party of this Agreement and each other Transaction Document to which it is a party and the performance of its
obligations hereunder and thereunder. 
 (e) Actions, Suits. (i) There are no actions, suits or proceedings pending,
or to the knowledge of any officer of Seller, threatened, against or affecting Seller, or any of its properties, in or before any court, arbitrator or other body; and (ii) there are no actions, suits or proceedings pending, or to the knowledge
of any officer of Servicer, threatened, against or affecting Servicer, or any of its properties, in or before any court, arbitrator or other body, as to which there is a reasonable possibility of an adverse determination and that, if adversely
determined, would reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. Such Seller Party is not in default with respect to any order of any Governmental Authority. 

(f) Binding Effect. This Agreement and each other Transaction Document to which such Seller Party is a party constitute the legal,
valid and binding obligations of such Seller Party enforceable against such Seller Party in accordance with their respective terms, except as such enforcement may be limited by applicable bankruptcy, insolvency, reorganization or other similar laws
relating to or limiting creditors’ rights generally and by general principles of equity (regardless of whether enforcement is sought in a proceeding in equity or at law). 

  
 19 

 (g) Accuracy of Information. No written reports, financial statements, certificates
or other written information, including, without limitation, any Monthly Report, Weekly Report or Daily Report (collectively, the “Information”) furnished by or on behalf of any Seller Party to the Administrative Agent, any Managing
Agent or any Purchaser in connection with the negotiation of this Agreement, any other Transaction Document, any transaction contemplated hereby or thereby or otherwise delivered hereunder or thereunder (as modified or supplemented by other
Information so furnished) contained, as of the date such Information was furnished (or, if such Information expressly related to a specific date, as of such specific date) any material misstatement of fact or omitted to state, as of the date such
Information was furnished (or, if such Information expressly related to a specific date, as of such specific date), any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not
misleading; provided, that with respect to projected financial information, each Seller Party represents only that such information was prepared in good faith based upon assumptions believed by it to be reasonable at the time. 

(h) Use of Proceeds. No proceeds of any Credit Event hereunder will be used (i) to purchase or carry “margin stock”
as defined in Regulation T, U or X promulgated by the Board of Governors of the Federal Reserve System from time to time or in a manner that violates any such regulation or (ii) to acquire any security in any transaction which is subject to
Section 12, 13 or 14 of the Exchange Act. 
 (i) Good Title. Immediately prior to each Credit Event hereunder,
Seller shall be the legal and beneficial owner of the Receivables and Related Security with respect thereto, free and clear of any Adverse Claim, except for (a) any Adverse Claim created under this Agreement, under the Receivables Sale
Agreement or under the Receivables Transfer Agreement and (b) Permitted Liens. There have been duly filed all financing statements or other similar instruments or documents necessary under the UCC (or any comparable law) of all appropriate
jurisdictions to perfect Seller’s ownership interest in each Receivable and, to the extent that a security interest therein may be perfected by the filing of such financing statements, in its Collections and the Related Security. 

(j) Perfection. This Agreement, together with the filing of the financing statements contemplated hereby, is effective to, and
shall, upon each purchase hereunder, transfer to the Administrative Agent for the benefit of the relevant Purchaser or Purchasers (and the Administrative Agent for the benefit of such Purchaser or Purchasers shall acquire from Seller) a valid and
perfected first priority undivided percentage ownership or security interest in each Receivable existing or hereafter arising and, to the extent that a security interest therein may be perfected by the filing of such financing statements, in the
Related Security and Collections with respect thereto, free and clear of any Adverse Claim, except for (a) any Adverse Claim created under this Agreement, under the Receivables Sale Agreement or under the Receivables Transfer Agreement and
(b) Permitted Liens. There have been duly filed all financing statements or other similar instruments or documents necessary under the UCC (or any comparable law) of all appropriate jurisdictions to perfect the Administrative Agent’s (on
behalf of the Purchasers) ownership or security interest in the Receivables, the Related Security and the Collections. Seller has not, within a period of one year prior to the date hereof, (i) changed the location of its principal place of
business or chief executive office or its organizational structure, (ii) changed its legal name, (iii) changed its “location” (within the meaning of Section 9-307 of the UCC as in effect in all applicable jurisdictions), or
(iv) become a “new debtor” (as defined in Section 9-102(a)(56) of the UCC as in effect in all applicable jurisdictions) with respect to a currently effective security agreement previously entered into by any other Person.

  
 20 

 (k) Places of Business and Locations of Records. The principal places of business
and chief executive office of such Seller Party and the offices where it keeps all of its Records are located at the address(es) listed on Exhibit III or such other locations of which the Administrative Agent has been notified in accordance
with Section 7.2(a). Seller’s Federal Employer Identification Number is correctly set forth on Exhibit III. 
 (l) Collections. Each Seller Party has at all times satisfied and duly performed the terms of Section 7.1(j) and Section 8.2. The names and addresses of all Collection
Banks, together with the account numbers of the Collection Accounts of Seller at each Collection Bank and the post office box number of each Lock-Box, are listed on Exhibit IV (as such Exhibit IV may be amended or supplemented from
time to time by Seller by delivery of a new Exhibit IV to the Administrative Agent). Seller has not granted any Person, other than the Administrative Agent as contemplated by this Agreement, dominion or “control” (within the meaning
of Section 9-104 of the UCC of all applicable jurisdictions) of, or the right to give instructions with respect to the disposition of funds, without the consent of any other Person, with respect to any Lock-Box or Collection Account, or the
right to take dominion or “control” (within the meaning of Section 9-104 of the UCC of all applicable jurisdictions) of any such Lock-Box or Collection Account at a future time or upon the occurrence of a future event. The
Administrative Agent has a valid and perfected first priority security interest in each Lock-Box and Collection Account. 
 (m)
Material Adverse Effect. (i) Such Seller Party has heretofore furnished to the Administrative Agent and the Managing Agents Marathon’s consolidated or combined balance sheet and consolidated or combined statements of income,
stockholders equity and cash flows (A) as of and for the fiscal year ended December 31, 2010, reported on by PricewaterhouseCoopers LLP, independent public accountants, and (B) as of and for the fiscal quarter and the portion of the
fiscal year most recently ended prior to the date hereof for which quarterly financial statements of Marathon are available, certified by its chief financial officer. Such financial statements present fairly, in all material respects, the financial
position and results of operations and cash flows of Marathon and its consolidated Subsidiaries as of such dates and for such periods on a consolidated basis in accordance with GAAP, subject to year end audit adjustments and the absence of footnotes
in the case of the statements referred to in clause (B) above. 
 (ii) Since December 31, 2010, in the case of the
initial Servicer, and since the date of its formation, in the case of Seller, no event, condition or other circumstance in respect of such Seller Party has occurred or exists that would have a Material Adverse Effect. 

(n) Names. In the past five (5) years, (i) Seller has not used any corporate names, trade names or assumed names other
than the name in which it has executed this Agreement and (ii) Seller has not been organized in any jurisdiction other than the jurisdiction in which it is currently organized. 

(o) Ownership of Seller. MPC LP directly owns 100% of the issued and outstanding equity interests of Seller, free and clear of any
Adverse Claim, other than Permitted Liens. Such equity interests are validly issued, fully paid and nonassessable, and there are no options, warrants or other rights to acquire equity interests of Seller. 

(p) Not an Investment Company. Such Seller Party is not an “investment company” as defined in, or subject to regulation
under, the Investment Company Act of 1940, as amended, or any successor statute. 
 (q) Compliance with Law. Such Seller
Party has complied in all respects with all applicable laws, rules, regulations, orders, writs, judgments, injunctions, decrees or awards to which it may be subject, except where the failure to so comply would not reasonably be expected to have a
Material Adverse Effect. Each Receivable, together with the Contract related thereto, does not contravene any 

  
 21 

 
laws, rules or regulations applicable thereto (including, without limitation, laws, rules and regulations relating to truth in lending, fair credit billing, fair credit reporting,
equal credit opportunity, fair debt collection practices and privacy), and no part of such Contract is in violation of any such law, rule or regulation, except where such contravention or violation would not reasonably be expected to have a Material
Adverse Effect. 
 (r) Compliance with Credit and Collection Policy. Such Seller Party has complied in all material
respects with the Credit and Collection Policy with regard to each Receivable and the related Contract, and has not made any material change in or material amendment to such Credit and Collection Policy, except such change or amendment as to which
the Administrative Agent has been notified and any necessary consents have been obtained in accordance with Section 7.1(a)(vii). 
 (s) Payments to Originators. With respect to each Receivable transferred to Seller under the Receivables Sale Agreement or to MPC LP under the Receivables Transfer Agreement, the applicable
Originator has received reasonably equivalent value in consideration therefor and such transfer was not made for or on account of an antecedent debt. No transfer by any Originator of any Receivable under the Receivables Sale Agreement or the
Receivables Transfer Agreement, as applicable, is or may be voidable as a fraudulent transfer under Section 547 of the Federal Bankruptcy Code or a voidable preference under Section 548 of the Federal Bankruptcy Code. 

(t) Enforceability of Contracts. Each Contract with respect to each Receivable is effective to create, and has created, a legal,
valid and binding obligation of the related Obligor to pay the Outstanding Balance of the Receivable created thereunder and any accrued interest thereon, enforceable against the Obligor in accordance with its terms, except as such enforcement may be
limited by applicable bankruptcy, insolvency, reorganization or other similar laws relating to or limiting creditors’ rights generally and by general principles of equity (regardless of whether enforcement is sought in a proceeding in equity or
at law). 
 (u) Eligible Receivables. Each Receivable included in the Net Receivables Balance as an Eligible Receivable
on the date of its purchase under the Receivables Sale Agreement and, if applicable, under the Receivables Transfer Agreement was an Eligible Receivable on such purchase date. 
 (v) Net Receivables Balance. Seller has determined that, immediately after giving effect to each purchase hereunder, the Net Receivables Balance is at least equal to the sum of (i) the
Aggregate Capital, plus (ii) the L/C Undrawn Amount, plus (iii) the Aggregate Reserves. 
 (w)
Accounting. Such Seller Party treats the transactions contemplated by the Receivables Sale Agreement as sales and/or capital contributions and the transactions contemplated by the Receivables Transfer Agreement as sales, for all purposes,
including, without limitation, accounting purposes; provided, however, that the consolidated financial statements of Marathon and Seller are prepared in accordance with GAAP and, as a result of the consolidation required by GAAP, the
transfers shall be reflected as a financing by Marathon in its consolidated financial statements, and such Seller Party, in respect of financial statements that are prepared on or after the date of this Agreement, (i) has made appropriate
notations in any such consolidated financial statements (or in the accompanying notes) to indicate that Seller is a separate legal entity from Marathon and to indicate that the assets and credit of Seller are not available to satisfy the debts and
obligations of Marathon and (ii) has listed the assets of Seller separately on any balance sheet of such Seller Party prepared on a standalone basis. 
 (x) No Amortization Event. No event has occurred and is continuing that constitutes an Amortization Event or a Potential Amortization Event. 

  
 22 

 (y) Solvency. After giving effect to the sale or contribution of Receivables and any
Incremental Purchases and Reinvestments, as applicable, to be made on such date and to the application of the proceeds therefrom, Seller (i) is not “insolvent” (as such term is defined in the Federal Bankruptcy Code), (ii) is
able to pay its debts as they become due and (iii) does not have unreasonably small capital for the business in which it is engaged or for any business or transaction in which it reasonably expects to engage. 

(z) Taxes. Each of such Seller Party and, in the case of Servicer, its Subsidiaries has filed or caused to be filed all Tax
returns and reports required to have been filed by it and has paid or caused to be paid all Taxes required to have been paid by it, except, in the case of Servicer only, (a) Taxes or the filing of Tax returns or reports that are being contested
in good faith by appropriate proceedings and for which Servicer or such Subsidiary, as applicable, has set aside on its books adequate reserves or (b) to the extent that the failure to do so would not reasonably be expected to result in a
Material Adverse Effect. Seller has paid when due any taxes payable by Seller in connection with the Receivables. 
 (aa)
ERISA. No ERISA Event has occurred or is reasonably expected to occur that would reasonably be expected to result in a Material Adverse Effect. 
 (bb) Subsidiaries; Business. In the case of Seller, (i) it has no Subsidiaries, (ii) since its formation, it has conducted no business other than entering into and performing its
obligations under the Transaction Documents to which it is a party and such other activities incidental to the foregoing and (iii) the Transaction Documents to which it is a party are the only agreements to which it is a party. 

(cc) Retained Interest. (i) MPC LP owns a net economic interest in the Receivables in an amount at least equal to 5.0% of the
Net Receivables Balance as required under Article 122a of the CRD, (ii) MPC LP has not changed the manner (as contemplated under Article 122a of the CRD) in which it retains such net economic interest since the date of this Agreement, and
(iii) MPC LP has not entered into any short position or hedge with respect to such net economic interest. Notwithstanding any provision in this Agreement or any other Transaction Document to the contrary, a breach of the representation and
warranty under this clause (cc) of this Section 5.1 shall not constitute an Amortization Event. 
 ARTICLE VI

 CONDITIONS OF CREDIT EVENTS 
 Section 6.1 Conditions Precedent to Effectiveness of the Original RPA. The parties hereto acknowledge and agree that the Original RPA became effective upon satisfaction of each of the
following conditions precedent: (a) the Administrative Agent and the Managing Agents shall have received those documents listed on Schedule B-I, (b) the Spinoff Transaction (as defined in the Original RPA) shall have been
completed, (c) the Revolving Credit Agreement shall have become effective in accordance with the terms thereof, (d) MPC LP and Seller shall have marked their respective records evidencing the Receivables to reflect the sales thereof
contemplated by the Receivables Sale Agreement and by this Agreement in a manner reasonably satisfactory to the Administrative Agent, (e) the L/C Collateral Account shall have been established and (f) the Administrative Agent and the
Purchasers shall have received all fees and, to the extent invoiced at least two (2) Business Days prior to the date of the Original RPA, expenses required to be paid on such date pursuant to the terms of this Agreement and the Fee Letter.

 Section 6.2 Conditions Precedent to All Credit Events. Each Credit Event shall be subject to the further
conditions precedent that (a) Servicer shall have delivered to the Administrative Agent on or prior to the date of such Credit Event, in form and substance satisfactory to the Administrative Agent, all Daily Reports, Weekly Reports and Monthly
Reports as and when due under 

  
 23 

 
Section 8.5; (b) the Facility Termination Date shall not have occurred; and (c) on the date of each such Credit Event, both before and immediately after giving effect to
such Credit Event, the following statements shall be true (and acceptance of the proceeds of such Credit Event shall be deemed a representation and warranty by Seller that such statements are then true; provided, that if an Amortization Event
or Potential Amortization Event shall exist as of the date of any Reinvestment and such Reinvestment automatically occurs in accordance with the terms of this Section 6.2, no Seller Party shall be deemed to have made a representation or
warranty as to the absence of such Amortization Event or Potential Amortization Event): 
 (i) the representations and
warranties set forth in Section 5.1 are true and correct in all material respects on and as of the date of such Credit Event as though made on and as of such date (unless such representation or warranty refers to an earlier date, in
which case such representation or warranty shall be true and correct in all material respects on and as of such earlier date), except that the materiality standard in this clause (i) shall not apply to any such representation or warranty that
is expressly qualified by a materiality standard or contains any carve-out or exception based on the absence of a Material Adverse Effect by its express terms; 
 (ii) no event has occurred and is continuing, or would result from such Credit Event, that will constitute an Amortization Event, and no event has occurred and is continuing, or would result from such
Credit Event, that would constitute a Potential Amortization Event; and 
 (iii) (x) the Aggregate Capital plus the
L/C Undrawn Amount does not exceed the Purchase Limit, (y) the L/C Obligations do not exceed the L/C Sublimit and (z) the Purchaser Interest does not exceed 100%. 
 It is expressly understood that each Reinvestment shall, unless otherwise directed by the Administrative Agent, occur automatically on each day that Servicer shall receive any Collections without the
requirement that any further action be taken on the part of any Person and notwithstanding the failure of Seller to satisfy any of the foregoing conditions precedent in respect of such Reinvestment. The failure of Seller to satisfy any of the
foregoing conditions precedent in respect of any Reinvestment shall give rise to a right of the Administrative Agent, which right may be exercised at any time on demand of the Administrative Agent, to rescind the related purchase and direct Seller
to pay to the Administrative Agent for the benefit of the Purchasers an amount equal to the Collections prior to the Amortization Date that shall have been applied to the affected Reinvestment. 

Section 6.3 Conditions Precedent to Amendment and Restatement of Original RPA and Initial Credit Event. The effectiveness of
the amendment and restatement of the Original RPA as set forth in this Agreement and the initial Credit Event hereunder are subject to the conditions precedent that: (a) the Administrative Agent and the Managing Agents shall have received those
documents listed on Schedule B-II and (b) Marathon Canada shall have marked its books and records in accordance with Section 4.1(e) of the Transfer Agreement. 

  
 24 

 ARTICLE VII 
 COVENANTS 
 Section 7.1 Affirmative Covenants of the Seller Parties.
Until the Final Payout Date, each Seller Party hereby covenants, as to itself, as set forth below: 
 (a) Financial
Reporting. Such Seller Party will maintain, for itself and, in the case of Servicer, each of its Subsidiaries, a system of accounting established and administered in accordance with GAAP, and furnish or cause to be furnished to the
Administrative Agent (and the Administrative Agent shall promptly forward the same to each Managing Agent): 
 (i) Annual
Reporting. (A) Within ninety (90) days after the end of each fiscal year of Marathon, its audited consolidated balance sheet and related statements of operations, stockholders’ equity and cash flows as of the end of and for such
year, setting forth in each case in comparative form the figures for the previous fiscal year, all reported on by PricewaterhouseCoopers LLP or other independent public accountants of recognized national standing (without a “going concern”
or like qualification or exception and without any qualification or exception as to the scope of such audit) to the effect that such consolidated financial statements present fairly in all material respects the financial condition and results of
operations of Marathon and its consolidated Subsidiaries on a consolidated basis in accordance with GAAP consistently applied (provided, that the requirements of this Section 7.1(a)(i)(A) with respect to the delivery of financial
statements shall be deemed satisfied by publicly filing Marathon’s Form 10-K for such Fiscal Year with the SEC, and such financial statements shall be deemed to have been delivered to each Managing Agent and the Administrative Agent under
this Section 7.1(a)(i)(A) on the date such Form 10-K has been posted on the SEC website accessible through http://www.sec.gov/edgar/searchedgar/webusers.htm or such successor webpage of the SEC thereto) and (B) within ninety
(90) days after the end of each fiscal year of Seller, unaudited financial statements (which shall include balance sheets, statements of income and retained earnings and a statement of cash flows) for Seller for such fiscal year certified in a
manner acceptable to the Administrative Agent by an Authorized Officer of Seller. 
 (ii) Quarterly Reporting.
(A) Within forty-five (45) days after the end of the first three (3) quarterly periods of each fiscal year of Marathon, its unaudited consolidated balance sheet and related statements of operations, stockholders’ equity and cash
flows as of the end of and for such fiscal quarter and the then elapsed portion of the fiscal year, setting forth in each case in comparative form the figures for the corresponding period or periods of (or, in the case of the balance sheet, as of
the end of) the previous fiscal year, all certified by one of its financial officers as presenting fairly, in all material respects, the financial condition and results of operations of Marathon and its consolidated Subsidiaries on a consolidated
basis in accordance with GAAP consistently applied, subject to normal year-end audit adjustments and the absence of footnotes (provided, that the requirements of this Section 7.1(a)(ii)(A) with respect to the delivery of financial
statements shall be deemed satisfied by publicly filing Marathon’s Form 10-Q for such fiscal quarter with the SEC, and such financial statements shall be deemed to have been delivered to each Managing Agent the Administrative Agent under
this Section 7.1(a)(ii)(A) on the date such Form 10-Q has been posted on the SEC website accessible through http://www.sec.gov/edgar/searchedgar/webusers.htm or such successor webpage of the SEC thereto) and (B) forty-five
(45) days after the end of the first three (3) quarterly periods of each fiscal year of Seller, unaudited balance sheets of Seller as at the end of each such period and statements of income and retained earnings and a statement of cash
flows for Seller for the period from the beginning of such fiscal year to the end of such quarter, all certified by an Authorized Officer of Seller. 
 (iii) Compliance Certificate. Together with the delivery of the financial statements required under Sections 7.1(a)(i) and (ii), a compliance certificate in substantially the form of
Exhibit V signed by such Seller Party’s Authorized Officer and dated the date of such annual financial statement or such quarterly financial statement, as the case may be. 

(iv) Shareholders Statements and Reports and SEC Filings. Promptly after the same become publicly available, copies of all
periodic and other reports, proxy statements and other materials filed by Marathon with the SEC, or distributed by Marathon to its shareholders generally, as the case may 

  
 25 

 
be (provided, that that the requirements of this clause (iv) shall be deemed satisfied by publicly filing such documents with the SEC, and such documents shall be deemed to have been
delivered to the Administrative Agent under this clause (iv) on the date such documents have been posted on the SEC website accessible through http://www.sec.gov/edgar/searchedgar/webusers.htm or such successor webpage of the SEC thereto).

 (v) [Reserved]. 
 (vi) Copies of Notices. Promptly upon its receipt of any notice, request for consent, certification, report or other communication under or pursuant to any Transaction Document from any Person
other than the Administrative Agent, any Managing Agent or any Purchaser, copies of the same. 
 (vii) Change in Credit and
Collection Policy. At least thirty (30) days prior to the effectiveness of any material change in or material amendment to the Credit and Collection Policy, a copy of the Credit and Collection Policy then in effect and a notice
(A) indicating such change or amendment, and (B) if such proposed change or amendment would be reasonably likely to adversely affect the collectibility of the Receivables or decrease the credit quality of any newly created Receivables,
requesting the Required Managing Agents’ consent thereto. 
 (viii) Other Information. Promptly, from time to time,
such other information, documents, Records or reports relating to the Receivables or the condition or operations, financial or otherwise, of such Seller Party as the Administrative Agent or any Managing Agent may from time to time reasonably request
in order to protect the interests of the Administrative Agent, the Managing Agents or the Purchasers under or as contemplated by this Agreement. 
 (b) Notices. Such Seller Party will notify the Administrative Agent in writing of any of the following promptly upon learning of the occurrence thereof, describing the same and, if applicable, the
steps being taken with respect thereto: 
 (i) Amortization Events or Potential Amortization Events. The occurrence of
each Amortization Event and each Potential Amortization Event, in each case of which any Authorized Officer of a Seller Party obtains knowledge, and a statement of an Authorized Officer of such Seller Party describing the nature of such occurrence
and the actions, if any, being taken or to be taken in connection therewith. 
 (ii) Judgment and Proceedings.
(A) (1) The entry of any judgment or decree against Servicer or any of its respective Subsidiaries if the aggregate amount of all judgments and decrees then outstanding against Servicer and its Subsidiaries exceeds $100,000,000 after
deducting (a) the amount with respect to which Servicer or any such Subsidiary is insured and with respect to which the insurer has assumed responsibility in writing, and (b) the amount for which Servicer or any such Subsidiary is
otherwise indemnified, and (2) the institution of any litigation, arbitration proceeding or governmental proceeding against Servicer as to which there is a reasonable possibility of an adverse determination and that, if adversely determined,
individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect; and (B) the entry of any judgment or decree or the institution of any litigation, arbitration proceeding or governmental proceeding against
Seller. 
 (iii) Material Adverse Effect. The occurrence of any event or condition that has had, or would reasonably be
expected to have, a Material Adverse Effect. 

  
 26 

 (iv) Termination Date. The occurrence of the “Termination Date” under and
as defined in the Receivables Sale Agreement or the “Termination Date” under and as defined in the Receivables Transfer Agreement. 
 (v) Defaults Under Other Agreements. The occurrence of a default or an event of default or other event which, with the giving of notice or the passage of time or both, would constitute a default or
an event of default under any other financing arrangement (in respect of, in the case of Servicer only, an amount in excess of $100,000,000) pursuant to which such Seller Party is a debtor or an obligor. 

(vi) Downgrade of Marathon. Any downgrade in the rating of any Indebtedness of Marathon by S&P or by Moody’s, setting
forth the Indebtedness affected and the nature of such change. 
 (vii) Revolving Credit Agreement. Any amendment,
restatement, waiver of the occurrence of an “Event of Default” under, or replacement of the Revolving Credit Agreement, together with a copy of the same; provided, that the notice requirements of this Section 7.1(b)(vii)
shall be deemed satisfied by publicly filing a special periodic report with the SEC describing such an amendment, restatement, waiver of the occurrence of an “Event of Default” under, or replacement of the Revolving Credit Agreement, and
such notice shall be deemed to have been delivered to the Administrative Agent under this Section 7.1(b)(vii) on the date such special periodic report has been posted on the SEC website accessible through
http://www.sec.gov/edgar/searchedgar/webusers.htm or such successor webpage of the SEC thereto). 
 (viii) Appointment of
Independent Manager. The decision to appoint a new director or manager of Seller as the “Independent Manager” for purposes of this Agreement, such notice to be issued not less than ten (10) days prior to the effective date of such
appointment and to certify that the designated Person satisfies the criteria set forth in the definition herein of “Independent Manager.” 
 (c) Compliance with Laws and Preservation of Existence. Such Seller Party will comply in all respects with all applicable laws, rules, regulations, orders, writs, judgments, injunctions, decrees or
awards to which it may be subject, except where the failure to so comply would not reasonably be expected to have a Material Adverse Effect. Such Seller Party will preserve and maintain its limited liability company or limited partnership existence,
as applicable, and its rights, franchises and privileges in the jurisdiction of its organization, and qualify and remain qualified in good standing as a foreign limited liability company or limited partnership, as applicable, in each jurisdiction in
which such qualification is necessary in view of its business and operations or the ownership of its properties; provided Servicer shall not be required to so preserve and maintain such rights, franchises and privileges or to remain so
qualified if the failure to do so would not reasonably be expected to have a Material Adverse Effect. 
 (d) Audits. Such
Seller Party will furnish to the Administrative Agent from time to time such information with respect to it and the Receivables as the Administrative Agent may reasonably request. Such Seller Party will, from time to time during regular business
hours as requested by the Administrative Agent or any Managing Agent upon reasonable notice and subject to any applicable restrictions or limitations on access to any facility or information that is classified or restricted by contract or by law,
regulation or governmental guidelines, and at the sole cost of such Seller Party, permit the Administrative Agent, the Managing Agents or their respective agents or representatives (i) to examine and make copies of and abstracts from all
Records in the possession or under the control of such Person relating to the Receivables and the Related Security, including, without limitation, the related Contracts, and (ii) to visit the offices and properties of such Person for the
purpose of examining such materials described in clause (i) above, and to discuss matters relating to such Person’s financial condition or the Receivables and the Related Security or any Person’s performance under any of the
Transaction 

  
 27 

 
Documents or any Person’s performance under the Contracts and, in each case, with any of the officers or employees of Seller or Servicer having knowledge of such matters; provided,
that at all times other than during the continuation of an Amortization Event, such Seller Party shall only be required to permit one (1) such visit during any calendar year and shall only be responsible for the cost of one (1) such visit
during any calendar year; provided, further, that notwithstanding that no Amortization Event is then continuing, if (x) a visit previously conducted during any calendar year produced audit results that (A) were not reasonably
satisfactory to the Administrative Agent, (B) were incomplete as a result of the failure of any Seller Party to furnish information reasonably requested by the Administrative Agent or (C) otherwise indicated the existence of any
circumstance reasonably warranting additional investigation or (y) the Administrative Agent notifies such Seller Party of the existence of any circumstance reasonably warranting additional investigation, then such Seller Party shall permit one
(1) additional visit during such calendar year. Information obtained during the course of an audit conducted pursuant to this Section 7.1(d) shall be subject to the provisions of Section 14.5. 

(e) Keeping and Marking of Books and Records. 
 (i) Servicer will maintain and implement administrative and operating procedures (including, without limitation, an ability to recreate Records evidencing Receivables in the event of the destruction of
the originals thereof), and keep and maintain all documents, books, Records and other information reasonably necessary or advisable for the collection of all Receivables (including, without limitation, Records adequate to permit the immediate
identification of each new Receivable and all Collections of and adjustments to each existing Receivable). Servicer will give the Administrative Agent (and the Administrative Agent shall forward such written notice to each Managing Agent) written
notice of any material change in the administrative and operating procedures referred to in the previous sentence. 
 (ii) Such
Seller Party will on or prior to the date hereof, mark its master data processing Records and other books and Records relating to the Purchaser Interest with a legend, acceptable to the Administrative Agent, describing the Purchaser Interest.

 (f) Compliance with Contracts and Credit and Collection Policy. Such Seller Party will timely and fully
(i) perform and comply with all provisions, covenants and other promises required to be observed by it under the Contracts related to the Receivables, and (ii) comply in all respects with the Credit and Collection Policy in regard to each
Receivable and the related Contract. 
 (g) Performance and Enforcement of Receivables Sale Agreement and Receivables
Transfer Agreement. Seller will, and will require MPC LP, as Originator, to, perform each of their respective obligations and undertakings under and pursuant to the Receivables Sale Agreement, will acquire Receivables thereunder in compliance
with the terms thereof and will enforce the rights and remedies accorded to Seller under the Receivables Sale Agreement and to Seller (by assignment from MPC LP under the Receivables Sale Agreement) under the Receivables Transfer Agreement. Seller
will take all actions to perfect and enforce its rights and interests (and the rights and interests of the Administrative Agent, the Managing Agents and the Purchasers as assignees of Seller) under the Receivables Sale Agreement or the Receivables
Transfer Agreement as the Administrative Agent or any Managing Agent may from time to time reasonably request, including, without limitation, making claims to which it may be entitled under any indemnity, reimbursement or similar
provision contained in the Receivables Sale Agreement or the Receivables Transfer Agreement. 
 (h) Ownership. Seller
will take all necessary action to (i) vest legal and equitable title to the Receivables, the Related Security and the Collections acquired under the Receivables Sale Agreement irrevocably in Seller, free and clear of any Adverse Claims (other
than (a) Permitted Liens and (b) Adverse Claims in favor of the Administrative Agent and the Purchasers), including, without limitation, 

  
 28 

 
the filing of all financing statements or other similar instruments or documents necessary under the UCC (or any comparable law) of all appropriate jurisdictions to perfect Seller’s interest
in such Receivables, Related Security and Collections and such other action to perfect, protect or more fully evidence the interest of Seller therein as the Administrative Agent or any Managing Agent may reasonably request, and (ii) establish
and maintain, in favor of the Administrative Agent, for the benefit of the Purchasers, a valid and perfected first priority undivided percentage ownership interest (and/or a valid and perfected first priority security interest) in all Receivables,
Related Security and Collections to the full extent contemplated herein, free and clear of any Adverse Claims (other than (a) Permitted Liens and (b) Adverse Claims in favor of the Administrative Agent for the benefit of the Purchasers),
including, without limitation, the filing of all financing statements or other similar instruments or documents necessary under the UCC (or any comparable law) of all appropriate jurisdictions to perfect the Administrative Agent’s
(for the benefit of the Purchasers) interest in such Receivables, Related Security and Collections and such other action to perfect, protect or more fully evidence the interest of the Administrative Agent for the benefit of the Purchasers as the
Administrative Agent or any Managing Agent may reasonably request. 
 (i) Purchasers’ Reliance. Seller acknowledges
that the Administrative Agent, the Managing Agents and the Purchasers are entering into the transactions contemplated by this Agreement in reliance upon Seller’s identity as a legal entity that is separate from any other Person. Therefore, from
and after the date of execution and delivery of this Agreement, Seller shall take all reasonable steps, including, without limitation, all steps that the Administrative Agent, any Managing Agent or any Purchaser may from time to time reasonably
request, to maintain Seller’s identity as a separate legal entity and to make it manifest to third parties that Seller is an entity with assets and liabilities distinct from those of each Related Entity and not just a division of any Related
Entity. Without limiting the generality of the foregoing and in addition to the other covenants set forth herein, Seller will: 
 (A) conduct its own business in its own name and require that all full-time employees of Seller, if any, identify themselves as such and not as employees of any Related Entity (including, without
limitation, by means of providing appropriate employees with business or identification cards identifying such employees as Seller’s employees); 
 (B) compensate all employees, consultants and agents directly, from Seller’s own funds, for services provided to Seller by such employees, consultants and agents and, to the extent any employee,
consultant or agent of Seller is also an employee, consultant or agent of any Related Entity, allocate the compensation of such employee, consultant or agent between Seller and such Related Entity, on a basis that reflects the services rendered to
Seller and such Related Entity; 
 (C) maintain separate offices and, if such office is located in the offices of
any Related Entity, Seller shall lease such office at a fair market rent; 
 (D) have a separate telephone
number, which will be answered only in its name and have separate stationery, invoices and checks in its own name; 
 (E) conduct all transactions with each Related Entity (including, without limitation, any delegation of its obligations hereunder as Servicer) strictly on an arm’s length basis, allocate all overhead
expenses (including, without limitation, telephone and other utility charges) for items shared between Seller and any Related Entity on the basis of actual use to the extent practicable and, to the extent such allocation is not practicable, on a
basis reasonably related to actual use; 

  
 29 

 (F) at all times have a Board of Managers consisting of three
(3) members, at least one (1) member of which is an Independent Manager; 
 (G) observe all limited
liability company formalities as a distinct entity, and ensure that all limited liability company actions relating to (A) the selection, maintenance or replacement of the Independent Manager, (B) the dissolution or liquidation of Seller or
(C) the initiation of, participation in, acquiescence in or consent to any bankruptcy, insolvency, reorganization or similar proceeding involving Seller, are duly authorized by unanimous vote of its Board of Managers (including the Independent
Manager); 
 (H) maintain Seller’s books and records separate from those of any Related Entity and otherwise
readily identifiable as its own assets rather than assets of any Related Entity; 
 (I) prepare its financial
statements separately from those of each Related Entity and insure that any consolidated financial statements of any Related Entity that include Seller and that are filed with the SEC or any other governmental agency have notes clearly stating that
Seller is a separate corporate entity and that its assets will be available first and foremost to satisfy the claims of the creditors of Seller; 
 (J) except as herein specifically otherwise provided, maintain the funds or other assets of Seller separate from, and not commingled with, those of any Related Entity and only maintain bank accounts or
other depository accounts to which Seller alone is the account party, into which Seller (and Servicer on its behalf) alone makes deposits and from which Seller alone (or Servicer on its behalf and Administrative Agent hereunder) has the power to
make withdrawals; 
 (K) pay all of Seller’s operating expenses from Seller’s own assets (except for
certain payments by any Related Entity or other Persons pursuant to allocation arrangements that comply with the requirements of this Section 7.1(i)); 

(L) operate its business and activities such that: (i) it does not engage in any business or activity of any kind, or
enter into any transaction or indenture, mortgage, instrument, agreement, contract, lease or other undertaking, other than the transactions contemplated and authorized by the Principal Transaction Documents and activities incidental thereto; and
(ii) does not create, incur, guarantee, assume or suffer to exist any indebtedness or other liabilities, whether direct or contingent, other than (1) as a result of the endorsement of negotiable instruments for deposit or collection or
similar transactions in the ordinary course of business, (2) the incurrence of obligations under this Agreement, under the Fee Letter or as expressly contemplated hereby, (3) the incurrence of obligations, as expressly contemplated in the
Receivables Sale Agreement and the Subordinated Note, to make payment to MPC LP, as an Originator, thereunder for the purchase of Receivables from MPC LP under the Receivables Sale Agreement, and (4) the incurrence of operating expenses in the
ordinary course of business of the type otherwise contemplated by this Agreement; 
 (M) maintain its
organizational documents in conformity with this Agreement, such that (1) it does not amend, restate, supplement or otherwise modify its organizational documents in any respect that would impair its ability to comply with the terms or
provisions of any of the Transaction Documents, including, without limitation, Section 7.1(i) of this Agreement; and (2) its operating agreement, at all times that this Agreement is in effect, provides for not less than ten
(10) days’ prior written notice to the Administrative Agent of the replacement or appointment of any director that is to serve as an Independent Manager for 

  
 30 

 
purposes of this Agreement and the condition precedent to giving effect to such replacement or appointment that Seller certify that the designated Person satisfies the criteria set forth in the
definition herein of “Independent Manager”, and comply at all times with the terms of such organizational documents; 
 (N) maintain the effectiveness of, and continue to perform under the Principal Transaction Documents to which it is a party (other than, with the consent of the applicable L/C Issuer, a Letter of Credit
or Letter of Credit Application); 
 (O) maintain its corporate separateness such that it does not merge or
consolidate with or into, or convey, transfer, lease or otherwise dispose of (whether in one transaction or in a series of transactions, and except as otherwise contemplated herein) all or substantially all of its assets (whether now owned or
hereafter acquired) to, or acquire all or substantially all of the assets of, any Person, nor at any time create, have, acquire, maintain or hold any interest in any Subsidiary; 

(P) maintain at all times the Required Capital Amount (as defined in the Receivables Sale Agreement) and refrain from
making any dividend, distribution, redemption of capital stock or payment of any subordinated indebtedness which would cause the Required Capital Amount to cease to be so maintained; and 

(Q) take such other actions as are necessary on its part to ensure that the facts and assumptions set forth in the opinion
issued by Baker Botts L.L.P., as counsel for Seller, in connection with the closing or initial Credit Event under this Agreement and relating to substantive consolidation issues, and in the certificates accompanying such opinion, remain true and
correct in all material respects at all times. 
 (j) Collections. Such Seller Party will (1) direct all Obligors to
remit Collections directly to a Lock-Box or a Collection Account, (2) cause all proceeds from all Lock-Boxes to be directly deposited by a Collection Bank into a Collection Account and (3) cause each Lock-Box and Collection Account to be
subject at all times to a Collection Account Agreement that is in full force and effect. In the event any payments relating to Receivables are remitted directly to Seller or any Affiliate of Seller, Seller will remit (or will cause all such payments
to be remitted) directly to a Collection Bank and deposited into a Collection Account within two (2) Business Days following receipt thereof, and, at all times prior to such remittance, Seller will itself hold or, if applicable, will cause such
payments to be held in trust for the exclusive benefit of the Administrative Agent, the Managing Agents and the Purchasers. Seller will maintain exclusive ownership, dominion and control (subject to the terms of this Agreement) of each Lock-Box and
Collection Account and shall not grant the right to take dominion and control of any Lock-Box or Collection Account at a future time or upon the occurrence of a future event to any Person, except to the Administrative Agent as contemplated by this
Agreement. Each Seller Party shall take all steps necessary to ensure that the Administrative Agent has “control” (within the meaning of Section 9-104 of the UCC of all applicable jurisdictions) over each Collection Account and
Lock-Box. 
 (k) Taxes. Servicer will, and will cause each of its Subsidiaries to, pay its Tax liabilities and other
governmental obligations which, if unpaid, would reasonably be expected to result in an Adverse Claim upon any property of Servicer or such Subsidiary before the same shall become delinquent or in default, except to the extent that (a) the
validity or amount thereof is being contested in good faith by appropriate proceedings and Servicer or such Subsidiary has set aside on its books adequate reserves with respect thereto in accordance with GAAP or (b) the failure to make such
payment would not reasonably be expected to result in a Material Adverse Effect. Seller will file all Tax returns and reports required by law to be filed by it and will promptly pay all Taxes and other governmental charges at any time owing.

  
 31 

 
Seller will pay when due any Taxes payable in connection with the Receivables, exclusive of Taxes on or measured by income or gross receipts of Conduit Purchaser, the Administrative Agent or any
Committed Purchaser. 
 (l) Insurance. Seller will maintain in effect, or cause to be maintained in effect, at
Seller’s own expense, such casualty and liability insurance as Seller shall deem appropriate in its good faith business judgment. 
 (m) Payment to MPC LP, as Originator. With respect to any Receivable purchased by Seller from MPC LP, such sale shall be effected under, and in compliance with the terms of, the Receivables Sale
Agreement, including, without limitation, the terms relating to the amount and timing of payments to be made to MPC LP in respect of the purchase price for such Receivable. 

(n) Accounting. Such Seller Party shall treat the transactions contemplated by the Receivables Sale Agreement as sales and/or
capital contributions and the transactions contemplated by the Receivables Transfer Agreement as sales, for all purposes, including, without limitation, accounting purposes, notwithstanding the fact that the consolidated financial statements of
Marathon and Seller shall be prepared in accordance with GAAP and, as a result of the consolidation required by GAAP, the transfers will be reflected as a financing by Marathon in its consolidated financial statements, and such Seller Party agrees
that (i) appropriate notations shall be made in any such consolidated financial statements (or in the accompanying notes) to indicate that Seller is a separate legal entity from Marathon and its Affiliates (other than Seller) and to indicate
that the assets and credit of Seller are not available to satisfy the debts and obligations of Marathon and its Affiliates (other than Seller) and (ii) the assets of Seller shall be listed separately on any balance sheet of such Seller Party
prepared on a standalone basis. 
 Section 7.2 Negative Covenants of the Seller Parties. Until the Final Payout
Date, each Seller Party hereby covenants, as to itself, that: 
 (a) Name Change, Offices and Records. Seller will not
make any change to its name (within the meaning of Sections 9-503 and 9-507(c) of any applicable enactment of the UCC), type or jurisdiction of organization, become a “new debtor” (as defined in Section 9-102(a)(56) of any
applicable enactment of the UCC) with respect to a currently effective security agreement previously entered into by any other Person, change its “location” (within the meaning of Section 9-307 of any applicable enactment of the UCC)
or change the location where the majority of its books and Records are maintained unless, at least forty five (45) days prior to the effective date of any such name change, change in type or jurisdiction of organization, or change in location
of its books and records, such Seller Party notifies the Administrative Agent and (except with respect to a change of location of books and records) delivers to the Administrative Agent (i) such financing statements (Forms UCC-1 and UCC-3) as
the Administrative Agent may reasonably request to reflect such name change or change in type or jurisdiction of organization, (ii) if the Administrative Agent or any Managing Agent shall so request, an opinion of counsel, in form and substance
reasonably satisfactory to the Administrative Agent and such Managing Agent, as to such Seller Party’s valid existence and good standing and the perfection and priority of the Administrative Agent’s ownership or security interest in the
Receivables, the Related Security and Collections, and (iii) such other documents and instruments as the Administrative Agent or any Managing Agent may reasonably request in connection therewith, and has taken all other steps to ensure that the
Administrative Agent, for the benefit of itself and the Purchasers, continues to have a first priority, perfected ownership or security interest in the Receivables, the Related Security related thereto and any Collections thereon. 

(b) Change in Payment Instructions to Obligors. Except as may be required by the Administrative Agent pursuant to
Section 8.2(b), such Seller Party will not add or terminate any bank as a 

  
 32 

 
Collection Bank, or make any change in the instructions to Obligors regarding payments to be made to any Lock-Box or Collection Account, unless the Administrative Agent shall have received, at
least ten (10) days before the proposed effective date therefor, (i) written notice of such addition, termination or change and (ii) with respect to the addition of a Collection Bank or a Collection Account or Lock-Box, an executed
Collection Account Agreement with respect to the new Collection Account or Lock-Box; provided, however, that Servicer may make changes in instructions to Obligors regarding payments without notice to the Administrative Agent if such
new instructions require such Obligor to make payments to another existing Collection Account or Lock-Box. 
 (c)
Modifications to Contracts and Credit and Collection Policy. Such Seller Party will not, and will not permit any Originator to, make any change in or amendment to the Credit and Collection Policy that would be reasonably likely to adversely
affect the collectibility of the Receivables or decrease the credit quality of any newly created Receivables, except such change or amendment as to which the Administrative Agent and the Managing Agents have been notified and any necessary consents
have been obtained in accordance with Section 7.1(a)(vii). Except as provided in Section 8.2(c), Servicer will not, and will not permit any Originator to, extend, amend or otherwise modify the terms of any Receivable or any
Contract related thereto other than in accordance with the Credit and Collection Policy. 
 (d) Sales, Liens. Seller will
not sell, assign (by operation of law or otherwise) or otherwise dispose of, or grant any option with respect to, or create or suffer to exist any Adverse Claim (other than Permitted Liens) upon (including, without limitation, the filing of any
financing statement) or with respect to, any Receivable, Related Security or Collections or upon or with respect to any Contract under which any Receivable arises, or any Lock-Box or Collection Account, or assign any right to receive income with
respect thereto (other than, in each case, in favor of the Administrative Agent and the Purchasers as provided for herein), and Seller will defend the right, title and interest of the Administrative Agent and the Purchasers in, to and under any of
the foregoing property, against all claims of third parties claiming through or under Seller or any Originator. Seller will not create or suffer to exist any mortgage, pledge, security interest, encumbrance, lien, charge or other similar arrangement
on any of its inventory or the financing or lease of which gives rise to any Receivable. 
 (e) Net Receivables Balance.
At no time prior to the Amortization Date shall Seller permit the Net Receivables Balance to be less than an amount equal to the sum of (i) the Aggregate Capital plus (ii) the L/C Undrawn Amount plus (iii) the Aggregate
Reserves. 
 (f) Termination Date Determination. Seller will not designate the “Termination Date” (as defined
in the Receivables Sale Agreement), or send any written notice to MPC LP in respect thereof, without the prior written consent of the Administrative Agent and the Required Managing Agents, except with respect to the occurrence of such Termination
Date arising pursuant to Section 5.1(d) of the Receivables Sale Agreement. 
 (g) Restricted Junior Payments. From
and after the occurrence of any Amortization Event or any Potential Amortization Event, Seller will not make any Restricted Junior Payment if, after giving effect thereto, Seller would fail to meet its obligations set forth in
Section 7.2(e). 
 (h) Changes to Principal Transaction Documents. In the case of Seller, except as otherwise
permitted herein, it shall not terminate, amend, modify, waive any breach or default under or otherwise modify any Principal Transaction Document or grant any waiver, consent or indulgence thereunder without the prior written consent of (x) in
the case of a Principal Transaction Document other than a Letter of Credit or Letter of Credit Application, the Administrative Agent and the Required Managing Agents or (y) in the case of a Letter of Credit or Letter of Credit Application, the
applicable L/C Issuer. 

  
 33 

 (i) Limitation on Transactions with Affiliates. In the case of Seller, it shall not
enter into, or be a party to any transaction with any of its Affiliates, except for: (i) the transactions contemplated hereby, by the Receivables Sale Agreement and by the other Transaction Documents; (ii) capital contributions by MPC LP
to Seller which are in compliance with the Transaction Documents; (iii) Restricted Junior Payments which are in compliance with applicable law and this Agreement; and (iv) to the extent not otherwise prohibited under applicable law and
this Agreement, other transactions permitted by its operating agreement in the nature of employment contracts, directors’ or manager’s fees and similar ordinary course items, upon fair and reasonable terms materially no less favorable to
it than would be obtained in a comparable arm’s-length transaction with a Person not an Affiliate. 
 ARTICLE VIII

 ADMINISTRATION AND COLLECTION 
 Section 8.1 Designation of Servicer. (a) The servicing, administration and collection of the Receivables shall be conducted by such Person (the “Servicer”) so designated from
time to time in accordance with this Section 8.1. MPC LP is hereby designated as, and hereby agrees to perform the duties and obligations of, Servicer pursuant to the terms of this Agreement. The Administrative Agent may, at any time
after the occurrence and during the continuance of an Amortization Event, at the direction of the Required Managing Agents, designate as Servicer (i) any Person to succeed MPC LP or (ii) any successor to such Servicer that replaced MPC LP;
provided, however, that in either case, no such Person shall be a Marathon Competitor. 
 (b) (i) Without the
prior written consent of the Administrative Agent and the Required Managing Agents, MPC LP shall not be permitted to delegate any of its duties or responsibilities as Servicer to any Person other than (A) Seller; (B) one or more Affiliates
of MPC LP, upon written notice to the Administrative Agent and the Managing Agents; and (C) with respect to certain Charged-Off Receivables, outside collection agencies in accordance with its customary practices. None of Seller of any such
Affiliate shall be permitted to further delegate to any other Person any of the duties or responsibilities of Servicer so delegated to it by MPC LP. 
 (ii) If at any time the Administrative Agent shall designate as Servicer any Person other than MPC LP, all duties and responsibilities theretofore delegated by MPC LP to Seller or any such Affiliate may,
at the discretion of the Administrative Agent, be terminated forthwith on notice given by the Administrative Agent to MPC LP and to Seller or such Affiliate, as applicable. 
 (c) Notwithstanding any delegation of MPC LP’s duties as Servicer pursuant to the foregoing subsection (b)(i), (i) MPC LP shall be and remain primarily liable to the Administrative Agent
and the Purchasers for the full and prompt performance of all duties and responsibilities of Servicer hereunder and (ii) the Administrative Agent and the Purchasers shall be entitled to deal exclusively with MPC LP in matters relating to the
discharge by Servicer of its duties and responsibilities hereunder. The Administrative Agent and the Purchasers shall not be required to give notice, demand or other communication to any Person other than MPC LP in order for communication to
Servicer and its sub-servicer or other delegate with respect thereto to be accomplished. MPC LP, at all times that it is Servicer, shall be responsible for providing any sub-servicer or other delegate of Servicer with any notice given to Servicer
under this Agreement. 

  
 34 

 Section 8.2 Duties of Servicer. (a) Servicer shall take or cause to be taken
all such actions as may be necessary or advisable to collect each Receivable from time to time, all in accordance with applicable laws, rules and regulations, with reasonable care and diligence, and in accordance with the Credit and Collection
Policy. 
 Servicer will instruct all Obligors to pay all Collections directly to a Lock-Box or Collection Account. Servicer
shall effect a Collection Account Agreement with each Collection Bank. In the case of any remittances received in any Lock-Box or Collection Account that shall have been identified, to the satisfaction of Servicer, to not constitute Collections or
other proceeds of the Receivables or the Related Security, Servicer shall promptly remit such items to the Person identified to it as being the owner of such remittances. From and after the date the Administrative Agent delivers to any Collection
Bank a Collection Notice pursuant to Section 8.3, the Administrative Agent may request that Servicer, and Servicer thereupon promptly shall instruct all Obligors with respect to the Receivables, to remit all payments thereon to a new
depositary account specified by the Administrative Agent and, at all times thereafter, Seller and Servicer shall not deposit or otherwise credit, and shall not permit any other Person to deposit or otherwise credit to such new depositary account any
cash or payment item other than Collections. 
 Servicer acknowledges and agrees that, notwithstanding the fact that the title
of the Lock-Boxes and Collection Accounts may include the name of Marathon Petroleum Company LP as Servicer, Seller owns all right, title and interest in and to such Lock-Boxes and Collection Accounts and such Lock-Boxes and Collection Accounts are
so titled for administrative convenience only. 
 (b) Servicer shall administer the Collections in
accordance with the procedures described herein and in Article II. Servicer shall set aside and hold in trust for the account of Seller and the Purchasers all Collections in accordance with Article II. Servicer shall, upon the request
of the Administrative Agent after the occurrence and during the continuance of an Amortization Event at the direction of the Required Managing Agents, segregate, in a manner acceptable to the Administrative Agent, all cash, checks and other
instruments received by it from time to time constituting Collections from the general funds of Servicer or Seller prior to the remittance thereof in accordance with Article II (which, for the avoidance of doubt, shall not include amounts
subject to a Reinvestment). If Servicer shall be required to segregate Collections pursuant to the preceding sentence, Servicer shall segregate and deposit with a bank designated by the Administrative Agent such allocable share of Collections of
Receivables set aside for the Purchasers on the second
(2nd) Business Day following receipt by Servicer of
such Collections, duly endorsed or with duly executed instruments of transfer. 
 (c) Servicer may, in accordance with the
Credit and Collection Policy, extend the maturity of any Receivable or adjust the Outstanding Balance of any Receivable as Servicer determines to be appropriate to maximize Collections thereof; provided, however, that such extension or
adjustment shall not alter the status of such Receivable as a Delinquent Receivable or Charged-Off Receivable or limit the rights of the Administrative Agent, the Managing Agents or the Purchasers under this Agreement. Notwithstanding anything to
the contrary contained herein, after the occurrence of the Amortization Date, the Administrative Agent shall have the absolute and unlimited right to direct Servicer to commence or settle any legal action with respect to any Receivable or to
foreclose upon or repossess any Related Security. 
 (d) Servicer shall hold in trust for Seller and the Purchasers all Records
that (i) evidence or relate to the Receivables, the related Contracts and Related Security or (ii) are otherwise necessary or desirable to collect the Receivables and shall, as soon as practicable upon demand of the Administrative Agent,
deliver or make available to the Administrative Agent all such Records, at a place selected by the Administrative Agent. Servicer shall, from time to time at the request of the Administrative Agent after

  
 35 

 
the occurrence and during the continuance of an Amortization Event at the direction of the Required Managing Agents, furnish to the Administrative Agent and the Managing Agents (promptly after
any such request) a calculation of the amounts set aside for the Purchasers pursuant to Article II. 
 (e) Any payment by
an Obligor in respect of any indebtedness owed by it to any Originator or Seller shall, except as otherwise specified by such Obligor or otherwise required by contract or law, be applied as a Collection of any Receivable of such Obligor (starting
with the oldest such Receivable) to the extent of any amounts then due and payable thereunder before being applied to any other receivable or other obligation of such Obligor. 
 Section 8.3 Collection Notices. The Administrative Agent is authorized at any time after the occurrence and during the continuance of an Amortization Event and upon the written direction of
the Required Managing Agents to date and to deliver to the Collection Banks the Collection Notices. Seller hereby transfers to the Administrative Agent for the benefit of the Purchasers, effective when the Administrative Agent delivers such notice,
the exclusive ownership and control of each Lock-Box and the Collection Accounts. In case any authorized signatory of Seller whose signature appears on a Collection Account Agreement shall cease to have such authority before the delivery of such
notice, such Collection Notice shall nevertheless be valid as if such authority had remained in force. Seller hereby authorizes the Administrative Agent, and agrees that the Administrative Agent shall be entitled after the occurrence and during the
continuance of an Amortization Event to (i) endorse Seller’s name on checks and other instruments representing Collections, (ii) enforce the Receivables, the related Contracts and the Related Security and (iii) take such action
as shall be necessary or desirable to cause all cash, checks and other instruments constituting Collections of Receivables to come into the possession of the Administrative Agent rather than Seller. 

Section 8.4 Responsibilities of Seller. Anything herein to the contrary notwithstanding, the exercise by the Administrative
Agent, the Managing Agents and the Purchasers of their rights hereunder shall not release Servicer, any Originator or Seller from any of their duties or obligations with respect to any Receivables or under the related Contracts. None of the
Administrative Agent, the Managing Agents or the Purchasers shall have any obligation or liability with respect to any Receivables or related Contracts, nor shall any of them be obligated to perform the obligations of Seller. 

Section 8.5 Reports. 
 (a) Servicer shall prepare and forward to the Administrative Agent (and the Administrative Agent shall promptly forward the same to each Managing Agent) (i) during a Monthly Reporting Period, on each
Monthly Settlement Date, a Monthly Report, (ii) during a Weekly Reporting Period, on each Monthly Settlement Date, a Monthly Report and, upon the written request of the Required Managing Agents, on Tuesday of each calendar week (or if such day
is not a Business Day, on the next succeeding Business Day) (each such date the “Weekly Reporting Date”), a Weekly Report covering the period from and including Monday of the preceding week to but excluding Monday of such week and
(iii) during a Daily Reporting Period, on each Monthly Settlement Date, a Monthly Report and, upon the written request of the Required Managing Agents, on each Business Day (or such other schedule as may be consented to by the Required Managing
Agents) (each such date the “Daily Reporting Date”), a Daily Report covering the immediately preceding Business Day (provided, that a Daily Report covering the first
(1st) Business Day following a weekend or holiday or
both shall also cover such weekend or holiday or both), in each case, certified by an Authorized Officer of Servicer; it being understood that Servicer may provide interim reporting at any time and from time to time (including upon any
change in or cancellation of any Special Concentration Limit). In the event that Servicer is required to furnish any Weekly Report or Daily Report as provided herein, and if the last day of the week covered by such Weekly Report or if the day
covered by such Daily Report, as applicable, occurs during the period commencing on the day of 

  
 36 

 
any calendar month when Crude Oil Receivables generated during the immediately preceding calendar month are payable and ending on the date of the following calendar month on which Crude Oil
Receivables generated during the calendar month immediately preceding such following month are invoiced, then the computation of the Net Receivables Balance set forth in such Weekly Report or Daily Report, as applicable, shall include the aggregate
amount of all Crude Oil Receivables for which invoices have not yet been issued but which would qualify as Eligible Receivables had an invoice been issued in respect thereof. 
 (b) If the rating system of Moody’s or S&P shall change, or if either such rating agency shall cease to be in the business of rating corporate debt obligations, Servicer, the Managing Agents and
the Administrative Agent shall negotiate in good faith to amend, in a manner acceptable to Servicer and the Required Managing Agents, the reporting obligations of Servicer to reflect such changed rating system or the unavailability of ratings from
such rating agency and, pending the effectiveness of any such amendment Servicer’s reporting obligations hereunder shall be determined by reference to the rating most recently in effect prior to such change or cessation. 

Section 8.6 Servicing Fees. In consideration of MPC LP’s agreement to act as Servicer hereunder, the Purchasers hereby
agree that, so long as MPC LP shall continue to perform as Servicer hereunder, Seller shall pay over to MPC LP a fee (the “Servicing Fee”) on each Monthly Settlement Date, in arrears for the immediately preceding month, equal to one
percent (1.0%) per annum of the average aggregate Outstanding Balance of all Receivables during such period, as compensation for its servicing activities. Notwithstanding the foregoing, if Servicer is replaced by the Administrative Agent, the
successor Servicer shall receive a servicing fee in an amount agreed upon by the Administrative Agent and the successor Servicer which reflects the then prevailing market rates for servicing similar portfolios of receivables (not to exceed one
hundred ten percent (110%) of the aggregate reasonable costs and expenses incurred by such Person in connection with the performance of its obligations as Servicer hereunder). 

ARTICLE IX 

AMORTIZATION EVENTS 
 Section 9.1 Amortization Events. The occurrence of any one or more of the following events shall constitute an “Amortization Event”: 

(a) (i) Any Seller Party, any Originator or Marathon shall fail to make any payment or deposit required hereunder (including,
without limitation, a payment under Section 1.5(n)(ii)) when due and, for any such payment or deposit which is not in respect of Capital or required under Section 2.6, such failure continues for three (3) Business Days;

 (ii) Servicer shall fail to deliver any Monthly Report, Weekly Report or Daily Report as and when required hereunder and such
failure shall remain unremedied for (i) in the case of a Monthly Report, two (2) Business Days and (ii) in the case of a Weekly Report or Daily Report, one (1) Business Day; or 

(iii) Any Seller Party, any Originator or Marathon shall fail to perform or observe any term, covenant or agreement hereunder (other than
as referred to in clause (i) of this paragraph (a) and paragraph 9.1(e)) and such failure shall continue for five (5) consecutive Business Days. 
 (b) Any representation or warranty made by any Seller Party, any Originator or Marathon in this Agreement, any other Transaction Document or any amendment or modification thereof or waiver thereunder, or
in any report, certificate, financial statement or other document furnished pursuant to or in 

  
 37 

 
connection with any Transaction Document or any amendment or modification thereof or waiver thereunder shall prove to have been incorrect in any material respect when made or deemed made (except
that the materiality standard in this clause (b) shall not apply to any such representation or warranty that is expressly qualified by a materiality standard or contains any carve-out or exception based on a Material Adverse Effect by its
express terms). 
 (c) (i) Failure of Seller to pay any Indebtedness when due; or (ii) the failure of Marathon, any
Originator or Servicer to make any payment in excess of $1,000,000 in the aggregate (whether of principal, interest or fees) in respect of any Indebtedness in an aggregate principal amount exceeding $100,000,000, when and as the same shall become
due and payable, and such failure shall continue after the applicable grace period, if any, specified in the agreement or instrument relating to such Indebtedness; or (iii) any event or condition occurs that results in any Indebtedness of
Marathon, any Originator or any Seller Party in an aggregate principal amount exceeding $100,000,000 becoming due prior to its scheduled maturity; provided, that this clause (iii) shall not apply to secured Indebtedness that becomes due
as a result of the voluntary sale or transfer of the property or assets securing such Indebtedness or is voluntarily prepaid in full. 
 (d) (i) Any Seller Party, any Originator or Marathon shall generally not pay its debts as such debts become due or shall admit in writing its inability to pay its debts generally or shall make a
general assignment for the benefit of creditors; (ii) any involuntary proceeding shall be instituted by or against any Seller Party, any Originator or Marathon seeking to adjudicate it bankrupt or insolvent, or seeking liquidation, winding up,
reorganization, arrangement, adjustment, protection, relief or composition of it or its debts, or of a substantial part of its assets, under any law relating to bankruptcy, insolvency or reorganization or relief of debtors, or seeking the entry of
an order for relief or the appointment of a receiver, trustee, custodian, sequestrator, conservator or other similar official for it or any substantial part of its property, in any such case, such proceeding or petition shall continue undismissed
for sixty (60) days or an order or decree approving or ordering any of the foregoing shall be entered by such court; (iii) any Seller Party, any Originator or Marathon shall (A) voluntarily commence any proceeding or file any petition
seeking liquidation, winding up, reorganization, arrangement, adjustment, protection, relief or composition of it or its debts, or of a substantial part of its assets, under any law relating to bankruptcy, insolvency or reorganization or relief of
debtors, (B) consent to the institution of, or fail to contest in a timely and appropriate manner, any proceeding or petition described in subclause (ii) of this clause (d), (C) apply for or consent to the appointment of a receiver,
trustee, custodian, sequestrator, conservator or other similar official for it or any substantial part of its property, or (D) file an answer admitting the material allegations of a petition filed against it in any such proceeding or
(iv) any Seller Party, any Originator or Marathon shall take any limited liability company, limited partnership corporate action, as applicable, to authorize or for the purpose of effecting any of the actions set forth in clauses (i),
(ii) or (iii) above in this subsection (d). 
 (e) Seller shall fail to comply with the terms of
Section 2.6 hereof. 
 (f) As at the end of any calendar month: 

(i) the average of the Delinquency Ratios as of the end of such calendar month and the two preceding calendar months shall exceed 1.50%;
or 
 (ii) the average of the Default Ratios as of the end of such calendar month and the two preceding calendar months shall
exceed 1.00%; or 
 (iii) the average of the Dilution Ratios as of the end of such calendar month and the two preceding calendar
months shall exceed 6.00%; or 

  
 38 

 (iv) the average of the Turnover Ratios as of the end of such calendar month and the two
preceding calendar months shall exceed 20.00. 
 (g) (i) A Change of Control shall occur; (ii) Marathon shall cease to
own, directly or indirectly, 100% of the equity interests of Seller, Servicer (if Servicer is MPC LP or an Affiliate of Marathon) or any Originator; or (iii) MPC LP shall cease to directly own 100% of the equity interests of Seller. 

(h) (i) One or more final judgments for the payment of money in excess of $10,000 shall be entered against Seller or (ii) one
or more final judgments for the payment of money in an amount in excess of $100,000,000, individually or in the aggregate, shall be entered against Servicer on claims not covered by insurance or as to which the insurance carrier has denied its
responsibility, and such judgment shall continue unsatisfied and in effect for thirty (30) consecutive days without a stay of execution. 
 (i) (i) The “Termination Date” under and as defined in the Receivables Sale Agreement shall occur under the Receivables Sale Agreement or MPC LP shall for any reason cease to transfer, or cease
to have the legal capacity to transfer, or otherwise be incapable of transferring Receivables to Seller under the Receivables Sale Agreement or (ii) the “Termination Date” under and as defined in the Receivables Transfer Agreement
shall occur under the Receivables Transfer Agreement or Marathon Canada shall for any reason cease to transfer, or cease to have the legal capacity to transfer, or otherwise be incapable of transferring Receivables to MPC LP under the Receivables
Transfer Agreement. 
 (j) This Agreement or any other Principal Transaction Document shall terminate in whole or in part
(except in accordance with its terms or with the consent of the parties thereto and, other than with respect to a Letter of Credit or Letter of Credit Application, the Administrative Agent), or shall cease to be effective or to be the legally valid,
binding and enforceable obligation of any Seller Party or any Originator, as applicable (except with the consent of the parties thereto and, other than with respect to a Letter of Credit or Letter of Credit Application, the Administrative Agent), or
any Seller Party, any Originator or Marathon shall directly or indirectly contest in any manner such effectiveness, validity, binding nature or enforceability of this Agreement or any other Principal Transaction Document, or the Administrative Agent
for the benefit of the Purchasers shall cease to have a valid and perfected first priority security interest in the Receivables, the Related Security and the Collections with respect thereto and the Collection Accounts, free and clear of any Adverse
Claims, except for (a) any Adverse Claim created under this Agreement, under the Receivables Sale Agreement or under the Receivables Transfer Agreement and (b) Permitted Liens. 

(k) Marathon shall fail to perform or observe any term, covenant or agreement required to be performed by it under the Performance
Undertaking, or the Performance Undertaking shall cease to be effective or to be the legally valid, binding and enforceable obligation of Marathon, or Marathon shall directly or indirectly contest in any manner such effectiveness, validity, binding
nature or enforceability. 
 (l) Any Person shall be appointed as an Independent Manager of Seller without prior notice thereof
having been given to the Administrative Agent in accordance with Section 7.1(b)(viii). 
 (m) Marathon shall fail to
comply with any of its financial covenants set forth in Section 6.07 or 6.08 of the Revolving Credit Agreement as in effect from time to time. 
 (n) An ERISA Event shall have occurred that, when taken together with all other ERISA Events that have occurred, could reasonably be expected to result in a Material Adverse Effect. 

  
 39 

 (o) The Internal Revenue Service shall file notice of a lien pursuant to Section 430
or Section 6321 of the Code with regard to any of the assets of any Seller Party or any of the Receivables, Related Security or Collections in an amount in excess of $10,000,000 and such lien shall not have been released within fifteen
(15) days; or the PBGC shall, or shall indicate its intention to, file notice of a lien pursuant to Section 303 or Section 4068 of ERISA with regard to any of the assets of any Seller Party in an amount in excess of $10,000,000 and
such lien shall not have been released within fifteen (15) days. 
 Section 9.2 Remedies. Upon the occurrence
and during the continuation of an Amortization Event, the Administrative Agent, upon the direction of the Required Managing Agents shall take any of the following actions: (i) replace the Person then acting as Servicer, (ii) declare the
Amortization Date to have occurred, whereupon the Amortization Date shall forthwith occur, without demand, protest or further notice of any kind, all of which are hereby expressly waived by each Seller Party; provided, however, that
upon the occurrence of an Amortization Event described in Section 9.1(d)(ii), or of an actual or deemed entry of an order for relief with respect to any Seller Party under the Federal Bankruptcy Code, the Amortization Date shall
automatically occur, without demand, protest or any notice of any kind, all of which are hereby expressly waived by each Seller Party, (iii) to the fullest extent permitted by applicable law, declare that the Default Fee shall accrue with
respect to any of the Aggregate Unpaids outstanding at such time, (iv) deliver the Collection Notices to the Collection Banks, and (v) notify Obligors of the Purchasers’ interest in the Receivables. The aforementioned rights and
remedies shall be without limitation, and shall be in addition to all other rights and remedies of the Administrative Agent, the Managing Agents and the Purchasers otherwise available under any other provision of this Agreement, by operation of law,
at equity or otherwise, all of which are hereby expressly preserved, including, without limitation, all rights and remedies provided under the UCC, all of which rights shall be cumulative. 

ARTICLE X 

INDEMNIFICATION 

Section 10.1 Indemnities by the Seller Parties. Without limiting any other rights that the Administrative Agent, any Managing
Agent, any L/C Issuer, any Funding Source or any Purchaser may have hereunder or under applicable law, (A) Seller hereby agrees to indemnify (and pay upon demand to) the Administrative Agent, each Managing Agent, each Funding Source, each L/C
Issuer and each Purchaser and their respective assigns, officers, directors, agents and employees (each an “Indemnified Party”) from and against any and all damages, losses, claims, taxes, liabilities, costs or expenses, for any
increased capital charges due to a breach of any representation or warranty under Section 5.1(cc) hereof and for all other amounts payable, including reasonable attorneys’ fees and disbursements (all of the foregoing being
collectively referred to as “Indemnified Amounts”) awarded against or incurred by any of them arising out of or as a result of this Agreement or the acquisition, either directly or indirectly, by a Purchaser or an L/C Issuer of an
interest in the Receivables, and (B) Servicer hereby agrees to indemnify (and pay upon demand to) each Indemnified Party for Indemnified Amounts awarded against or incurred by any of them arising out of Servicer’s activities as Servicer
hereunder excluding, however, in all of the foregoing instances under the preceding clauses (A) and (B): 
 (i) Indemnified
Amounts to the extent a final judgment of a court of competent jurisdiction holds that such Indemnified Amounts resulted from gross negligence or willful misconduct on the part of the Indemnified Party seeking indemnification or material breach by
such Indemnified Party of the express terms of the Transaction Documents; 
 (ii) Indemnified Amounts to the extent the same
includes losses in respect of Receivables that are uncollectible on account of the insolvency, bankruptcy or lack of creditworthiness of the related Obligor; or 

  
 40 

 (iii) taxes imposed by the jurisdiction in which such Indemnified Party’s principal
executive office is located, on or measured by the overall net income of such Indemnified Party to the extent that the computation of such taxes is consistent with the characterization for income tax purposes of the Purchases by the Administrative
Agent, for the benefit of the Purchasers and L/C Issuers as a loan or loans by the Purchasers to Seller secured by the Receivables, the Related Security, the Collection Accounts and the Collections; 

provided, however, that nothing contained in this sentence shall limit the liability of any Seller Party or limit the recourse of the
Purchasers or the L/C Issuers to any Seller Party, any Originator or Marathon for amounts otherwise specifically provided to be paid by such Seller Party, any Originator or Marathon, as applicable, under the terms of this Agreement or any other
Transaction Document. Without limiting the generality of the foregoing indemnification, but subject to the exclusions set forth in clauses (i) through (iii) above, Seller shall indemnify each Indemnified Party for Indemnified Amounts
(including, without limitation, losses in respect of uncollectible receivables, regardless of whether reimbursement therefor would constitute recourse to Seller or Servicer) relating to or resulting from: 

(i) any representation or warranty made by any Seller Party, any Originator or Marathon (or any officers of any such
Person) under or in connection with this Agreement, any other Transaction Document or any other written information or report delivered by any such Person pursuant hereto or thereto, including, without limitation, the representations and warranties
under Section 5.1(cc) hereof, which shall have been false or incorrect when made or deemed made; 

(ii) the failure by Seller, Servicer, any Originator or Marathon to comply with any applicable law, rule or regulation
with respect to any Receivable or Contract related thereto, or the nonconformity of any Receivable or Contract included therein with any such applicable law, rule or regulation or any failure of any Originator to keep or perform any of its
obligations, express or implied, with respect to any Contract; 
 (iii) any failure of Seller, Servicer, any
Originator or Marathon to perform its duties, covenants or other obligations in accordance with the provisions of this Agreement or any other Transaction Document; 

(iv) any products liability, personal injury or damage suit, or other similar claim arising out of or in connection with
merchandise, insurance or services that are the subject of any Contract or any Receivable; 
 (v) any dispute,
claim, offset or defense (other than discharge in bankruptcy of the Obligor) of the Obligor to the payment of any Receivable (including, without limitation, a defense based on such Receivable or the related Contract not being a legal, valid and
binding obligation of such Obligor enforceable against it in accordance with its terms), or any other claim resulting from the sale of the merchandise or service related to such Receivable or the furnishing or failure to furnish such merchandise or
services; 
 (vi) the commingling of Collections of Receivables at any time with other funds; 

(vii) any investigation, litigation or proceeding related to or arising from this Agreement or any other Transaction
Document, the transactions contemplated hereby, the use of the proceeds of a Credit Event or draw under any Letter of Credit, the ownership of the Purchaser Interest or any other investigation, litigation or proceeding relating to Seller, Servicer,
any Originator or Marathon in which any Indemnified Party becomes involved as a result of any of the transactions contemplated hereby; 

  
 41 

 (viii) any inability to litigate any claim against any Obligor in respect of
any Receivable as a result of such Obligor being immune from civil and commercial law and suit on the grounds of sovereignty or otherwise from any legal action, suit or proceeding; 

(ix) any Amortization Event described in Section 9.1(d); 

(x) any failure of Seller to acquire and maintain legal and equitable title to, and ownership of any Receivable and the
Related Security and Collections with respect thereto from MPC LP, free and clear of any Adverse Claim (other than as created hereunder), or any failure of Seller to give reasonably equivalent value to MPC LP under the Receivables Sale Agreement in
consideration of the transfer by MPC LP of any Receivable, or any attempt by any Person to void such transfer under statutory provisions or common law or equitable action; 

(xi) any failure to vest and maintain vested in the Administrative Agent for the benefit of the Purchasers, or to transfer
to the Administrative Agent for the benefit of the Purchasers, legal and equitable title to, and ownership of, a first priority perfected undivided percentage ownership interest (to the extent of the Purchaser Interest contemplated hereunder) or
security interest in the Receivables, the Related Security and the Collections and the Collection Accounts and Lock-Boxes, free and clear of any Adverse Claim (except as created by the Transaction Documents); 

(xii) the failure to have filed, or any delay in filing, financing statements or other similar instruments or documents
under the UCC of any applicable jurisdiction or other applicable laws with respect to any Receivable, the Related Security and Collections with respect thereto, and the proceeds of any thereof, whether at the time of any Credit Event or at any
subsequent time; 
 (xiii) any action or omission (other than as expressly contemplated by this Agreement or any
other Principal Transaction Document) by any Seller Party, any Originator or Marathon which reduces or impairs the rights of the Administrative Agent, the Managing Agents, the L/C Issuers or the Purchasers with respect to any Receivable or the value
of any such Receivable; 
 (xiv) any attempt by any Person to void any Credit Event hereunder under statutory
provisions or common law or equitable action; 
 (xv) the failure of any Receivable included in the calculation
of the Net Receivables Balance as an Eligible Receivable to be an Eligible Receivable at the time so included; or 
 (xvi) any Letter of Credit issued in connection herewith or the use of the proceeds thereof by the applicable beneficiary or any affiliate, agent, employee or assignee thereof. THE FOREGOING
INDEMNIFICATION SHALL APPLY WHETHER OR NOT SUCH LIABILITIES AND COSTS ARE IN ANY WAY OR TO ANY EXTENT, IN WHOLE OR IN PART, CAUSED BY ANY NEGLIGENT ACT OR OMISSION OF ANY L/C ISSUER, ANY PURCHASER, THE ADMINISTRATIVE AGENT, ANY MANAGING AGENT OR
THEIR RESPECTIVE AFFILIATES. 

  
 42 

 Section 10.2 Increased Cost and Reduced Return. 

(a) If any Regulatory Change (i) subjects any Purchaser, any L/C Issuer or any Funding Source to any charge or withholding on or
with respect to any Funding Agreement or this Agreement or a Purchaser’s, L/C Issuer’s or Funding Source’s obligations under a Funding Agreement or this Agreement, or on or with respect to the Receivables, or changes the basis of
taxation of payments to any Purchaser, any L/C Issuer or any Funding Source of any amounts payable under any Funding Agreement or this Agreement (except for changes in the rate of tax on the overall net income of a Purchaser, L/C Issuer or Funding
Source or taxes excluded by Section 10.1) or (ii) imposes, modifies or deems applicable any reserve, assessment, fee, tax, insurance charge, special deposit or similar requirement against assets of, deposits with or for the account
of, or liabilities of a Funding Source, an L/C Issuer or a Purchaser, or credit extended by a Funding Source, an L/C Issuer or a Purchaser pursuant to a Funding Agreement or this Agreement or (iii) imposes any other condition the result of
which is to increase the cost to a Funding Source, an L/C Issuer or a Purchaser of performing its obligations under a Funding Agreement or this Agreement, or to reduce the rate of return on a Funding Source’s, an L/C Issuer’s or
Purchaser’s capital as a consequence of its obligations under a Funding Agreement or this Agreement, or to reduce the amount of any sum received or receivable by a Funding Source, an L/C Issuer or a Purchaser under a Funding Agreement or this
Agreement, or to require any payment calculated by reference to the amount of interests or loans held or interest received by it, then, promptly upon presentation to Seller by the applicable Managing Agent of a certificate setting forth the basis
for such determination and the additional amounts reasonably determined by such Managing Agent to compensate such Funding Source, L/C Issuer or Purchaser, Seller shall pay to such Managing Agent, for the benefit of the relevant Funding Source, L/C
Issuer or Purchaser the amount set forth on such certificate; provided, that (x) such Funding Source, L/C Issuer or Purchaser shall have applied consistent return metrics to other similarly situated borrowers or obligors (after
consideration of facility pricing, structure, usage patterns, capital treatment and relationship) with respect to such increased costs or reduced returns and (y) to the extent that any Funding Agreement described in this
Section 10.2(a) covers facilities in addition to this Agreement, each Conduit Purchaser or Funding Source, as the case may be, shall allocate the liability for any such increased costs or reductions among Seller and other Persons with
whom such Conduit Purchaser or Funding Source, as the case may be, has entered into agreements to purchase interests in or finance receivables and other financial assets (“Other Customers”), and Seller shall not be liable for any
such increased costs or reductions that are attributable to any Other Customer. The term “Regulatory Change” shall mean (i) the adoption after the date hereof of any applicable law, rule or regulation (including any applicable
law, rule or regulation regarding capital adequacy) or any change therein after the date hereof, (ii) any change after the date hereof in the interpretation or administration thereof by any governmental authority, central bank or comparable
agency charged with the interpretation or administration thereof, or compliance with any request or directive (whether or not having the force of law) of any such authority, central bank or comparable agency, or (iii) the compliance, whether
commenced prior to or after the date hereof, by any Funding Source or Purchaser with the requirements of (a) the final rule titled Risk-Based Capital Guidelines; Capital Adequacy Guidelines; Capital Maintenance: Regulatory Capital; Impact of
Modifications to Generally Accepted Accounting Principles; Consolidation of Asset-Backed Commercial Paper Programs; and Other Related Issues, adopted by the United States bank regulatory agencies on December 15, 2009 (the “FAS
166/167 Capital Guidelines”) or (b) the Dodd-Frank Wall Street Reform and Consumer Protection Act, or any existing or future rules, regulations, guidance, interpretations or directives from the U.S. bank regulatory agencies
relating to the FAS 166/167 Capital Guidelines or the Dodd-Frank Wall Street Reform and Consumer Protection Act (whether or not having the force of law). 
 (b) The certificate of the applicable Purchaser, L/C Issuer or Funding Source setting forth the amount or amounts necessary to compensate such Purchaser, L/C Issuer or Funding Source pursuant to
paragraph (a) of this Section 10.2 shall be conclusive absent manifest error. 

  
 43 

 (c) Failure or delay on the part of any L/C Issuer, Purchaser or Funding Source to demand
compensation pursuant to this Section shall not constitute a waiver of such L/C Issuer’s, such Purchaser’s or such Funding Source’s right to demand such compensation; provided, that Seller shall not be required to compensate an
L/C Issuer, Purchaser or Funding Source pursuant to this Section for any increased costs or reductions incurred more than 180 days prior to the date that such L/C Issuer, Purchaser or Funding Source, as the case may be, notifies Seller in writing of
the Regulatory Change giving rise to such increased costs or reductions and of such L/C Issuer’s, Purchaser’s or Funding Source’s intention to claim compensation therefor; provided, further, that if the Regulatory Change
giving rise to such increased costs or reductions is retroactive, then the 180-day period referred to above shall be extended to include the period of retroactive effect thereof. 

(d) If any Purchaser, any L/C Issuer or any Funding Source has or anticipates having any claim for compensation from Seller pursuant to
clause (iii) of the definition of Regulatory Change appearing in paragraph (a) of this Section 10.2, and such Purchaser, L/C Issuer or Funding Source reasonably determines, following consultation with Seller, that having the
facility evidenced by this Agreement publicly rated by one credit rating agency would reduce the amount of such compensation by an amount deemed by such Purchaser or Funding Source to be material, such Purchaser or Funding Source (or the related
Managing Agent) shall provide written notice to Seller and Servicer (a “Ratings Request”) that such Purchaser, L/C Issuer or Funding Source intends to request a public rating of the facility from one credit rating agency selected by
such Purchaser, L/C Issuer or Funding Source and reasonably acceptable to Seller, of at least “AA” from S&P and “Aa2” from Moody’s, or the equivalent thereof from any other such credit rating agency (the
“Required Rating”). Upon receipt of any such notice, Seller shall promptly notify such Purchaser, L/C Issuer or Funding Source either (x) that Seller has elected to pay the compensation giving rise to such request for a
Required Rating and promptly thereafter pay such compensation to such Purchaser, L/C Issuer or Funding Source, as applicable, or (y) Seller has elected to, and thereafter Seller and Servicer shall, cooperate with such Purchaser’s, L/C
Issuer’s or Funding Source’s efforts to obtain the Required Rating, and use commercially reasonable efforts to provide the applicable credit rating agency (either directly or through distribution to the Administrative Agent, such
Purchaser, L/C Issuer or Funding Source or the related Managing Agent), any information (subject to the agreement of the credit rating agency to maintain the confidentiality of any information so provided which relates to any Obligor) requested by
such credit rating agency for purposes of providing and monitoring the Required Rating; provided, that notwithstanding Seller’s election to cooperate in connection with obtaining the Required Ratings, neither failure to obtain the
Required Rating nor failure to have the facility rated (if Seller has acted in good faith to attempt to obtain such rating) shall constitute an Amortization Event. The requesting Purchaser, L/C Issuer or Funding Source shall pay the initial fees
payable to the credit rating agency for providing the rating and all ongoing fees payable to the credit rating agency for the continued monitoring of the rating. Nothing in this Section 10.2(d) shall preclude any Purchaser, L/C Issuer or
Funding Source from demanding compensation from Seller pursuant to Section 10.2(a) hereof at any time and without regard to whether the Required Rating shall have been obtained, or shall require any Purchaser, L/C Issuer or Funding
Source to obtain any rating on the facility prior to demanding any such compensation from Seller; provided, however, in demanding such compensation the applicable Purchaser, L/C Issuer or Funding Source shall take into account and give
effect to any reduction in amounts payable under Section 10.2(a) due to the Required Rating(s) having been obtained. 
 Section 10.3 Other Costs and Expenses. Seller shall pay to the Administrative Agent, the Managing Agents, the L/C Issuers and the Purchasers on demand all reasonable costs and out-of-pocket
expenses in connection with the preparation, execution, delivery and administration of this Agreement, the transactions contemplated hereby and the other documents to be delivered hereunder (including any amendments, restatements, supplements or
other modifications of the foregoing), including without limitation, the cost of Purchasers’ auditors auditing the books, records and procedures of Seller, 

  
 44 

 
reasonable fees of the rating agencies, reasonable fees and out-of-pocket expenses of legal counsel for to the Administrative Agent, the Managing Agents, the L/C Issuers and the Purchasers with
respect thereto and with respect to advising to the Administrative Agent, each Managing Agent, each L/C Issuer and each Purchasers as to their respective rights and remedies under this Agreement and the other Transaction Documents; provided,
that in connection with the closing of the transactions contemplated hereby and the other Transaction Documents, Seller shall only be obligated to reimburse the costs and expenses of one primary law firm serving as external counsel to the
Administrative Agent, the Managing Agents, the L/C Issuers and the Purchasers and such special local counsel as the Administrative Agent and the Managing Agents may deem necessary in connection therewith. Seller shall pay to the Administrative
Agent, each Managing Agent, each L/C Issuer and each Purchaser on demand any and all costs and expenses of the Administrative Agent, the Managing Agents, the L/C Issuers and the Purchasers, if any, including reasonable counsel fees and expenses in
connection with the enforcement of this Agreement, the other Transaction Documents and the other documents delivered hereunder and in connection with any restructuring or workout of this Agreement or such documents, or the administration of this
Agreement following an Amortization Event. 
 ARTICLE XI 
 THE ADMINISTRATIVE AGENT & THE MANAGING AGENTS 
 Section 11.1
Authorization and Action. Each Purchaser hereby designates and appoints (i) JPMorgan to act as its agent hereunder and under each other Transaction Document, and (ii) the Managing Agent in its Purchase Group to act as its agent
hereunder and under each other Transaction Document, and authorizes the Administrative Agent and such Purchaser’s Managing Agent, as the case may be, to take such actions as agent on its behalf and to exercise such powers as are delegated to
the Administrative Agent or such Managing Agent by the terms of this Agreement and the other Transaction Documents together with such powers as are reasonably incidental thereto. Neither the Administrative Agent nor the Managing Agents shall have
any duties or responsibilities, except those expressly set forth herein or in any other Transaction Document, or any fiduciary relationship with any Purchaser, and no implied covenants, functions, responsibilities, duties, obligations or liabilities
on the part of the Administrative Agent or the Managing Agents shall be read into this Agreement or any other Transaction Document or otherwise exist for the Administrative Agent or the Managing Agents. In performing their functions and duties
hereunder and under the other Transaction Documents, (i) the Administrative Agent shall act solely as agent for the Purchasers, (ii) each Managing Agent shall act solely as managing agent for the Conduit Purchasers, Committed Purchasers
and L/C Issuer, if any, in its Purchase Group, and (iii) neither the Administrative Agent nor any Managing Agent shall be deemed to have assumed any obligation or relationship of trust or agency with or for any Seller Party or any of such
Seller Party’s successors or assigns. Neither the Administrative Agent nor any Managing Agent shall be required to take any action that exposes the Administrative Agent or such Managing Agent to personal liability or that is contrary to this
Agreement, any other Transaction Document or applicable law. The appointment and authority of the Administrative Agent and the Managing Agents hereunder shall terminate upon the Final Payout Date. Each Purchaser hereby authorizes the Administrative
Agent to file each of the UCC financing statements on behalf of such Purchaser (the terms of which shall be binding on such Purchaser). 
 Section 11.2 Delegation of Duties. The Administrative Agent and the Managing Agents may execute any of their respective duties under this Agreement and each other Transaction Document by or
through agents or attorneys in fact and shall be entitled to advice of counsel concerning all matters pertaining to such duties. Neither the Administrative Agent nor any Managing Agent shall be responsible for the negligence or misconduct of any
agents or attorneys in fact selected and maintained by it with reasonable care. 

  
 45 

 Section 11.3 Exculpatory Provisions. None of the Administrative Agent, the
Managing Agents or any of their respective directors, officers, agents or employees shall be (i) liable for any action lawfully taken or omitted to be taken by it or them under or in connection with this Agreement or any other Transaction
Document (except for its, their or such Person’s own gross negligence or willful misconduct), or (ii) responsible in any manner to any of the Purchasers or any L/C Issuer for any recitals, statements, representations or warranties made by
any Seller Party, any Originator or Marathon contained in this Agreement, any other Transaction Document or any certificate, report, statement or other document referred to or provided for in, or received under or in connection with, this Agreement,
or any other Transaction Document or for the value, validity, effectiveness, genuineness, enforceability or sufficiency of this Agreement, or any other Transaction Document or any other document furnished in connection herewith or therewith, or for
any failure of any Seller Party, any Originator or Marathon to perform its obligations hereunder or thereunder, or for the satisfaction of any condition specified in Article VI, or for the perfection, priority, condition, value or sufficiency
of any collateral pledged in connection herewith. Neither the Administrative Agent nor any Managing Agent shall be under any obligation to any Purchaser or any L/C Issuer to ascertain or to inquire as to the observance or performance of any of the
agreements or covenants contained in, or conditions of, this Agreement or any other Transaction Document, or to inspect the properties, books or records of the Seller Parties, the Originators or Marathon. Neither the Administrative Agent nor any
Managing Agent shall be deemed to have knowledge of any Amortization Event or Potential Amortization Event unless the Administrative Agent or such Managing Agent, as applicable, has received notice from Seller or a Purchaser. No Managing Agent shall
have any responsibility hereunder to any Purchaser other than the Purchasers in its Purchase Group. 
 Section 11.4
Reliance by Administrative Agent. 
 (a) The Administrative Agent shall in all cases be entitled to rely, and shall be
fully protected in relying, upon any document or conversation believed by it to be genuine and correct and to have been signed, sent or made by the proper Person or Persons and upon advice and statements of legal counsel (including, without
limitation, counsel to Seller), independent accountants and other experts selected by the Administrative Agent. The Administrative Agent shall in all cases be fully justified in failing or refusing to take any action under this Agreement or any
other Transaction Document unless it shall first receive such advice or concurrence of the Managing Agents, the Required Managing Agents or all of the Purchasers, as applicable, as it deems appropriate and it shall first be indemnified to its
satisfaction by the Purchasers, provided that unless and until the Administrative Agent shall have received such advice, the Administrative Agent may take or refrain from taking any action, as the Administrative Agent shall deem advisable and in the
best interests of the Purchasers. The Administrative Agent shall in all cases be fully protected in acting, or in refraining from acting, in accordance with a request of the Managing Agents, the Required Managing Agents or all of the Purchasers, as
applicable, and such request and any action taken or failure to act pursuant thereto shall be binding upon all the Purchasers. 

(b) Each Managing Agent shall in all cases be entitled to rely, and shall be fully protected in relying, upon any document or
conversation believed by it to be genuine and correct and to have been signed, sent or made by the proper Person or Persons and upon advice and statements of legal counsel (including, without limitation, counsel to Seller), independent accountants
and other experts selected by such Managing Agent. Each Managing Agent shall in all cases be fully justified in failing or refusing to take any action under this Agreement or any other Transaction Document unless it shall first receive such advice
or concurrence or the Purchasers in its related Purchase Group, as it deems appropriate and it shall first be indemnified to its satisfaction by such Purchasers, provided that unless and until such Managing Agent shall have received such advice,
such Managing Agent may take or refrain from taking any action, as such Managing Agent shall deem advisable and in the best interests of the Purchasers in its related Purchase Group. Each Managing Agent shall in all cases be fully protected in
acting, or in refraining from acting, in accordance with a request of the Purchasers in its related Purchase Group, and such request and any action taken or failure to act pursuant thereto shall be binding upon all such Purchasers. 

  
 46 

 Section 11.5 Non-Reliance on Administrative Agent, Managing Agents, L/C Issuers and
Other Purchasers. Each Purchaser expressly acknowledges that none of the Administrative Agent, the Managing Agents, L/C Issuers, other Purchasers or any of their respective officers, directors, employees, agents, attorneys in fact or Affiliates
has made any representations or warranties to it and that no act by the Administrative Agent, any Managing Agent, any L/C Issuer or any other Purchaser hereafter taken, including, without limitation, any review of the affairs of any Seller Party,
any Originator or Marathon, shall be deemed to constitute any representation or warranty by the Administrative Agent, such Managing Agent, such L/C Issuer or such other Purchaser. Each Purchaser represents and warrants to the Administrative Agent,
the Managing Agents, the L/C Issuer and the other Purchasers that it has and will, independently and without reliance upon the Administrative Agent, any Managing Agent, any L/C Issuer or any other Purchaser and based on such documents and
information as it has deemed appropriate, made its own appraisal of and investigation into the business, operations, property, prospects, financial and other conditions and creditworthiness of Seller and the other Seller Parties, the Originators or
Marathon and made its own decision to enter into this Agreement, the other Transaction Documents and all other documents related hereto or thereto. 
 Section 11.6 Reimbursement and Indemnification. The Committed Purchasers agree to reimburse and indemnify the Administrative Agent and each L/C Issuer, and the Committed Purchasers in each
Purchase Group agree to reimburse the Managing Agent for such Purchase Group, and their respective officers, directors, employees, representatives and agents ratably according to their (a) Pro Rata Shares (in the case of any reimbursement any
indemnity obligations owing to its Managing Agent) or (b) ratable shares of the Purchase Limit (in the case of any reimbursement and indemnity obligations owing to the Administrative Agent or the L/C Issuer), to the extent not paid or
reimbursed by the Seller Parties, the Originators or Marathon (i) for any amounts for which the Administrative Agent, in its capacity as Administrative Agent, or such Managing Agent, acting in its capacity as a Managing Agent, is entitled to
reimbursement by the Seller Parties, the Originators or Marathon hereunder or under any other Transaction Document, (ii) for any other expenses incurred by the Administrative Agent, in its capacity as Administrative Agent, or any Managing
Agent, acting in its capacity as a Managing Agent, and acting on behalf of its related Purchasers, in connection with the administration and enforcement of this Agreement and the other Transaction Documents, (iii) for any amounts for which any
L/C Issuer, acting in its capacity as L/C Issuer, is entitled to reimbursement by the Seller Parties, the Originators or Marathon hereunder and (iv) to any L/C Issuer, for any other expenses incurred by the L/C Issuer, in its capacity as L/C
Issuer, in connection with the administration and enforcement of this Agreement and the other Transaction Documents 

Section 11.7 Administrative Agent in its Individual Capacity. The Administrative Agent, each Managing Agent and each of their
respective Affiliates may make loans to, accept deposits from and generally engage in any kind of business with Seller or any Affiliate of Seller as though it were not the Administrative Agent or a Managing Agent hereunder. With respect to the
Purchases pursuant to this Agreement, the Administrative Agent and each Managing Agent shall have the same rights and powers under this Agreement in its individual capacity as any Purchaser and may exercise the same as though it were not the
Administrative Agent or a Managing Agent, and the terms “Committed Purchaser”, “Purchaser”, “Committed Purchasers”, “L/C Issuer” and “Purchasers” shall include the
Administrative Agent and each Managing Agent in its individual capacity. 
 Section 11.8 Successor Administrative
Agent. The Administrative Agent may, upon thirty (30) days’ prior notice to Seller and the Managing Agents, and the Administrative Agent shall, upon the direction of all of the Purchasers (other than the Administrative Agent, in its
individual capacity) 

  
 47 

 
resign as Administrative Agent. Each Managing Agent may, upon thirty (30) days’ prior notice to Seller, the Administrative Agent, the Purchasers in its Purchase Group, and each Managing
Agent shall, upon the direction of all of the Purchasers in its Purchase Group (other than the Managing Agent, in its individual capacity), resign as a Managing Agent. If the Administrative Agent shall resign, then the Required Managing Agents
during such thirty-day period shall appoint from among the Purchasers a successor Administrative Agent. If a Managing Agent shall resign, then the Purchasers in its Purchase Group shall appoint a successor managing agent during such thirty-day
period. If for any reason no successor Administrative Agent or Managing Agent is so appointed during such thirty-day period, then effective upon the termination of such thirty-day period, the Purchasers shall perform all of the duties of the
Administrative Agent or the Purchasers in the applicable Purchase Group shall perform all of the duties of such Managing Agent, as applicable, hereunder and under the other Transaction Documents and Seller and Servicer (as applicable) shall make all
payments in respect of the Aggregate Unpaids directly to the applicable Purchasers and for all purposes shall deal directly with the Purchasers. After the effectiveness of any retiring Managing Agent’s or any Administrative Agent’s
resignation hereunder as Managing Agent or Administrative Agent, the retiring Managing Agent or Administrative Agent shall be discharged from its duties and obligations hereunder and under the other Transaction Documents and the provisions of this
Article XI and Article X shall continue in effect for its benefit with respect to any actions taken or omitted to be taken by it while it was Managing Agent or Administrative Agent under this Agreement and under the other Transaction
Documents. 
 ARTICLE XII 
 ASSIGNMENTS; PARTICIPATIONS 
 Section 12.1 Assignments. (a) The
parties hereto hereby agree and consent to the complete or partial assignment by each Conduit Purchaser of all or any portion of its rights under, interest in, title to and obligations under this Agreement (i) to the Committed Purchasers
pursuant to this Agreement or to a Funding Source pursuant to a Funding Agreement, (ii) to any other Purchaser, any Managing Agent or the Administrative Agent or any of their respective Affiliates (other than an issuer of commercial paper notes
or other entity which obtains funds from such an issuer of commercial paper notes), (iii) to any other issuer of commercial paper notes or other entity which obtains funds from such an issuer of commercial paper notes, which in either case
(x) is sponsored or administered by the Managing Agent of such Conduit Purchaser’s Purchase Group or administered by any Affiliate of such Managing Agent and (y) has a short-term debt rating of “A-1” or better by S&P and
“P-1” or better by Moody’s or (iv) to any other Person with the consent of Seller (which consent shall not be unreasonably withheld, conditioned or delayed); provided that, if an Amortization Event has occurred and is
continuing, consent of Seller shall not be required for any such assignment pursuant to this clause (iv); provided, further, that in no event shall any Conduit Purchaser assign any of its rights, interests or obligations under this
Agreement to a Marathon Competitor, and upon any such assignment, such Conduit Purchaser shall be released from its obligations so assigned. Further, Seller, Servicer, the Administrative Agent, the related Managing Agent and each related Committed
Purchaser hereby agree that any assignee of a Conduit Purchaser of this Agreement or all or any of the interests of any Conduit Purchaser shall have all of the rights and benefits under this Agreement as if the term “Conduit Purchaser”
explicitly referred to such party, and no such assignment shall in any way impair the rights and benefits of any Conduit Purchaser hereunder. Neither Seller nor Servicer shall have the right to assign its rights or obligations under this Agreement
(other than the delegation by Servicer of its duties or responsibilities as Servicer as permitted under and in accordance with Section 8.1(b)(i)). 
 (b) Any Committed Purchaser may at any time and from time to time assign to one or more Persons (“Purchasing Committed Purchasers”) all or any part of its rights and obligations under
this Agreement pursuant to an assignment agreement, substantially in the form set forth in Exhibit VII hereto (the “Assignment Agreement”) executed by such Purchasing Committed Purchaser and such selling

  
 48 

 
Committed Purchaser; provided that Seller’s consent (which consent shall not be unreasonably withheld, conditioned or delayed) shall be required for any such assignment unless:
(i) such assignment is to any other Purchaser, any Managing Agent or the Administrative Agent or any of their respective Affiliates, (ii) such assignment is to any issuer of commercial paper notes or other entity which obtains funds from
such an issuer of commercial paper notes, which in either case is sponsored or administered by the Managing Agent of such Committed Purchaser’s Purchase Group or administered by any Affiliate of such Managing Agent or (iii) an Amortization
Event has occurred and is continuing; provided, further, that the consent of each L/C Issuer shall be required for any assignment by a Committed Purchaser of its Commitment or any portion thereof; provided, further, that
in no event shall any Committed Purchaser assign any of its rights, interests or obligations under this Agreement to a Marathon Competitor. The consent of the Managing Agent and any L/C Issuer for such Committed Purchaser’s Purchase Group shall
be required prior to the effectiveness of any such assignment. Each assignee of a Committed Purchaser must (i) have a short-term debt rating of “A-1” or better by S&P and “P-1” by Moody’s and (ii) agree to
deliver to the Administrative Agent, promptly following any request therefor by the Administrative Agent or any Conduit Purchaser in its Purchase Group, an enforceability opinion in form and substance satisfactory to the Administrative Agent and
such Conduit Purchaser. Upon delivery of the executed Assignment Agreement to the Administrative Agent and the related Managing Agent, such selling Committed Purchaser shall be released from its obligations hereunder to the extent of such
assignment. Thereafter the Purchasing Committed Purchaser shall for all purposes be a Committed Purchaser party to this Agreement and shall have all the rights and obligations of a Committed Purchaser under this Agreement to the same extent as if it
were an original party hereto and no further consent or action by Seller, the Purchasers, the Managing Agents or the Administrative Agent shall be required. 
 Section 12.2 Participations. Any Committed Purchaser may, in the ordinary course of its business at any time sell to one or more Persons (each a “Participant”) participating
interests in its Pro Rata Share of the Capital of the Committed Purchasers, its Commitment or any other interest of such Committed Purchaser hereunder. Notwithstanding any such sale by a Committed Purchaser of a participating interest to a
Participant, such Committed Purchaser’s rights and obligations under this Agreement shall remain unchanged, such Committed Purchaser shall remain solely responsible for the performance of its obligations hereunder, and Seller, the Purchasers,
the Managing Agents and the Administrative Agent shall continue to deal solely and directly with such Committed Purchaser in connection with such Committed Purchaser’s rights and obligations under this Agreement. Each Committed Purchaser agrees
that any agreement between such Committed Purchaser and any such Participant in respect of such participating interest shall not restrict such Committed Purchaser’s right to agree to any amendment, supplement, waiver or modification to this
Agreement, except for any amendment, supplement, waiver or modification described in Section 14.1(b)(i). 

Section 12.3 Federal Reserve. Notwithstanding any provision herein to the contrary, any Purchaser may at any time pledge or
grant a security interest in all or any portion of its rights (including, without limitation, any interests in the Purchaser Interest and any rights to payment of Capital and Yield) under this Agreement to secure obligations of such Purchaser to a
Federal Reserve Bank, without notice to or consent of any Seller Party, the Administrative Agent, any Managing Agent or any other Purchaser; provided that no such pledge or grant of a security interest shall release a Purchaser from any of
its obligations hereunder, or substitute any such pledgee or grantee for such Purchaser as a party hereto. 
 Section 12.4
Replacement of Purchase Groups. If (i) any Purchaser or Funding Source requests compensation under Section 10.2(a), (ii) any Committed Purchaser becomes a Defaulting Committed Purchaser or ceases to have a short-term
debt rating of “A-1” or better by S&P or “P-1” or better by Moody’s or (iii) any Managing Agent or Purchaser fails to consent to any proposed amendment, modification, waiver or consent with respect to any provision
hereof that requires the unanimous approval 

  
 49 

 
of all Managing Agents or Purchasers, or the approval of each of the Managing Agents or Purchasers affected thereby (in each case in accordance with Section 14.1), and the consent of
the Required Managing Agents shall have been obtained with respect to such amendment, modification, waiver or consent, then Seller may, at its sole expense and effort (including payment of any applicable processing and recordation fees), upon notice
to the related Managing Agent and the Administrative Agent, require each Purchaser in such Managing Agent’s Purchase Group assign and delegate, without recourse (in accordance with and subject to the restrictions contained in
Section 12.1), all of its respective interests, rights and obligations under this Agreement to an assignee that shall assume such obligations (which assignee may be another Conduit Purchaser or Committed Purchaser, as applicable, if a
Conduit Purchaser or Committed Purchaser accepts such assignment); provided, that (x) Seller shall have received the prior written consent of the Administrative Agent with respect to any assignee that is not already a member of a
Purchase Group hereunder, which consent shall not unreasonably be withheld, conditioned or delayed, (y) each member of such assigning Purchase Group shall have received payment of an amount equal to all outstanding Capital, L/C Obligations,
accrued CP Costs and Yield in respect thereof, accrued fees and all other Aggregate Unpaids payable to it hereunder, from the assignee (to the extent of such outstanding Capital) or Seller (in the case of all other amounts) and (z) in the case
of any such assignment resulting from a claim for compensation under Section 10.2(a), such assignment will result in a reduction in such compensation or payments. A Purchaser shall not be required to make any such assignment and
delegation if, prior thereto, as a result of a waiver by such Purchaser or otherwise, the circumstances entitling Seller to require such assignment and delegation cease to exist. 

ARTICLE XIII 

EXTENSION OF TERM; TERMINATING PURCHASE GROUPS 

Section 13.1 Extension of Term; Terminating Purchase Groups. (a) Seller may, at any time during the
period which is no more than ninety (90) days or less than sixty (60) days immediately preceding the Liquidity Termination Date (as such date may have previously been extended pursuant to this Section 13.1(a)), request that the
then applicable Liquidity Termination Date (the “Scheduled Liquidity Termination Date”) be extended for up to 364 days. Any such request shall be in writing and delivered to the Administrative Agent and each Managing Agent, and
shall be subject to the following conditions: (i) no Committed Purchaser shall have an obligation to extend the Liquidity Termination Date at any time, and (ii) any such extension with respect to any Committed Purchaser shall be effective
only upon the written agreement of the Administrative Agent, the applicable Managing Agent, such Committed Purchaser, Seller and Servicer. Each Managing Agent shall respond to any such request on behalf of the Committed Purchasers in its Purchase
Group no later than the fifteenth (15th) day prior to
the Scheduled Liquidity Termination Date (the “Response Deadline”) and a failure by any Managing Agent to respond by the Response Deadline shall be deemed to be a rejection of the requested extension. In the event that at least one
Committed Purchaser agrees to extend the Scheduled Liquidity Termination Date, the Seller Parties, the Administrative Agent, the extending Committed Purchasers, the applicable Managing Agent or Managing Agents and the applicable Conduit Purchaser or
Conduit Purchasers shall enter into such documents as such extending Committed Purchasers may deem necessary or appropriate to reflect such extension, and all reasonable costs and expenses incurred by such Committed Purchasers, Conduit Purchasers
and Managing Agents and the Administrative Agent (including reasonable attorneys’ fees) shall be paid by Seller (provided, that Seller shall not, in connection with any such extension, be liable for the fees and expenses of more than one
separate law firm at any one time for the Committed Purchasers, Conduit Purchasers, Managing Agents and the Administrative Agent collectively). In the event that any Committed Purchaser declines the request to extend the Liquidity Termination Date
(each such Committed Purchaser being referred to herein as a “Terminating Committed Purchaser” and, together with its related Conduit Purchaser, being referred to herein as a “Terminating Purchaser”; the Purchase
Group of each Terminating Purchaser being referred to herein as a “Terminating Purchase Group”), and the Commitment of such Terminating Committed Purchaser is not 

  
 50 

 
assigned to another Person in accordance with the terms of Article XII prior to the Scheduled Liquidity Termination Date, the Commitment of such Terminating Committed Purchaser shall
automatically terminate on the Scheduled Liquidity Termination Date, and the Purchase Limit shall be reduced by an amount equal to each such Terminating Committed Purchaser’s Commitment on the Scheduled Liquidity Termination Date. 

(b) Upon reduction to zero of the Capital of all interests in the Purchaser Interest of a Terminating Purchase Group (after application
of Collections thereto pursuant to Sections 2.2 and 2.3) (i) all rights and obligations of the Managing Agent and Purchasers in such Terminating Purchase Group hereunder shall be terminated, (ii) such Terminating
Purchase Group shall cease to be a “Purchase Group” hereunder and (iii) the related Terminating Committed Purchaser shall no longer be a “Committed Purchaser” hereunder; provided, however, that the
provisions of Article X shall continue in effect for the benefit of the Managing Agent and of each Purchaser in such Terminating Purchase Group with respect to Capital held by such Purchasers prior to such termination. 

ARTICLE XIV 

MISCELLANEOUS 

Section 14.1 Waivers and Amendments. (a) No failure or delay on the part of the Administrative Agent, any Managing
Agent, any L/C Issuer or any Purchaser in exercising any power, right or remedy under this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or remedy preclude any other further exercise
thereof or the exercise of any other power, right or remedy. The rights and remedies herein provided shall be cumulative and nonexclusive of any rights or remedies provided by law. Any waiver of this Agreement shall be effective only in the specific
instance and for the specific purpose for which given. 
 (b) No provision of this Agreement may be amended, supplemented,
modified or waived except in writing in accordance with the provisions of this Section 14.1(b). Seller, the Administrative Agent and the Required Managing Agents, may enter into written amendments, supplements, modifications or waivers
of any provisions of this Agreement, provided, however, that no such amendment, supplement, modification or waiver shall: 
 (i) without the consent of each affected Purchaser, (A) extend the Liquidity Termination Date or the date of any payment or deposit of Collections by Seller or Servicer, (B) reduce the rate or
extend the time of payment of Yield or any CP Costs (or any component of Yield or CP Costs), (C) reduce any fee payable to any Managing Agent or the Administrative Agent for the benefit of the Purchasers, (D) except pursuant to Article
XII hereof, change the amount of the Capital of any Purchaser, any Committed Purchaser’s Pro Rata Share (except pursuant to Section 13.1) or any Committed Purchaser’s Commitment, (E) amend, modify or waive any
provision of the definition of Required Managing Agents or this Section 14.1(b), (F) consent to or permit the assignment or transfer by Seller of any of its rights and obligations under this Agreement, (G) change the definition
of “Aggregate Reserves,” “Default Ratio,” “Delinquency Ratio,” “Dilution Ratio,” “Dilution Reserve,” “Eligible Receivable,” “Loss
Reserve,” “Loss Percentage,” “Purchaser Interest,” “Special Concentration Limit,” “Turnover Ratio” or “Yield and Servicing Reserve”, (H) amend or
modify any defined term (or any defined term used directly or indirectly in such defined term) used in clauses (A) through (G) above in a manner that would circumvent the intention of the restrictions set forth in such clauses or
(I) release the lien of the Administrative Agent for the benefit of the Purchasers on all or substantially all of the Receivables; or 
 (ii) without the written consent of any L/C Issuer, amend, modify or waive any provision of this Agreement if the effect thereof is to affect the rights or duties of such L/C Issuer; or 

  
 51 

 (iii) without the written consent of the then Administrative Agent or any Managing Agent,
as applicable, amend, modify or waive any provision of this Agreement if the effect thereof is to affect the rights or duties of such Administrative Agent or Managing Agent. 
 Notwithstanding the foregoing, Seller, the Administrative Agent and the Required Managing Agents may enter into amendments to modify any of the terms or provisions of Article XI, Article
XII, or any other provision of this Agreement without the consent of any L/C Issuer, provided that such amendment has no negative impact upon such L/C Issuer. Any modification or waiver made in accordance with this Section 14.1 shall
apply to each of the Purchasers equally and shall be binding upon Seller, Servicer, the Managing Agents, the L/C Issuers, the Purchasers and the Administrative Agent.  
 Section 14.2 Notices. Except as provided in this Section 14.2, all communications and notices provided for hereunder shall be in writing (including email, telecopy or electronic
facsimile transmission or similar writing) and shall be given to the other parties hereto at their respective addresses or telecopy numbers set forth on Schedule D hereto or at such other address, facsimile or telecopy number or email
address as such Person may hereafter specify for the purpose of notice to each of the other parties hereto. Each such notice or other communication shall be effective (i) if given by email or telecopy, upon the receipt thereof, (ii) if
given by mail, three (3) Business Days after the time such communication is deposited in the mail with first class postage prepaid or (iii) if given by any other means, when received at the address set forth on Schedule D hereto or
as otherwise specified pursuant to this Section 14.2. Seller hereby authorizes the Administrative Agent and each Managing Agent to effect purchases and each Managing Agent to make Tranche Period and Interest Rate selections based on
telephonic notices made by any Person whom the Administrative Agent or such Managing Agent, as applicable, in good faith believes to be acting on behalf of Seller. Seller agrees to deliver promptly to the Administrative Agent (and the Administrative
Agent shall promptly forward such written confirmation to each Managing Agent) a written confirmation of each telephonic notice signed by an Authorized Officer of Seller; provided, however, the absence of such confirmation shall not
affect the validity of such notice. If the written confirmation differs from the action taken by the Administrative Agent or any Managing Agent, the records of the Administrative Agent or such Managing Agent, as applicable, shall govern absent
manifest error. 
 Section 14.3 Setoff; Ratable Payments. (a) Right of Setoff. If an Amortization Event
shall have occurred and be continuing, each Purchaser is hereby authorized at any time and from time to time, to the fullest extent permitted by law, to set off and apply any and all deposits (general or special, time or demand, provisional or
final, but excluding Cash-Collateral which shall be applied in accordance with the terms of this Agreement only) at any time held and other obligations at any time due and owing by such Purchaser to or for the credit or the account of Seller against
any of and all the obligations of Seller now or hereafter existing under this Agreement held by such Purchaser, irrespective of whether or not such Purchaser shall have made any demand under this Agreement and although such obligations may be
unmatured. The rights of each Purchaser under this Section are in addition to other rights and remedies (including other rights of setoff) which such Purchaser may have. Each Purchaser agrees to promptly notify Seller and the Administrative Agent
after any such setoff and application by such Purchaser. 
 (b) If any Purchaser or L/C Issuer, whether by setoff or otherwise,
has payment made to it with respect to any portion of the Aggregate Unpaids owing to such Purchaser or such L/C Issuer (other than payments received pursuant to Section 10.2 or 10.3) in a greater proportion than that received by
any other Purchaser or other L/C Issuer, as applicable, entitled to receive a ratable share of such Aggregate Unpaids, each such Purchaser and L/C Issuer agrees, promptly upon demand, to purchase for cash without recourse or warranty a portion of
such Aggregate Unpaids held by the other Purchasers or other L/C Issuers so that after such purchase each Purchaser will hold its ratable proportion of such Aggregate 

  
 52 

 
Unpaids; provided that if all or any portion of such excess amount is thereafter recovered from such Purchaser or L/C Issuer, as applicable, such purchase shall be rescinded and the purchase
price restored to the extent of such recovery, but without interest. 
 Section 14.4 Protection of Ownership Interests
of the Purchasers. (a) Each Seller Party agrees that from time to time, at Seller’s expense, it will promptly execute and deliver all instruments and documents, and take all actions, that may be necessary or desirable, or that the
Administrative Agent or any Managing Agent may request, to perfect, protect or more fully evidence the Purchaser Interest, or to enable the Administrative Agent, the Managing Agents or the Purchasers to exercise and enforce their rights and remedies
hereunder. At any time after the occurrence of the Amortization Date, the Administrative Agent shall, at the written direction of the Required Managing Agents, direct Seller or Servicer to, notify the Obligors of Receivables, at Seller’s
expense, of the ownership or security interests of the Purchasers under this Agreement and may also direct that payments of all amounts due or that become due under any or all Receivables be made directly to the Administrative Agent or its designee.
Seller or Servicer (as applicable) shall, at any Purchaser’s request, withhold the identity of such Purchaser in any such notification. 
 (b) If any Seller Party fails to perform any of its obligations hereunder, the Administrative Agent, any Managing Agent or any Purchaser may (but shall not be required to) perform, or cause performance
of, such obligations, and the Administrative Agent’s, such Managing Agent’s or such Purchaser’s costs and expenses incurred in connection therewith shall be payable by Seller as provided in Section 10.3. Each Seller Party
irrevocably authorizes the Administrative Agent at any time and from time to time in the sole discretion of the Administrative Agent, and appoints the Administrative Agent as its attorney-in-fact, to act on behalf of such Seller Party (i) to
execute on behalf of Seller as debtor and to file financing statements necessary or desirable in the Administrative Agent’s sole discretion to perfect and to maintain the perfection and priority of the interest of the Purchasers in the
Receivables and (ii) to file a carbon, photographic or other reproduction of this Agreement or any financing statement with respect to the Receivables as a financing statement in such offices as the Administrative Agent in its sole discretion
deems necessary or desirable to perfect and to maintain the perfection and priority of the interests of the Purchasers in the Receivables. This appointment is coupled with an interest and is irrevocable. The Administrative Agent agrees that it shall
not exercise the rights under the foregoing appointment except after the occurrence and during the continuance of an Amortization Event. 
 Section 14.5 Confidentiality. (a) Each of the Administrative Agent, the Managing Agents, the L/C Issuers and the Purchasers agrees to maintain the confidentiality of the Information (as
defined below), except that Information may be disclosed (a) to its and its Affiliates’ directors, officers, employees and agents, including accountants, legal counsel and other advisors (it being understood that the Persons to whom such
disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential), (b) upon the request or demand of any regulatory authority having jurisdiction over such Administrative
Agent, Managing Agent, L/C Issuer or Purchaser, as applicable, or its Affiliates (in which case such Person shall, except with respect to any audit or examination conducted by bank accountants or any governmental bank regulatory authority exercising
examination or regulatory authority, (i) promptly notify Seller in advance of such disclosure, to the extent permitted by law, and (ii) so furnish only that portion of such information which the applicable Person is legally required to
disclose), (c) to the extent required by any legal, judicial, administrative proceeding or other process or otherwise as required by applicable laws or regulations or by any subpoena or similar legal process (in which case such Administrative
Agent, Managing Agent, L/C Issuer or Purchaser, as applicable, shall (i) promptly notify Seller in advance of such disclosure, to the extent permitted by law, and (ii) so furnish only that portion of such information which the applicable
Person is legally required to disclose), (d) to any other party to this Agreement, (e) in connection with the exercise of any remedies hereunder or any suit, action or proceeding relating to this Agreement or the enforcement

  
 53 

 
of rights hereunder, (f) subject to an agreement containing provisions no less restrictive than those of this Section, to any assignee of or Participant in, or any prospective assignee of or
Participant in, any of its rights or obligations under this Agreement, (g) to the rating agencies, any commercial paper dealer, providers of credit enhancement or liquidity to any Conduit Purchaser and any equity investor in any Conduit
Purchasers, (h) to a nationally recognized statistical rating organization in compliance with Rule 17g-5 under the Exchange Act (or to any other rating agency in compliance with any similar rule or regulation in any relevant jurisdiction),
(i) with the consent of Seller, or (j) to the extent such Information (i) becomes publicly available other than as a result of a breach of this Section or (ii) becomes available to the Administrative Agent, any Managing Agent,
any L/C Issuer or any Purchaser on a nonconfidential basis from a source other than a Seller Party or one of its Affiliates; provided, that (notwithstanding the foregoing) no such nonpublic information which contains projections or forecasts
with respect to a Seller Party or any of its Affiliates shall be disclosed, disseminated or otherwise made available pursuant to clause (f) above. For the purposes of this Section, “Information” means all information received
from Marathon or any of its Subsidiaries relating to Marathon or any of its Affiliates (including, without limitation, MOC, to the extent MOC is an Affiliate of Marathon) or their business, other than any such information that is available to the
Administrative Agent, any Managing Agent, any L/C Issuer or any Purchaser on a nonconfidential basis prior to disclosure by Marathon or any of its Affiliates. Any Person required to maintain the confidentiality of Information as provided in this
Section shall be considered to have complied with its obligation to do so if such Person has exercised the same degree of care to maintain the confidentiality of such Information as such Person would accord to its own confidential information.

 (b) Each Seller Party, each Managing Agent and each Purchaser shall maintain and shall cause each of its directors, officers,
employees and agents to maintain the confidentiality of this Agreement, the Fee Letter, the other Transaction Documents and the other confidential or proprietary information with respect to the Administrative Agent, each Managing Agent, each L/C
Issuer and each Purchaser and their respective businesses obtained by it or them in connection with the structuring, negotiating and execution of the transactions contemplated herein, except that such Seller Party, such Managing Agent, such L/C
Issuer and such Purchaser and its officers and employees may disclose such information to such Seller Party’s, such Managing Agent’s, such L/C Issuer’s and such Purchaser’s external accountants and attorneys and as required by
any applicable law or order of any judicial or administrative proceeding, and each Purchaser may disclose such information in accordance with the provisions of Section 14.5(a). Anything herein to the contrary notwithstanding, each Seller
Party, each Purchaser, each Managing Agent, each L/C Issuer, the Administrative Agent, each Indemnified Party and any successor or assign of any of the foregoing (and each employee, representative or other agent of any of the foregoing) may disclose
to any and all Persons, without limitation of any kind, the “tax treatment” and “tax structure” (in each case, within the meaning of Treasury Regulation Section 1.6011-4) of the transactions contemplated herein and all
materials of any kind (including opinions or other tax analyses) that are or have been provided to any of the foregoing relating to such tax treatment or tax structure, and it is hereby confirmed that each of the foregoing have been so authorized
since the commencement of discussions regarding the transactions. 
 Section 14.6 Bankruptcy Petition. Seller,
Servicer, the Administrative Agent, each Managing Agent, each L/C Issuer and each Purchaser hereby covenants and agrees that, prior to the date that is one year and one day after the payment in full of all outstanding senior indebtedness of any
Conduit Purchaser or, if applicable, any Related CP Issuer, it will not institute against, or join any other Person in instituting against, such Conduit Purchaser or any Related CP Issuer any bankruptcy, reorganization, arrangement, insolvency or
liquidation proceedings or other similar proceeding under the laws of the United States or any state of the United States. 

  
 54 

 Section 14.7 Limited Recourse. Notwithstanding anything to the contrary
contained herein, the obligations of any Conduit Purchaser under this Agreement are solely the obligations of such Conduit Purchaser and shall be payable at such time as funds are received by or are available to such Conduit Purchaser in excess of
funds necessary to pay in full all outstanding Commercial Paper and, if applicable, all obligations and liabilities of such Conduit Purchaser to any Related CP Issuer, and, to the extent funds are not available to pay such obligations, the claims
relating thereto shall not constitute a claim against such Conduit Purchaser but shall continue to accrue. Each party hereto agrees that the payment of any claim (as defined in Section 101 of the Federal Bankruptcy Code) of any such party shall
be subordinated to the payment in full of all Commercial Paper. 
 No recourse under any obligation, covenant or agreement of
any Conduit Purchaser contained in this Agreement shall be had against any member, manager, officer, director, employee or agent of such Conduit Purchaser, the Administrative Agent, the Managing Agents, the L/C Issuers, the other Purchasers or any
of their respective Affiliates (solely by virtue of such capacity) by the enforcement of any assessment or by any legal or equitable proceeding, by virtue of any statute or otherwise; it being expressly agreed and understood that this Agreement is
solely an obligation of such Conduit Purchaser individually, and that no personal liability whatever shall attach to or be incurred by any incorporator, stockholder, officer, director, member, employee or agent of such Conduit Purchaser, the
Administrative Agent, the Managing Agents, the L/C Issuers, the other Purchasers or any of their respective Affiliates (solely by virtue of such capacity) or any of them under or by reason of any of the obligations, covenants or agreements of such
Conduit Purchaser contained in this Agreement, or implied therefrom, and that any and all personal liability for breaches by such Conduit Purchaser of any of such obligations, covenants or agreements, either at common law or at equity, or by
statute, rule or regulation, of every such member, manager, officer, director, employee or agent is hereby expressly waived as a condition of and in consideration for the execution of this Agreement; provided that the foregoing shall not
relieve any such Person from any liability it might otherwise have as a result of fraudulent actions taken or omissions made by them. 
 Section 14.8 Limitation of Liability. No claim may be made by any Seller Party or any other Person against the Administrative Agent, any Managing Agent, any Purchaser, any L/C Issuer, any
Funding Source or their respective Affiliates, directors, officers, employees, attorneys or agents for any special, indirect, consequential or punitive damages in respect of any claim for breach of contract or any other theory of liability arising
out of or related to the transactions contemplated by this Agreement, or any act, omission or event occurring in connection therewith; and each Seller Party hereby waives, releases, and agrees not to sue upon any claim for any such damages, whether
or not accrued and whether or not known or suspected to exist in its favor. 
 Section 14.9 CHOICE OF LAW. THIS
AGREEMENT AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK (INCLUDING SECTIONS 5-1401 AND 5-1402 OF THE GENERAL OBLIGATIONS LAW
OF THE STATE OF NEW YORK BUT OTHERWISE WITHOUT REGARD TO CONFLICT OF LAW PRINCIPLES). 
 Section 14.10 CONSENT TO
JURISDICTION. (a) EACH SELLER PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY SUBMITS, FOR ITSELF AND ITS PROPERTY, TO THE NONEXCLUSIVE JURISDICTION OF THE SUPREME COURT OF THE STATE OF NEW YORK SITTING IN NEW YORK COUNTY AND OF THE UNITED
STATES DISTRICT COURT OF THE SOUTHERN DISTRICT OF NEW YORK, AND ANY APPELLATE COURT FROM ANY THEREOF, IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT, OR FOR RECOGNITION OR ENFORCEMENT OF ANY

  
 55 

 
JUDGMENT, AND EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY AND UNCONDITIONALLY AGREES THAT ALL CLAIMS IN RESPECT OF ANY SUCH ACTION OR PROCEEDING MAY BE HEARD AND DETERMINED IN SUCH NEW YORK
STATE OR, TO THE EXTENT PERMITTED BY LAW, IN SUCH FEDERAL COURT. EACH OF THE PARTIES HERETO AGREES THAT A FINAL JUDGMENT IN ANY SUCH ACTION OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN
ANY OTHER MANNER PROVIDED BY LAW. NOTHING IN THIS AGREEMENT SHALL AFFECT ANY RIGHT THAT THE ADMINISTRATIVE AGENT, ANY MANAGING AGENT, ANY L/C ISSUER OR ANY PURCHASER MAY OTHERWISE HAVE TO BRING ANY ACTION OR PROCEEDING RELATING TO THIS AGREEMENT
AGAINST ANY SELLER PARTY OR ITS PROPERTIES IN THE COURTS OF ANY JURISDICTION. 
 (b) EACH SELLER PARTY HEREBY IRREVOCABLY AND
UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT IT MAY LEGALLY AND EFFECTIVELY DO SO, ANY OBJECTION WHICH IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY SUIT, ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT IN ANY COURT
REFERRED TO IN PARAGRAPH (a) OF THIS SECTION. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY LAW, THE DEFENSE OF AN INCONVENIENT FORUM TO THE MAINTENANCE OF SUCH ACTION OR PROCEEDING IN ANY SUCH COURT.

 (c) EACH PARTY TO THIS AGREEMENT IRREVOCABLY CONSENTS TO SERVICE OF PROCESS IN THE MANNER PROVIDED FOR NOTICES IN SECTION
14.2. NOTHING IN THIS AGREEMENT WILL AFFECT THE RIGHT OF ANY PARTY TO THIS AGREEMENT TO SERVE PROCESS IN ANY OTHER MANNER PERMITTED BY LAW. 
 Section 14.11 WAIVER OF JURY TRIAL. EACH PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, TRIAL BY JURY IN ANY JUDICIAL PROCEEDING INVOLVING, DIRECTLY OR
INDIRECTLY, ANY MATTER (WHETHER SOUNDING IN TORT, CONTRACT OR OTHERWISE) IN ANY WAY ARISING OUT OF, RELATED TO, OR CONNECTED WITH THIS AGREEMENT, ANY DOCUMENT EXECUTED BY ANY SELLER PARTY PURSUANT TO THIS AGREEMENT OR THE RELATIONSHIP ESTABLISHED
HEREUNDER OR THEREUNDER. 
 Section 14.12 Integration; Binding Effect; Survival of Terms. 

(a) This Agreement and each other Transaction Document contain the final and complete integration of all prior expressions by the parties
hereto with respect to the subject matter hereof and shall constitute the entire agreement among the parties hereto with respect to the subject matter hereof superseding all prior oral or written understandings. 

(b) This Agreement shall create and constitute the continuing obligations of the parties hereto in accordance with its terms and shall
remain in full force and effect until terminated in accordance with its terms; provided, however, that the rights and remedies with respect to (i) any breach of any representation and warranty made by any Seller Party pursuant to
Article V, (ii) the indemnification and payment provisions of Article X, Article XI and Sections 14.5, 14.6, 14.7 and 14.8 shall be continuing and shall survive any termination of this
Agreement. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns (including any trustee in bankruptcy). 

  
 56 

 Section 14.13 Counterparts; Severability; Section References. This Agreement
may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall constitute one and the same
Agreement. Delivery of an executed counterpart of a signature page to this Agreement by facsimile or electronic mail in .pdf format shall be effective as delivery of a manually executed counterpart of this Agreement. Any provisions of this Agreement
which are prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or
unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. Unless otherwise expressly indicated, all references herein to “Article,” “Section,” “Schedule”
or “Exhibit” shall mean articles and sections of, and schedules and exhibits to, this Agreement. 
 Section 14.14
Agent Roles. (a) Each of the Managing Agents, the L/C Issuers and the Purchasers acknowledges that JPMorgan acts, or may in the future act, (i) as Administrative Agent for the Purchasers, (ii) as Managing Agent for one or more
Conduit Purchasers and Committed Purchasers in its Purchase Group, (iii) as administrative agent for any Conduit Purchaser or any Committed Purchaser, (iv) as issuing and paying agent for certain Commercial Paper, (v) to provide
credit or liquidity enhancement for the timely payment for certain Commercial Paper and (vi) to provide other services from time to time for certain Conduit Purchaser and/or certain Committed Purchaser (collectively, the “JPMorgan
Roles”). Without limiting the generality of this Section 14.14, each Committed Purchaser hereby acknowledges and consents to any and all JPMorgan Roles and agrees that in connection with any JPMorgan Role, JPMorgan may take, or
refrain from taking, any action that it, in its discretion, deems appropriate, including, without limitation, in its role as administrative agent for any such Conduit Purchaser. 

(b) Managing Agent Institution Roles. Each of the Purchasers and L/C Issuers acknowledges that each Person that serves as a
Managing Agent hereunder (a “Managing Agent Institution”) acts, or may in the future act, (i) as Managing Agent for one or more Conduit Purchasers and Committed Purchasers in its Purchase Group, (ii) as issuing and paying
agent for each such Conduit Purchaser’s Commercial Paper, (iii) to provide credit or liquidity enhancement for the timely payment for each such Conduit Purchaser’s Commercial Paper and (iv) to provide other services from time to
time for some or all of the Conduit Purchasers (collectively, the “Managing Agent Institution Roles”). Without limiting the generality of this Section 14.14(b), each Committed Purchaser hereby acknowledges and consents
to any and all Managing Agent Institution Roles and agrees that in connection with any Managing Agent Institution Role, the applicable Managing Agent Institution may take, or refrain from taking, any action that it, in its discretion, deems
appropriate, including, without limitation, in its role as administrative agent for the related Conduit Purchaser. 

Section 14.15 Characterization. (a) It is the intention of the parties hereto that each Purchase hereunder shall
constitute and be treated as an absolute and irrevocable sale, which purchase shall provide the applicable Purchaser with the full benefits of ownership of the applicable interest in the Purchaser Interest. Except as specifically provided in this
Agreement, each Purchase hereunder is made without recourse to Seller; provided, however, that (i) Seller shall be liable to each Purchaser, each Managing Agent and the Administrative Agent for all representations, warranties,
covenants and indemnities made by Seller pursuant to the terms of this Agreement, and (ii) such sale does not constitute and is not intended to result in an assumption by any Purchaser, any Managing Agent or the Administrative Agent or any
assignee thereof of any obligation of Seller or any Originator or any other Person arising in connection with the Receivables, the Related Security, or the related Contracts, or any other obligations of Seller or any Originator. 

  
 57 

 (b) In addition to any ownership interest which the Administrative Agent, on behalf of the
Purchasers, may from time to time acquire pursuant hereto, Seller hereby grants to the Administrative Agent, for the ratable benefit of the Purchasers and the other Indemnified Parties, a valid and perfected security interest in all of Seller’s
right, title and interest in, to and under all Receivables now existing or hereafter arising, the Collections, each Lock-Box, each Collection Account, all Related Security, all other rights and payments relating to such Receivables, all of
Seller’s rights, title, and interest in, to and under the Receivables Sale Agreement (including, without limitation, (a) all rights to indemnification arising thereunder, (b) all rights of MPC LP under the Receivables Transfer
Agreement transferred to Seller pursuant to the Receivables Sale Agreement and (c) all UCC financing statements filed pursuant thereto), all amounts paid to Cash-Collateralize any Letter of Credit, all proceeds of any of the foregoing and all
other assets in which the Administrative Agent has acquired, may hereafter acquire and/or purports to have acquired an interest hereunder, prior to all other liens on and security interests therein to secure the prompt and complete payment of the
Aggregate Unpaids. The Administrative Agent and the Purchasers shall have, in addition to the rights and remedies that they may have under this Agreement, all other rights and remedies provided to a secured creditor under the UCC and other
applicable law, which rights and remedies shall be cumulative. 
 (c) If, notwithstanding the intention of the parties expressed
above, any sale or transfer by Seller hereunder shall be characterized as a secured loan and not a sale or such sale shall for any reason be ineffective or unenforceable (any of the foregoing being a “Recharacterization”), then this
Agreement shall be deemed to constitute a security agreement under the UCC and other applicable law. In the case of any Recharacterization, Seller represents and warrants that each remittance of Collections to the Administrative Agent or the
Purchasers hereunder will have been (i) in payment of a debt incurred in the ordinary course of its business or financial affairs and (ii) made in the ordinary course of its business or financial affairs. 

Section 14.16 USA PATRIOT Act. Each Committed Purchaser that is subject to the requirements of the USA Patriot Act
(Title III of Pub. L. 107-56 (signed into law October 26, 2001)) (the “Act”) hereby notifies the Seller Parties that pursuant to the requirements of the Act, it is required to obtain, verify and record information that
identifies each Seller Party, which information includes the name and address of the each Seller Party and other information that will allow such Committed Purchaser to identify each Seller Party in accordance with the Act. 

Section 14.17 Amendment and Restatement; Consent to Amendment of Receivables Sale Agreement and Performance Undertaking and
Receivables Transfer Agreement. This Agreement amends, restates and supersedes in its entirety the Original RPA and shall not constitute a novation thereof. It is the intent of each of the parties hereto that all references to the Original RPA
in any Transaction Document to which such party is a party and which becomes or remains effective on or after the date hereof shall be deemed to mean and be references to this Agreement. By its signature hereto, the Administrative Agent and each
Managing Agent consents to the terms of (1) the Amended and Restated Receivables Sale Agreement of even date herewith between MPC LP, as seller and the Seller, as buyer, (2) the Amended and Restated Performance Undertaking of even date
herewith by Marathon in favor of the Seller and (3) the Receivables Transfer Agreement of even date herewith between Marathon Canada, as seller and MPC LP, as buyer. 
 [SIGNATURE PAGES FOLLOW] 

  
 58 

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed and
delivered by their duly authorized officers as of the date hereof. 
  

			
	MPC TRADE RECEIVABLES COMPANY LLC, as Seller
		
	By:	 	 /s/ Donald C. Templin

		 	Name: Donald C. Templin
		 	Title: President
	
	MARATHON PETROLEUM COMPANY LP, as Servicer
	
	By: MPC Investment LLC, its general partner
		
	By:	 	 /s/ Donald C. Templin

		 	Name: Donald C. Templin
		 	Title: Senior Vice President and Chief Financial Officer

 Signature Page to 
 Amended and Restated Receivables Purchase Agreement 
 MPC Trade
Receivables Company LLC 

 
					
	CHARIOT FUNDING LLC, as a Conduit Purchaser
		
	By:	 	JPMorgan Chase Bank, N.A., its attorney-in-fact
		
	By:	 	 /s/ John M. Kuhns

		 	Name:	 	John M. Kuhns
		 	Title:	 	Executive Director
	
	JPMORGAN CHASE BANK, N.A., as a Committed Purchaser, as a Managing Agent, as an L/C Issuer and as Administrative Agent
		
	By:	 	 /s/ John M. Kuhns

		 	Name:	 	John M. Kuhns
		 	Title:	 	Executive Director

  

Signature Page to 
 Amended and Restated Receivables Purchase Agreement 
 MPC Trade
Receivables Company LLC 

					
	
	BANK OF AMERICA, N.A., as a Committed Purchaser, as a Managing Agent and as an L/C Issuer
		
	By:	 	 /s/ Nina Austin

		 	Name:	 	Nina Austin
		 	Title:	 	Vice President

  

Signature Page to 
 Amended and Restated Receivables Purchase Agreement 
 MPC Trade
Receivables Company LLC 

					
	
	VICTORY RECEIVABLES CORPORATION, as a Conduit Purchaser
		
	By:	 	 /s/ David V. DeAngelis

		 	Name:	 	David V. DeAngelis
		 	Title:	 	Vice President
	
	THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., NEW YORK BRANCH, as a Committed Purchaser
		
	By:	 	 /s/ Andrew Oram

		 	Name:	 	Andrew Oram
		 	Title:	 	Managing Director
	
	THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., NEW YORK BRANCH, as a Managing Agent
		
	By:	 	 /s/ Aditya Reddy

		 	Name:	 	Aditya Reddy
		 	Title:	 	Managing Director
	
	THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., NEW YORK BRANCH, as an L/C Issuer
		
	By:	 	 /s/ Andrew Oram

		 	Name:	 	Andrew Oram
		 	Title:	 	Managing Director

  

Signature Page to 
 Amended and Restated Receivables Purchase Agreement 
 MPC Trade
Receivables Company LLC 

					
	
	CHARTA, LLC as a Conduit Purchaser
		
	By:	 	Citibank, N.A. as attorney-in fact
		
	By:	 	 /s/ Kosta Karantzoulis

		 	Name:	 	Kosta Karantzoulis
		 	Title:	 	Vice President
	
	CITIBANK, N.A., as a Committed Purchaser, as a Managing Agent and as an L/C Issuer
		
	By:	 	 /s/ Kosta Karantzoulis

		 	Name:	 	Kosta Karantzoulis
		 	Title:	 	Vice President

  

Signature Page to 
 Amended and Restated Receivables Purchase Agreement 
 MPC Trade
Receivables Company LLC 

					
	
	MARKET STREET FUNDING LLC, as a Conduit Purchaser
		
	By:	 	 /s/ Karla L. Boyd

		 	Name:	 	Karla L. Boyd
		 	Title:	 	Vice President
	
	PNC BANK, NATIONAL ASSOCIATION, as a Committed Purchaser and as an L/C Issuer
		
	By:	 	 /s/ Thomas E. Redmond

		 	Name:	 	Thomas E. Redmond
		 	Title:	 	Senior Vice President
	
	PNC BANK, NATIONAL ASSOCIATION, as a Managing Agent
		
	By:	 	 /s/ William Falcon

		 	Name:	 	William Falcon
		 	Title:	 	Vice President

  

Signature Page to 
 Amended and Restated Receivables Purchase Agreement 
 MPC Trade
Receivables Company LLC 

					
	
	WINDMILL FUNDING CORPORATION, as a Conduit Purchaser
		
	By:	 	 /s/ Jill A. Russo

		 	Name:	 	Jill A. Russo
		 	Title:	 	Vice President
	
	THE ROYAL BANK OF SCOTLAND PLC, as a Committed Purchaser, as a Managing Agent and as an L/C Issuer
		
	By:	 	RBS Securities, Inc., as agent
		
	By:	 	 /s/ Gregory S. Blanck

		 	Name:	 	Gregory S. Blanck
		 	Title:	 	Managing Director

  

Signature Page to 
 Amended and Restated Receivables Purchase Agreement 
 MPC Trade
Receivables Company LLC 

 EXHIBIT I 
 DEFINITIONS 
 As used in this Agreement, the following terms shall have the
following meanings (such meanings to be equally applicable to both the singular and plural forms of the terms defined): 

“Accrual Period” means (i) in respect of each Tranche of a Committed Purchaser in a Commercial Paper Purchase Group
for which Yield accrues by reference to the Adjusted LIBO Rate and each Tranche of a Conduit Purchaser funded by Tranche Funded Commercial Paper, the entire Tranche Period thereof and (ii) in respect of each Tranche of a Conduit Purchaser
funded by Pooled Commercial Paper, each Tranche of a Committed Purchaser in a Balance Sheet Purchase Group and each Tranche of a Committed Purchaser for which Yield accrues by reference to the Alternate Base Rate, each calendar month;
provided that the initial Accrual Period hereunder means the period from (and including) the date of the initial Credit Event hereunder to (and including) the last day of the calendar month thereafter. 

“Adverse Claim” means, with respect to any asset, (a) any mortgage, deed of trust, lien, pledge, hypothecation,
assignment for security, encumbrance, charge or security interest in, on or of such asset or (b) any other similar right or claim in, to or on such asset. 
 “Adjusted LIBO Rate” means, (x) with respect to any Tranche of a Committed Purchaser for any Tranche Period, the weighted average (rounded upward, if necessary, to the next 1/16 of
1%) equal to the product of (a) the LIBO Rate for such Tranche Period multiplied by (b) the Statutory Reserve Rate; and (y) with respect to any Committed Purchaser in a Balance Sheet Purchase Group, on any day during an Accrual
Period, the rate (rounded upward, if necessary, to the next 1/16 of 1%) equal to (a) LMIR for such day multiplied by (b) the Statutory Reserve Rate. 
 “Administrative Agent” has the meaning set forth in the preamble to this Agreement. 
 “Affiliate” means, with respect to a specified Person, another Person that directly, or indirectly through one or more intermediaries, Controls or is Controlled by or is under common
Control with the Person specified. As used in this definition, “Control” means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a Person, whether through the ability to
exercise voting power, by contract or otherwise, and “Controlling” and “Controlled” have meanings correlative thereto. 
 “Aggregate Capital” means, on any date of determination, the aggregate amount of Capital outstanding on such date. 

“Aggregate Reduction” has the meaning specified in Section 1.3. 

“Aggregate Reserves” means, on any date of determination, the sum of the Loss Reserve, the Dilution Reserve and the
Yield and Servicing Reserve. 
 “Aggregate Unpaids” means, at any time, an amount equal to the sum of all
accrued and unpaid fees under the Fee Letter, CP Costs, Yield, Fronting Fees, Other L/C Fees, Aggregate Capital, all L/C Obligations and all other unpaid Obligations (whether due or accrued) at such time. 

“Agreement” means this Amended and Restated Receivables Purchase Agreement, as it may be amended, restated, supplemented
or otherwise modified and in effect from time to time. 

  
 Exh. I-1

 “Alternate Base Rate” means for any day, a rate per
annum equal to the greatest of (a) the Prime Rate in effect on such day, (b) the Federal Funds Effective Rate in effect on such day plus
 1/2 of 1%, and (c) the Adjusted LIBO Rate for
a one month Tranche Period on such day (or if such day is not a Business Day, the immediately preceding Business Day) plus 1%; provided that, for the avoidance of doubt, the Adjusted LIBO Rate for any day shall be based on the rate appearing
on the Reuters BBA Libor Rates Page 3750 (or on any successor or substitute page of such service, or any successor or substitute for such service) at approximately 11:00 a.m. London time on such day. Any change in the Alternate Base Rate due to
a change in the Prime Rate, the Federal Funds Effective Rate or the Adjusted LIBO Rate shall be effective from and including the effective date of such change in the Prime Rate, the Federal Funds Effective Rate or the Adjusted LIBO Rate,
respectively. 
 “Amortization Date” means the earliest to occur of (i) the Business Day
immediately prior to the occurrence of an Amortization Event set forth in Section 9.1(d)(ii), (ii) the Business Day specified in a written notice from the Administrative Agent delivered at the direction of the Required Managing
Agents following the occurrence of any other Amortization Event, (iii) the date which is fifteen (15) days after the Administrative Agent’s receipt of written notice from Seller that it wishes to terminate the facility evidenced by
this Agreement, (iv) the Liquidity Termination Date, (v) the “Termination Date” under and as defined in the Receivables Sale Agreement and (vi) the “Termination Date” under and as defined in the Receivables
Transfer Agreement. 
 “Amortization Event” has the meaning specified in Section 9.1. 

“Applicable Margin” has the meaning specified in the Fee Letter. 

“Asphalt Products” means asphalt cement, asphalt cement binders, cutback asphalt, flux, asphalt emulsions, polymer
modified asphalt cement, polymer modified asphalt emulsions, micro-surfacing emulsions, chemically modified asphalt, crack sealant products and related high performance products, excluding, for the avoidance of doubt, wellsite fluids, tops and
distillate. 
 “Asphalt Receivable” means a Receivable that relates to a Contract (a) which has an
original payment due date that is more than thirty (30) days but less than ninety-one (91) days after the invoice date and (b) pursuant to or under which the Obligor is obligated to pay for Asphalt Products. 

“Assignment Agreement” has the meaning set forth in Section 12.1(b). 

“Authorized Officer” means, with respect to any Person, its president, any vice president, manager, corporate
controller, assistant controller, treasurer, assistant treasurer or chief financial officer, or of its general partner or managing member, if applicable. 
 “Auto-Extension Letter of Credit” has the meaning set forth in Section 1.5(e)(ii). 
 “Balance Sheet Purchase Group” means each Purchase Group that does not include a Conduit Purchaser and is identified on Schedule A hereto (or in the Assignment Agreement
pursuant to which such Purchase Group became party hereto) as a “Balance Sheet Purchase Group”, or which has been designated in writing to Seller and the Administrative Agent as a “Balance Sheet Purchase Group” by the Managing
Agent thereof. 
 “Broken Funding Costs” means for any Tranche which: (i) has its Capital reduced without
compliance by Seller with the notice requirements hereunder, (ii) does not become subject to an Aggregate Reduction following the delivery of any Reduction Notice, (iii) is assigned to the Committed Purchasers pursuant to the Funding
Agreement or (iv) otherwise is terminated prior to the date on which it 

  
 Exh. I-2

 
was originally scheduled to end; an amount equal to the excess, if any, of (A) the CP Costs or Yield (as applicable) that would have accrued during the remainder of the Tranche Periods or
the tranche periods for Commercial Paper determined by the applicable Managing Agent to relate to such Tranche (as applicable) subsequent to the date of such reduction, assignment or termination (or in respect of clause (ii) above, the date
such Aggregate Reduction was designated to occur pursuant to the Reduction Notice) of the Capital of such Tranche if such reduction, assignment or termination had not occurred or such Reduction Notice had not been delivered, over (B) the sum of
(x) to the extent all or a portion of such Capital is allocated to another Tranche, the amount of CP Costs or Yield actually accrued during the remainder of such period on such Capital for the new Tranche, and (y) to the extent such
Capital is not allocated to another Tranche, the income, if any, actually received during the remainder of such period by the holder of such Tranche from investing the portion of such Capital not so allocated. In the event that the amount referred
to in clause (B) exceeds the amount referred to in clause (A), the relevant Purchaser or Purchasers agree to pay to Seller the amount of such excess. All Broken Funding Costs shall be due and payable hereunder on the first Settlement Date after
demand. 
 “Business Day” means any day on which banks are not authorized or required to close in New York, New
York, Charlotte, North Carolina, Cincinnati, Ohio, Pittsburgh, Pennsylvania or Chicago, Illinois and The Depository Trust Company of New York is open for business, and, if the applicable Business Day relates to any computation or payment to be made
with respect to the Adjusted LIBO Rate, any day on which dealings in dollar deposits are carried on in the London interbank market. 
 “Capital” of any Purchaser or L/C Issuer means, at any time, (A) the portion of the Purchase Price paid by such Purchaser to Seller in consideration of an Incremental Purchase
plus (B) the aggregate amount paid by such Purchaser to an L/C Issuer pursuant to Section 1.5 plus (C) with respect to an L/C Issuer, the aggregate amount of Reimbursement Obligations owing to such L/C Issuer
minus (D) sum of the aggregate amount of Collections and other payments received by the Administrative Agent, the Managing Agents or the Purchasers in respect thereof which in each case are applied to reduce such Capital in accordance
with the terms and conditions of this Agreement; provided that such Capital shall be restored (in accordance with Section 2.5) in the amount of any Collections or other payments so received and applied if at any time the
distribution of such Collections or payments are rescinded, returned or refunded for any reason. 
 “Capital Lease
Obligations” of any Person means the obligations of such Person to pay rent or other amounts under any lease of (or other arrangement conveying the right to use) real or personal property, or a combination thereof, which obligations are
required to be classified and accounted for as capital leases on a balance sheet of such Person under GAAP (as GAAP was in effect on December 31, 2010), and the amount of such obligations shall be the capitalized amount thereof determined in
accordance with GAAP (as GAAP was in effect on December 31, 2010). 
 “Cash-Collateralize” means to pledge
to the Administrative Agent, for the benefit of the applicable L/C Issuer (and the participating Purchasers), and deposit into the L/C Collateral Account, as collateral for the L/C Obligations, immediately available funds (x) unless otherwise
expressly provided herein, in an amount equal to the Required Cash-Collateral Amount and (y) pursuant to documentation in form and substance satisfactory to the Administrative Agent and the applicable L/C Issuer; and
“Cash-Collateral” shall have a correlative meaning. 
 “Change of Control” means the
occurrence of any of the following: (a) the acquisition of ownership, directly or indirectly, beneficially or of record, by any Person or group (within the meaning of Rule 13d-5 of the Exchange Act as in effect on the date hereof), of
Equity Interests representing more than 35% of the aggregate ordinary voting power represented by the issued and outstanding Equity Interests of Marathon entitled to vote in the election of directors (other than such Equity Interests having

  
 Exh. I-3

 
such power only by reason of the happening of a contingency which contingency has not yet happened); (b) during any period of twenty-five consecutive months, commencing on or after
June 30, 2011, a majority of the members of the board of directors of Marathon ceases to be composed of individuals (i) who were members of such board on the first day of such period, (ii) whose election, nomination or appointment to
such board was approved by individuals referred to in clause (i) above constituting at the time of such election, nomination or appointment at least a majority of such board or (iii) whose election, nomination or appointment to such board
was approved by individuals referred to in clauses (i) and (ii) above constituting at the time of such election, nomination or appointment at least a majority of such board; or (c) the occurrence of a “Change of Control”
event as set forth in clause (2) of the definition of “Change of Control” in the Indenture with respect to the Senior Notes dated as of February 1, 2011. For purposes of this definition, the following terms shall have the
following meanings: 
 “Equity Interests” means shares of capital stock, partnership interests,
membership interests in a limited liability company, beneficial interests in a trust or other equity ownership interests in a Person, and any warrants, options or other rights entitling the holder thereof to purchase or acquire any such equity
interest (other than any debt security which by its terms is convertible at the option of the holder into Equity Interests, to the extent such holder has not so converted such debt security). 

“Senior Notes” means, collectively, Marathon’s 3 1/2% Senior Notes due 2016, 5 1/8% Senior Notes due 2021 and 6 1/2% Senior Notes due 2041. 

“Charged-Off Receivable” means a Receivable: (i) as to which the Obligor thereof has taken any action, or suffered
any event to occur, of the type described in Section 9.1(d) (as if references to Seller Party therein refer to such Obligor), (ii) as to which the Obligor thereof, if a natural person, is deceased, (iii) which, consistent with
the Credit and Collection Policy, would be written off Servicer’s or Seller’s books as uncollectible, (iv) which has been identified by Servicer or Seller as uncollectible or (v) as to which any payment, or part thereof, remains
unpaid for more than ninety (90) days past invoice for such payment. 
 “Code” means the Internal Revenue
Code of 1986, as amended and in effect from time to time. 
 “Collection Account” means each concentration
account, depositary account, lock-box account or similar account in which any Collections are collected or deposited and which is listed on Exhibit IV. 
 “Collection Account Agreement” means an agreement in form and substance acceptable to the Administrative Agent, by and among Seller, the Administrative Agent, Servicer (if applicable) and
the applicable Collection Bank. 
 “Collection Bank” means, at any time, any of the banks holding one or more
Collection Accounts. 
 “Collection Notice” means a notice, in substantially the form attached to, or otherwise
conforming the requirements set forth in, the applicable Collection Account Agreement, from the Administrative Agent to a Collection Bank. 
 “Collections” means, with respect to any Receivable, all cash collections and other cash proceeds in respect of such Receivable, including, without limitation, all yield, principal,
Finance Charges, recoveries or other related amounts accruing in respect thereof and all cash proceeds of Related Security with respect to such Receivable and any Deemed Collections. 

  
 Exh. I-4

 “Commercial Paper” means, with respect to any Conduit Purchaser, the
promissory notes issued by such Conduit Purchaser or, if applicable, its Related CP Issuer, in the commercial paper market. 

“Commercial Paper Purchase Group” means, each Purchase Group listed on Schedule A hereto (or in the Assignment
Agreement pursuant to which such Purchase Group became party hereto) as a “Commercial Paper Purchase Group”, or which has been designated in writing to Seller and the Administrative Agent as a “Commercial Paper Purchase Group” by
the Managing Agent thereof. 
 “Committed Purchasers” has the meaning set forth in the preamble to this
Agreement. 
 “Commitment” means, for each Committed Purchaser, the commitment of such Committed Purchaser to
fund its Pro Rata Share of each Purchase and to incur its Pro Rata Share of participation interests in respect of L/C Purchases under Section 1.5(f), such Pro Rata Share not to exceed, in the aggregate, the amount set forth opposite such
Committed Purchaser’s name on Schedule A to this Agreement or, in the case of a Committed Purchaser that becomes a party to this Agreement pursuant to an Assignment Agreement, the amount set forth therein as such Committed
Purchaser’s “Commitment”, in each case, as such amount may be modified in accordance with the terms hereof. 

“Commitment Fee” has the meaning specified in the Fee Letter. 

“Conduit Purchaser” has the meaning set forth in the preamble to this Agreement. 

“Concentration Limit” means, at any time, for any Obligor, an amount equal to the product of (a) the highest of the
following, as applicable: (i) one quarter of the Loss Reserve Floor (the “Standard Concentration Limit”); (ii) with respect to any Obligor with a Debt Rating of “AA” or better by S&P and “Aa2” or
better by Moody’s (a “Tier I Concentration Limit”), 8.0%; (iii) with respect to any Obligor with a Debt Rating of “BBB-” or better by S&P and “Baa3” or better by Moody’s (a “Tier II
Concentration Limit”), 4.0%; or (iv) such other amount (a “Special Concentration Limit”) for such Obligor set forth on Schedule E hereof, so long as such Obligor has a Debt Rating of “BBB-” or
better by S&P and “Baa3” or better by Moody’s, and (b) the Eligible Receivables Balance at such time; provided, that in the case of an Obligor and any Affiliate of such Obligor, the Concentration Limit shall be
calculated as if such Obligor and such Affiliate are one Obligor; and provided, further, that the Administrative Agent may, upon direction of the Required Managing Agents, upon not less than three (3) Business Days’ notice to
Seller, cancel any Special Concentration Limit without retroactive effect. 
 “Contract” means, with respect to
any Receivable, any and all instruments, agreements, invoices or other writings pursuant to which such Receivable arises or which evidences such Receivable. 
 “CP Costs” means, 
 (a) with respect to Pooled Commercial Paper
for any day, the sum of (i) discount or yield accrued on Pooled Commercial Paper of such Conduit Purchaser on such day, plus (ii) any and all accrued commissions in respect of placement agents and Commercial Paper dealers, and
issuing and paying agent fees incurred, in respect of such Pooled Commercial Paper for such day, plus (iii) other costs associated with funding received by Conduit Purchaser pursuant to any program liquidity facilities, swing line
facilities or other credit facilities in connection with receivable purchase facilities which are funded by Pooled Commercial Paper for such day, plus (iv) other costs associated with funding small or odd-lot amounts with respect to all
receivable purchase facilities which are funded by Pooled Commercial Paper for such day, minus (v) any accrual of income net of expenses received on such day from investment of collections received under all receivable purchase
facilities funded substantially with Pooled Commercial Paper, minus (vi) any payment received on such day net of expenses in respect of Broken Funding Costs related to the prepayment of any Capital funded or maintained by a Conduit
Purchaser pursuant to the terms of any receivable purchase facilities funded substantially with Pooled Commercial Paper; and 

  
 Exh. I-5

 (b) with respect to any Tranche Funded Commercial Paper for any day, a rate of
interest equal to the per annum rate (expressed as a percentage and an interest yield equivalent and calculated on the basis of a 360-day year) equivalent to the weighted average of the per annum rates (as determined by the related Managing Agent)
paid or payable by such Tranche Funding Conduit Purchaser from time to time as interest on or otherwise in respect of Commercial Paper that is allocated, in whole or in part, by its related Managing Agent to fund the purchase or maintenance of
any Capital (and which may also be allocated in part to the funding of other assets of such Tranche Funding Conduit Purchaser) during such Tranche Period (or portion thereof) as determined by the related Managing Agent, which rates shall
reflect and give effect to (i) certain documentation and transaction costs (including dealer and placement agent commissions) associated with the issuance of the Commercial Paper and (ii) other borrowings by such Tranche Funding
Conduit Purchaser, including borrowings to fund small or odd dollar amounts that are not easily accommodated in the commercial paper market, to the extent such amounts are allocated, in whole or in part, by the related Managing Agent to fund such
Tranche Funding Conduit Purchaser’s purchase or maintenance of Capital during such Tranche Period. 

“CRD” means the Capital Requirements Directive which is comprised of Directives 2006/48/EC of the European Parliament
and of the Council of 14 June 2006 relating to the taking up and pursuit of the business of credit institutions and Directive 2006/49/EC of the European Parliament and of the Council of 14 June 2006 on the capital adequacy of investment
firms and credit institutions, as amended from time to time. 
 “Credit and Collection Policy” means MPC
LP’s credit and collection policies and practices relating to Contracts and Receivables existing on the date hereof and attached as Schedule C hereto, as modified from time to time in accordance with this Agreement. 

“Credit Event” means (i) a Purchase, (ii) the renewal, extension, increase, decrease or other modification of
a Letter of Credit or (iii) any Reinvestment. 
 “Crude Oil Receivable” means any Receivable arising from
the sale of crude oil or the rendering of services in connection therewith. 
 “Daily Report” means a report,
in form and substance mutually agreed upon by Servicer and the Managing Agents (appropriately completed), furnished by Servicer to the Managing Agents and the Administrative Agent pursuant to Section 8.5. 

“Daily Reporting Period” means any Level 3 Ratings Period. 

“Debt Rating” means, with respect to any Person at any time, the senior unsecured long-term debt rating assigned by
S&P or Moody’s for such Person, in each case without giving effect to any third party credit enhancement. 

“Deemed Collections” means the aggregate of all amounts Seller shall have been deemed to have received as a Collection
of a Receivable. Seller shall be deemed to have received a Collection (i) if at any time the Outstanding Balance of any such Receivable is either (x) reduced as a result of any defective or rejected goods or services, any discount or any
adjustment or otherwise by Seller or any Originator (other than cash Collections on account of the Receivables) or (y) reduced or canceled as a result of a setoff in respect of any claim by any Person (whether such claim arises out of the same
or a related transaction or an unrelated transaction), such Deemed Collection being equal to the amount of such reduction, discount 

  
 Exh. I-6

 
or other adjustment or (ii) if at any time any of the representations or warranties in clauses (i), (j), (q), (r), (s), (t), (u) and
(z) of Section 5.1 are no longer true with respect to any Receivable, in an amount equal to the Outstanding Balance of such Receivable. 
 “Default Fee” means with respect to any amount due and payable by Seller in respect of any Aggregate Unpaids, an amount equal to interest on any such unpaid Aggregate Unpaids at a rate
per annum equal to the sum of (a) 2.00%, (b) the Applicable Margin and (c) the Alternate Base Rate. 

“Default Ratio” means, for any calendar month, a percentage equal to (i) the aggregate Outstanding Balance of all
Receivables (without duplication) which remain unpaid for more than sixty (60) but less than ninety-one (91) days past invoice as of the end of such month (other than any Asphalt Receivable which is not past due) plus the aggregate
Outstanding Balance of all Receivables (without duplication) which, consistent with the Credit and Collection Policy, were or should have been written off Seller’s books as uncollectible during such month divided by (ii) the aggregate
Outstanding Balance of all Receivables as of the end of such month; provided, that any Receivable that would otherwise be included in the calculation of the “Default Ratio” because such Receivable has aged the specified number of
days past invoice, may be netted, for the purposes of this calculation, with any credits (x) that have been issued for the purpose of writing off a portion if such Receivable due to the bankruptcy of the Obligor thereof and (y) that are
specifically denoted as applying to the invoice that gave rise to such Receivable. 
 “Defaulting Committed
Purchaser” means any Committed Purchaser that, as determined by the Administrative Agent, (a) has failed to fund any of its obligations to participate in any Letter of Credit or reimburse any L/C Issuer, including in respect of
Incremental Purchases to pay any Reimbursement Obligations, within three (3) Business Days of the date required to be funded by it hereunder, (b) has notified any Seller Party, the Administrative Agent, any Managing Agent or any other
Purchaser that it does not intend to comply with such funding obligations or has made a public statement to that effect with respect to such funding obligations hereunder or under other agreements in which it commits to extend credit, (c) has
failed, within three (3) Business Days after request by the Administrative Agent, to confirm in a manner satisfactory to the Administrative Agent that it will comply with such funding obligations, or (d) has, or has a direct or indirect
parent company that has, taken any action, or suffered any event to occur, of the type described in Section 9.1(d) (as if references to Seller Party therein refer to such Committed Purchaser or such direct or indirect parent company);
provided, that a Committed Purchaser should not be deemed Defaulting Committed Purchaser hereunder solely by virtue of any control of or ownership interest in, or the acquisition of any ownership interest in, such Person or the exercise of
control over such Person by a Governmental Authority or instrumentality thereof if and for so long as such ownership interest does not result in or provide such Person with immunity from the jurisdiction of courts within the United States or from
the enforcement of judgments or writs of attachment on its assets or permit such Person (or such governmental authority or instrumentality) to reject, repudiate, disavow or disaffirm obligations such as those under this Agreement. 

“Delinquency Ratio” means, for any calendar month, a percentage equal to (i) the aggregate Outstanding Balance of
all Receivables that were Delinquent Receivables as of the end of such month divided by (ii) the aggregate Outstanding Balance of all Receivables as of the end of such month; provided that any Receivable that would otherwise be included
in the calculation of the “Delinquency Ratio” because such Receivable has aged more than sixty (60) days past invoice, may be netted, for the purposes of this calculation, with any credits (i) that have been issued for the
purpose of writing off a portion of such Receivable due to the bankruptcy of the Obligor thereof and (ii) that are specifically denoted as applying to the invoice that gave rise to such Receivable. 

  
 Exh. I-7

 “Delinquent Receivable” means a Receivable as to which any payment, or
part thereof, remains unpaid for more than sixty (60) days past invoice (other than an Asphalt Receivable which is not past due). 
 “Dilution Horizon Ratio” means, as of any date, a ratio computed as of the last day of the most recently ended calendar month by dividing (i) one half of the aggregate amount of
gross sales of the Originators generated during the most recently ended calendar month by (ii) the Net Receivables Balance as of the most recently ended calendar month. 
 “Dilution Ratio” means, as of the end of any calendar month, the ratio (expressed as a percentage) computed as of the last day of such calendar month by dividing (i) the aggregate
amount of Dilutions (other than Discount Credits and Rebate Credits) which occurred during such calendar month by (ii) the aggregate amount of gross sales of the Originators generated during the most recently ended calendar month. 

“Dilution Reserve” means, on any date, an amount equal to the Dilution Reserve Percentage at such time multiplied by the
Net Receivables Balance at such time. 
 “Dilution Reserve Floor” means 8.0%. 

“Dilution Reserve Percentage” means, on any date, the greater of (i) the Dilution Reserve Floor and (ii) the
amount expressed as a percentage and calculated in accordance with the following formula: 
 DRP = {(SF x ED) + ((DS – ED)
x (DS / ED))} x DHR 
 where: 
  

					
	SF	  	=	  	2.25.
			
	ED	  	=	  	the average of the Dilution Ratios for the twelve (12) most recently ended calendar months.
			
	DS	  	=	  	the highest Dilution Ratio during the twelve (12) most recently ended calendar months.
			
	DHR	  	=	  	the Dilution Horizon Ratio at such time.

 “Dilutions” means, at any time, the aggregate amount of reductions or cancellations
described in clause (i) of the definition of “Deemed Collections”. 
 “Discount Credits” means,
credits issued by Servicer or any Originator to Obligors in respect of early pay discounts. 
 “Discount Credits
Ratio” means, for any calendar month, the ratio (expressed as a percentage) computed as of the last day of such month by dividing (i) the aggregate amount of Discount Credits for such month by (ii) the aggregate amount of gross
sales of the Originators generated during such month. 
 “Discount Proxy Amount” means, as of any date, an
amount equal to the highest Discount Credits Ratio during the six (6) most recently ended calendar months multiplied by the aggregate amount of gross sales of the Originators generated during the most recently ended calendar month. 

“Drawing Date” is defined in Section 1.5(f)(i). 

  
 Exh. I-8

 “Eligible Investments” shall mean: 

(a) direct obligations of, or guaranteed as to the full and timely payment of principal and interest by, the United States or obligations
of any agency or instrumentality thereof, if such obligations are backed by the full faith and credit of the United States; 

(b) federal funds, certificates of deposit, time deposits, demand deposits, notes and bankers’ acceptances of any United States
depository institution or trust company organized under the laws of the United States or any state thereof and subject to examination and supervision by federal or state financial institutions regulatory authorities; provided, however,
that the short-term obligations of such depository institution or trust company are rated “A-1+” by S&P and “P-1” by Moody’s; 
 (c) commercial paper, demand notes, master notes, promissory notes or other short-term debt obligations of any corporation incorporated under the laws of the United States or any state thereof which on
the date of the acquisition are rated “A-1+” by S&P and “P-1” by Moody’s; 
 (d) investment in
money market funds rated “Aam” or better by S&P and “Aa” or better by Moody’s; and 
 (e) any other
investment approved in writing by the Administrative Agent in consultation with Seller. 
 “Eligible
Receivable” means, at any time, a Receivable: 
 (i) the Obligor of which: 

(a) if a natural person, is a resident of the United States or, if a corporation or other business organization, either
(x) is organized under the laws of the United States or any political subdivision thereof, is a resident of the United States or any political subdivision thereof and has a place of business within the United States, (y) if the Obligor
thereof is a resident of, or organized under the laws of, Canada, the Outstanding Balance of which, when added to the aggregate Outstanding Balance of all other Eligible Receivables the Obligor of which is a resident of, or organized under the laws
of, Canada, does not exceed twenty percent (20.0%) of the aggregate Outstanding Balance of all Receivables at such time, or (z) if the Obligor thereof is a resident of, or organized under the laws of, a country other than the United States
or Canada the Outstanding Balance of which, when added to the aggregate Outstanding Balance of all other Eligible Receivables the Obligor of which is a resident of, or organized under the laws of, a country other than the United States or Canada,
does not exceed five percent (5.0%) of the aggregate Outstanding Balance of all Receivables at such time; 

(b) is not an Affiliate of any of the parties hereto (other than an Affiliate of any Purchaser); and 

(c) is either (x) a Governmental Authority at the state or local level of a State within the United States or
(y) a United States Federal Governmental Authority, so long as the Outstanding Balance of such Receivable when added to the aggregate Outstanding Balance of all other Eligible Receivables the Obligor of which is a United States Federal
Governmental Authority, does not exceed five percent (5.0%) of the aggregate Outstanding Balance of all Receivables at such time, 

  
 Exh. I-9

 (ii) the Obligor of which is not the Obligor of Charged-Off Receivables, the
balance of which exceeds twenty-five percent (25%) or more of all Receivables of such Obligor, 
 (iii)
which is not a Charged-Off Receivable or a Receivable as to which any payment, or part thereof, remains unpaid for more than thirty (30) days past invoice (other than an Asphalt Receivable which is not past due), 

(iv) which is either (x) due and payable by its terms within thirty (30) days of the original billing date
therefor or (y) is an Asphalt Receivable which is not past due, so long as the Outstanding Balance of such Asphalt Receivable, when added to the aggregate Outstanding Balance of all other Asphalt Receivables, does not exceed five percent
(5.0%) of the aggregate Outstanding Balance of all Receivables at such time, and, in each case, has not had its payment terms extended, 
 (v) which is an “account” or “chattel paper” within the meaning of Section 9-102(2) and Section 9-102(11), respectively, of the UCC of all applicable jurisdictions,

 (vi) which is denominated and payable either (x) only in United States dollars in the United States or
(y) only in Canadian dollars in Canada, so long as the Outstanding Balance of such Receivable, when added to the aggregate Outstanding Balance of all other Eligible Receivables which are denominated and payable in Canadian dollars in Canada
does not exceed 2.5% of the aggregate Outstanding Balance of all Receivables at such time, 
 (vii) which arises
under a Contract which, together with such Receivable, is in full force and effect and constitutes the legal, valid and binding obligation of the related Obligor enforceable against such Obligor in accordance with the terms of such Contract,

 (viii) which arises under a Contract which does not contain any enforceable restriction on assignability of
such Receivable that is effective under applicable law (taking into account the applicable UCC), 
 (ix) which
arises under a Contract that contains an obligation to pay a specified sum of money, contingent only upon the sale of goods or the provision of services by the applicable Originator, 

(x) which, together with the Contract related thereto, does not contravene any law, rule or regulation applicable thereto
(including, without limitation, any law, rule and regulation relating to truth in lending, fair credit billing, fair credit reporting, equal credit opportunity, fair debt collection practices, privacy, trading with the enemy and trade and similar
sanctions) and with respect to which no part of the Contract related thereto is in violation of any such law, rule or regulation, 
 (xi) which satisfies all applicable requirements of the Credit and Collection Policy, 
 (xii) which was generated in the ordinary course of the applicable Originator’s business, 
 (xiii) which arises solely from the sale of goods or the provision of services to the related Obligor by the applicable Originator, and not by any other Person (in whole or in part), 

  
 Exh. I-10

 (xiv) which is not subject to (A) any right of rescission, set off
(excluding offsets pursuant to credit balance arrangements, net-outs, setoff of delivery or payment obligations, customer deposits held at the applicable Originator, potential excise tax offsets and other similar customary contractual arrangements
between such Originator and the related Obligor), counterclaim or any other defense (including defenses arising out of violations of usury laws) of the applicable Obligor against the applicable Originator, (B) any other Adverse Claim (other
than Permitted Liens) or (C) any contra balance (which, during any Level 2 Ratings Period or any Level 3 Ratings Period, shall be deemed to include all accounts payable owing from the applicable Originator to any Affiliate of an Obligor), and
the Obligor thereon holds no right as against the applicable Originator to cause such Originator to repurchase the goods or merchandise the sale of which shall have given rise to such Receivable (except with respect to sale discounts effected
pursuant to the Contract, or defective goods returned in accordance with the terms of the Contract), 
 (xv) as
to which the applicable Originator has satisfied and fully performed all obligations on its part with respect to such Receivable required to be fulfilled by it, and no further action is required to be performed by any Person with respect thereto
other than payment thereon by the applicable Obligor, and 
 (xvi) all right, title and interest to and in which
has been validly transferred (A) in the case of a Receivable originated by Marathon Canada, (i) by Marathon Canada directly to MPC LP under and in accordance with the Receivables Transfer Agreement and (ii) thereafter by MPC LP
directly to Seller under and in accordance with the Receivables Sale Agreement and (B) in the case of a Receivable originated by MPC LP, by MPC LP directly to Seller under and in accordance with the Receivables Sale Agreement, and, in each such
case, Seller has good and marketable title thereto free and clear of any Adverse Claim (other than Permitted Liens). 

“Eligible Receivables Balance” means the aggregate Outstanding Balance of all Eligible Receivables less the sum
of (i) the Discount Proxy Amount and (ii) the Rebate Accrual Amount. 
 “ERISA” means the Employee
Retirement Income Security Act of 1974, as amended from time to time. 
 “ERISA Affiliate” means any trade or
business (whether or not incorporated) that, together with Marathon, is treated as a single employer under Section 414(b) or (c) of the Code or, solely for purposes of Section 302 of ERISA and Section 412 of the Code, is treated
as a single employer under Section 414 of the Code. 
 “ERISA Event” means (a) any “reportable
event”, as defined in Section 4043 of ERISA or the regulations issued thereunder with respect to a Plan (other than an event for which the 30 day notice period is waived); (b) the existence with respect to any Plan of an
“accumulated funding deficiency” (as defined in Section 412 of the Code or Section 302 of ERISA), whether or not waived; (c) the filing pursuant to Section 412(d) of the Code or Section 303(d) of ERISA of an
application for a waiver of the minimum funding standard with respect to any Plan; (d) the incurrence by Marathon or any of its ERISA Affiliates of any liability under Title IV of ERISA with respect to the termination of any Plan;
(e) the receipt by Marathon or any ERISA Affiliate from the PBGC or a plan administrator of any notice relating to an intention to terminate any Plan or Plans or to appoint a trustee to administer any Plan; (f) the incurrence by Marathon
or any of its ERISA Affiliates of any liability with respect to the withdrawal or partial withdrawal from any Plan or Multiemployer Plan; or (g) the receipt by Marathon or any ERISA Affiliate of any notice, or the receipt by any Multiemployer
Plan from Marathon or any ERISA Affiliate of any notice, concerning the imposition of Withdrawal Liability or a determination that a Multiemployer Plan is, or is expected to be, insolvent or in reorganization, within the meaning of Title IV of
ERISA. 

  
 Exh. I-11

 “Exchange Act” means the United States Securities Exchange Act of 1934, as
amended. 
 “Excluded Receivables” means all indebtedness and other obligations owed to an Originator or in
which an Originator has a security interest or other interest, including, without limitation, any indebtedness, obligation or interest constituting an account, chattel paper, instrument or general intangible, arising in connection with the extension
of credit under proprietary credit card services by such Originator, and further includes, without limitation, the obligation to pay any Finance Charges with respect thereto. 
 “Facility Termination Date” means the earlier of (i) the Liquidity Termination Date and (ii) the Amortization Date. 

“Federal Bankruptcy Code” means Title 11 of the United States Code entitled “Bankruptcy,” as amended and
any successor statute thereto. 
 “Federal Funds Effective Rate” means, for any day, the weighted average
(rounded upwards, if necessary, to the next 1/100 of 1%) of the rates on overnight Federal funds transactions with members of the Federal Reserve System arranged by Federal funds brokers, as published on the next succeeding Business Day by the
Federal Reserve Bank of New York, or, if such rate is not so published for any day that is a Business Day, the average (rounded upwards, if necessary, to the next 1/100 of 1%) of the quotations for such day for such transactions received by the
Administrative Agent from three Federal funds brokers of recognized standing selected by it. 
 “Fee Letter”
means that certain letter agreement dated as of July 1, 2011, by and among Seller, the Managing Agents and the Administrative Agent, as it may be amended, restated, supplemented or otherwise modified and in effect from time to time. 

“Final Payout Date” means the date on which the Commitments hereunder shall have expired or terminated, the Aggregate
Unpaids have been indefeasibly paid in full in cash, all Letters of Credit have terminated or expired or have been Cash-Collateralized and this Agreement terminates in accordance with its terms. 

“Finance Charges” means, with respect to a Contract, any finance, interest, late payment charges or similar charges
owing by an Obligor pursuant to such Contract. 
 “Fronting Fees” is defined in Section 1.5(k).

 “Funding Agreement” means this Agreement and any agreement or instrument executed by any Funding
Source with or for the benefit of a Conduit Purchaser or, if applicable, its Related CP Issuer. 
 “Funding
Source” means (i) any Committed Purchaser, (ii) any insurance company, bank or other funding entity providing liquidity, credit enhancement or back-up purchase support or facilities to a Conduit Purchaser, (iii) any agent,
administrator or manager of a Conduit Purchaser, or (iv) any holding company in respect of any of the foregoing. 

“GAAP” means generally accepted accounting principles in effect in the United States of America as of the date of this
Agreement. 

  
 Exh. I-12

 “Governmental Authority” means any national, state or local government
(whether domestic or foreign), any political subdivision thereof or any other governmental, quasi-governmental, judicial, regulatory, public or statutory instrumentality, authority, body, agency, bureau or entity (including any zoning authority, the
Comptroller of the Currency or the Federal Reserve Board, any central bank or any comparable authority). 
 “Group L/C
Sublimit” means, with respect to any Purchase Group, the amount set forth on Schedule A hereto (or in the Assignment Agreement pursuant to which such Purchase Group became party hereto) subject to assignment pursuant to
Section 12.1. 
 “Group Purchase Limit” means, with respect to any Purchase Group, the amount set
forth on Schedule A hereto (or in the Assignment Agreement pursuant to which such Purchase Group became party hereto) subject to assignment pursuant to Section 12.1, as such amount may be reduced in accordance with
Section 1.1(b). 
 “Guarantee” of or by any Person (the “guarantor”) means any
obligation, contingent or otherwise, of the guarantor guaranteeing or having the economic effect of guaranteeing any Indebtedness or other obligation of any other Person (the “primary obligor”) in any manner, whether directly or
indirectly, and including any obligation of the guarantor, direct or indirect, (a) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness or other obligation or to purchase (or to advance or supply
funds for the purchase of) any security for the payment thereof, (b) to purchase or lease property, securities or services for the purpose of assuring the owner of such Indebtedness or other obligation of the payment thereof, (c) to
maintain working capital, equity capital or any other financial statement condition or liquidity of the primary obligor so as to enable the primary obligor to pay such Indebtedness or other obligation or (d) as an account party in respect of
any letter of credit or letter of guaranty issued to support such Indebtedness or obligation; provided, that the term Guarantee shall not include endorsements for collection or deposit in the ordinary course of business. 

“Incremental Purchase” is defined in Section 1.1(a). 

“Indebtedness” of any Person means, without duplication, (a) all obligations of such Person for borrowed money,
(b) all obligations of such Person evidenced by bonds, debentures, notes or similar instruments, (c) all obligations of such Person under conditional sale or other title retention agreements relating to property acquired by such Person,
(d) all obligations of such Person in respect of the deferred purchase price of property or services (excluding (i) accounts payable and accrued liabilities incurred in the ordinary course of business and (ii) amounts which are being
contested in good faith and for which reserves in conformity with GAAP have been provided), (e) all Indebtedness of others secured by (or for which the holder of such Indebtedness has an existing right, contingent or otherwise, to be secured
by) any Adverse Claim on property owned or acquired by such Person (other than, in the case of property owned or acquired by Marathon or any Subsidiary thereof, Adverse Claims on equity interests in joint ventures which are permitted under the
Revolving Credit Agreement), whether or not the Indebtedness secured thereby has been assumed, but only to the extent of such property’s fair market value, (f) all Guarantees by such Person of Indebtedness of others, (g) all Capital
Lease Obligations of such Person, (h) all obligations, contingent or otherwise, of such Person as an account party in respect of letters of credit and letters of guaranty and (i) all obligations, contingent or otherwise, of such Person in
respect of bankers’ acceptances. The Indebtedness of any Person shall include the Indebtedness of any other entity (including any partnership in which such Person is a general partner) to the extent such Person is legally liable therefor as a
result of such Person’s ownership interest in or other relationship with such entity, except to the extent the terms of such Indebtedness provide that such Person is not liable therefor. The Indebtedness of any Person shall not include
endorsements of checks, bills of exchange and other instruments for deposit or collection in the ordinary course of business. 

  
 Exh. I-13

 “Indemnified Amounts” is defined in Section 10.1. 

“Indemnified Party” is defined in Section 10.1. 

“Independent Manager” shall mean a member of the Board of Managers of Seller who (x) (i) shall not have been
at the time of such Person’s appointment or at any time during the preceding five years, and shall not be as long as such Person is a manager of Seller, (A) a director, officer, employee, partner, shareholder, member, manager or Affiliate
of any of the following Persons (collectively, the “Independent Parties”): Servicer, any Originator, Marathon or any of their respective Subsidiaries or Affiliates (other than Seller), (B) a supplier to any of the Independent
Parties, (C) a Person controlling or under common control with any partner, shareholder, member, manager, Affiliate or supplier of any of the Independent Parties, or (D) a member of the immediate family of any director, officer, employee,
partner, shareholder, member, manager, Affiliate or supplier of any of the Independent Parties; (ii) has prior experience as an independent director or manager for a corporation or limited liability company whose charter documents required the
unanimous consent of all independent directors or managers thereof before such corporation or limited liability company could consent to the institution of bankruptcy or insolvency proceedings against it or could file a petition seeking relief under
any applicable federal or state law relating to bankruptcy and (iii) has at least three years of employment experience with one or more entities that provide, in the ordinary course of their respective businesses, advisory, management or
placement services to issuers of securitization or structured finance instruments, agreements or securities or (y) has been approved in writing by the Administrative Agent and the Managing Agents. 

“Interest Rate” means, the Adjusted LIBO Rate or the Alternate Base Rate, as applicable, with respect to each Tranche
funded or maintained by a Committed Purchaser or a Conduit Purchaser other than through the issuance of Pooled Commercial Paper. 
 “JPMorgan” means JPMorgan Chase Bank, N.A., in its individual capacity and its successors. 
 “L/C Collateral Account” has the meaning set forth in Section 1.5(o). 
 “L/C Issuer” means, each Person listed on Schedule A hereto (or in the Assignment Agreement pursuant to which such Person became party hereto) as an “L/C Issuer”, or
which has been designated in writing to Seller and the Administrative Agent as an “L/C Issuer” by the related Managing Agent, together with their respective successors and permitted assigns hereunder. 

“L/C Obligations” means, at any time, the sum, without duplication, of (a) the L/C Undrawn Amount at such time
plus (b) the aggregate unpaid amount at such time of all Reimbursement Obligations. 
 “L/C
Purchase” is defined in Section 1.1(a). 
 “L/C Sublimit” means $1,000,000,000.

 “L/C Undrawn Amount” means, at any time, the aggregate undrawn amount of all outstanding Letters of Credit
at such time. 
 “Letter of Credit” means a stand-by letter of credit issued by an L/C Issuer pursuant to this
Agreement in United States Dollars for the account of MPC LP or an Affiliate of MPC LP at the request of MPC LP under and pursuant to the Receivables Sale Agreement. 
 “Letter of Credit Application” has the meaning set forth in Section 1.5(b). 

  
 Exh. I-14

 “Letter of Credit Request” has the meaning set forth in
Section 1.5(b). 
 “Level 1 Ratings Period” means any period of time during which the Debt Rating
of Marathon is (i) “BBB-” or higher by S&P or (ii) “Baa3” or higher by Moody’s; provided, that if the ratings of S&P and Moody’s differ by more than one level, the rating one level below the
higher of the two ratings shall control. 
 “Level 2 Ratings Period” means any period of time, other than a
Level 3 Rating Period, during which the Debt Rating of Marathon is (i) lower than “BBB-” by S&P and (ii) lower than “Baa3” by Moody’s; provided, that if the ratings of S&P and Moody’s differ by
more than one level, the rating one level below the higher of the two ratings shall control. 
 “Level 3 Ratings
Period” means any period of time during which (A) the Debt Rating of Marathon is (i) “BB-” or lower by S&P or (ii) “Ba3” or lower by Moody’s; provided, that if the ratings of S&P and
Moody’s differ by more than one level, the rating one level below the higher of the two ratings shall control, or (B) Marathon ceases to have a Debt Rating by S&P or Moody’s (other than by reason of such rating agency ceasing to
be in the business of rating corporate debt obligations). 
 “LIBO Rate” means, with respect to any Capital for
any Tranche Period, the rate appearing on Reuters BBA Libor Rates Page 3750 (or on any successor or substitute page of such service, or any successor or substitute for such service, providing rate quotations comparable to those currently
provided on such page of such service, as determined by the Administrative Agent from time to time for purposes of providing quotations of interest rates applicable to dollar deposits in the London interbank market) at approximately 11:00 a.m.,
London time, two (2) Business Days prior to the commencement of such Tranche Period, as the rate for dollar deposits with a maturity comparable to such Tranche Period. In the event that such rate is not available at such time for any reason,
then the “LIBO Rate” with respect to such Capital for such Tranche Period shall be the rate at which dollar deposits of $5,000,000 and for a maturity comparable to such Tranche Period are offered by the principal London office of the
Administrative Agent in immediately available funds in the London interbank market at approximately 11:00 a.m., London time, two Business Days prior to the commencement of such Tranche Period. 

“Liquidity Termination Date” means June 30, 2014, subject to the extension thereof with respect to all or part of
the Commitments pursuant to Section 13.1. 
 “LMIR” means, for any day, the one-month
“Eurodollar Rate” for deposits in dollars as reported on Reuters Screen LIBOR01 Page or on any successor or substitute page of such service, or any successor or substitute for such service, for the purpose of displaying offered rates of
leading banks for London interbank deposits in United States dollars, as of 11:00 a.m. (London time) on such date, or if such day is not a Business Day, then the immediately preceding Business Day (or if not so reported, then as determined by the
relevant Managing Agent from another recognized source for interbank quotation), in each case, changing when and as such rate changes. 
 “Lock-Box” means each locked postal box with respect to which a bank who has executed a Collection Account Agreement has been granted exclusive access for the purpose of retrieving and
processing payments made on the Receivables and which is listed on Exhibit IV. 
 “Loss Horizon Ratio”
means, as of any date, a ratio computed as of the last day of the most recently ended calendar month by dividing (i) the aggregate amount of gross sales of the Originators during the most recently ended calendar month by (ii) the Net
Receivables Balance as of the last day of such calendar month. 

  
 Exh. I-15

 “Loss Percentage” means, at any time, the greater of (i) the Loss
Reserve Floor and (ii) the amount expressed as a percentage and calculated in accordance with the following formula: 
  

					
	LP	  	=	  	LR x LHR x SF
	
	where:
			
	LR	  	=	  	the greatest three-month average Loss Ratio during the immediately preceding 12-month period.
			
	LHR	  	=	  	the Loss Horizon Ratio at such time.
			
	SF	  	=	  	2.25.

 “Loss Ratio” means, on any date, the ratio (expressed as a percentage) computed as of
the last day of the most recently ended calendar month equal to (i) the aggregate Outstanding Balance of all Receivables (without duplication) which remain unpaid for more than sixty (60) but less than ninety-one (91) days past
invoice plus the aggregate Outstanding Balance of all Receivables (without duplication) which, consistent with the Credit and Collection Policy, were or should have been written off Seller’s books as uncollectible during the most recently ended
calendar month plus the aggregate Outstanding Balance of all Receivables (without duplication) with respect to which the related Obligors are subject to a proceeding of the type described in Section 9.1(d) but which have not yet been
written off Seller’s books as uncollectible, divided by (ii) the aggregate amount of gross sales of the Originators generated during the calendar month which ended two (2) calendar months prior to such last day. 

“Loss Reserve” means, on any date, an amount equal to the product of (a) the Loss Percentage multiplied by
(b) the Net Receivables Balance as of the close of business of Servicer on such date. 
 “Loss Reserve
Floor” means 10.0%. 
 “Managing Agent” has the meaning set forth in the preamble to this Agreement.

 “Marathon” means Marathon Petroleum Corporation, a Delaware corporation. 

“Marathon Canada” means Marathon Petroleum Trading Canada LLC, a Delaware limited liability company. 

“Marathon Competitor” means any competitor of Marathon engaged in the business of refining, trading, marketing or
producing petroleum or petroleum products (other than a financial institution or an Affiliate thereof). 
 “Material
Adverse Effect” means a material adverse effect on (i) the financial condition or operations of any Seller Party and its Subsidiaries, taken as a whole, (ii) the ability of any Seller Party to perform its obligations under this
Agreement or Marathon to perform its obligations under the Performance Undertaking, (iii) the legality, validity or enforceability of this Agreement or any other Transaction Document, (iv) any Purchaser’s interest in the Receivables
generally or in any significant portion of the Receivables, the Related Security or the Collections with respect thereto, or (v) the collectibility of the Receivables generally or of any material portion of the Receivables. 

“MOC” means Marathon Oil Corporation, a Delaware corporation. 

  
 Exh. I-16

 “Monthly Report” means a report, in substantially the form of Exhibit
VI hereto (appropriately completed), furnished by Servicer to the Administrative Agent pursuant to Section 8.5. 

“Monthly Reporting Period” means any Level 1 Ratings Period. 

“Monthly Settlement Date” means (a) for each of the first six full calendar months after the
date hereof, the 25th day of such month and (b) for
each calendar month thereafter, the 20th day of such
month. 
 “Moody’s” means Moody’s Investors Service, Inc. and any successor thereto. 

“MPC LP” has the meaning set forth in the preamble to this Agreement. 

“Multiemployer Plan” means a multiemployer plan as defined in Section 4001(a)(3) of ERISA. 

“Net Receivables Balance” means, at any time, the Eligible Receivables Balance at such time reduced by the aggregate
amount by which the Outstanding Balance of all Eligible Receivables of each Obligor and its Affiliates exceeds the Concentration Limit for such Obligor. 
 “Obligations” shall have the meaning set forth in Section 2.1. 
 “Obligor” means a Person obligated to make payments pursuant to a Contract. 
 “Originator” means each of (i) MPC LP, in its capacity as seller under the Receivables Sale Agreement and (ii) Marathon Canada, in its capacity as seller under the Receivables
Transfer Agreement. 
 “Other L/C Fees” is defined in Section 1.5(k). 

“Outstanding Balance” of any Receivable at any time means the then outstanding principal balance thereof. 

“Participant” has the meaning set forth in Section 12.2. 

“PBGC” means the Pension Benefit Guaranty Corporation referred to and defined in ERISA and any successor entity
performing similar functions. 
 “Performance Undertaking” means that certain Amended and Restated Performance
Undertaking, dated as of October 1, 2011, by Marathon in favor of Seller, as the same may be further amended, restated, supplemented or otherwise modified from time to time. 

“Permitted Liens” means any liens (a) for taxes, assessments and governmental charges or levies in such case are
either (i) not overdue or (ii) the validity or amount thereof is being contested in good faith by appropriate proceedings and as to which adequate reserves are set aside in accordance with GAAP and (b) of a collecting bank in the
ordinary course of processing items for payment. 
 “Person” means an individual, partnership, corporation
(including a business trust), limited liability company, joint stock company, trust, unincorporated association, joint venture or other entity, or a government or any political subdivision or agency thereof. 

“Plan” means any employee pension benefit plan (other than a Multiemployer Plan) subject to the provisions of
Title IV of ERISA or Section 412 of the Code or Section 302 of ERISA, and in respect of which the Borrower or any ERISA Affiliate is (or, if such plan were terminated, would under Section 4069 of ERISA be deemed to be) an
“employer” as defined in Section 3(5) of ERISA. 

  
 Exh. I-17

 “Pooled Commercial Paper” means Commercial Paper notes of a Conduit
Purchaser (or, if applicable, its Related CP Issuer) subject to any particular pooling arrangement by such Conduit Purchaser, but excluding Commercial Paper issued by such Conduit Purchaser (or, if applicable, its Related CP Issuer) for a tenor and
in an amount specifically requested by any Person in connection with any agreement effected by such Conduit Purchaser. 

“Potential Amortization Event” means an event which, with the passage of time or the giving of notice, or both, would
constitute an Amortization Event. 
 “Prime Rate” means the rate of interest per annum publicly announced from
time to time by JPMorgan as its prime rate in effect at its office located in New York City; each change in the Prime Rate shall be effective from and including the date such change is publicly announced as being effective. 

“Principal Transaction Documents” has the meaning set forth in the definition of “Transaction Documents”.

 “Pro Rata Share” means, for each Committed Purchaser, a percentage (expressed out to five decimal places)
equal to (i) the Commitment of such Committed Purchaser, divided by (ii) the aggregate amount of all Commitments of all Committed Purchasers hereunder, adjusted as necessary to give effect to the application of the terms of
Section 1.5(n). If all of the Commitments have terminated or expired, the Pro Rata Shares shall be determined based upon the Commitments most recently in effect. 
 “Purchase” means an Incremental Purchase or an L/C Purchase. 

“Purchase Group” means each group consisting of a Managing Agent, one or more related Committed Purchasers, any related
Conduit Purchasers and a related L/C Issuer, if any. 
 “Purchase Group Share” means, with respect to any
Purchase Group, the percentage (expressed out to five decimal places) equivalent to the fraction, the numerator of which is the aggregate Commitments of all Committed Purchasers in such Purchase Group and the denominator of which is the Purchase
Limit. If all of the Commitments have terminated or expired, the Purchase Group Shares shall be determined based upon the Commitments most recently in effect. 
 “Purchase Limit” means $1,000,000,000, adjusted as necessary to give effect to any reduction pursuant to Section 1.1(b). 

“Purchase Notice” has the meaning set forth in Section 1.2. 

“Purchase Price” means, with respect to any Incremental Purchase, the amount paid to or for the benefit of Seller in
connection therewith (including in satisfaction of Reimbursement Obligations in respect of any Letter of Credit), which shall not exceed the least of (i) the amount requested by Seller in the applicable Purchase Notice, as applicable,
(ii) the unused portion of the Purchase Limit on the applicable purchase date and (iii) the excess, if any, of the Net Receivables Balance (less the Aggregate Reserves) on the applicable purchase date over the sum of the Aggregate Capital
and the L/C Undrawn Amount determined as of the date of the most recent Daily Report, Weekly Report or Monthly Report, as applicable. 
 “Purchasers” means each Conduit Purchaser, each Committed Purchaser and each L/C Issuer. 
 “Purchaser Interest” means, at any time, the undivided percentage ownership interest (computed as set forth below) of the Purchasers and L/C Issuers in (i) each Receivable arising
prior to the time of the 

  
 Exh. I-18

 
most recent computation or recomputation of such undivided interest, (ii) all Related Security with respect to each such Receivable, and (iii) all Collections with respect to, and other
proceeds of, each such Receivable. Such undivided percentage interest shall equal: 
  

					
		  	 AC + UA
	  	
		  	NRB – AR	  	

 where: 
  

					
	AC	  	=	  	Aggregate Capital.
			
	UA	  	=	  	L/C Undrawn Amount less the amount of Cash-Collateral on deposit in the L/C Collateral Account.
			
	 AR
	  	=	  	the Aggregate Reserves.
			
	 NRB
	  	=	  	the Net Receivables Balance.

 The Purchaser Interest shall be computed time to time pursuant to Section 1.1(c) hereof. 

“Purchasing Committed Purchaser” has the meaning set forth in Section 12.1(b). 

“Rebate Accrual Amount” means, as of any date, the amount of accruals set forth on the balance sheet of Servicer or any
Originator relating to volume rebates on such date. 
 “Rebate Credits” means credits issued by Servicer or the
applicable Originator to Obligors in respect of volume rebates. 
 “Receivable” means all indebtedness and
other obligations, other than Excluded Receivables, owed to Seller or the applicable Originator (at the time it arises, and before giving effect to any transfer or conveyance under the Receivables Transfer Agreement, the Receivables Sale Agreement
or hereunder) or in which Seller or the applicable Originator has a security interest or other interest, including, without limitation, any indebtedness, obligation or interest constituting an account, chattel paper, instrument or general
intangible, arising in connection with the sale of crude oil, condensate or refined petroleum products or the rendering of services in connection therewith by such Originator, and further includes, without limitation, the obligation to pay any
Finance Charges with respect thereto. Indebtedness and other rights and obligations arising from any one transaction, including, without limitation, indebtedness and other rights and obligations represented by an individual invoice, shall constitute
a Receivable separate from a Receivable consisting of the indebtedness and other rights and obligations arising from any other transaction; provided further, that any indebtedness, rights or obligations referred to in the immediately
preceding sentence shall be a Receivable regardless of whether the account debtor or Seller treats such indebtedness, rights or obligations as a separate payment obligation. 
 “Receivables Sale Agreement” means that certain Amended and Restated Receivables Sale Agreement, dated as of October 1, 2011, by and between MPC LP, as seller, and Seller, as buyer,
as the same may be further amended, restated or otherwise modified from time to time. 
 “Receivables Transfer
Agreement” means that certain Receivables Transfer Agreement, dated as of October 1, 2011, by and between Marathon Canada, as seller, and MPC LP, as buyer, as the same may be amended, restated or otherwise modified from time to time.

  
 Exh. I-19

 “Records” means, with respect to any Receivable, all Contracts and other
documents, books, records and other information (including, without limitation, computer programs, tapes, disks, punch cards, data processing software and related property and rights) relating to such Receivable, any Related Security therefor and
the related Obligor. 
 “Reduction Notice” has the meaning set forth in Section 1.3. 

“Regulatory Change” has the meaning set forth in Section 10.2(a). 

“Reimbursement Obligations” shall mean all outstanding matured reimbursement or repayment obligations of Seller to any
L/C Issuer (and the participating Purchasers) with respect to amounts drawn on a Letter of Credit, whether pursuant to Section 1.5 or otherwise. 
 “Reinvestment” has the meaning set forth in Section 2.2(a). 
 “Related CP Issuer” means, with respect to any Conduit Purchaser, any asset backed commercial paper conduit that issues Commercial Paper to provide funding to such Conduit Purchaser in
connection with its Capital hereunder. 
 “Related Entity” means Marathon, Servicer (so long as Servicer is MPC
LP or an Affiliate of Marathon), each Originator and each of their respective Affiliates and their respective successors. 

“Related Security” means, with respect to any Receivable: 

(i) all of Seller’s interest in the inventory and goods (including returned or repossessed inventory or goods), if
any, the sale, financing or lease of which by the applicable Originator gave rise to such Receivable, and all insurance contracts with respect thereto, 
 (ii) all other security interests or liens and property subject thereto from time to time, if any, purporting to secure payment of such Receivable, whether pursuant to the Contract related to such
Receivable or otherwise, together with all financing statements and security agreements describing any collateral securing such Receivable, 
 (iii) all guaranties, letters of credit, letter of credit rights, “supporting obligations” (within the meaning of Section 9-102(a) of all applicable enactments of the UCC), insurance and
other agreements or arrangements of whatever character from time to time supporting or securing payment of such Receivable whether pursuant to the Contract related to such Receivable or otherwise, 

(iv) all service contracts and other contracts and agreements associated with such Receivable, 

(v) all Records related to such Receivable, 

(vi) all of Seller’s right, title and interest in, to and under the Receivables Sale Agreement in respect of such
Receivable (including, without limitation, any rights of MPC LP under the Receivables Transfer Agreement transferred to Seller under the Receivables Sale Agreement) and all of Seller’s right, title and interest in, to and under the Performance
Undertaking, and 
 (vii) all proceeds of any of the foregoing. 

  
 Exh. I-20

 “Required Cash-Collateral Amount” means, with respect to a Letter of
Credit, the sum of (x) the Stated Amount of such Letter of Credit plus (y) the amount of any interest or fees accrued or to accrue on each Letter of Credit through the stated expiration thereof, including, without limitation,
Undrawn L/C Fees, Fronting Fees and Other L/C Fees. 
 “Required Managing Agents” means, at any time, the
Managing Agents whose Group Purchase Limits together exceed fifty percent (50%) of the Purchase Limit at such time. 

“Required Notice Period” means, (x) with respect to any Aggregate Reduction, in a proposed amount which is equal to
or less than $400,000,000, no later than 3:00 p.m. (Chicago time) on the Business Day that is two (2) Business Days immediately prior to the Business Day on which such Aggregate Reduction is to occur and (y) with respect to any Aggregate
Reduction, in a proposed amount which is greater than $400,000,000, no later than 3:00 p.m. (Chicago time) on the Business Day that is four (4) Business Days immediately prior to the Business Day on which such Aggregate Reduction is to occur.

 “Required Rating” has the meaning set forth in Section 10.2(d). 

“Restricted Junior Payment” means (i) any dividend or other distribution, direct or indirect, on account of any
shares of any class of equity interests of Seller now or hereafter outstanding, except a dividend payable solely in shares of that class of equity interests or in any junior class of equity interests of Seller, (ii) any redemption, retirement,
sinking fund or similar payment, purchase or other acquisition for value, direct or indirect, of any shares of any class of equity interests of Seller now or hereafter outstanding, (iii) any payment or prepayment of principal of, premium, if
any, or interest, fees or other charges on or with respect to, and any redemption, purchase, retirement, defeasance, sinking fund or similar payment and any claim for rescission with respect to the Subordinated Loans (as defined in the Receivables
Sale Agreement), (iv) any payment made to redeem, purchase, repurchase or retire, or to obtain the surrender of, any outstanding warrants, options or other rights to acquire shares of any class of equity interests of Seller now or hereafter
outstanding, and (v) any payment of management fees by Seller (except for reasonable management fees to any Originator or its Affiliates in reimbursement of actual management services performed). 

“Revolving Credit Agreement” means that certain Revolving Credit Agreement dated as of March 11, 2011, by and among
Marathon, the Lenders party thereto and JPMorgan, as administrative agent. 
 “S&P” means
Standard & Poor’s Ratings Services, a Standard & Poor’s Financial Services LLC business, and any successor thereto. 
 “Scheduled Liquidity Termination Date” has the meaning set forth in Section 13.1. 
 “SEC” means the United States Securities and Exchange Commission or any Governmental Authority succeeding to the functions of said Commission. 

“Seller” has the meaning set forth in the preamble to this Agreement. 

“Seller Parties” has the meaning set forth in the preamble to this Agreement. 

“Servicer” means at any time the Person (which may be the Administrative Agent) then authorized pursuant to Article
VIII to service, administer and collect Receivables. The initial Servicer hereunder is MPC LP. 

  
 Exh. I-21

 “Servicing Fee” has the meaning set forth in Section 8.6.

 “Settlement Date” means each of (i) each Monthly Settlement Date, (ii) the last day of the
relevant Tranche Period in respect of Capital funded by a Conduit Purchaser with Tranche Funded Commercial Paper and (iii) the last day of the relevant Tranche Period in respect of Capital funded or maintained by any Committed Purchaser.

 “Special Concentration Limit” has the meaning set forth in the definition of “Concentration
Limit”. 
 “Standard Concentration Limit” has the meaning set forth in the definition of
“Concentration Limit”. 
 “Stated Amount” means, with respect to any Letter of Credit at any time,
the maximum amount that may be drawn thereunder in accordance with its terms at such time. 
 “Statutory Reserve
Rate” means a fraction (expressed as a decimal), the numerator of which is the number one and the denominator of which is the number one minus the aggregate of the maximum reserve percentages (including any marginal, special, emergency or
supplemental reserves) expressed as a decimal established by the Board to which the Administrative Agent is subject for eurocurrency funding (currently referred to as “Eurocurrency Liabilities” in Regulation D of the Board). Such
reserve percentages shall include those imposed pursuant to such Regulation D. Tranches for which Yield is calculated based on the Adjusted Libor Rate shall be deemed to constitute eurocurrency funding and to be subject to such reserve requirements
without benefit of or credit for proration, exemptions or offsets that may be available from time to time to any Committed Purchaser under such Regulation D or any comparable regulation. The Statutory Reserve Rate shall be adjusted
automatically on and as of the effective date of any change in any reserve percentage. 
 “Subsidiary” of a
Person means (i) any corporation more than 50% of the outstanding securities having ordinary voting power of which shall at the time be owned or controlled, directly or indirectly, by such Person or by one or more of its Subsidiaries or by such
Person and one or more of its Subsidiaries, or (ii) any partnership, association, limited liability company, joint venture or similar business organization more than 50% of the ownership interests having ordinary voting power of which shall at
the time be so owned or controlled. 
 “Taxes” means any present or future taxes, levies, imposts, duties,
deductions, withholdings, assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto. 
 “Terminating Committed Purchaser” has the meaning set forth in Section 13.1(a). 
 “Terminating CP Tranche” has the meaning set forth in Section 3.4(b). 
 “Terminating Purchaser” has the meaning set forth in Section 13.1(a). 
 “Terminating Purchase Group” has the meaning set forth in Section 13.1(a). 
 “Terminating Tranche” has the meaning set forth in Section 4.3(b). 
 “Termination Percentage” has the meaning set forth in Section 2.2(b). 

  
 Exh. I-22

 “Tier I Concentration Limit” has the meaning set forth in the definition
of “Concentration Limit”. 
 “Tier II Concentration Limit” has the meaning set forth in the
definition of “Concentration Limit”. 
 “Tranche” means any portion of Capital funded or maintained
(x) by a Conduit Purchaser either through the issuance of Pooled Commercial Paper, through the issuance of Tranche Funded Commercial Paper or pursuant to a Funding Agreement (but not any combination thereof) and, if applicable, with a single
Tranche Period, or (y) by a Committed Purchaser which accrues Yield by reference to a single Interest Rate type and, if applicable, with a single Tranche Period. 
 “Tranche Funded Commercial Paper” means Commercial Paper issued by a Conduit Purchaser for a tenor and in an amount specifically requested by Seller hereunder. 

“Tranche Funding Conduit Purchaser” means each Conduit Purchaser that is identified as a “Tranche Funding
Conduit Purchaser” on Schedule A hereto or in the Assignment Agreement pursuant to which it becomes a party hereto. 
 “Tranche Period” means, with respect to a Tranche: 
  

	 	(a)	if Yield for such Tranche is calculated on the basis of the Adjusted LIBO Rate, a period of one, two, three or six months, or such other period as may be mutually
agreeable to the related Managing Agent and Seller, commencing on a Business Day selected by Seller or the related Managing Agent pursuant to this Agreement. Such Tranche Period shall end on the day in the applicable succeeding calendar month which
corresponds numerically to the beginning day of such Tranche Period, provided, however, that if there is no such numerically corresponding day in such succeeding month, such Tranche Period shall end on the last Business Day of such
succeeding month; or 

  

	 	(b)	in the case of any Tranche of a Conduit Purchaser funded through the issuances of Tranche Funded Commercial Paper, a period not less than sixty (60), and not more
than two hundred seventy (270) days commencing on a Business Day selected by Seller and agreed to by the related Managing Agent; provided, that after the Facility Termination Date, each such Tranche Period shall end on or prior to the
next succeeding Settlement Date. 

 If any Tranche Period would end on a day which is not a Business Day, such Tranche Period
shall end on the next succeeding Business Day, provided, however, that in the case of Tranche Periods corresponding to the Adjusted LIBO Rate, if such next succeeding Business Day falls in a new month, such Tranche Period shall end on the
immediately preceding Business Day. In the case of any Tranche Period which commences before the Amortization Date and would otherwise end on a date occurring after the Amortization Date, such Tranche Period shall end on the Amortization Date. The
duration of each Tranche Period which commences after the Amortization Date shall be of such duration as reasonably selected by the Administrative Agent. 
 “Transaction Documents” means, collectively, (i) this Agreement, each Purchase Notice, each Letter of Credit Request, each Letter of Credit Application, each Letter of Credit, the
Receivables Sale Agreement, the Receivables Transfer Agreement, each Collection Account Agreement, the Performance Undertaking, the Fee Letter, the Subordinated Note (as defined in the Receivables Sale Agreement) (collectively, the
“Principal Transaction Documents”) and (ii) all other instruments, documents and agreements executed and delivered in connection herewith. 

  
 Exh. I-23

 “Turnover Ratio” means, with respect to any calendar month, an amount
equal to (i) the aggregate Outstanding Balance of all Receivables as of the beginning of such calendar month, divided by (ii) the aggregate amount of Collections from Obligors during such calendar month, multiplied by (iii) 30.

 “Weekly Report” means a report, in form and substance mutually agreed upon by Servicer and the Managing
Agents (appropriately completed), furnished by Servicer to the Managing Agents and the Administrative Agent pursuant to Section 8.5. 
 “Weekly Reporting Period” means any Level 2 Ratings Period. 

“UCC” means the Uniform Commercial Code as from time to time in effect in the specified jurisdiction. 

“Undrawn L/C Fee” has the meaning specified in the Fee Letter. 

“Yield” means: 
 (a) for each respective Accrual Period relating to a Tranche funded or maintained by a Committed Purchaser in a Commercial Paper Purchase Group or a Conduit Purchaser (other than through the issuance of
Pool Funded Commercial Paper), an amount equal to the product of (x) the sum of (i) the Applicable Margin and (ii) the applicable Interest Rate for each Tranche multiplied by (y) the Capital for each day elapsed during such
Accrual Period, annualized on a 360 day basis; 
 (b) for a Tranche funded or maintained by a Committed Purchaser in a Balance
Sheet Purchase Group, an amount equal to the product of (x) the applicable Interest Rate for such Tranche multiplied by (y) the Capital of such Tranche for each day elapsed during such Accrual Period, annualized on a 360 day basis; and

 (c) for each draw under a Letter of Credit that has not yet been reimbursed, an amount equal to the product of (x) the
sum of (i) the Applicable Margin and (ii) the Alternate Base Rate multiplied by (y) the amount of such draw for each day elapsed prior to the repayment of such amount, annualized on a 360 day basis 

“Yield and Servicing Reserve” means, on any date, an amount equal to (x) 1.50% multiplied by (y) the Net
Receivables Balance as of the close of business of Servicer on such date. 
 All accounting terms not specifically defined
herein shall be construed in accordance with GAAP. All terms used in Article 9 of the UCC in the State of New York, and not specifically defined herein, are used herein as defined in such Article 9. 

  
 Exh. I-24

 EXHIBIT II-A 
 FORM OF PURCHASE NOTICE 
 [Date] 
 JPMorgan Chase Bank, N.A., as 
 Administrative Agent 

10 S. Dearborn 
 Chicago, Illinois 60603-0596

 Attention: Asset Backed Securities Conduit Group 
 Re: PURCHASE NOTICE 
 Ladies and Gentlemen: 

Reference is hereby made to the Amended and Restated Receivables Purchase Agreement dated as of October 1, 2011, by and among MPC
Trade Receivables Company LLC, a Delaware limited liability company (“Seller”), Marathon Petroleum Company LP, a Delaware limited partnership, as Servicer, the entities from time to time party thereto as Conduit Purchasers, the
entities from time to time party thereto as Committed Purchasers, the entities from time to time party thereto as Managing Agents and JPMorgan Chase Bank, N.A., as Administrative Agent (as amended, restated, supplemented or otherwise modified from
time to time, the “Receivables Purchase Agreement”). Capitalized terms used but not defined herein shall have the meanings assigned to such terms in the Receivables Purchase Agreement. 

The Administrative Agent and each Managing Agent is hereby notified of the following Incremental Purchase: 

 

			
	 Purchase Price:
	  	$            1
		
	 Date of Purchase:
	  	
		
	 Requested Interest Rate:
	  	[Adjusted LIBO Rate] [Alternate Base Rate] [Pooled Commercial Paper rate] [Tranche Funded Commercial Paper rate]
		
	 Requested Tranche Period (if applicable):
	  	

 Each Managing Agent should wire-transfer its related Purchase Group Share of the Purchase Price in
immediately available funds on the above-specified date of purchase to: 
 MPC Trade Receivables Company LLC 

PNC Bank, National Association 
 500 First
Avenue 
 Pittsburgh, PA 15219 

041000124 
  

	1 	 Must be at least $5,000,000 

  
 Exh. II-A-1

 Reference: Tom Mosholder 
 Telephone advice to: Tom Mosholder @ tel. No. (713) 296-2480 
 Please advise
[Name] at telephone no ( )                      if the Conduit Purchaser(s) in your Purchase Group will not be making this purchase. 

In connection with the Incremental Purchase to be made on the above listed “Date of Purchase” (the “Purchase
Date”), Seller hereby certifies that the following statements are true on the date hereof: 
 (i) the representations
and warranties set forth in Section 5.1 of the Receivables Purchase Agreement are true and correct in all material respects (except that the materiality standard in this clause (i) shall not apply to any such representation or warranty
that is expressly qualified by a materiality standard or contains any carve-out or exception based on a Material Adverse Effect by its express terms) on and as of the date of this Purchase Notice (unless such representation or warranty refers to an
earlier date, in which case such representation or warranty shall be true and correct on and as of such earlier date); 
 (ii)
no event has occurred and is continuing, or would result from the proposed Incremental Purchase, that will constitute an Amortization Event, and no event has occurred and is continuing, or would result from the proposed Incremental Purchase, that
would constitute a Potential Amortization Event; 
 (iii) (1) the Facility Termination Date has not occurred, (2) the
Aggregate Capital plus the L/C Undrawn Amount does not exceed the Purchase Limit, (3) the L/C Obligations do not exceed the L/C Sublimit and (4) the Purchaser Interest does not exceed 100%; and 

(iv) the amount of Aggregate Capital is $             after giving effect to
the Incremental Purchase to be made on the Purchase Date. 
  

			
	Very truly yours,
	
	MPC TRADE RECEIVABLES COMPANY LLC
		
	 By:
	 	  

		 	Name:
		 	Title:

  
 Exh. II-A-2

 EXHIBIT II-B 
 FORM OF LETTER OF CREDIT REQUEST 
 [Date] 

JPMorgan Chase Bank, N.A., as 
 Administrative
Agent 
 10 S. Dearborn 
 Chicago,
Illinois 60603-0596 
 Attention: Asset Backed Securities Conduit Group 
 [ADDRESS FOR MANAGING AGENT OF APPLICABLE L/C ISSUER] 
 Re: LETTER OF CREDIT
REQUEST 
 Ladies and Gentlemen: 
 Reference is hereby made to the Amended and Restated Receivables Purchase Agreement dated as of October 1, 2011, by and among MPC Trade Receivables Company LLC, a Delaware limited liability company
(“Seller”), Marathon Petroleum Company LP, a Delaware limited partnership, as Servicer, the entities from time to time party thereto as Conduit Purchasers, the entities from time to time party thereto as Committed Purchasers, the
entities from time to time party thereto as Managing Agents and JPMorgan Chase Bank, N.A., as Administrative Agent (as amended, restated, supplemented or otherwise modified from time to time, the “Receivables Purchase Agreement”).
Capitalized terms used but not defined herein shall have the meanings assigned to such terms in the Receivables Purchase Agreement. 
 Each of the Administrative Agent and the related Managing Agent of the L/C Issuer of the below described Letter of Credit is hereby notified of the following request for [the issuance of a Letter of
Credit][the [amendment][renewal][extension] of an outstanding Letter of Credit]: 
  

			
	 Letter of Credit No.:2
	  	
		
	 L/C Issuer:
	  	
		
	 Stated Amount:
	  	$            3
		
	 Date of [Issuance][Amendment][Renewal][Extension]:
	  	
		
	 Account Party:
	  	
		
	 Beneficiary:
	  	
		
	 Requested Expiration Date:
	  	

  

	2 	 For a request for amendment, renewal or extension only. 

	3 	 Must be at least $5,000,000 

  
 Exh. II-B-1

 Please provide the current form of the applicable L/C Issuer’s Letter of Credit
Application and deliver the requested Letter of Credit on the above-specified date to: 
 [Account Party] 

[Account Party Address] 
 Attention: [Name]

 Telephone No.: ( ) 

In connection with the [issuance][amendment][extension][renewal] of Letter of Credit to be made on the above listed “Date of
[Issuance][Amendment][Renewal][Extension]” (the “Specified Date”), Seller hereby certifies that the following statements are true on the date hereof: 
 (i) the representations and warranties set forth in Section 5.1 of the Receivables Purchase Agreement are true and correct in all material respects (except that the materiality standard in this
clause (i) shall not apply to any such representation or warranty that is expressly qualified by a materiality standard or contains any carve-out or exception based on a Material Adverse Effect by its express terms) on and as of the date of
this Letter of Credit Request (unless such representation or warranty refers to an earlier date, in which case such representation or warranty shall be true and correct on and as of such earlier date); 

(ii) no event has occurred and is continuing, or would result from the proposed [issuance][amendment][extension][renewal] of Letter of
Credit, that will constitute an Amortization Event or a Potential Amortization Event; 
 (iii) (1) the Facility Termination Date
has not occurred, (2) the Aggregate Capital plus the L/C Undrawn Amount does not exceed the Purchase Limit, (3) the L/C Obligations do not exceed the L/C Sublimit and (4) the Purchaser Interest does not exceed 100%; and

 (iv) the L/C Undrawn Amount is $             after giving effect
to the [issuance][amendment][extension][renewal] of Letter of Credit to be made on the Specified Date. 

			
	Very truly yours,
	
	MPC TRADE RECEIVABLES COMPANY LLC
		
	 By:
	 	  

		 	Name:
		 	Title:

  
 Exh. II-B-2

 EXHIBIT III 
 PLACES OF BUSINESS OF THE SELLER PARTIES; 
 LOCATIONS OF RECORDS; 

FEDERAL EMPLOYER IDENTIFICATION NUMBER OF SELLER 
 Marathon Petroleum Company LP 
  

			
	Places of Business/Chief Executive Office:	  	 539 S. Main Street
 Findlay,
Ohio 45840

		
	Record Locations:	  	 539 S. Main Street
 Findlay,
Ohio 45840

 MPC Trade Receivables Company LLC 

 

			
	Places of Business/Chief Executive Office:	  	 539 S. Main Street, Suite 1091-M

Findlay, Ohio 45840

		
	Record Locations:	  	 539 S. Main Street
 Findlay,
Ohio 45840

		
	Federal Employer Identification Number:	  	90-0725871

  
 Exh. III-1

 EXHIBIT IV 
 NAMES OF COLLECTION BANKS; COLLECTION ACCOUNTS; LOCK-BOXES 
  

			
	 Name of Collection Bank
	  	 Address of Collection Bank

		
	PNC Bank, National Association	  	 155 East Broad Street

Columbus, OH 43215

		
	Bank of America, N.A.	  	 901 Main Street
 7th
Floor
 Dallas, TX 75202

		
	Fifth Third Bank	  	 38 Fountain Square Plaza

Cincinnati, OH 45202

		
	JPMorgan Chase Bank, N.A.	  	 1 Chase Manhattan Plaza
 New
York, NY 10005

		
	JPMorgan Chase Bank, N.A.	  	 200 Bay Street
 Royal Bank
Plaza
 South Tower, Suite 1300

Toronto, Ontario CA

  
 Exh. IV-1

 EXHIBIT V 
 FORM OF COMPLIANCE CERTIFICATE 
 To:  JPMorgan Chase Bank, N.A., as Administrative Agent

 This Compliance Certificate (this “Certificate”) is furnished pursuant to that certain Amended and Restated
Receivables Purchase Agreement dated as of October 1, 2011, by and among MPC Trade Receivables Company LLC, a Delaware limited liability company (“Seller”), Marathon Petroleum Company LP, a Delaware limited partnership, as
Servicer, the entities from time to time party thereto as Conduit Purchasers, the entities from time to time party thereto as Committed Purchasers, the entities from time to time party thereto as Managing Agents and JPMorgan Chase Bank, N.A., as
Administrative Agent (as amended, restated, supplemented or otherwise modified from time to time, the “Agreement”). Capitalized terms used but not defined in this Certificate shall have the meanings assigned to such terms in the
Agreement. 
 THE UNDERSIGNED HEREBY CERTIFIES THAT: 
 1. I am the duly authorized                      of Seller. 

2. I have reviewed the terms of the Agreement and I have made, or have caused to be made under my supervision, a reasonably detailed
review of the transactions entered into by Seller and financial condition of Seller during the accounting period covered by the attached financial statements. 
 3. The examinations described in paragraph 2 did not disclose, and I have no knowledge of, the existence of any condition or event which constitutes an Amortization Event or Potential Amortization
Event during or at the end of the accounting period covered by the attached financial statements or as of the date of this Certificate, except as set forth in paragraph 5 below. 

4. Schedule I attached hereto sets forth financial data and computations evidencing the compliance with certain covenants of the
Agreement, all of which data and computations are true, complete and correct based on the review described in paragraph 2 above. 
 5. Described below are the exceptions, if any, to paragraph 3 by listing, in detail, the nature of the condition or event, the period during which it has existed and the action which Seller has
taken, is taking, or proposes to take with respect to each such condition or event: 
  

			
		  	  

	
	  

			
	  
	  	

 The foregoing certifications, together with the computations set forth in Schedule I hereto
and the financial statements delivered with this Certificate in support hereof, are made and delivered this      day of
                    , 20    . 

  
 Exh. V-1

 IN WITNESS WHEREOF, the undersigned has caused this Certificate to be duly executed and
delivered as of the date first set forth above. 
  

			
	MPC TRADE RECEIVABLES COMPANY LLC
		
	 By:
	 	  

		 	Name:
		 	Title:

  
 Exh. V-2

 SCHEDULE I TO COMPLIANCE CERTIFICATE 

 

	 	A.	Schedule of Compliance as of                     ,
         with Section      of the Agreement. 

 This
schedule relates to the month ended:          

  
 Exh. V-3

 EXHIBIT VI 
 FORM OF MONTHLY REPORT 
 The attached is a true and accurate accounting pursuant
to the terms of the Amended and Restated Receivables Purchase Agreement dated as of October 1, 2011, by and among MPC Trade Receivables Company LLC, a Delaware limited liability company (“Seller”), Marathon Petroleum Company
LP, a Delaware limited partnership, as Servicer, the entities from time to time party thereto as Conduit Purchasers, the entities from time to time party thereto as Committed Purchasers, the entities from time to time party thereto as Managing
Agents and JPMorgan Chase Bank, N.A., as Administrative Agent (as amended, restated, supplemented or otherwise modified from time to time, the “Receivables Purchase Agreement”), and I have no knowledge of the existence of any
conditions or events which constitute an Amortization Event or Potential Amortization Event, as each such term is defined under the Receivables Purchase Agreement, during or at the end of the accounting period covered by this monthly report or as of
the date of this certificate, except as set forth below. 
  

			
	MPC TRADE RECEIVABLES COMPANY LLC
		
	 By:
	 	  

		 	Name:
		 	Title:
		 	Date:

  
 Exh. VI-1

 EXHIBIT VII 
 FORM OF ASSIGNMENT AGREEMENT 
 THIS ASSIGNMENT AGREEMENT (this “Assignment
Agreement”) is entered into as of the      day of                     , 20    , by and between
                             (“Assignor”) and
                     (“Assignee”). 
 PRELIMINARY STATEMENTS 
 A. This Assignment Agreement is being executed and
delivered in accordance with Section 12.1(b) of that certain Amended and Restated Receivables Purchase Agreement dated as of October 1, 2011, by and among MPC Trade Receivables Company LLC, a Delaware limited liability company
(“Seller”), Marathon Petroleum Company LP, a Delaware limited partnership, as Servicer, the entities from time to time party thereto as Conduit Purchasers, the entities from time to time party thereto as Committed Purchasers, the
entities from time to time party thereto as Managing Agents and JPMorgan Chase Bank, N.A., as Administrative Agent (as amended, restated, supplemented or otherwise modified from time to time, the “Receivables Purchase Agreement”).
Capitalized terms used and not otherwise defined herein are used with the meanings set forth or incorporated by reference in the Receivables Purchase Agreement. 
 B. Assignor is a Committed Purchaser party to the Purchase Agreement, and Assignee wishes to become a Committed Purchaser under the Receivables Purchase Agreement; and 

C. Assignor is selling and assigning to Assignee an undivided
                    % (the “Transferred Percentage”) interest in all of Assignor’s rights and obligations under the Receivables
Purchase Agreement and the Transaction Documents, including, without limitation, Assignor’s Commitment and (if applicable) Assignor’s Capital as set forth herein. 
 AGREEMENT 
 The parties hereto hereby agree as follows: 

1. The sale, transfer and assignment effected by this Assignment Agreement shall become effective (the “Effective Date”)
two (2) Business Days (or such other date reasonably selected by the Administrative Agent in its sole discretion) following the date on which a notice substantially in the form of Schedule II to this Assignment Agreement
(“Effective Notice”) is delivered by the Administrative Agent to Assignor and Assignee and the related Conduit Purchaser(s), if any. From and after the Effective Date, Assignee shall be a Committed Purchaser party to the Receivables
Purchase Agreement for all purposes thereof as if Assignee were an original party thereto and Assignee agrees to be bound by all of the terms and provisions contained therein. 
 2. If Assignor has no outstanding Capital under the Receivables Purchase Agreement, on the Effective Date, Assignor shall be deemed to have hereby transferred and assigned to Assignee, without recourse,
representation or warranty (except as provided in paragraph 6 below), and the Assignee shall be deemed to have hereby irrevocably taken, received and assumed from Assignor, the Transferred Percentage of Assignor’s Commitment and all rights
and obligations associated therewith under the terms of the Receivables Purchase Agreement, including, without limitation, the Transferred Percentage of Assignor’s future funding obligations under Article I of the Receivables Purchase
Agreement. 

  
 Exh. VII-1

 3. If Assignor has any outstanding Capital under the Receivables Purchase Agreement, at or
before 12:00 noon, local time of Assignor, on the Effective Date Assignee shall pay to Assignor, in immediately available funds, an amount equal to the sum of (i) the Transferred Percentage of the outstanding Capital of Assignor’s
Purchaser Interests (such amount, being hereinafter referred to as the “Assignee’s Capital”); (ii) all accrued but unpaid (whether or not then due) Yield attributable to Assignee’s Capital; and (iii) accruing but
unpaid fees and other costs and expenses payable in respect of Assignee’s Capital for the period commencing upon each date such unpaid amounts commence accruing, to and including the Effective Date (the “Assignee’s Acquisition
Cost”); whereupon, Assignor shall be deemed to have sold, transferred and assigned to Assignee, without recourse, representation or warranty (except as provided in paragraph 6 below), and Assignee shall be deemed to have hereby
irrevocably taken, received and assumed from Assignor, the Transferred Percentage of Assignor’s Commitment and the Capital of Assignor’s Purchaser Interests (if applicable) and all related rights and obligations under the Receivables
Purchase Agreement and the Transaction Documents, including, without limitation, the Transferred Percentage of Assignor’s future funding obligations under Article I of the Receivables Purchase Agreement. 

4. Concurrently with the execution and delivery hereof, Assignor will provide to Assignee copies of all documents requested by Assignee
which were delivered to Assignor pursuant to the Receivables Purchase Agreement, including any Information, which Assignee may request, and Assignee hereby agrees to be subject to Section 14.5 of the Receivables Purchase Agreement in respect of
all Information so received. 
 5. Each of the parties to this Assignment Agreement agrees that at any time and from time to
time upon the written request of any other party, it will execute and deliver such further documents and do such further acts and things as such other party may reasonably request in order to effect the purposes of this Assignment Agreement.

 6. By executing and delivering this Assignment Agreement, Assignor and Assignee confirm to and agree with each other, the
Administrative Agent and the Committed Purchasers as follows: (a) other than the representation and warranty that it has not created any Adverse Claim upon any interest being transferred hereunder, Assignor makes no representation or warranty
and assumes no responsibility with respect to any statements, warranties or representations made by any other Person in or in connection with the Receivables Purchase Agreement or the Transaction Documents or the execution, legality, validity,
enforceability, genuineness, sufficiency of value to Assignee, the Receivables Purchase Agreement or any other instrument or document furnished pursuant thereto or the perfection, priority, condition, value or sufficiency of any collateral;
(b) Assignor makes no representation or warranty and assumes no responsibility with respect to the financial condition of Seller, any Obligor, any Seller Affiliate or the performance or observance by Seller, any Obligor, any Seller Affiliate of
any of their respective obligations under the Transaction Documents or any other instrument or document furnished pursuant thereto or in connection therewith; (c) Assignee confirms that it has received a copy of the Receivables Purchase
Agreement and copies of such other Transaction Documents, and other documents and information as it has requested and deemed appropriate to make its own credit analysis and decision to enter into this Assignment Agreement; (d) Assignee will,
independently and without reliance upon the Administrative Agent, Conduit Purchaser, Seller or any other Committed Purchaser or Purchaser and based on such documents and information as it shall deem appropriate at the time, continue to make its own
credit decisions in taking or not taking action under the Receivables Purchase Agreement and the Transaction Documents; (e) Assignee appoints and authorizes the Administrative Agent to take such action as agent on its behalf and to exercise
such powers under the Transaction Documents as are delegated to the Administrative Agent by the terms thereof, together with such powers as are reasonably incidental thereto; and (f) Assignee agrees that it will perform in accordance with their
terms all of the obligations which, by the terms of the Purchase Agreement and the other Transaction Documents, are required to be performed by it as a Committed Purchaser or, when applicable, as a Purchaser. 

  
 Exh. VII-2

 7. Each party hereto represents and warrants to and agrees with the Administrative Agent
that it is aware of and will comply with the provisions of the Receivables Purchase Agreement, including, without limitation, Sections 4.1 and 14.6 and 14.7 thereof. 
 8. Schedule I hereto sets forth the revised Commitment of Assignor and the Commitment of Assignee, as well as administrative information with respect to Assignee. 

9. THIS ASSIGNMENT AGREEMENT AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS ASSIGNMENT AGREEMENT SHALL BE
GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 
 10. Assignee hereby represents that it is
not a Marathon Competitor. 
 11. Assignee hereby covenants and agrees that, prior to the date which is one year and one day
after the payment in full of all senior indebtedness for borrowed money of Conduit Purchaser, it will not institute against, or join any other Person in instituting against, Conduit Purchaser any bankruptcy, reorganization, arrangement, insolvency
or liquidation proceedings or other similar proceeding under the laws of the United States or any state of the United States. 

  
 Exh. VII-3

 IN WITNESS WHEREOF, the parties hereto have caused this Assignment Agreement to be executed
by their respective duly authorized officers of the date hereof. 
  

			
	[ASSIGNOR]
		
	By:	 	  

		 	Name:
		 	Title:
	
	[ASSIGNEE]
		
	By:	 	  

		 	Name:
		 	Title:
	
	[MPC TRADE RECEIVABLES COMPANY LLC
		
	By:	 	  

		 	Name:
		 	Title:]4

  

	4 	 With respect to any assignment requiring consent of Seller under Section 12.1, unless consent of Seller is separately obtained.

  
 Exh. VII-4

 SCHEDULE I TO ASSIGNMENT AGREEMENT 

LIST OF LENDING OFFICES, ADDRESSES 
 FOR NOTICES AND COMMITMENT AMOUNTS 
 Date:
                    ,          
 Transferred Percentage:             % 
  

									
	 	  	 A-1
	  	 A-2
	  	 B-1
	  	 B-2

					
	Assignor	  	Commitment (prior to giving effect to the Assignment Agreement)	  	Commitment (after giving effect to the Assignment Agreement)	  	Outstanding Capital (if any)	  	Ratable Share of Outstanding Capital
					
	 	  	 	  	 A-2
	  	 B-1
	  	 B-2

	Assignee	  	Commitment (prior to giving effect to the Assignment Agreement)	  	Commitment (after giving effect to the Assignment Agreement)	  	Outstanding Capital (if any)	  	Ratable Share of Outstanding Capital

 Address for Notices 
 Attention: 
 Phone: 
 Fax: 

  
 Exh. VII-5

 SCHEDULE II TO ASSIGNMENT AGREEMENT 

EFFECTIVE NOTICE 
 [DATE] 
  

			
	TO:	  	                             
           , Assignor
		  	                             
           
		  	                             
           
		  	                             
           
		
	TO:	  	                             
           , Assignee
		  	                             
           
		  	                             
           
		  	                             
           
		
	TO:	  	MPC Trade Receivables Company LLC
		  	539 South Main Street
		  	Findlay, Ohio 45840
		  	Attention: Garry L. Peiffer

 The undersigned, as Administrative Agent under the Amended and Restated Receivables Purchase Agreement
dated as of October 1, 2011, by and among MPC Trade Receivables Company LLC, a Delaware limited liability company (“Seller”), Marathon Petroleum Company LP, a Delaware limited partnership, as Servicer, the entities from time to
time party thereto as Conduit Purchasers, the entities from time to time party thereto as Committed Purchasers, the entities from time to time party thereto as Managing Agents and JPMorgan Chase Bank, N.A., as Administrative Agent, hereby
acknowledges receipt of executed counterparts of a completed Assignment Agreement dated as of                     ,
         between                     , as Assignor, and
                    , as Assignee. Capitalized terms defined in such Assignment Agreement are used herein as therein defined. 

1. Pursuant to such Assignment Agreement, you are advised that the Effective Date will be
                    ,         . 
 2. Pursuant to such Assignment Agreement, the Assignee is required to pay $             to Assignor at or before 12:00 noon (local time of
Assignor) on the Effective Date in immediately available funds.] 
  

			
	Very truly yours,
	
	 JPMORGAN CHASE BANK, N.A.,
 individually and as Administrative Agent

		
	 By:
	 	  

			
	 Name:
	 	  

			
	 Title:
	 	  

  
 Exh. VII-6

 SCHEDULE A 
 PURCHASE GROUPS; COMMITMENTS; GROUP L/C SUBLIMITS; GROUP PURCHASE LIMITS 
  

																							
	 Purchase

Group
	  	Managing Agent	  	Conduit
Purchaser(s)	 	Purchase Group
Type	  	Committed
Purchaser(s)	  	Commitment	 	  	L/C Issuer	  	Group L/C
Sublimit	 	  	Group
Purchase Limit	 
									
	JPMorgan Purchase Group	  	JPMorgan Chase
Bank, N.A.	  	Chariot Funding
LLC *	 	Commercial Paper
Purchase Group	  	JPMorgan Chase
Bank, N.A.	  	$	200,000,000	  	  	JPMorgan Chase
Bank, N.A.	  	$	200,000,000	  	  	$	200,000,000	  
									
	BofA Purchase Group	  	Bank of America,
N.A.	  	N/A	 	Balance Sheet
Purchase Group	  	Bank of America,
N.A.	  	$	175,000,000	  	  	Bank of America,
N.A.	  	$	175,000,000	  	  	$	175,000,000	  
									
	BTMU Purchase Group	  	The Bank of Tokyo-
Mitsubishi UFJ, Ltd.,
New York Branch	  	Victory
Receivables
Corporation*	 	Commercial Paper
Purchase Group	  	The Bank of Tokyo-
Mitsubishi UFJ,
Ltd., New York
Branch	  	$	175,000,000	  	  	The Bank of Tokyo-
Mitsubishi UFJ, Ltd.,
New York Branch	  	$	175,000,000	  	  	$	175,000,000	  
									
	Citibank Purchase Group	  	Citibank, N.A.	  	CHARTA, LLC*	 	Commercial Paper
Purchase Group	  	Citibank, N.A.	  	$	175,000,000	  	  	Citibank, N.A.	  	$	175,000,000	  	  	$	175,000,000	  
									
	PNC Purchase Group	  	PNC Bank, National
Association	  	Market Street
Funding LLC*	 	Commercial Paper
Purchase Group	  	PNC Bank, National
Association	  	$	100,000,000	  	  	PNC Bank, National
Association	  	$	300,000,000	  	  	$	100,000,000	  
									
	RBS Purchase Group	  	The Royal Bank of
Scotland plc	  	Windmill Funding
Corporation*	 	Commercial Paper
Purchase Group	  	The Royal Bank of
Scotland plc	  	$	175,000,000	  	  	The Royal Bank of
Scotland plc	  	$	175,000,000	  	  	$	175,000,000	  
		  		  		 		  		  	  
	  
	 	  		  				  	  
	  
	 
	 TOTALS
	  		  		 		  		  	$	1,000,000,000	  	  			  	$	1,000,000,000	  
		  		  		 		  		  	  
	  
	 	  		  				  	  
	  
	 

  

	*	Tranche Funding Conduit Purchaser 

  
 Sch. A-1

 SCHEDULE B-I 
 DOCUMENTS TO BE DELIVERED PRIOR TO EFFECTIVENESS OF ORIGINAL RPA 
 See attached

  
 Sch. B-I-1

 CLOSING CHECKLIST 

$1,000,000,000 TRADE RECEIVABLES PURCHASE FACILITY 
 among 
 MARATHON PETROLEUM CORPORATION, as Performance Guarantor, 

MARATHON PETROLEUM COMPANY LP, as Servicer, 
 MPC TRADE RECEIVABLES COMPANY LLC, as Seller, 
 THE CONDUIT PURCHASERS FROM TIME TO
TIME PARTY THERETO, 
 THE COMMITTED PURCHASERS FROM TIME TO TIME PARTY THERETO, 

THE MANAGING AGENTS FROM TIME TO TIME PARTY THERETO, 
 THE L/C ISSUERS FROM TIME TO TIME PARTY THERETO, 
 and 

JPMORGAN CHASE BANK, N.A., as Administrative Agent 
 July 1, 2011 
  
  

 

			
	Performance Guarantor:	  	Marathon Petroleum Corporation (“Marathon”)
	Originator:	  	Marathon Petroleum Company LP (“MPC LP”)
	Servicer:	  	MPC LP
	Seller:	  	MPC Trade Receivables Company LLC
	Conduit Purchasers:	  	Chariot Funding LLC, Victory Receivables Corporation, CHARTA, LLC, Market Street Funding LLC and Windmill Funding Corporation
	Committed Purchasers:	  	JPMorgan Chase Bank, N.A. (“JPMorgan”), Bank of America, N.A.. (“Bank of America”), The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch (“BTMU”),
Citibank, N.A.. (“Citibank”), PNC Bank, National Association (“PNC”) and The Royal Bank of Scotland plc (“RBS”)
	L/C Issuers:	  	JPMorgan and each other Committed Purchaser
	Managing Agents:	  	JPMorgan, Bank of America, BTMU, Citibank, PNC and RBS
	Structuring Agent:	  	J.P. Morgan Securities LLC
	Administrative Agent:	  	JPMorgan
	Counsel to Marathon:	  	Baker Botts L.L.P. (“Baker Botts”)
	Counsel to Managing Agents:	  	Sidley Austin LLP (“Sidley”)

  

					
		  	PRINCIPAL DOCUMENTS
		
	1	  	Receivables Sale Agreement between Originator, as seller, and Seller, as buyer
			
	2	  	 Exhibit I
	  	Definitions
			
	3	  	 Exhibit II
	  	Form of Subordinated Note
			
	4	  	 Schedule A
	  	List of Closing Documents
			
	5	  	 Schedule B
	  	Notice Addresses
			
	6	  	 Schedule C
	  	Principal Place of Business; Location of Records; FEIN
			
	7	  	 Schedule D
	  	Account Information
		
	8	  	Receivables Purchase Agreement among Seller, Servicer, the Conduit Purchasers, the Committed Purchasers, the L/C Issuers, the Managing Agents and the Administrative
Agent
			
	9	  	 Exhibit I
	  	Definitions
			
	10	  	 Exhibit II-A
	  	Form of Purchase Notice

  
 Sch. B-I-2

					
	11	  	 Exhibit II-B
	  	Form of Letter of Credit Request
			
	12	  	 Exhibit III
	  	Places of Business of the Seller Parties; Locations of Records; FEIN(s)
			
	13	  	 Exhibit IV
	  	Names of Collection Banks; Collection Accounts; Lock-Boxes
			
	14	  	 Exhibit V
	  	Form of Compliance Certificate
			
	15	  	 Exhibit VI
	  	Form of Monthly Report
			
	16	  	 Exhibit VII
	  	Form of Assignment Agreement
			
	17	  	 Schedule A
	  	Purchase Groups; Commitments; Group L/C Sublimits; Group Purchase Limits
			
	18	  	 Schedule B
	  	Documents to Be Delivered to the Administrative Agent on or Prior to the Initial Credit Event
			
	19	  	 Schedule C
	  	Credit and Collection Policy
			
	20	  	 Schedule D
	  	Notice Addresses
			
	21	  	 Schedule E
	  	Special Concentration Limits
		
	22	  	Subordinated Note executed by Seller in favor of Originator
		
	23	  	Performance Undertaking by Performance Guarantor in favor of Seller
		
	24	  	Fee Letter among Seller, Managing Agents and Administrative Agent
		
	25	  	Administrative Agent Fee Letter between Seller and Administrative Agent
		
	26	  	Fronting Fee Letter between Seller and JPMorgan
		
	27	  	Fronting Fee Letter between Seller and Bank of America
		
	28	  	Fronting Fee Letter between Seller and RBS
		
	29	  	Fronting Fee Letter between Seller and Citibank
		
	30	  	Fronting Fee Letter between Seller and BTMU
		
	31	  	Fronting Fee Letter between Seller and PNC
		
		  	ORGANIZATIONAL DOCUMENTS/GOOD STANDINGS
		
	32	  	 Secretary’s Certificate of Marathon

(i)       Certificate of Incorporation, certified by Secretary of State of
Delaware
 (ii)      By-Laws

(iii)     Resolutions

(iv)     Incumbency

		
	33	  	 Secretary’s Certificate of MPC LP

(i)       Certificate of Partnership, certified by Secretary of State of
Delaware
 (ii)      Partnership Agreement

(iii)     Resolutions

(iv)     
Incumbency

  
 Sch. B-I-3

					
	34	  	Good Standing Certificate for Marathon issued by Secretary of State of Delaware
		
	35	  	Good Standing Certificate for MPC LP issued by Secretary of State of Delaware
		
	36	  	 Secretary’s Certificate of Seller

(i)       Certificate of Formation, certified by Secretary of State of
Delaware
 (ii)      Limited Liability Company Agreement

(iii)     Resolutions

(iv)     Incumbency

		
	37	  	Good Standing Certificate for Seller issued by Secretary of State of Delaware
		
		  	UCC, TAX AND JUDGMENT SEARCHES & FILINGS
		
	38	  	Pre-Filing UCC Search Report of UCC financing statements filed against Originator
		
	39	  	Tax lien and judgment search against Originator
		
	40	  	UCC Search Report of UCC financing statements filed against Seller
		
	41	  	Tax Lien and Judgment Search Report against Seller
		
	42	  	UCC-1 Financing Statement, naming Originator, as debtor/seller, Seller, as secured party/purchaser/assignor and Administrative Agent, as assignee
		
	43	  	UCC-1 Financing Statement, naming Seller, as debtor and Administrative Agent, as secured party
		
		  	LEGAL OPINIONS
		
	44	  	Opinion of Baker Botts regarding no conflict with law or material agreements, no consents, enforceability, Investment Company Act of 1940 matters and UCC matters with
respect to Marathon, MPC LP and Seller
		
	45	  	Opinion of Baker Botts regarding true sale and substantive consolidation matters with respect to Seller, MPC LP and Marathon
		
		  	LIQUIDITY DOCUMENTATION
		
	46	  	Conduit Agreements

  
 Sch. B-I-4

 SCHEDULE B-II 
 DOCUMENTS TO BE DELIVERED PRIOR TO EFFECTIVENESS OF AMENDMENT AND 
 RESTATEMENT OF
ORIGINAL RPA AND INITIAL CREDIT EVENT 
 See attached 

  
 Sch. B-II-1

			
	Performance Guarantor:	  	Marathon Petroleum Corporation (“Marathon”)
	Originators:	  	Marathon Petroleum Company LP (“MPC LP”) and Marathon Petroleum Trading Canada LLC (“Marathon Canada”)
	Servicer:	  	MPC LP
	Seller:	  	MPC Trade Receivables Company LLC
	Conduit Purchasers:	  	Chariot Funding LLC, Victory Receivables Corporation, CHARTA, LLC, Market Street Funding LLC and Windmill Funding Corporation
	Committed Purchasers:	  	JPMorgan Chase Bank, N.A. (“JPMorgan”), Bank of America, N.A.. (“Bank of America”), The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch (“BTMU”),
Citibank, N.A.. (“Citibank”), PNC Bank, National Association (“PNC”) and The Royal Bank of Scotland plc (“RBS”)
	L/C Issuers:	  	JPMorgan and each other Committed Purchaser
	Managing Agents:	  	JPMorgan, Bank of America, BTMU, Citibank, PNC and RBS
	Structuring Agent:	  	J.P. Morgan Securities LLC
	Administrative Agent:	  	JPMorgan
	Counsel to Marathon:	  	Baker Botts L.L.P. (“Baker Botts”)
	Counsel to Managing Agents:	  	Sidley Austin LLP (“Sidley”)

  

					
		  	PRINCIPAL DOCUMENTS
		
	1	  	Receivables Transfer Agreement between Marathon Canada, as seller, and MPC LP, as buyer
			
	2	  	 Exhibit I
	  	Definitions
			
	3	  	 Schedule A
	  	List of Closing Documents
			
	4	  	 Schedule B
	  	Notice Addresses
			
	5	  	 Schedule C
	  	Principal Place of Business; Location of Records; FEIN
			
	6	  	 Schedule D
	  	Account Information
		
	7	  	Amended and Restated Receivables Sale Agreement between MPC LP, as seller, and Seller, as buyer
			
	8	  	 Exhibit I
	  	Definitions
			
	9	  	 Exhibit II
	  	Form of Subordinated Note
			
	10	  	 Schedule A
	  	List of Closing Documents
			
	11	  	 Schedule B
	  	Notice Addresses
			
	12	  	 Schedule C
	  	Principal Place of Business; Location of Records; FEIN
			
	13	  	 Schedule D
	  	Account Information
		
	14	  	Amended and Restated Receivables Purchase Agreement among Seller, Servicer, the Conduit Purchasers, the Committed Purchasers, the L/C Issuers, the Managing Agents and
the Administrative Agent
			
	15	  	 Exhibit I
	  	Definitions
			
	16	  	 Exhibit II-A
	  	Form of Purchase Notice
			
	17	  	 Exhibit II-B
	  	Form of Letter of Credit Request

  
 Sch. B-II-2

					
	18	  	 Exhibit III
	  	Places of Business of the Seller Parties; Locations of Records; FEIN(s)
			
	19	  	 Exhibit IV
	  	Names of Collection Banks; Collection Accounts; Lock-Boxes
			
	20	  	 Exhibit V
	  	Form of Compliance Certificate
			
	21	  	 Exhibit VI
	  	Form of Monthly Report
			
	22	  	 Exhibit VII
	  	Form of Assignment Agreement
			
	23	  	 Schedule A
	  	Purchase Groups; Commitments; Group L/C Sublimits; Group Purchase Limits
			
	24	  	 Schedule B-I
	  	Documents to Be Delivered to the Administrative Agent on or Prior to the Initial Credit Event
			
	25	  	 Schedule B-II
	  	Documents to Be Delivered to the Administrative Agent on or Prior to the Restatement Effective Date
			
	26	  	 Schedule C
	  	Credit and Collection Policy
			
	27	  	 Schedule D
	  	Notice Addresses
			
	28	  	 Schedule E
	  	Special Concentration Limits
		
	29	  	Amended and Restated Performance Undertaking by Performance Guarantor in favor of Seller
		
	30	  	Blocked Account Control Agreement among Seller, the Servicer, [Marathon Canada], the Administrative Agent and JPMorgan Chase Bank, N.A. in respect of account maintained
at Toronto branch
		
	31	  	Blocked Account Control Agreement among Seller, the Servicer, [Marathon Canada], the Administrative Agent and JPMorgan Chase Bank, N.A. in respect of account maintained
at New York branch
		
		  	ORGANIZATIONAL DOCUMENTS/GOOD STANDINGS
		
	32	  	Good Standing Certificate for Marathon issued by Secretary of State of Delaware
		
	33	  	Good Standing Certificate for MPC LP issued by Secretary of State of Delaware
		
	34	  	 Secretary’s Certificate of Marathon Canada

(i)       Certificate of Incorporation, certified by Secretary of State of
Delaware
 (ii)      By-Laws

(iii)     Resolutions

(iv)     Incumbency

		
	35	  	Good Standing Certificate for Marathon Canada issued by Secretary of State of Delaware
		
	36	  	Good Standing Certificate for Seller issued by Secretary of State of Delaware
		
		  	UCC, TAX AND JUDGMENT SEARCHES & FILINGS
		
	37	  	Pre-Filing UCC Search Report of UCC financing statements filed against Marathon Canada
		
	38	  	Tax lien and judgment search against Marathon Canada
		
	39	  	Bring-down UCC Search Report of UCC financing statements filed against MPC LP
		
	40	  	UCC-1 Financing Statement, naming Marathon Canada, as debtor/seller, MPC LP, as first secured party/purchaser/assignor, Seller, as second secured
party/purchaser/assignor and Administrative Agent, as assignee

  
 Sch. B-II-3

					
	41	  	UCC-3 Amendment in respect of Financing Statement, naming Originator, as debtor/seller, Seller, as secured party/purchaser/assignor and Administrative Agent, as
assignee, restating the collateral description
		
		  	LEGAL OPINIONS
		
	42	  	Opinion of Baker Botts regarding corporate matters, no conflict with law or material agreements, no consents, enforceability and UCC matters with respect to Marathon,
Marathon Canada, MPC LP and Seller
		
	43	  	Opinion of Baker Botts regarding (i) true sale matters with respect to MPC LP and Marathon Canada and (ii) substantive consolidation matters with respect to Seller and
Marathon Canada

  
 Sch. B-II-4

 SCHEDULE C 
 CREDIT AND COLLECTION POLICY 
 [On file with Administrative Agent] 

  
 Sch. C-1

 SCHEDULE D 
 NOTICE ADDRESSES 
  

			
	Seller:	 	
		
		 	MPC Trade Receivables Company LLC
		 	539 South Main Street, Suite 1091-M
		 	Findlay, Ohio 45840
		 	Attention: Peter Gilgen
		 	Fax: (419) 421-3997
		 	Phone: (855) 623-9009
		 	Email: PGilgen@MarathonPetroleum.com
	
	Servicer:
		
		 	Marathon Petroleum Company LP
		 	539 South Main Street
		 	Finlay, Ohio 45840
		 	Attention: Peter Gilgen
		 	Fax: (419) 421-3997
		 	Email: PGilgen@MarathonPetroleum.com
	
	Administrative Agent:
		
		 	JPMorgan Chase Bank, N.A.
		 	Asset Backed Securities Conduit Group
		 	10 S. Dearborn
		 	Chicago, Illinois 60603
		 	Fax: (312) 732-4487
	
	JPMorgan Purchase Group:
	
	Managing Agent, Committed Purchaser & L/C Issuer:
		
		 	JPMorgan Chase Bank, N.A.
		 	Asset Backed Securities Conduit Group
		 	10 S. Dearborn
		 	Chicago, Illinois 60603
		 	Fax: (312) 732-4487
	
	Conduit Purchaser:
		
		 	Chariot Funding LLC
		 	c/o JPMorgan Chase Bank, N.A., as Administrative Agent

  
 Sch. D-1

			
		 	Asset Backed Securities Conduit Group
		 	10 S. Dearborn
		 	Chicago, Illinois 60603
		 	Fax: (312) 732-1844
	
	Bank of America Purchase Group:
	
	Managing Agent, Committed Purchaser & L/C Issuer:
		
		 	Bank of America, N.A.
		 	214 North Tryon Street, 21st Floor
		 	NC1-027-21-01
		 	Charlotte, North Carolina 28255
		 	Attention: Securitization Finance Group
		 	Fax: (704) 388-9169
		 	Phone: (980) 386-7922
	
	BTMU Purchase Group:
	
	Managing Agent, Committed Purchaser & L/C Issuer:
		
		 	The Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch
		 	1251 Avenue of the Americas
		 	New York, New York 10020-1104
	
	Conduit Purchaser:
		
		 	 Victory Receivables Corporation

c/o Bank of Tokyo-Mitsubishi UFJ, Ltd., New York Branch

		 	1251 Avenue of the Americas
		 	New York, New York 10020-1104
	
	Citibank Purchase Group:
	
	Managing Agent, Committed Purchaser & L/C Issuer:
		
		 	Citibank, N.A.
		 	c/o Robert Kohl
		 	Global Securitization Products
		 	750 Washington Boulevard
		 	Stamford, Connecticut 06901
		 	Fax: (914) 274-9038
		 	Phone: (203) 975-6383
	
	Conduit Purchaser:
		
		 	CHARTA, LLC
		 	c/o Robert Kohl

  
 Sch. D-2

			
		 	Global Securitization Products
		 	 750 Washington Boulevard

		 	 Stamford, Connecticut 06901

		 	 Fax: (914) 274-9038

		 	 Phone: (203) 975-6383

	
	PNC Purchase Group:
	
	Managing Agent, Committed Purchaser & L/C Issuer:
		
		 	PNC Bank, National Association
		 	Three PNC Plaza, P3-P3PP-04-1
		 	Pittsburgh, Pennsylvania 15222
		 	Attention: Tony Stahley
	
	Conduit Purchaser:
		
		 	 Market Street Funding LLC
 PNC
Bank, National Association

		 	Three PNC Plaza, P3-P3PP-04-1
		 	Pittsburgh, Pennsylvania 15222
		 	Attention: Tony Stahley
	
	RBS Purchase Group:
	
	Managing Agent, Committed Purchaser & L/C Issuer:
		
		 	The Royal Bank of Scotland plc
		 	550 West Jackson Boulevard
		 	Suite 1800
		 	Chicago, Illinois 60661
		 	Attention: Bernard Koh
		 	Fax: (203) 873-5750
		 	Phone: (312) 664-6576
	
	Conduit Purchaser:
		
		 	Windmill Funding Corporation
		 	c/o Global Securitization Services, LLC
		 	114 West 47th Street
		 	New York, New York 10036
		 	Attention: Jill Russo
		 	Fax: (212) 302-8767
		 	Phone: (212) 302-5151

  
 Sch. D-3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00194-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00194-of-00352.parquet"}]]